id|sentence|entity1|entity2|pos1|pos2|arg1|arg2|ent1_type1|ent2_type|label|sent_id
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|pomalidomide|CRBN|13|20.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|0
22982773|To gain a better understanding of this oxime specificity problem for future design of improved reactivators, we conducted a QSAR analysis for oxime reactivation of AChE inhibited by OP agents and their analogues.|oxime|AChE|24|27.0|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR|1
9256165|Exposure of stimulated fetal rat calvaria osteoblasts (FRCO) to sulfasalazine did not show accumulation of the intracellular sPLA2 protein as tested by western blot; however, enzymatic activity of PLA2 in disrupted cells was definitely increased.|sulfasalazine|PLA2|12|33.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2
9013583|We demonstrate that several other NSAIDs, including fenoprofen, ibuprofen, and flufenamic acid, are also PPARgamma ligands and induce adipocyte differentiation of C3H10T1/2 cells.|ibuprofen|PPARgamma|11|19.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3
18055877|Using primary human T-lymphocytes, we show that the heterocyclic thionamides carbimazole and propylthiouracil inhibit synthesis of the proinflammatory cytokines tumor necrosis factor (TNF)alpha and interferon (IFN)gamma.|carbimazole|interferon (IFN)gamma|12|29.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|4
23531031|Methods: Stabilized anaplastic thyroid cancer cell lines (BHT-101 and CAL-62) and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the histone deacetylase inhibitor LBH589.|LBH589|histone deacetylase|33|30.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|5
23220589|AChE was easier reactivated after paraoxon treatment.|paraoxon|AChE|6|1.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR|6
23623843|Administration of KBTP (200, 400 and 800mg/kgbw) in mice ahead of CCl4 injection could observably antagonize the CCl4-induced increases in serum ALT, AST, TG and TC, and the hepatic MDA and 8-iso-PGF2a levels, respectively.|CCl4|ALT|21|25.0|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|7
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|thiazolidinedione|peroxisome proliferator-activated receptor gamma|11|21.0|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|8
10047461|These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 kinase activities.|Tomudex|cyclin E|20|40.0|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|9
10193663|Kinetic studies comparing the binding of [3H]eletriptan and [3H]sumatriptan to the human recombinant 5-HT1B and 5-HT1D receptors expressed in HeLa cells revealed that both radioligands bound with high specificity (>90%) and reached equilibrium within 10-15 min.|[3H]eletriptan|human recombinant 5-HT1B|7|18.0|Arg1:T12|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|10
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|glutamine|kynurenine aminotransferase I|25|12.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|11
15078100|QR2 catalyzes the two-electron reduction of menadione via the oxidation of N-alkylated or N-ribosylated nicotinamides.|menadione|QR2|7|1.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|12
23395669|We concluded that sophocarpine could alleviate hepatocyte steatosis and the potential mechanism might be the activated signaling pathway of AMPK.|sophocarpine|AMPK|4|20.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR|13
8842678|MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imipramine, maprotiline, amitriptyline, zimeldine, nomifensine, and viloxazine.|imipramine|MAO-B|18|1.0|Arg1:T2|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|14
8740147|In addition, another drug that is both a substrate of uptake1 and a MAO inhibitor, debrisoquine, was investigated in the study.|debrisoquine|MAO|18|15.0|Arg1:T23|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR|15
9873034|Bulky imidazoles like clotrimazole block NO synthesis by inhibiting assembly of the iNOS dimer, revealing a new means to control cellular NO synthesis.|NO|iNOS|6|13.0|Arg1:T12|Arg2:T49|CHEMICAL|GENE-Y|PRODUCT-OF|16
9626023|Some NSAIDs (eg, flurbiprofen, ketoprofen) were COX-1 selective, some (eg, ibuprofen, naproxen) were essentially nonselective, while others (eg, diclofenac, mefenamic acid) were COX-2 selective.|diclofenac|COX-2|31|37.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|17
10768298|RESULTS: Topiramate Ki values for HCA I, HCA II, HCA IV, and HCA VI were approximately 100, 7, 10, and >100 microM, respectively.|Topiramate|HCA IV|3|13.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|18
17340133|Cytokine challenge at low L: -arginine also enhances iNOS mRNA expression, but translation into iNOS protein is diminished, leading to lowered nitric oxide production.|L: -arginine|iNOS|5|10.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|19
23164673|Transduction with constitutively active forms of GSK-3β could protect against the downregulation of p65 and upregulation of cleaved-PARP that are induced by cinobufagin treatment.|cinobufagin|PARP|23|19.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|20
17606858|Conversely fenofibrate increased peroxisome proliferator-activated receptor-alpha, peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression, and acetyl coenzyme A carboxylase phosphorylation (P<0.05 for all) in aldosterone-infused hearts; uncoupling protein-3 and medium-chain acyl coenzyme A dehydrogenase protein expression decreased with fenofibrate (P<0.05 and P<0.01, respectively, versus aldosterone-infused), suggesting that improved myocardial remodeling is independent of fatty acid oxidation.|fenofibrate|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|2|8.0|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|21
10882160|In human volunteers, both entacapone and tolcapone dose-dependently inhibit the COMT activity in erythrocytes, improve the bioavailability and decrease the elimination of levodopa, and inhibit the formation of 3-O-methyldopa (3-OMD).|entacapone|COMT|6|12.0|Arg1:T31|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|22
23435367|  Ferredoxin 1 (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including steroid hormone synthesis in mammalian tissues.|steroid|Ferredoxin 1|21|1.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF|23
12126787|The AGE-induced increases in VEGF expression and PKC activation were inhibited by the pan-specific PKC inhibitor, calphostin C, and by the antioxidant drug and compounds, gliclazide, N-acetylcysteine, and vitamin E.|calphostin C|PKC|18|15.0|Arg1:T3|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|24
16232421|On the other hand, the FUM1 (fumarase) gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all.|fumarate|FUM1|19|7.0|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF|25
23274898|ATP-dependent 2-NBDG uptake was also inhibited by the G protein βγ subunit-interacting peptide βark-ct and by the phosphatidylinositol 3-kinase-γ (PI3Kγ) inhibitor AS605240.|AS605240|PI3Kγ|24|21.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|26
23322164|This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R.|acylcarnitine|CPT2|11|4.0|Arg1:T5|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|27
23271002|CAN significantly inhibited the production of NO and the release of TNF-α induced by LPS in macrophage RAW 264.7. Western blot showed that CAN can downregulate the expression of iNOS protein.|CAN|iNOS|25|31.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|28
23291264|Interestingly, tubular CCL2 mRNA levels increased soon after cisplatin administration, whereas CCL2 mRNA levels in whole kidney first decreased and then increased.|cisplatin|CCL2|10|14.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|29
15713990|In this study we investigated whether detectable FPPs activity was present in human colorectal cancer (CRC), also evaluating in vitro the role of this enzyme in the growth and apoptosis of CRC cells by using Pamidronate (PAM), a FPPs activity inhibitor.|PAM|FPPs|41|45.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|30
23059626|mRNA levels of receptor activator of nuclear factor kappa-B (RANK), its ligand RANKL, tumor necrosis factor alpha (TNF-α) and RANKL/osteoprotegerin (OPG) ratio were diminished in the periodontium of CCL3(-/-) mice and in the group treated with Met-RANTES.|Met|receptor activator of nuclear factor kappa-B|48|4.0|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|31
12023506|Comparing the K(i) values with the therapeutically relevant concentrations of unbound inhibitors in the plasma, probenecid alone was predicted to inhibit hOAT4-mediated organic anion transport in vivo.|probenecid|hOAT4|20|26.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|32
6701456|The binding of FHA-HIS was inhibited on 35-79% of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine.|clemastine|FHA|21|4.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|33
23228696|Furthermore, metformin was able to not only decrease the paclitaxel-induced p38 MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.|metformin|p38|3|12.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|34
11006272|In radioligand binding assays, membranes prepared from COS-7 cells transfected with LTB(4)-R2 cDNA displayed high affinity (K(d) = 0.17 nm) for [(3)H]LTB(4).|[(3)H]LTB(4)|LTB(4)-R2|32|13.0|Arg1:T27|Arg2:T39|CHEMICAL|GENE-Y|DIRECT-REGULATOR|35
23601990|The results showed that most of the synthesized compounds exhibited nanomolar potency against CEase, much better than the parent flavonoids.|flavonoids|CEase|21|14.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|36
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|AM411|CB(1)|229|224.0|Arg1:T9|Arg2:T39|CHEMICAL|GENE-Y|AGONIST|37
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HCB|glutathione S-transferase placental form|35|9.0|Arg1:T19|Arg2:T28|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|38
9873034|The N-terminal oxygenase domain (amino acids 1-498; iNOSox) in each subunit binds heme, L-Arg, and tetrahydrobiopterin (H4B), is the site of NO synthesis, and is responsible for the dimeric interaction, which must occur to synthesize NO.|NO|iNOSox|30|10.0|Arg1:T21|Arg2:T51|CHEMICAL|GENE-Y|PRODUCT-OF|39
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|NKCC2|20|14.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|40
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|3-NP|succinate dehydrogenase|6|22.0|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|41
23624852|RESULTS: VTA NMDAR blockade with AP-5 decreased, while VTA NMDAR activation with NMDA increased NAc peak phasic DA release.|NMDA|NMDAR|15|12.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|42
19259968|RESULTS: The antiallodynic action of nortriptyline was not affected by cotreatment with the alpha(2)-AR antagonist yohimbine, the beta(1)-AR antagonists atenolol or metoprolol, or the beta(3)-AR antagonist SR 59230A.|yohimbine|alpha(2)-AR|21|15.0|Arg1:T17|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST|43
11067741|Argininosuccinate synthetase, a key enzyme in the metabolism of l-citrulline to l-arginine, increased as well, perhaps in response to dimunition of the intracellular arginine pool corresponding to the observed high output of NO*.|l-citrulline|Argininosuccinate synthetase|11|1.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE|44
23589499|Docking experiments for the most active compounds into the MAO-B and MAO-A binding pockets highlighted different interactions between the derivative classes (2-arylbenzofurans and 3-arylcoumarins), and provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of these scaffolds.|3-arylcoumarins|MAO-A|25|12.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|45
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|cibenzoline|NCX|17|25.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|46
8710929|These events are stimulated by NE and by guanethidine, an hNET substrate, and they are blocked by cocaine and the antidepressant desipramine.|desipramine|hNET|24|12.0|Arg1:T11|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|47
11179439|The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.|dexrazoxane|DNA topoisomerase II|7|3.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|48
23381681|At the beginning of the calving and breeding seasons, cows supplemented with Se had greater (P < 0.01) whole blood Se concentration (WBSe) and glutathione peroxidase activities (GSH-Px) than cows receiving no supplemental Se; cows fed seleno-yeast had greater (P ≤ 0.05) WBSe than cows fed sodium selenite, but GSH-Px did not differ (P ≥ 0.25) between the two sources.|Se|glutathione peroxidase|14|30.0|Arg1:T23|Arg2:T38|CHEMICAL|GENE-N|ACTIVATOR|49
18061638|Norethisterone activated PR, AR, and ERalpha.|Norethisterone|ERalpha|1|8.0|Arg1:T22|Arg2:T58|CHEMICAL|GENE-Y|ACTIVATOR|50
15494548|Valdecoxib potently inhibits recombinant COX-2, with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for celecoxib, 0.5 microM for rofecoxib, and 5 microM for etoricoxib.|etoricoxib|COX-2|37|5.0|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|51
23446230|  Cytochrome P450 epoxygenase 2J2 (CYP2J2) metabolizes arachidonic acids to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.|arachidonic acids|CYP2J2|9|6.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|52
16530878|Glutamine synthetase activity and glutamine de novo synthesis were measured using, respectively, a standard enzymatic assay and [13C]-nuclear magnetic resonance spectroscopy.|glutamine|Glutamine synthetase|5|1.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF|53
15261283|Compound 2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole, expressed clozapine-like in vitro binding profile at D(2), 5-HT(2A) and alpha 1 receptors and a higher affinity for 5-HT(1A) receptors than clozapine.|2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole|5-HT(2A)|2|30.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|54
8344937|alpha 2M-methylamine, which binds with high affinity to alpha 2MR/LRP, did not bind to gp330.|methylamine|LRP|3|12.0|Arg1:T3|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR|55
18061638|Danazol activated PR and AR.|Danazol|AR|1|5.0|Arg1:T2|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR|56
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|L-serine|(L-serine dehydratase|19|2.0|Arg1:T1|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE|57
23489628|Identification and synthesis of N-(thiophen-2-yl) benzamide derivatives as BRAF(V600E) inhibitors.|N-(thiophen-2-yl) benzamide|BRAF|5|12.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|58
23348500|NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5-mediated responses in both recombinant and native systems.|NCFP|mGlu5|1|11.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR|59
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|tiagabine|GAT1|3|21.0|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|60
23435367|  Ferredoxin 1 (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including steroid hormone synthesis in mammalian tissues.|steroid hormone|FDX1|21|4.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|PRODUCT-OF|61
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|estrone sulfate|OAT3|19|22.0|Arg1:T22|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|62
23466342|The suppression of MDR1 promoter activity and protein expression was mediated through mollugin-induced activation of AMP-activated protein kinase (AMPK).|mollugin|AMP-activated protein kinase|13|16.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|63
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|ethynylestradiol|multidrug resistance-associated protein 2|24|35.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|64
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|nifedipine|Ca(v)1.2|56|59.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|65
23570999|Wattakaka volubilis steroidal glycoside mixture (WVSM) and PPG (1-50μM) significantly inhibited the COX-2 and iNOS enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.|steroidal glycoside|iNOS|3|19.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|66
23327877|Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.|DHEAS|OATP1B1|17|40.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE|67
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|l-valine|LAT3|29|11.0|Arg1:T15|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|68
17620346|The in vitro covalent binding was inhibited in the presence of beta-aminopropionitrile, D-penicillamine, and hydralazine, which suggested that the aldehyde group of allysine in human elastin was relevant to the covalent binding.|hydralazine|human elastin|17|28.0|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|69
17082235|Our work shows that sulfonylureas and glinides additionally bind to PPARgamma and exhibit PPARgamma agonistic activity.|sulfonylureas|PPARgamma|5|11.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|70
17092971|These drug effects on Ca(2+) mobilization and ERK2 phosphoprotein expression were mediated through dopamine hD(2L) receptors, as they all were blocked by (-)raclopride, whereas (-)raclopride and other dopamine D(2) receptor antagonists (haloperidol, risperidone, ziprasidone, olanzapine, clozapine and quetiapine) were inactive on their own in both assays.|ziprasidone|dopamine D(2) receptor|54|42.0|Arg1:T13|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST|71
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|camphor|TRPV3|6|17.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR|72
10381812|The expression of each alpha1-adrenoceptor was significantly decreased by in vivo application of antisense oligonucleotides targeted against each subtype.|oligonucleotides|alpha1-adrenoceptor|15|5.0|Arg1:T1|Arg2:T4|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|73
23402841|The values of mean corpuscular hemoglobin concentration and mean corpuscular hemoglobin increased in the STX group.|STX|hemoglobin|15|6.0|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|74
17442055|Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain.|kynurenate|aspartate aminotransferase|7|2.0|Arg1:T18|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|75
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|Pristimerin|cyclooxygenase-2|1|26.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|76
15942707|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|VEGF|3|12.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|77
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|COX-2|5|39.0|Arg1:T9|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|78
11319232|Triacsin C, a competitive inhibitor of both ACS1 and ACS4, inhibited ACS activity similarly in endoplasmic reticulum, MAM, and mitochondria, suggesting that a hitherto unidentified triacsin-sensitive ACS is present in mitochondria.|Triacsin C|ACS|1|14.0|Arg1:T9|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR|79
19549602|Truncation of amitriptyline binding motif on TrkA abrogates the receptor dimerization by amitriptyline.|amitriptyline|TrkA|3|7.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|DIRECT-REGULATOR|80
23200901|The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.|hypaconitine|efflux transporters|16|4.0|Arg1:T29|Arg2:T48|CHEMICAL|GENE-N|SUBSTRATE|81
23590882|These results support the hypothesis that apoplastic amino acids acting through heteromeric GLR3.2/GLR3.4 channels affect lateral root development via Ca(2+) signaling in the phloem.|amino acids|GLR3.2|8|13.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|PART-OF|82
23325562|Conversely, AMPK inhibitor compound C or GSK3β inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells.|compound C|AMPK|5|3.0|Arg1:T1|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|83
2112956|We tested these five acyl-CoA dehydrogenases for their ability to dehydrogenate valproyl-CoA using pure enzyme preparations isolated from rat liver mitochondria.|valproyl-CoA|acyl-CoA dehydrogenases|12|5.0|Arg1:T13|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE|84
14633536|  UNLABELLED: The effect of dopamine D2 receptor antagonists, such as chlorpromazine and haloperidol, on pupil size in awake subjects suggests that these drugs might also alter pupillary reflex dilation and pupil size during general anesthesia.|haloperidol|dopamine D2 receptor|15|6.0|Arg1:T14|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST|85
23288946|PLD2 interacts functionally with the glycerol channel aquaporin-3 (AQP3) to produce phosphatidylglycerol (PG); however, wounding resulted in decreased PG production, suggesting a potential PG deficiency in wounded cells.|phosphatidylglycerol|PLD2|14|1.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF|86
23641955|In this study, liver and kidney relative activity factors were developed for UGT1A1, 1A9 and 2B7 to allow for in vitro-in vivo extrapolation of intrinsic clearance data to whole organ clearance using recombinant human UGT isoforms applying this to laropiprant as a model substrate.|laropiprant|human UGT|42|36.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE|87
10200266|  The MWFE polypeptide of mammalian complex I (the proton-translocating NADH-quinone oxidoreductase) is 70 amino acids long, and it is predicted to be a membrane protein.|amino acids|NADH-quinone oxidoreductase|16|11.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|PART-OF|88
22986217|In addition, soy isoflavones regulated plasma glucose, leptin and adiponectin contents after treatment for two months.|isoflavones|adiponectin|5|12.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|89
18450949|Administration of cevimeline hydrochloride, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one.|cevimeline hydrochloride|M3 muscarinic receptor|3|7.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|AGONIST|90
9873034|Clotrimazole also bound to iNOSox dimers in the absence of L-Arg and H4B and caused their dissociation.|Clotrimazole|iNOSox|1|5.0|Arg1:T39|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|91
23453838|Analogs with Z=Br, I, or OTs were weak inhibitors of the AChEs, and methyl phosphonates (R=Me) were more potent than the corresponding ethyl phosphonates (R=Et).|Z=Br, I, or OTs|AChEs|3|14.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|92
8589992|Cell lines stably expressing EAA3a protein formed homomeric ligand-gated ion channels responsive, in order of decreasing affinity to domoate, kainate, L-glutamate and (RS)-alpha-amino-3-hydroxy-5- methylisoxazole-propionate (AMPA).|(RS)-alpha-amino-3-hydroxy-5- methylisoxazole-propionate|EAA3a|26|5.0|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|93
11969359|The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and milrinone, reduced the GM-CSF release in a concentration dependent manner.|milrinone|PDE3|17|13.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|94
23591111|HDAC inhibition was observed for 3, to a lesser extent than SAHA, and rationalized by molecular docking into the active site of HDAC8.|SAHA|HDAC|13|1.0|Arg1:T7|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|95
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|dopamine|EC 1.14.16.1|7|19.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|96
16819260|Among them, tamibarotene (Am80) is an RARalpha- and RARbeta-specific (but RARgamma- and RXRs-nonbinding) synthetic retinoid that is effective in the treatment of psoriasis patients and relapsed APL.|Am80|RARbeta|6|12.0|Arg1:T8|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|97
16298345|To do this we cloned and expressed CCR5 from rhesus macaque and compared the binding properties of [125I]-MIP-1beta and [3H]-maraviroc with human recombinant CCR5.|125I|human recombinant CCR5|19|28.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|98
18715952|PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).|PGE(2)|EP(4)|1|39.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|99
12470615|Resiquimod-stimulated pDC also produce a number of other cytokines including TNF-alpha and IP-10.|Resiquimod|cytokines|1|9.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|100
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|Hydrogen sulfide|cystathionine beta-synthase|1|26.0|Arg1:T1|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF|101
16010590|CONCLUSIONS: The combination of TFT with the antifolates AG337, ZD1694 and GW1843 is mainly additive when the drugs are given simultaneously and this is mediated by an additive TS inhibition and DNA damage.|GW1843|TS|14|31.0|Arg1:T22|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR|102
16627864|METHODS: Anesthetized rats received either Ringer's (Vehicle/Shock), 10 microg/kg/min of the beta(1)-adrenoceptor agonist dobutamine (Dob/Shock), or 10 microg/kg/min dobutamine and 500 microg/kg/min of the beta(1)-adrenoceptor antagonist esmolol (Dob/Esmolol/Shock) for 6 h.|esmolol|beta(1)-adrenoceptor|43|37.0|Arg1:T23|Arg2:T45|CHEMICAL|GENE-Y|ANTAGONIST|103
22406476|Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6K1 and S6.|aspirin|S6|7|14.0|Arg1:T12|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|104
23265465|We also applied the metabolite to mouse adipocytes and found that 2-HPPA was less effective at reducing leptin secretion than the parent compound genistein.|genistein|leptin|24|18.0|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|105
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|I3S|c-Src|60|73.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR|106
23407783|The CRF(1) receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and D-cycloserine.|SSR125543|CRF(1) receptor|8|2.0|Arg1:T15|Arg2:T19|CHEMICAL|GENE-Y|ANTAGONIST|107
17409426|Sulindac sulfide inhibited 14-3-3epsilon proteins in HT-29 and DLD-1 cells in a time- and concentration-dependent manner.|Sulindac sulfide|14-3-3epsilon proteins|1|4.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|108
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|beta-alanine|GAT2|10|28.0|Arg1:T22|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|109
12085361|In rats, rifamycin SV and rifampicin were shown to interfere with hepatic organic anion uptake by inhibition of the organic anion transporting polypeptides Oatp1 and Oatp2.|rifamycin SV|Oatp1|4|25.0|Arg1:T3|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|110
23208609|In line with the increased CYP19A1 mRNA expression, 2-ITX increased catalytic activity of aromatase in H295R cells as measured by cognate aromatase assays.|2-ITX|CYP19A1|10|6.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|111
20426763|Second messenger studies revealed the presence of phospholipase C-coupled 5HT(2A) receptors in h-CM and h-TM cells where they stimulated phosphoinositide (PI) hydrolysis and mobilized intracellular Ca(2+) when challenged with a variety of 5HT(2A-C) receptor agonists (e.g. alpha-methyl-5HT, (R)-DOI, alpha-methyl-5HT, BW-723C86, MK-212, mCPP, cabergoline, AL-34662).|cabergoline|5HT(2A)|65|10.0|Arg1:T13|Arg2:T39|CHEMICAL|GENE-Y|AGONIST|112
23291559|  KCNK1, a member of the family of two-pore K(+) ion channels, is specifically induced in the livers of male mice after phenobarbital treatment.|phenobarbital|KCNK1|27|1.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|ACTIVATOR|113
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|alcoholamines|histamine H1-receptor|17|13.0|Arg1:T4|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST|114
11243491|METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [buspirone (partial 5-HT1A agonist), anpirtoline (5-HT1B agonist)] in the mouse forced swimming test.|buspirone|5-HT1A|60|63.0|Arg1:T25|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|115
10334992|Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor.|bile acids|farnesoid X receptor|6|13.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR|116
23583603|Both ICI treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ERα) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.|ICI|estrogen receptor alpha|2|16.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|117
15133083|bis(Ethyl) oligoamine analogues of polyamines, such as SL-11144 and SL-11158, as well as arylamine analogues [BW-1, a bis(phenylbenzyl) 3-7-3 analogue] blocked uptake and interconversion of spermine at micromolar levels and, in the case of BW-1, acted as substrate for PAO.|BW-1|PAO|47|53.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|118
23020787|Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.|quinolone|efflux transporters|8|23.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|119
23494106|Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.|JWH-122|TNFα|32|38.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|120
1868500|Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.|fibric acids|LDL|4|27.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|121
23494944|AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase (AChE) in all regions.|AlCl3|AChE|1|18.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|122
23500491|Previous studies have revealed that the ATP binding step is crucial both for the power stroke to produce motility and for the inter-domain regulation of ATPase activity to guarantee the processive movement of dimeric KIFs. Here, we report the first crystal structure of KIF4 complexed with the non-hydrolyzable ATP analog, AMPPNP (adenylyl imidodiphosphate), at 1.7Å resolution.|ATP|KIF4|51|46.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|123
23385959|These findings are the first to show that long-term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38(MAPK) phosphorylation and caspase activity in the striatum.|Mn|MAPK|12|33.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|ACTIVATOR|124
10516958|  Ziprasidone is a novel antipsychotic agent which binds with high affinity to 5-HT1A receptors (Ki = 3.4 nM), in addition to 5-HT1D, 5-HT2, and D2 sites.|Ziprasidone|5-HT1D|1|25.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|125
23313623|Km and Vmax values of entecavir were 250 μM and 0.83 nmol/mg protein/30s (OAT1) and 23 μM and 1.1 nmol/mg protein/30 s (OAT3), respectively.|entecavir|OAT1|6|15.0|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|126
12137927|Chronic treatment with the NET inhibitor, desipramine (DMI), reduced NET levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.|desipramine|NET|8|14.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|127
10755406|A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C.|mitomycin C|NQO1|14|9.0|Arg1:T17|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE|128
10891536|  5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (TS).|FdUrd|thymidylate synthase|8|36.0|Arg1:T29|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|129
2833901|Similarly, felodipine and the p-chloro analogue inhibited myosin light chain kinase activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate.|p-chloro|myosin light chain kinase|6|9.0|Arg1:T4|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|130
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|rizatriptan|5-ht1f|10|22.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|131
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|Phenelzine|MAO-B|1|12.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|132
17408613|In this study, irbesartan was investigated in comparison with fenfluramine, an established satiating drug, and the angiotensin converting enzyme (ACE) inhibitor captopril.|captopril|ACE|27|24.0|Arg1:T16|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|133
10365684|Exposure to MMI (1 microM and 10 microM) or PTU (10 microM and 100 microM) for 2 days caused a significant increase in cellular TPO activity; 100 microM MMI inhibited cellular TPO activity.|MMI|TPO|34|37.0|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|134
12170055|The analgesic action of meperidine was blocked by naloxone but not by the alpha 2-adrenoceptor antagonists yohimbine and RX821002.|yohimbine|alpha 2-adrenoceptor|17|14.0|Arg1:T9|Arg2:T31|CHEMICAL|GENE-N|ANTAGONIST|135
10688973|The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist (-)-quadazocine exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.|(-)-quadazocine|opioid receptor|14|11.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|ANTAGONIST|136
22983118|At concentrations that produced similar levels of neuronal death, DOI promoted a higher increase in the activity of both caspases than MDMA.|MDMA|caspases|23|21.0|Arg1:T24|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR|137
12652111|A combination of cilostazol (>15 microM) and the PDE4 selective inhibitor, rolipram (5 microM), inhibited levels of cytosolic cAMP-PDE activity similar to those inhibited by milrinone on its own.|cilostazol|cAMP-PDE|4|26.0|Arg1:T20|Arg2:T48|CHEMICAL|GENE-N|INHIBITOR|138
12907245|Vinblastine, doxorubicin, or etoposide (VP-16) induced apoptotic cell death in KB-3 carcinoma cells, with similar kinetic profiles of PARP cleavage, caspase 3 activation, and mitochondrial cytochrome c release.|etoposide|caspase 3|6|27.0|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR|139
15478125|Some sulfamates were also shown to possess potent inhibitory activity against acyl coenzyme A:cholesterol acyltransferase, an enzyme involved in cholesterol metabolism.|sulfamates|acyl coenzyme A:cholesterol acyltransferase|2|12.0|Arg1:T11|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|140
23537005|The present study provides a comprehensive characterization of the oxidative metabolism of BDE-47 by human liver microsomes and P450 2B6.|BDE-47|P450 2B6|13|19.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|141
15210974|Furthermore, there is a high degree of correlation between binding affinities of a series of LEV derivatives to SV2A in fibroblasts and to the LEV-binding site in brain.|LEV|SV2A|17|20.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR|142
10471277|Labeling with [(125)I]IAS was blocked by 10 microM (-)-alprenolol and inhibited by addition of GTP gamma S, and [125I]IAS migrated at the same position on an SDS-PAGE gel as the beta 2AR labeled by the antagonist photoaffinity label [125I]iodoazidobenzylpindolol ([125I]IABP).|GTP|beta 2AR|24|44.0|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|143
23063590|Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that artemisinic acid regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA (HMG CoA) reductase gene, which was mediated through reduced expression of the CCAAT/enhancer-binding protein (C/EBP) α gene.|artemisinic acid|hydroxymethylglutaryl CoA (HMG CoA) reductase|16|28.0|Arg1:T15|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|144
12898700|The oxidative stress conditions following DEM treatment activate L-cystine transport in TR-MUL cells due to the enhanced transcription of the xCT gene.|DEM|xCT|6|21.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|145
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|HSD|6|35.0|Arg1:T21|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|146
23403272|Furthermore, inhibition of HO-1 with zinc protoporphyrin IX (ZNPP) significantly reversed the protective effect of Paeoniflorin against radiation-induced damage in EA.hy926 cells.|ZNPP|HO-1|11|5.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|147
23597507|Intraplantar or intrathecal administered Phα1β reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with SB366791, a specific TRPV1 antagonist.|SB366791|TRPV1|21|25.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|ANTAGONIST|148
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide|5-HT receptor|10|1.0|Arg1:T17|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST|149
16982784|We also showed that (i) k3 was the rate-limiting step for the hydrolysis of cefotaxime by Asp104Lys, (ii) the Km for cefotaxime of the doubly substituted Asp104Lys Gly238Ser variant approached that of the Gly238Ser beta-lactamase as pH increased, and (iii) Lys at position 104 functions in an energetically additive manner with the Gly238Ser substitution to enhance catalysis of cephalothin.|cephalothin|Gly238Ser|67|61.0|Arg1:T8|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE|150
2394753|  In a recent study it has been shown that mitochondrial creatine kinase from chicken brain (Mia-CK) and heart (Mib-CK) are two distinct isoenzymes differing in ten out of the thirty N-terminal amino acids (Hossle, J.P., Schlegel, J., Wegmann, G., Wyss, M., Bohlen, P., Eppenberger, H.M., Wallimann, T., and Perriard J.C. (1988) Biochem.|N-terminal amino acids|Mia-CK|35|17.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|PART-OF|151
12183691|Several organic anions such as valproate, as well as organic cations, significantly inhibited carnitine and TEA uptake by OCTN2, and valproate showed Na(+)-dependent inhibition of OCTN2-mediated TEA uptake.|Na(+)|OCTN2|26|33.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|152
16885432|The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modafinil affects wakefulness by interacting with catecholamine transporters in brain.|modafinil|NET|25|13.0|Arg1:T10|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|153
1328609|  Etorphine, a potent opioid agonist, has been reported to bind to both mu and epsilon opioid receptors.|Etorphine|opioid|1|5.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|AGONIST|154
18559268|Taxanes with affinities for microtubules well above their affinities for P-glycoprotein are shown not to be affected by multidrug resistance.|Taxanes|P-glycoprotein|1|11.0|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|155
23396090|In contrast, liposomal CDDP induced expression of genes from DNA damage pathways and several genes of the extrinsic pathway of apoptosis (TNFRSF10B-DR5, CD70-TNFSF7).|CDDP|TNFRSF10B|5|24.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|156
23042728|  In utero exposure to valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, causes neural tube, heart, and limb defects.|VPA|histone deacetylase|8|12.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|157
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|phospho-Akt|3|11.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|158
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|nateglinide|PPARgamma|17|24.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|159
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|sertindole|human ether-a-go-go-related gene|4|34.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|160
11309248|Digoxin (10(-5) M) or digitoxin (10(-5) M), but not ouabain, decreased the expression of P450scc and steroidogenic acute regulatory (StAR) protein in rat granulosa cells.|Digoxin|P450scc|1|27.0|Arg1:T22|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|161
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|etravirine|hPXR|3|15.0|Arg1:T4|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR|162
2833901|Felodipine and the p-chloro analogue inhibited Ca2+/calmodulin-dependent caldesmon kinase with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.|Felodipine|caldesmon kinase|1|8.0|Arg1:T38|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR|163
15011952|The triphosphates of 4'-thio-FAC (4'-thio-FACTP) exhibited the potent inhibitory action against DNA polymerase alpha, whereas it showed moderate inhibition against DNA polymerase beta and little inhibition against DNA polymerase gamma.|4'-thio-FACTP|DNA polymerase gamma|6|31.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|164
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|methoxy|DAT|38|59.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR|165
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|NO|inducible NO synthase|11|22.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|166
23340252|Cellular fractionation assays demonstrated that TF treatment promoted the activating serine phosphorylation of GR, augmenting its cytoplasmic-to-nuclear translocation as well as its enrichment at glucocorticoid response elements on the glucocorticoid-induced leucine zipper gene promoter.|serine|GR|11|14.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PART-OF|167
10768298|  PURPOSE: This study investigated the effectiveness of topiramate (TPM) as an inhibitor of six isozymes of carbonic anhydrase (CA).|topiramate|CA|9|23.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|168
23374869|In most instances, C6-substituted phthalides exhibit MAO-B specific inhibition.|phthalides|MAO-B|6|8.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|169
23220589|The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.|BT-05|AChE|25|5.0|Arg1:T18|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR|170
12795776|After pretreatment with placebo, the terbutaline infusion caused a significant decrease in serum potassium and increases in serum glucose and insulin.|terbutaline|insulin|7|22.0|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|171
12170055|CONCLUSION: Meperidine is a potent agonist at the alpha2 adrenoceptors at its clinically relevant concentrations, especially at the alpha(2B)-adrenoceptor subtype.|Meperidine|alpha(2B)-adrenoceptor|3|21.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|172
10598120|Prolonged vasopeptidase inhibition increased median survival time after the start of treatment by 99 and 31% compared with vehicle and captopril, respectively (median survival times: 146, 221, and 290 days with vehicle, captopril, and omapatrilat, respectively; p < 0.001 for all comparisons).|captopril|vasopeptidase|22|2.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|173
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|pelargonidin|CYP1A1|3|8.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|174
23178381|Western blot analysis revealed that aspidin PB inhibited PI3K expression, phosphorylation of Ser473 Akt and Ser9 GSK3β followed by up-regulation of nonsteroidal anti-inflammatory drugs activated gene-1 (NAG-1) expression.|aspidin PB|GSK3β|6|18.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|175
10887187|Finally, cysteine 53 in the M1P1 external loop is required for functional expression of TWIK-2 but is not critical for subunit self-assembly.|cysteine|M1P1 external loop|3|7.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|PART-OF|176
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|kinase|1|8.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|177
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine|acetylcholinesterase|47|2.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|178
11319222|The thiazolidinedione (TZD) insulin-sensitizing drugs and peroxisome proliferator-activated receptor gamma (PPARgamma) ligands, troglitazone, rosiglitazone, and pioglitazone, strongly and specifically inhibited only ACS4, with an IC(50) of less than 1.5 microm.|TZD|ACS4|4|30.0|Arg1:T34|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|179
23401472|Bisulfite sequence analysis revealed that the CpG-rich region near the UGT1A1 promoter (-85 to +40) was hypermethylated (83%) in the kidney, whereas it was hypomethylated (37%) in the liver.|CpG|UGT1A1 promoter|7|11.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|PART-OF|180
23194750|Isolated rat femoral arteries segments were mounted in a wire myograph and challenged with 100mM KCl or phenylephrine (PE), in the absence or presence of troglitazone, rosiglitazone, pioglitazone, LY294002 (PI3K inhibitor) and 10-DEBC (Akt inhibitor).|troglitazone|PI3K|29|37.0|Arg1:T17|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|181
10373451|Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).|cGMP|human phosphodiesterase|14|7.0|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|182
23295228|  Potassium ions are non-essential activators of several aldehyde dehydrogenases (ALDHs), whereas a few others require the cation for activity.|Potassium|aldehyde dehydrogenases|1|8.0|Arg1:T1|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR|183
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|DVS|hNET|15|2.0|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|184
22406476|Aspirin changed nucleotide ratios and activated AMPK in CRC cells.|Aspirin|AMPK|1|7.0|Arg1:T2|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR|185
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|chlorpromazine sulfoxide|calmodulin|41|3.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|186
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|normeperidine|SERT|19|48.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|187
18423812|INTERVENTIONS: In the 8-week run-in period, all participants received the ACE inhibitor cilazapril (5 mg), the ARB telmisartan (80 mg), and the diuretic hydrochlorothiazide (12.5 mg) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg. Participants were then randomly assigned to 2 treatment sequences, either the addition of spironolactone (25 mg) (triple RAAS blockade) through 8 weeks followed by double RAAS blockade through 8 weeks (sequence 1) or double RAAS blockade followed by triple RAAS blockade (sequence 2).|cilazapril|ACE|15|13.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|188
23523258|These results suggested that 3-day treatment of Sch B could increase concentration and oral bioavailability of drug metabolized by CYP3A.|Sch B|CYP3A|8|20.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|189
9843368|Crystallographic comparison with the structurally related rat tyrosine hydroxylase binary complex with the oxidized cofactor 7,8-dihydrobiopterin revealed overlapping binding sites for the catechols and the cofactor, compatible with a competitive type of inhibition of the catechols versus BH4.|catechols|rat tyrosine hydroxylase|37|7.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|190
23212742|Examination of the plasma monohydroxy metabolite/25OHD3 ratios indicated selective induction of the CYP3A4-dependent 4β-hydroxylation pathway of 25OHD3 elimination.|25OHD3|CYP3A4|7|13.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR|191
12657913|  The effects of histamine H1-receptor antagonists, promethazine and homochlorcyclizine, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.|promethazine|histamine H1-receptor|8|4.0|Arg1:T16|Arg2:T29|CHEMICAL|GENE-Y|ANTAGONIST|192
23469927|  Soman forms a stable, covalent bond with tyrosine 411 of human albumin, with tyrosines 257 and 593 in human transferrin, and with tyrosine in many other proteins.|Soman|human albumin|1|12.0|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|193
19997047|  The phosphodiesterase inhibitor pentoxifylline (PTX) exerts multiple beneficial immunomodulatory effects in states of hyperinflammation.|pentoxifylline|phosphodiesterase|4|2.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|194
23570914|In a cell-based model, bleomycin suppressed Nrf2 activation via extracellular signal-related kinase phosphorylation, enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion.|bleomycin|Nrf2|6|8.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|195
23254196|Here, we report that genistein at physiologically relevant concentrations (0.1-10 μM) significantly inhibited thrombin-induced increase in endothelial monolayer permeability.|genistein|thrombin|6|17.0|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|196
17015480|TReP-132 synergizes with progesterone-bound PR to trans activate the p21 and p27 gene promoters at proximal Sp1-binding sites.|progesterone|PR|4|5.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|197
23478260|We report that two common variants of high-temperature requirement A1 (HTRA1) that increase the inherited risk of neovascular age-related macular degeneration (NvAMD) harbor synonymous SNPs within exon 1 of HTRA1 that convert common codons for Ala34 and Gly36 to less frequently used codons.|Ala|HTRA1|40|12.0|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|PART-OF|198
15240345|Mitochondria, which produce glyoxylate from hydroxyproline metabolism, contained both alanine:glyoxylate aminotransferase (AGT)2 and glyoxylate reductase activities, which can convert glyoxylate to glycine and glycolate, respectively.|glyoxylate|glyoxylate reductase|28|21.0|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|199
17486539|In contrast, the RA catabolising enzymes Cyp26A1 and Cyp26B1 which are known to be RA-responsive were not expressed at all in the developing eye.|RA|Cyp26B1|5|10.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE|200
16765071|The purified antibody was immunoreactive with 6-nitrotryptophan residue containing Cu, Zn-SOD but not immunoreactive with Cu, Zn-SOD, Mn-SOD, bovine serum albumin, and 3-nitrotyrosine residue containing Mn-SOD.|6-nitrotryptophan|SOD|7|20.0|Arg1:T17|Arg2:T44|CHEMICAL|GENE-N|PART-OF|201
12565907|  Human epidermal melanocytes hold the full capacity for autocrine de novo synthesis/regulation/recycling of the essential cofactor 6-tetrahydrobiopterin (6BH(4)) for conversion of L-phenylalanine via phenylalanine hydroxylase to L-tyrosine and for production of L-Dopa via tyrosine hydroxylase to initiate both pigmentation and catecholamine synthesis in these neural crest-derived cells.|6-tetrahydrobiopterin|tyrosine hydroxylase|17|39.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|202
10328230|Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.|batimastat|MMP-2|9|6.0|Arg1:T15|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|203
11118042|Sulindac sulfone inhibited COX-2 protein expression, which resulted in a decrease in prostaglandin synthase E2 production.|Sulindac sulfone|COX-2|1|4.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|204
23607523|This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) required for the formation of the benzopyranopyrrole core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.|benzopyranopyrrole|PKS|21|13.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF|205
23430109|Ponatinib (AP24534) is a multikinase inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia, irrespective of BCR-ABL KD mutation.|Ponatinib|multikinase|1|7.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|206
25598831|Canagliflozin, dapagliflozin, and empagliflozin are SGLT2 inhibitors approved as treatments for T2DM in the United States, Europe, and other countries.|empagliflozin|SGLT2|6|8.0|Arg1:T15|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|207
2125244|  The concentration of estramustine phosphate required to inhibit the assembly or to induce the disassembly of chick brain MAP2:tubulin microtubules is markedly dependent upon the microtubule protein concentration.|estramustine phosphate|chick brain MAP2|4|17.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR|208
11447307|This brief review summarizes the evidence linking endothelin-1 to the pathophysiology of chronic heart failure and the clinical results obtained in patients during acute, intravenous and more prolonged, oral administration with bosentan, a mixed ET(A)/ET(B)-receptor antagonist.|bosentan|ET(A)|34|38.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|209
23583258|Oxysterol-dependent NOX1 activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.|phenolic acids|NOX1|28|2.0|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|210
23551063| At a substrate concentration of 20 µM, the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 µM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs. The activities of UGTs 1A3, 1A8, 1A9, 2B4 and 2B7 were low, whereas UGT1A1 and UGT2B17 exhibited no HFC glucuronidation activity.|HFC|UGT1A6|12|19.0|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|211
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|naratriptan|5-HT1D|8|19.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|212
23607712|Therefore, in addition to its previously described functions, synaptotagmin-1 is involved in a rapid vesicular Ca(2+) sequestration through a Ca(2+) /H(+) antiport.|Ca(2+)|synaptotagmin-1|25|11.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|213
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|Troglitazone|PPARgamma|1|26.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|214
11330337|"However, fasciculin-2, a potent peptide inhibitor of acetylcholinesterase (IC50 24 nM), did prevent catabolism of acetylcholine in rat brain membranes with an atypical inhibition isotherm of [3H]-oxotremorine-M binding, thus permitting an estimation of the ""global affinity"" of acetylcholine (Ki 85 nM) for [3H]-oxotremorine-M-labelled muscarinic receptors in rat brain."|[3H]-oxotremorine-M|muscarinic receptors|32|60.0|Arg1:T21|Arg2:T50|CHEMICAL|GENE-N|DIRECT-REGULATOR|215
20372850|Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.|pyrimidine|thymidylate synthase|4|11.0|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|PRODUCT-OF|216
23639249|Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis.|Indoxyl 3-sulfate|c-Src|1|9.0|Arg1:T14|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR|217
17075268|  BACKGROUND: Histamine synthesized by histidine decarboxylase (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.|Histamine|HDC|3|9.0|Arg1:T3|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF|218
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H2R|1|16.0|Arg1:T1|Arg2:T59|CHEMICAL|GENE-Y|DIRECT-REGULATOR|219
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|Akt|1|6.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|220
16885432|In vitro, modafinil inhibited [(3)H]dopamine (IC(50) = 6.4 microM), [(3)H]norepinephrine (IC(50) = 35.6 microM), and [(3)H]serotonin (IC(50) > 500 microM) transport via the human DAT, NET, and SERT.|[(3)H]dopamine|human DAT|6|60.0|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|221
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|EGFR|1|19.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|222
17197042|Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.|foscarnet|DNA polymerase|15|7.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|223
14654525|SU11248 is an oral multitargeted kinase inhibitor with selectivity for fms-related tyrosine kinase 3/Flk2 (FLT3), platelet-derived growth factor receptor alpha/beta, vascular endothelial growth factor receptor 1/2, and KIT receptor tyrosine kinases.|SU11248|tyrosine kinases|1|35.0|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|224
10085232|These studies show clearly that, in all three GSTs, an aspartate residue at position 208 is a prerequisite for high activity in aflatoxin-exo-8,9-epoxide conjugation, although this alone is not sufficient; other residues in the vicinity, particularly residues 103-112, are important, perhaps for the optimal orientation of the aflatoxin-exo-8,9-epoxide in the active site for catalysis to occur.|aflatoxin-exo-8,9-epoxide|GSTs|25|10.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|DIRECT-REGULATOR|225
23244065|The three-step approach of CliEn-seq involves in vivo synthesis of S-adenosyl-L-methionine (SAM) analogues from cell-permeable methionine analogues by engineered SAM synthetase (methionine adenosyltransferase or MAT), in situ chromatin modification by engineered PMTs, subsequent enrichment and sequencing of the uniquely modified chromatins.|SAM|SAM synthetase|13|22.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|PRODUCT-OF|226
23519392|Amprenavir efficiently activated PXR and induced PXR target gene expression in vitro and in vivo.|Amprenavir|PXR|1|7.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|227
23291118|The 8-MOP analogs 19 and 24, incorporating at position 5 of the psoralen nucleus a butyl acrylate or a tert-butyl cinnamate moiety, were the most powerful inhibitors of soybean LOX and inhibited effectively lipid peroxidation.|8-MOP|soybean LOX|2|31.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|228
10411647|Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-hTH1 on binding of H4biopterin and Lerythro-dihydrobiopterin (H2biopterin).|Lerythro-dihydrobiopterin|hTH1|20|15.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|229
16313925|Preferential inhibition of human phosphodiesterase 4 by ibudilast.|ibudilast|human phosphodiesterase 4|8|4.0|Arg1:T16|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|230
17321471|The non-selective adenosine receptor agonist NECA, and the selective A(2A) receptor agonist CGS21680 also inhibited TNF-alpha production even more potently (IC(50)=4.8 and 2.3 nM, respectively).|NECA|adenosine receptor|6|3.0|Arg1:T23|Arg2:T45|CHEMICAL|GENE-N|AGONIST|231
1600046|While the substituted benzamide prokinetics (for example, metoclopramide, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.|metoclopramide|5-HT4|10|39.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|232
10626836|Neuron, 21 (1998) 907-918) further confirms that lithium enhances GluR3 responses by reducing desensitization, since lithium's effects are reversed in this mutant.|lithium|GluR3|12|14.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR|233
23142547|Rev1 stably interacts with Rad5 (a central component of the template switching pathway) via the C-terminal region of Rev1 and the N-terminal region of Rad5.|C|Rev1|18|21.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PART-OF|234
15210974|LEV and related compounds bind to SV2A expressed in fibroblasts, indicating that SV2A is sufficient for LEV binding.|LEV|SV2A|1|7.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|235
14633707|The observation that Ras-transformed cells can be sensitized to killing by ionizing radiation with GW572016 demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.|GW572016|Ras|15|4.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|236
15306222|Our results showed that the affinities of alpha1D-AR and alpha1B-AR for carvedilol are higher than that of the beta1-AR subtype, a major target in heart failure treatment.|carvedilol|beta1-AR|12|19.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|237
11319222|A non-TZD PPARgamma ligand, GW1929, which is 7-fold more potent than rosiglitazone, inhibited ACS1 and ACS4 poorly with an IC(50) of greater than 50 microm, more than 100-fold higher than was required for rosiglitazone, thereby demonstrating the specificity of TZD inhibition.|GW1929|ACS1|6|17.0|Arg1:T8|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|238
20590599|Other ligands (e.g. denopamine for beta(1); clenbuterol, AZ 40140d, salbutamol for beta(2)) were found to have subtype-selective intrinsic efficacy.|salbutamol|beta(2)|18|20.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|239
15618457|Incubation of eosinophils with isoproterenol or formoterol dose-dependently inhibited both spontaneous eosinophil apoptosis and apoptosis induced by Fas receptor activation.|isoproterenol|Fas receptor|5|18.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|240
1983158|CD1 mice were used, treated with saline, morphine CHl (5 mg/kg), and 1 or 10 mg/kg of the H1-antihistaminics tripelennamine, chlorpheniramine, diphenhydramine and cyclizine and the H2-antihistaminics ranitidine and cimetidine, all compounds by s.c. route.|cyclizine|H1|31|24.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|241
1665782|Therefore, in the present studies, animals were rendered tolerant to the delta-opioid receptor-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE), and receptor binding activities were measured.|[D-Pen2,D-Pen5]enkephalin|delta-opioid receptor|17|14.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|242
17223709|  Saccharopine dehydrogenase [N6-(glutaryl-2)-L-lysine:NAD oxidoreductase (L-lysine forming)] catalyzes the final step in the alpha-aminoadipate pathway for lysine biosynthesis.|lysine|Saccharopine dehydrogenase|26|1.0|Arg1:T12|Arg2:T40|CHEMICAL|GENE-Y|PRODUCT-OF|243
23313376|PTE also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.|PTE|p21|1|47.0|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|244
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|IMP|AdSS|17|4.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|245
16384941|Production of fluorescent reduced nicotinamide adenine dinucleotide (NADH) was used to measure enzymatic activity of mutant IMPDH1 proteins.|NADH|IMPDH1|9|19.0|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF|246
10420171|"These considerations illustrate the need to have additional research tools with which to test the ""DA hypothesis."" One strategy is to identify drugs which bind to the DA transporter (DAT ligands) but which do not inhibit DA uptake as effectively as cocaine."|DA|DAT|42|34.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|247
23416003|  Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF-FVIIa inhibitors.|Bicyclic pyrazinone and pyrimidinone amides|TF|1|12.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|248
23382381|Cellular responses to DNA damage induced by etoposide or doxorubicin include down-regulation of endogenous supervillin coincident with increases in p53.|etoposide|p53|8|20.0|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|249
15606893|Dissociation of [3H]S-citalopram from a complex with the SERT double-mutant, N208Q/N217Q, which has been suggested to be unable to self-assemble into oligomeric complexes, is retarded to an extent similar to that found with the wild-type, raising the possibility that the allosteric mechanism is mediated within a single subunit.|[3H]S-citalopram|SERT|3|12.0|Arg1:T18|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|250
17355958|Oxidation of Grx1 induced a complex pattern of disulfide-bonded dimers and oligomers formed between Cys-8 and either Cys-79 or Cys-83.|Cys|Grx1|20|3.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|PART-OF|251
1346768|All three subtypes have been shown to inhibit the activation of adenylate cyclase and thus reduce the levels of cAMP.|cAMP|adenylate cyclase|20|12.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PRODUCT-OF|252
11054378|The decrease in substrate phosphorylation by IKK-alpha and -beta is associated with a decrease in autophosphorylation of IKKs and can be antagonized by excess adenosine triphosphate.|adenosine triphosphate|IKKs|25|18.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|253
18480678|In both rodent and primate animal models, the binding of radiolabeled d-MPH to dopamine transporter was found to be selective, saturable, and reversible, whereas binding of l-MPH was diffuse and nonspecific.|d-MPH|dopamine transporter|13|15.0|Arg1:T24|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|254
9581512|  The protein tyrosine kinase (PTK) inhibitor piceatannol is also an inhibitor of the rat liver cyclic AMP-dependent protein kinase (PKA) catalytic subunit (cAK), rat brain Ca(2+)- and phospholipid-dependent protein kinase C (PKC), avian gizzard Ca(2+)-calmodulin-dependent myosin light chain kinae (MLCK), and of wheat embryo Ca(2+)-dependent protein kinase (CDPK) (IC50 values 3, 8, 12, and 19 microM, respectively).|piceatannol|PKC|9|44.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|255
15044619|Inhibitors of MRP1 (sulfinpyrazone, verapamil) and GST (dicumarol, curcumin) completely reversed the GSTM1-associated resistance to VCR, indicating that a MRP efflux function is necessary to potentiate GSTM1-mediated resistance to VCR.|sulfinpyrazone|MRP1|5|3.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|256
19119014|  Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.|methazolamide|CA|38|18.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|257
10682715|Iontophoresis of +/- propranolol, whose serotonergic actions include antagonism and partial agonism at 5-HT1 receptors, also increased serotonin and decreased firing (n=4).|+/- propranolol|5-HT1|3|15.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST|258
19057128|MMP-2 and MMP-9 expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and captopril inhibited them.|captopril|MMP-2|16|1.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|259
16926278|Binding of cGMP to GAF-A increases cNPK phosphorylation of PDE5 and improves catalytic site affinity for cGMP or inhibitors.|cGMP|GAF-A|3|5.0|Arg1:T15|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR|260
17046555|Inhibition of PKC by treatment of the cells with calphostin C, GF10923X, and LY379196 totally suppressed AGE-mediated p47phox translocation and ROS generation.|LY379196|p47phox|16|20.0|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|261
15765929|We studied the in vitro effect of piclamilast (RP73401), a selective phosphodiesterase (PDE)-4 inhibitor, compared to theophylline and prednisolone, on respiratory burst of sputum cells from mild asthmatics and COPD patients.|piclamilast|phosphodiesterase (PDE)-4|8|15.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|262
10089512|In order to address one aspect of the feasibility of performing time-resolved studies on AChE, a data set has been collected using the Laue technique on a trigonal crystal of Torpedo californica AChE soaked with the reversible inhibitor edrophonium, using a total X-ray exposure time of 24 ms.|edrophonium|Torpedo californica AChE|40|32.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR|263
3440035|The most potent compound, D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid (lorglumide, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini.|lorglumide|CCK|20|43.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|264
17899080|To improve FVIII secretion, a 14-amino-acid-long polypeptide with (G3) or without (G0; control) three N-linked glycosylation consensus sites was inserted upstream of the NH(2) terminus of a B-domain deleted FVIII protein.|NH(2)|FVIII|30|39.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|PART-OF|265
23284002|In conclusion, this study provides the first evidence implicating that TSA inhibits TGF-β-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-ARE signaling.|TSA|ARE|12|23.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|266
19203467|RESULTS: Both PLZ and VIG inhibited GABA-T and elevated GABA levels.|PLZ|GABA-T|4|8.0|Arg1:T46|Arg2:T77|CHEMICAL|GENE-Y|INHIBITOR|267
10401556|Combined concentration-ratio analysis demonstrated that tamsulosin, which does not discriminate between alpha 1A- and alpha 1L-adrenoceptors, and RS-17053 competed for binding at the same site in the SMA.|tamsulosin|alpha 1L-adrenoceptors|6|16.0|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|DIRECT-REGULATOR|268
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|1,2,3,7,8-pentachlorodibenzo-p-dioxin|vtg1|10|16.0|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|269
11489456|In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).|d-fenfluramine|5-HT2A|8|37.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|AGONIST|270
23583884|This initial action was accompanied by up-regulation of cyclooxygenase-2 (COX-2), an important inflammation marker within 1h after TCDD treatment.|TCDD|COX-2|21|11.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|271
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|SR141716A|CB(1)|119|99.0|Arg1:T32|Arg2:T49|CHEMICAL|GENE-Y|ANTAGONIST|272
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Ezrin|32|21.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|273
16298345|  The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel CCR5 antagonists, such as maraviroc (UK-427,857).|maraviroc|CCR5|26|21.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST|274
22982445|Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice.|Leukotriene D4|CysLT₁ R|1|9.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR|275
12498985|DEM caused a rapid (5-30 min) phosphorylation of p38(MAPK).|DEM|MAPK|1|13.0|Arg1:T23|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|276
23473803|Our data suggest that moexipril is a bona fide PDE4 inhibitor that may provide the starting point for development of novel PDE4 inhibitors with an improved therapeutic window.|moexipril|PDE4|5|10.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|277
16735460|Using site-directed mutagenesis, histidine (H), lysine (K), and arginine (R) residues of fNaDC-3 were replaced by alanine (A), isoleucine (I), or leucine (L).|lysine|fNaDC-3|10|22.0|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|PART-OF|278
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|M&B-28767|EP3|14|2.0|Arg1:T25|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR|279
23142599|To better understand chemical effects on vitellogenin gene regulation, we tested the hypothesis that activation of the aryl hydrocarbon receptor 2 (AHR2) by dioxin inhibits the estrogen receptor pathway regulation of 3 vitellogenin genes (vtg1-3) in vivo, using zebrafish (Danio rerio) as a model teleost.|dioxin|aryl hydrocarbon receptor 2|27|19.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR|280
23312283|FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor (FXR), a bile acid-activated nuclear receptor.|bile acid|farnesoid X receptor|23|15.0|Arg1:T13|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR|281
20605094|The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors.|adamantyl|human isoform II|14|7.0|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|282
1666931|Mononuclear leukocyte beta 2-adrenergic receptor densities (and binding affinities), measured with 125I-labelled pindolol, and isoproterenol-stimulated cyclic AMP accumulation, in samples from patients with insulin-dependent diabetes mellitus (IDDM) with diabetic autonomic neuropathy (n = 8), were no different from those in samples from patients with IDDM without neuropathy (n = 8), or from non-diabetic subjects (n = 8).|isoproterenol|beta 2-adrenergic receptor|19|3.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|283
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Rac-3|32|13.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|284
23212742|With human hepatocytes, treatment with phenobarbital, hyperforin, carbamazepine, and rifampin significantly increased the levels of CYP3A4, but not CYP24A1 or CYP27B1 mRNA.|carbamazepine|CYP3A4|11|20.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|285
23373444|Zr(IV) increased Hb binding constant to α-ZrP by 43-fold, and affinity enhancements followed the trend Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III).|Zr(IV)|Hb|1|6.0|Arg1:T42|Arg2:T66|CHEMICAL|GENE-N|DIRECT-REGULATOR|286
10683249|  Quinone oxidoreductases are flavoproteins that catalyze two-electron reduction and detoxification of quinones.|quinones|Quinone oxidoreductases|12|1.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE|287
16819260|  Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of nuclear hormone receptor superfamily.|Retinoid|nuclear hormone receptor|1|32.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR|288
8930173|  To identify selective compounds for nonadrenergic I1-imidazoline receptors (I1), the affinities of 22 ligands for [125I]p-iodoclonidine binding have been compared at human platelet I1-imidazoline binding sites (analyzed under norepinephrine mask of alpha-2 AR) and at human alpha-2A, alpha-2B and alpha-2C adrenoceptors stably expressed on transfected Chinese hamster ovary cells.|[125I]p-iodoclonidine|human platelet I1-imidazoline binding sites|19|28.0|Arg1:T2|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR|289
23527529|IPI-926 is both a substrate and inhibitor (IC50 = 1.9 µM) of P-glycoprotein.|IPI-926|P-glycoprotein|1|15.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|SUBSTRATE|290
17112405|Pranlukast, ketamine and edaravone decreased NMDA-induced injury; pranlukast (0.1 mg/kg) and ketamine inhibited the upregulated expression of the CysLT1 receptor.|ketamine|CysLT1 receptor|16|23.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|291
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|N|PDE5Delta1-321|17|23.0|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|PART-OF|292
10200320|15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus.|15d-PGJ2|NFkappaB|1|24.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|293
23639249|In the present study, using in vitro Th17 differentiation model, we examined effects of AhR activation by indoxyl 3-sulfate (I3S), a uremic toxin, on Th17 differentiation and investigated underlying mechanisms.|indoxyl 3-sulfate|AhR|20|17.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR|294
23317165|Modifications on the imidazole scaffold have led to a large amount of potent p38α MAP kinase inhibitors.|imidazole|p38α|4|14.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|295
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|betaine|GAT2|8|28.0|Arg1:T21|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|296
17168665|Other FASN inhibitors such as the cerulenin derivative C75, the beta-lactone orlistat, the green tea polyphenol epigallocatechin-3-gallate (EGCG) and other naturally occurring flavonoids (i.e., luteolin, quercetin, and kaempferol), as well as the antibiotic triclosan, have been identified and have been shown to limit cancer cell growth by inducing apoptotic cell death.|EGCG|FASN|21|2.0|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|297
11716850|  Mitiglinide (KAD-1229), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells.|KAD-1229|insulin|3|15.0|Arg1:T15|Arg2:T62|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|298
12172398|  PURPOSE: The effect of gemfibrozil is mediated by the activation of peroxisome proliferator-activated receptor alpha (PPAR alpha).|gemfibrozil|PPAR alpha|6|18.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|ACTIVATOR|299
12065695|Rheumatoid synovial cells expressed PPARgamma mRNA, and the PPARgamma ligands 15-deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone reduced the proliferation and induced apoptosis in synovial cells.|troglitazone|PPARgamma|22|10.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|300
23557993|During differentiation, DPHD promoted early expression of osteoblast transcription factors, RUNX2 and osterix.|DPHD|osterix|4|15.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|301
15358979|In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.|olanzapine|D2-like receptor|9|19.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|302
23639538|A dihydrochalcone and several homoisoflavonoids from Polygonatum odoratum are activators of adenosine monophosphate-activated protein kinase.|homoisoflavonoids|adenosine monophosphate-activated protein kinase|5|12.0|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|303
23246471|Poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-b-PCL) micelles were loaded with paclitaxel (cytotoxic agent), cyclopamine (hedgehog inhibitor), and gossypol (Bcl-2 inhibitor).|gossypol|Bcl-2|30|32.0|Arg1:T18|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|304
23592780|Human albumin serum (HSA) is the most abundant protein in plasma and is glycated by glucose.|glucose|HSA|18|5.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|305
8808167|  Ebastine is a long-acting nonsedating second generation histamine H1 receptor antagonist which binds preferentially to peripheral H1 receptors in vivo.|Ebastine|H1 receptors|1|17.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|306
11785774|COX-1 and COX-2 inhibitor, piroxicam (0.02 and 0.2 microg) and compound NS-398 (0.01 and 0.1 microg), respectively, were given intracerebroventricularly (i.c.v.) 15 min prior to i.c.v. adrenergic receptor agonists: phenylephrine (30 microg) and clonidine (10 microg), an alpha1- and alpha2-adrenergic agonist, and isoprenaline (20 microg) a non-selective beta-adrenergic agonist and clenbuterol (10 microg) a selective beta2-adrenergic agonist.|clenbuterol|adrenergic receptor|71|38.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|AGONIST|307
16627864|METHODS: Anesthetized rats received either Ringer's (Vehicle/Shock), 10 microg/kg/min of the beta(1)-adrenoceptor agonist dobutamine (Dob/Shock), or 10 microg/kg/min dobutamine and 500 microg/kg/min of the beta(1)-adrenoceptor antagonist esmolol (Dob/Esmolol/Shock) for 6 h.|dobutamine|beta(1)-adrenoceptor|23|17.0|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|AGONIST|308
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|TIC|MRP2|9|28.0|Arg1:T20|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|309
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|3β-hydroxysteroid dehydrogenase|6|32.0|Arg1:T21|Arg2:T45|CHEMICAL|GENE-N|INHIBITOR|310
17475673|In conclusion, immortalized SHR and WKY PTE cells take up l-alanine mainly through a high-affinity Na(+)-dependent amino acid transporter, with functional features of ASCT2 transport.|l-alanine|ASCT2|12|30.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|311
20497523|Next, effects of ER agonists (ethinyl-estradiol, an ERalpha selective agonist (ERA-63) and a selective ERbeta agonist (ERB-79) on the development of a tetanus toxoid (TT)-specific delayed type hypersensitivity response in wild type (WT) and in ERalpha- or ERbeta-deficient mice were investigated.|ERA-63|ERalpha|15|11.0|Arg1:T16|Arg2:T41|CHEMICAL|GENE-Y|AGONIST|312
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|AVM|P-gp|4|13.0|Arg1:T17|Arg2:T47|CHEMICAL|GENE-N|ACTIVATOR|313
23353701|Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.|AdOx|SAHH|6|19.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|314
9581512|Interaction with calmodulin may contribute to the inhibition of MLCK and CDPK by piceatannol.|piceatannol|MLCK|14|10.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|315
23523101|The protective effect of HSYA can be significantly attenuated by GW9662 via blocking PPARγ (p<0.05 or p<0.01).|GW9662|PPARγ|11|14.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|316
14629008|TMP caused induction of DnaK, DnaJ, GroEL, ClpB, and IbpA/B Hsps.|TMP|ClpB|1|11.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|ACTIVATOR|317
23621381|Areas covered: An extensive literature search was performed to analyze clinical cases of acute pancreatitis reported in the literature or to the Food and Drug Administration (FDA), in randomized clinical trials, and in observational studies with five DPP-4 inhibitors: sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin.|sitagliptin|DPP-4|46|43.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|318
17979301|Affinity of V782A for cGMP, vardenafil, sildenafil, tadalafil, or IBMX was reduced 5.5-, 23-, 10-, 3-, and 12-fold, respectively.|IBMX|V782A|14|3.0|Arg1:T13|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|319
11698075|These data indicate that a [3H]dofetilide binding assay using HERG membranes may help identify compounds that prolong the QT interval.|[3H]dofetilide|HERG|6|13.0|Arg1:T15|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|320
12411515|In conclusion, halothane, isoflurane and sevoflurane inhibit complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain.|isoflurane|NADH:ubiquinone oxidoreductase|6|13.0|Arg1:T10|Arg2:T48|CHEMICAL|GENE-N|INHIBITOR|321
17284757|OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of FADS2 affects the PUFA biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid (ALA) on myocardial infarction (MI).|alpha-linolenic acid|FADS2|31|19.0|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|322
17619763|Sutent and sorafenib are orally available inhibitors of the VEGFR and platelet derived growth factor receptor (PDGFR).|sorafenib|PDGFR|3|18.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|323
23500659|Furthermore, SIL significantly protected against testosterone-provoked decline in mRNA expression of P21(WAF1/Cip1) and Bax/Bcl-xl ratio as well as caspase-3 activity.|testosterone|caspase-3|7|23.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|324
16396637|An increase in liver ApoB mRNA correlated with an 82% and 46% increase in ApoB and triacylglycerol production respectively using in vivo Triton WR 1339.|Triton WR 1339|ApoB|25|17.0|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|325
10688973|The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent nociceptin receptor agonists.|piperidines|nociceptin receptor|3|17.0|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|AGONIST|326
11330337|"However, fasciculin-2, a potent peptide inhibitor of acetylcholinesterase (IC50 24 nM), did prevent catabolism of acetylcholine in rat brain membranes with an atypical inhibition isotherm of [3H]-oxotremorine-M binding, thus permitting an estimation of the ""global affinity"" of acetylcholine (Ki 85 nM) for [3H]-oxotremorine-M-labelled muscarinic receptors in rat brain."|[3H]-oxotremorine-M|muscarinic receptors|56|60.0|Arg1:T23|Arg2:T50|CHEMICAL|GENE-N|DIRECT-REGULATOR|327
23371303|Although not a β-lactam, the chemical structure of avibactam closely resembles portions of the cephem bicyclic ring system, and avibactam has been shown to bond covalently to β-lactamases.|avibactam|β-lactamases|22|30.0|Arg1:T41|Arg2:T59|CHEMICAL|GENE-N|DIRECT-REGULATOR|328
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AR|23|15.0|Arg1:T5|Arg2:T31|CHEMICAL|GENE-Y|PART-OF|329
14761877|The effects of activin A and DHT to increase PSA production were synergistic or additive.|DHT|PSA|7|10.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|330
23295227|  Only one crystal structure is currently available for tumor marker AKR1B10, complexed with NADP(+) and tolrestat, which is an aldose reductase inhibitor (ARI) of the carboxylic acid type.|tolrestat|AKR1B10|20|11.0|Arg1:T1|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR|331
23601990|The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase.|hydroxyl|CEase|8|29.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|332
17008880|Taken together, vitamin C uptake is increased in UVB-irradiated keratinocytes through the translocation of SVCT-1 and regulates inflammatory response in the skin via the downregulation of IL-8 and MCP-1 production.|vitamin C|MCP-1|4|30.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|333
23291264|Urinary levels of KIM-1 also increased 3-fold after cisplatin administration.|cisplatin|KIM-1|9|4.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|334
14610216|hOAT1 and hOAT3, but not hOAT2 and hOAT4 mediated the uptake of furosemide.|furosemide|hOAT1|14|1.0|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|335
9622938|  delta 1-pyrroline 5-carboxylate synthetase (P5C synthetase) catalyzes the ATP and the NAD(P)H-dependent conversion of L-glutamate to glutamate semialdehyde (GSA) which is the metabolic precursor for proline biosynthesis.|GSA|P5C synthetase|26|6.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF|336
17223000|METHODS: The effect of leukotriene D(4) and the leukotriene receptor antagonist, pranlukast hydrate (ONO-1078) on the regulation of MUC2/5AC gene expression and mucin secretion were observed in human airway NCI-H292 epithelial cells.|ONO-1078|leukotriene receptor|20|13.0|Arg1:T12|Arg2:T29|CHEMICAL|GENE-N|ANTAGONIST|337
9521275|Treatment using a combination of testosterone and the aromatase inhibitor testolactone may have significantly better effects on sexual function and also seizure frequency than testosterone alone.|testolactone|aromatase|11|9.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|338
23645677|The inhibitors KN-92 and H89 were able to block both pathways in mutant TRPC6 expressing cells, as well as the prolonged elevation of intracellular calcium levels upon carbachol stimulation seen in these cells.|carbachol|TRPC6|29|14.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR|339
9730867|The observed inhibition on IFN-gamma, GM-CSF, and IL-3 mRNA was blocked by the selective beta2AR antagonist ICI 118,551 (10(-6) M) and by timolol (10(-6) M), a nonselective antagonist.|timolol|GM-CSF|30|7.0|Arg1:T1|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|340
17327402|  The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.|gamma-carboxyglutamic acid|gamma-carboxylase|8|20.0|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF|341
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|growth-factor receptor tyrosine kinase|1|23.0|Arg1:T2|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR|342
11406192|In contrast, the structurally unrelated AMPA receptor potentiator CX 516 did not inhibit [(3)H]LY395153 binding at concentrations of up to 600 microM.|[(3)H]LY395153|AMPA receptor|15|7.0|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|343
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|Cabozantinib|MET|1|14.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|344
23384967|  Bisphenol A (BPA) and diethylstilbestrol (DES) are endocrine-disrupting chemicals that interact with the human pregnane X receptor (PXR).|DES|human pregnane X receptor|9|18.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|345
17389249|The data can be explained with a model in which the D439N mutation results in a dramatic slowing of Na(+) binding and a reduced affinity of the substrate-bound EAAC1 for Na(+).|Na(+)|EAAC1|34|32.0|Arg1:T11|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|346
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|phenethylamine|DAT|20|26.0|Arg1:T9|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR|347
9497025|The three D4-selective compounds, CP-293,019 (5.6-17.8 mg/kg), U-101,387 (3-30 mg/kg) and L-745,870 (1-10 mg/kg), also significantly blocked the losses in PPI produced by apomorphine.|L-745,870|D4|18|3.0|Arg1:T12|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|348
15306222|The affinity rank order and pKi values of ARs for carvedilol were as follows: alpha1D-AR (8.9)>alpha1B-AR (8.6)>beta1-AR (8.4)>beta2-AR (8.0)>alpha1A-AR (7.9)?alpha2C-AR (5.9)>alpha2B-AR (5.5)>alpha2A-AR (5.3).|carvedilol|beta2-AR|11|31.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|349
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|Probenecid|ATPase|1|16.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR|350
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile|insulin|10|50.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|351
22846225|The myristoylated ζ-pseudosubstrate peptide, ZIP, potently inhibits PKMζ biochemically in vitro, within cultured cells, and within neurons in hippocampal slices, and reverses LTP maintenance and erases long-term memory storage.|myristoylated ζ-pseudosubstrate peptide|PKMζ|2|10.0|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|352
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|pregnenolone|3 beta-HSD|21|11.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE|353
15132128|  PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (TP) inside target tissues.|5-fluorouracil|thymidine phosphorylase|12|17.0|Arg1:T10|Arg2:T43|CHEMICAL|GENE-Y|PRODUCT-OF|354
9254673|The results show that (1) smaller diameter TG neurons (<30 microm) respond to L-glutamate and kainate, and the currents gated by kainate desensitize with prolonged agonist exposure; (2) all kainate receptor subunits are detected to some extent by reverse transcriptase-PCR, whereas glutamate receptor subunits GluR5 and KA-2 are expressed at high levels in the TG; (3) there is an obvious similarity between the features of native kainate receptor channels in TG neurons and of heteromeric recombinant GluR5(R)/KA-2 channels in pharmacological properties, desensitization, rectification, ion permeability, and mean channel conductance; and (4) the age-dependent increase in GluR5 and KA-2 RNA levels in the TG is correlated well with an increased number of kainate-sensitive cells during postnatal development.|kainate|KA-2|136|122.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|355
23265191|Here, by comparing the biochemical and spectroscopic properties of quaternary (ISCU/NFS1/ISD11/FXN) and ternary (ISCU/NFS1/ISD11) complexes, we show that FXN stabilizes the quaternary complex and controls iron entry to the complex through activation of cysteine desulfurization.|cysteine|ISCU|40|13.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|PART-OF|356
9587031|Methylenetetrahydrofolate reductase deficiency impairs methyltetrahydrofolate synthesis, defects in cytosolic reduction of hydroxocobalamin (CblC/D) impair the synthesis of both methyl- and adenosyl cobalamin and deficiencies of methionine synthase (CblE/G) are associated with defective methyl cobalamin synthesis.|methyl cobalamin|methionine synthase|38|29.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF|357
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|KA|KATI|10|16.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF|358
23535185|Galangin decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8.|Galangin|interleukin|1|18.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|359
11893059|Donepezil hydrochloride inaugurates a new class of AChE inhibitors with longer and more selective action and with manageable adverse effects.|Donepezil hydrochloride|AChE|1|8.0|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR|360
23142789|Transient receptor potential cation channel, subfamily V, member 6 (TRPV6) and transient receptor potential cation channel, subfamily V, member 5 (TRPV5) are Ca entry channels responsible for Ca absorption in the kidney and intestine, respectively.|Ca|TRPV6|36|13.0|Arg1:T30|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE|361
23615073|Result showed that vitamin C treatment resulted in markedly reduced c-Rel nuclear translocation.|vitamin C|c-Rel|4|11.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|362
23339625|Time-dependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats.|dexamethasone|cytochrome P450 3A|15|9.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|363
17139155|OPH catalyzes the hydrolysis reaction of organophosphorus compounds to produce electrochemically active compounds such as p-nitrophenol and thiols from parathion and VX, respectively.|p-nitrophenol|OPH|16|1.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|PRODUCT-OF|364
9398183|The Y337 (F330) in mammalian acetylcholinesterase, which is replaced by A328 in human butyrylcholinesterase, is implicated in the binding of ligands such as huperzine A, edrophonium, and acridines and one end of bisquaternary compounds such as BW284C51 and decamethonium.|acridines|acetylcholinesterase|34|8.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|DIRECT-REGULATOR|365
23612487|S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.|S1P|glycogen synthase kinase-3β|1|16.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|366
1868500|Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.|fibric acids|low-density lipoproteins|4|24.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|367
16579965|Finally, TAP1 over-expressing cells accumulated alpha-TOS at higher levels compared to their normal counterparts.|alpha-TOS|TAP1|7|3.0|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|368
6319437|Since both TFP and W-7 are potent inhibitors of calmodulin, we investigated the possibility that inhibition of calmodulin was responsible for the loss of receptors.|W-7|calmodulin|5|10.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|369
23183084|Altogether, our data in this Z-12 cell model suggest that the beneficial effects of treatment with progestin observed in endometriosis patients might arise from decreased pre-receptor metabolism of the protective progesterone by the SRD5A1 and AKR1C enzymes.|progesterone|SRD5A1|32|35.0|Arg1:T13|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE|370
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|tumor necrosis factor-α|5|42.0|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|371
23085120|All these results suggest that B12H substantially protected CGNs against glutamate-induced neuronal excitotoxicity via activating α7nAChR/PI3-K/Akt cascade.|glutamate|Akt|11|17.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|372
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|ICA|EAG|19|25.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|373
17373776|The E1013D variant showed coupling between glutamine hydrolysis at the glutaminase site and 2-oxoglutarate-dependent L-glutamate synthesis at the synthase site, but a sigmoid dependence of initial velocity on L-glutamine concentration.|glutamine|E1013D|7|2.0|Arg1:T18|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE|374
23148920|The NaHS-induced eNOS phosphorylation and NO production were not affected by a PI3K/Akt inhibitor (wortmannin).|wortmannin|Akt|16|14.0|Arg1:T8|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR|375
16547010|Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase.|HQL-79|human hematopoietic prostaglandin D synthase|6|13.0|Arg1:T25|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|376
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|IKK-beta|1|30.0|Arg1:T18|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|377
23212742|With human hepatocytes, treatment with phenobarbital, hyperforin, carbamazepine, and rifampin significantly increased the levels of CYP3A4, but not CYP24A1 or CYP27B1 mRNA.|phenobarbital|CYP3A4|7|20.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|378
23478802|We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted cysteines crucial for electrophile activation (C621S, C641S, C665S).|serine|C621S|19|26.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|PART-OF|379
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|MCP-1|1|15.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|380
17289088|  Lymphocytes possess the essential components of a cholinergic system, including acetylcholine (ACh); choline acetyltransferase (ChAT), its synthesizing enzyme; and both muscarinic and nicotinic ACh receptors (mAChRs and nAChRs, respectively).|ACh|ChAT|14|20.0|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF|381
11959556|Cefditoren showed no difference in PBP affinity based on penicillin or cefditoren MICs, indicating a different PBP target for this agent.|Cefditoren|PBP|1|6.0|Arg1:T7|Arg2:T39|CHEMICAL|GENE-N|DIRECT-REGULATOR|382
23551063|UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-glucuronic acid than the other UGTs. 5.|UDP|UGTs|14|19.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE|383
12927226|RESULTS: Eprosartan tended to lower mean AP, it slightly increased heart rate (HR) (p<0.05), and markedly increased circulating Ang-II levels (p<0.01).|Eprosartan|Ang-II|3|28.0|Arg1:T11|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|384
17442055|The novel KAT had a pH optimum of 8.0 and a low capacity to transaminate glutamine or alpha-aminoadipate (the classic substrates of KAT I and KAT II, respectively).|alpha-aminoadipate|KAT II|18|27.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|385
23410161|Finally, compounds derived from the xanthine scaffold afford neuroprotection in Parkinson's disease through mechanisms that include dual adenosine A2A receptor antagonism and MAO-B inhibition.|xanthine|adenosine A2A receptor|7|20.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|386
23293300|In human hepatocytes, BOC inhibited CYP3A-mediated metabolism of midazolam, OATP1B-mediated hepatic uptake of pitavastatin, and both the uptake and metabolism of atorvastatin.|BOC|CYP3A|5|7.0|Arg1:T13|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|387
17185414|NVP-TAE684 also induced down-regulation of CD30 expression, suggesting that CD30 may be used as a biomarker of therapeutic NPM-ALK kinase activity inhibition.|NVP-TAE684|CD30|1|11.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|388
12907443|Weekly subcutaneous decitabine produces cumulative increases in HbF and total hemoglobin through a noncytotoxic mechanism of action.|decitabine|HbF|3|8.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|389
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|hexestrol|estrogen receptor|11|34.0|Arg1:T7|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|390
10898598|In mice, POCl(3) inhibits serum butyrylcholinesterase (BuChE) at a sublethal dose and muscle but not brain AChE at a lethal dose.|POCl(3)|BuChE|4|12.0|Arg1:T23|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|391
23598363|Our findings indicate that imatinib protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.|imatinib|BAX|5|22.0|Arg1:T7|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|392
23229510|We identified one compound, E235 (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide), that activated the ISR and dose-dependently increased levels of ATF4 in transformed cells.|E235|ATF4|6|36.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|393
23376608|In the presence of apigenin, diminution of p38 and p53 did not affect cell survival although apigenin activated the phosphorylation of p38 and p53 via increased c-Myc levels.|apigenin|c-Myc|18|28.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|394
19531491|The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin.|GTP|insulin|16|21.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|395
23519392|Computational docking studies combined with site-direct mutagenesis identified several key residues within the ligand binding pocket of PXR that constitute points of interaction with amprenavir.|amprenavir|PXR|25|18.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|396
23416191|Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.|HJC0123|STAT3|7|13.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|397
23521080|One exception is tranexamic acid (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to fibrin.|lysine|fibrin|14|22.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|398
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|rhodamine 123|P-gp|24|22.0|Arg1:T18|Arg2:T49|CHEMICAL|GENE-N|SUBSTRATE|399
23473803|  PDE4 is one of eleven known cyclic nucleotide phosphodiesterase families and plays a pivotal role in mediating hydrolytic degradation of the important cyclic nucleotide second messenger, cyclic 3'5' adenosine monophosphate (cAMP).|cyclic 3'5' adenosine monophosphate|PDE4|28|1.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|400
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|diazepam|AChE|34|14.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|401
7909690|The reaction, N-carbamyl-L-aspartate-->L-dihydroorotate (CA-asp-->DHO) catalyzed by malarial dihydroorotase is inhibited by L-6-thiodihydroorotate (TDHO) in vitro (Ki = 6.5 microM), and TDHO, as the free acid or methyl ester, induces a major accumulation of CA-asp in malaria.|CA-asp|malarial dihydroorotase|9|16.0|Arg1:T24|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|402
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|carbidopa|AAAD|16|14.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|403
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|glutathione|Slc25a11|38|25.0|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|404
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|DMI|beta2-AR|43|24.0|Arg1:T20|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|405
17185414|NVP-TAE684 treatment resulted in a rapid and sustained inhibition of phosphorylation of NPM-ALK and its downstream effectors and subsequent induction of apoptosis and cell cycle arrest.|NVP-TAE684|ALK|1|14.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|406
17125913|In conclusion, our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.|Cd|kinases|8|22.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|407
23256819|Second, in order to study the response of RHE to chemical sensitizers, the ((13)C)methyldodecanesulfonate was chosen as an NMR probe, and we compared adducts formed on human serum albumin (HSA) in solution and adducts formed in RHE.|((13)C)methyldodecanesulfonate|HSA|16|40.0|Arg1:T9|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|408
10082498|At 4 hours, losartan blocked 43% of the Ang II-induced systolic blood pressure increase; valsartan, 51%; and irbesartan, 88% (P<0.01 between drugs).|valsartan|Ang II|18|11.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|409
20517484|Rasagiline is a novel, potent, and irreversible monoamine oxidase type B (MAO-B) inhibitor which has been approved for treatment of PD.|Rasagiline|monoamine oxidase type B|1|10.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR|410
18079279|DHEA induced both PPARalpha mRNA and protein levels, as well as PP2A message in primary rat hepatocytes.|DHEA|PPARalpha|1|4.0|Arg1:T20|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|411
15481993|  The synthesis and pharmacological evaluation of new water-soluble phosphoramidate derivatives of the COX-2 selective inhibitor cimicoxib (4) are described.|phosphoramidate|COX-2|9|13.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|412
23284002|Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.|Trichostatin A|NF-E2-related factor 2|1|16.0|Arg1:T24|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|413
17645691|These included, biliverdin-IX alpha reductase and the sodium-dependent vitamin C transport proteins SVCT1 and SVCT2, whose expression levels were enhanced in maternal and fetal liver by melatonin treatment.|melatonin|SVCT1|29|14.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|414
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|TMAO|FMO3|29|12.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF|415
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|adrenaline|phenylalanine hydroxylase|3|16.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|416
8102973|It was found that clozapine is selective for the dopamine D4 vs.|clozapine|dopamine D4|5|10.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|417
23435541|In these MR clusters, NADPH oxidase subunits gp91(phox) and p47(phox) were aggregated and were markedly blocked by both statins.|statins|gp91(phox)|26|9.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|418
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|FADS|28|46.0|Arg1:T10|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|419
15252033|The PPACK-bound structure of W215A/E217A is identical to the structure of the PPACK-bound slow form of thrombin.|PPACK|E217A|2|6.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR|420
22750078|THPP-1 significantly increased phosphorylation of proteins in the striatum involved in synaptic plasticity, including the a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid receptor (AMPA) GluR1 subunit, extracellular receptor kinase (ERK), and cAMP-response element binding protein (CREB).|THPP-1|amino-3-hydroxy-5-methylisoxazole-4-proprionic acid receptor|1|18.0|Arg1:T13|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|421
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|carbetocin|OT|25|27.0|Arg1:T11|Arg2:T48|CHEMICAL|GENE-Y|AGONIST|422
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|MDA|human recombinant 5-HT2B receptors|34|42.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR|423
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|vardenafil|L765A|7|18.0|Arg1:T15|Arg2:T46|CHEMICAL|GENE-N|DIRECT-REGULATOR|424
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|collagen|1|16.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|425
16765071|  We have previously reported on the formation of 6-nitrotryptophan by the reaction of reactive nitrogen species with a tryptophan residue in human Cu, Zn-superoxide dismutase (SOD) (F.|6-nitrotryptophan|SOD|9|28.0|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|PART-OF|426
17602574|However, upon addition of NO to CDO in the presence of substrate l-cysteine, a low-spin {FeNO}7 (S = 1/2) signal that accounts for approximately 85% of the iron within the enzyme develops.|l-cysteine|CDO|14|8.0|Arg1:T3|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE|427
11723241|To gain further insight into the binding site, we examined the minimal structural changes necessary to transform low-affinity binding of dofetilide by the related bovine ether a-go-go channel bEAG to high-affinity binding of HERG.|dofetilide|bEAG|22|30.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|428
17089011|SK-Br3 cells cultured in the presence of topoisomerase IIalpha (TOP2A) inhibitors doxorubicin and etopoxide (VP-16) demonstrated a 2- to 3-fold increase in FAS promoter activity when compared with control cells growing in drug-free culture conditions.|etopoxide|topoisomerase IIalpha|16|8.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|429
12840797|  Erlotinib HCl (Tarceva; Genentech, Inc, South San Francisco, CA) is an orally available, highly selective, reversible inhibitor of epidermal growth factor receptor (HER1/EGFR) tyrosine kinase.|Erlotinib HCl|HER1|1|32.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|430
17355958|Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity.|cysteines|human cytosolic and mitochondrial glutaredoxins|5|7.0|Arg1:T25|Arg2:T38|CHEMICAL|GENE-N|PART-OF|431
23032515|This compound also produced a dose-dependent decrease in the expression of apoptotic proteins (cleaved PARP and caspase-3) induced by l-buthionine-(S,R)-sulfoximine (BSO) plus glutamate and stimulated glutathione and glutathione S-transferase activity.|BSO|caspase-3|30|18.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|432
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|catalase|4|24.0|Arg1:T27|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR|433
9730867|Concanavalin A (Con A)-induced IFN-gamma, GM-CSF, and IL-3 mRNAs are dose-dependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol.|fenoterol|beta2AR|30|28.0|Arg1:T9|Arg2:T45|CHEMICAL|GENE-Y|AGONIST|434
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|glycine|5-Aminolevulinic acid synthase|23|1.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|435
15132128|5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).|5-FU|TS|1|11.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|436
15572277|Aminophylline and DPCPX but not 8pSPT also reversed the protective action of A1/A2 adenosine receptor agonist, 2-chloroadenosine (2-CADO) and selective A1 adenosine receptor agonist, R-N6-phenylisopropyloadenosine (R-PIA), against 3-NPA-evoked convulsions.|R-PIA|A1 adenosine receptor|31|24.0|Arg1:T27|Arg2:T41|CHEMICAL|GENE-Y|AGONIST|437
15655513|In a human whole blood assay, IC(50) values for lumiracoxib were 0.13 microM for COX-2 and 67 microM for COX-1 (COX-1/COX-2 selectivity ratio 515).|lumiracoxib|COX-1|14|24.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|438
17184764|  We have previously shown that retinoic acid (RA) synthesized by the retinaldehyde dehydrogenase 2 (RALDH2) is required in forebrain development.|retinoic acid|RALDH2|6|18.0|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF|439
9587066|Gitelman's syndrome results from mutations in the SLC12A3 gene encoding the human thiazide-sensitive sodium chloride cotransporter, leading to impaired reabsorption of sodium chloride in the distal convoluted tubule.|sodium chloride|SLC12A3|24|9.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|440
23291264|Interestingly, tubular CCL2 mRNA levels increased soon after cisplatin administration, whereas CCL2 mRNA levels in whole kidney first decreased and then increased.|cisplatin|CCL2|10|14.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|441
10027835|Drugs inhibiting both MAO-A and MAO-B to a similar extent (tranylcypromine) or combinations of selective MAO-A and MAO-B inhibitors (esuprone plus LU 53439) had no advantage over MAO-A inhibition alone, but were less well tolerated.|tranylcypromine|MAO-B|12|6.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|442
23589499|3-(4'-Methoxyphenyl)-6-nitrocoumarin (15), with the same substitution pattern as that of compound 8, was found to be the most active MAO-B inhibitor of the coumarin series (IC50 =3 nM).|coumarin|MAO-B|32|28.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|443
23403203|Taken together, these findings indicate that antofine induces Cx43 gap junction disassembly by the PKCβ signaling pathway.|antofine|PKCβ|8|16.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR|444
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|putrescine|PAO|34|28.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|PRODUCT-OF|445
15102890|Reciprocally, glyburide blocked SR-BI-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 (IC(50) approximately 275-300 microM).|glyburide|SR-BI|3|5.0|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|446
17200663|Interphotoreceptor retinoid-binding protein (IRBP) is a component of the interphotoreceptor matrix (IPM) and is known to bind visual cycle retinoids.|retinoids|IRBP|24|5.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|447
8842678|MAO-A was inhibited by the following drugs (in ascending order of potency) : nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine.|maprotiline|MAO-A|22|1.0|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|448
23145773|Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis.|2,5-thiophene amides|17β-hydroxysteroid dehydrogenase type 2|4|11.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|449
23303191|Comparison of different human cell types revealed ∼50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.|UDP|Has1|37|31.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|450
20426763|As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose).|AL-34662|5HT(2C)|9|46.0|Arg1:T20|Arg2:T26|CHEMICAL|GENE-Y|AGONIST|451
17427197|  Elevated extracellular D-glucose increases transforming growth factor beta1 (TGF-beta1) release from human umbilical vein endothelium (HUVEC).|D-glucose|transforming growth factor beta1|3|5.0|Arg1:T6|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|452
23313623|Moreover, OAT1 and OAT3 are the targets of DDI between entecavir and JBP485.|JBP485|OAT3|14|5.0|Arg1:T16|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|453
18604229|The principal aim of the study was to find amiodarone analogues that retained human ether-a-go-go-related protein (hERG) channel inhibition but with reduced cytotoxicity.|amiodarone|human ether-a-go-go-related protein (hERG) channel|10|14.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|454
15369444|With the advent of newer third generation aromatase inhibitors (anastrozole, letrozole and exemestane) toxicities have been documented to be less and in some cases they are more efficacious than the standard, tamoxifen.|letrozole|aromatase|13|8.0|Arg1:T18|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|455
23295224|Biocatalytic production of alpha-hydroxy ketones and vicinal diols by yeast and human aldo-keto reductases.|alpha-hydroxy ketones|yeast and human aldo-keto reductases|4|10.0|Arg1:T18|Arg2:T36|CHEMICAL|GENE-N|PRODUCT-OF|456
22841391|Subsequently, we confirmed these proteins with the Western blotting approach, and found that methylselenol increased the expression of GADD 153 and p21 but reduced the level of c-Myc, E2F1 and Phos p38 MAP kinase.|methylselenol|GADD 153|16|21.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|457
16899342|  Voltage-dependent calcium channels (VDCCs) are heteromultimeric complexes that mediate calcium influx into cells in response to changes in membrane potential.|calcium|VDCCs|12|5.0|Arg1:T15|Arg2:T25|CHEMICAL|GENE-N|SUBSTRATE|458
23429912|This study focuses on determining whether treatment of TCDD-exposed UGS organ cultures with RSPO2 and/or RSPO3 is capable of rescuing the inhibitory effects of TCDD on canonical Wnt signaling and prostatic bud formation.|TCDD|Wnt|25|28.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|459
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|spermidine|SSAT|7|19.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|460
23046379|Immunohistochemical analysis also revealed that LPS-induced lipocalin-2 is expressed by brain endothelial cells and is partly co-localised with cyclooxygenase-2 (Cox-2), the rate-limiting enzyme for the production of inflammatory induced prostaglandin E(2) (PGE(2) ), which is the key mediator of fever.|prostaglandin E(2)|cyclooxygenase-2|33|19.0|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF|461
17526944|Dexamethasone increased DAX-1 expression and concordantly decreased StAR protein and mRNA in testicular cells.|Dexamethasone|StAR|1|8.0|Arg1:T23|Arg2:T50|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|462
16730121|Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.|ramelteon|MT1/MT2 receptor|3|10.0|Arg1:T14|Arg2:T18|CHEMICAL|GENE-N|AGONIST|463
7909690|Pyrazofurin induces accumulation of orotate and orotidine in malaria, consistent with inhibition of orotidine 5'-monophosphate (OMP) decarboxylase with subsequent dephosphorylation of the OMP accumulated.|Pyrazofurin|orotidine 5'-monophosphate (OMP) decarboxylase|1|15.0|Arg1:T4|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|464
10368299|E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized and evaluated by the Eisai Company in Japan.|N-benzylpiperidine|acetylcholinesterase|15|16.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|465
10688973|The affinity and functional profile of opioids possessing activity at the nociceptin receptor was determined using [3H]nociceptin and nociceptin-stimulated [35S]GTPgammaS binding.|[35S]GTPgammaS|nociceptin receptor|23|12.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|466
23228696|Furthermore, metformin was able to not only decrease the paclitaxel-induced p38 MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.|metformin|MAPK|3|13.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|467
23542513|  In this study, we found that 5-hydroxy-3,6,7,8,3'4'-hexamethoxyflavone (5HHMF) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase (iNOS) in BV2 microglia.|5HHMF|iNOS|12|35.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|468
16449355|In cirrhotic rats, Western blot analysis revealed a 170% increase in renal neutral endopeptidase protein content (P < 0.03), mainly in the proximal nephron and macula densa, and both candoxatrilat dosages increased plasma ANP levels, urinary volume, and urinary excretion of sodium, ANP, and cGMP compared with vehicle alone (all P < 0.03).|candoxatrilat|ANP|36|40.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|469
23117572|Expression of Na(+)/I(-) symporter (NIS (SLC5A5)), the glycoprotein responsible for iodide transport, has been demonstrated in normal testicular tissue.|iodide|NIS|23|13.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE|470
22491023|  Xanthurenic acid (XA), a molecule arising from tryptophan metabolism by transamination of 3-hydroxykynurenine, has recently been identified as an endogenous Group II (mGlu2 and mGlu3) metabotropic glutamate (mGlu) receptor ligand in vitro.|Xanthurenic acid|metabotropic glutamate (mGlu) receptor|1|32.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR|471
22619007|In addition, Silibinin caused an increase in p53 and p21 protein level as well as mRNA levels.|Silibinin|p53|4|9.0|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|472
23066988|Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by co-incubation with the AMPK inhibitor compound C.|Metformin|ghrelin|1|4.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|473
16857832|  The transsulfuration pathway, which aids in regulating homocysteine concentration and mediates cysteine synthesis, may be sensitive to vitamin B-6 status because cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CGL) require pyridoxal 5'-phosphate (PLP).|homocysteine|cystathionine gamma-lyase|9|30.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|474
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|GSH|human hematopoietic prostaglandin (PG) D synthase|25|7.0|Arg1:T5|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|475
16997906|These pyridoxal-5'-phosphate-dependent decarboxylases belong to the alanine racemase (AR) structural family together with diaminopimelate decarboxylase (DapDC), which catalyzes the final step of lysine biosynthesis in bacteria.|lysine|DapDC|28|19.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-N|PRODUCT-OF|476
10690753|Felbamate produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).|Felbamate|NR2B|1|36.0|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|477
1898092|p-Nitrophenyl acetate, substrate for esterase activity by the enzyme, partially prevented the protective effect of NAD+ against proteolysis.|p-Nitrophenyl acetate|esterase|1|6.0|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|478
8836655|Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.|ketanserin|5-HT2|13|20.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST|479
19498041|Relative agonist efficacy was measured at two points after M(3) receptor activation: the stimulation of guanosine 5'-O-(3-[(35)S]thio)triphosphate binding to G alpha subunits, and the subsequent increase in intracellular calcium levels.|guanosine 5'-O-(3-[(35)S]thio)triphosphate|G alpha|20|35.0|Arg1:T6|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR|480
19302827|This paracrine prostacyclin release, in turn, promoted differentiation and COX-2 induction in neighboring VSMC that were not exposed to iloprost.|prostacyclin|COX-2|3|12.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|481
17082235|  Most drugs currently employed in the treatment of type 2 diabetes either target the sulfonylurea receptor stimulating insulin release (sulfonylureas, glinides), or target the peroxisome proliferator-activated receptor (PPARgamma) improving insulin resistance (thiazolidinediones).|sulfonylureas|insulin|21|18.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|482
23455312|Finally, carotid artery-infusion of HENA (45 μM) dilated the pial cerebral arterioles via selective BK-channel targeting.|HENA|BK-channel|6|18.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR|483
17427197|TGF-beta1 and high D-glucose increased p42/44(mapk) and Smad2 phosphorylation, an effect blocked by PD-98059 (MEK1/2 inhibitor).|D-glucose|Smad2|4|11.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|484
11406192|The prototypic AMPA receptor potentiator cyclothiazide competitively inhibited [(3)H]LY395153 binding with a potency (K(i) approximately 7 microM) comparable to EC(50) values reported in electrophysiological studies.|cyclothiazide|AMPA receptor|6|3.0|Arg1:T3|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR|485
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|Δ(9)-tetrahydrocannabinol|CB(1)|73|9.0|Arg1:T28|Arg2:T47|CHEMICAL|GENE-Y|AGONIST|486
23122079|Moreover, use of the pharmacological AMP-activated protein kinase (AMPK) inhibitor compound C revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells.|compound C|AMPK|14|18.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|487
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|ICI 182,780|ER|1|24.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|488
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|N|caspase-3|6|22.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|489
16897483|  Alcohol dehydrogenases (ADH) participate in the biosynthetic pathway of aroma volatiles in fruit by interconverting aldehydes to alcohols and providing substrates for the formation of esters.|aldehydes|Alcohol dehydrogenases|18|1.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|490
23367873|EXPERT OPINION: JAK inhibitor therapy is entering a significant new era with the advent on the market of the JAK1/2 inhibitor ruxolitinib and the pan-JAK inhibitor tofacitinib, with unprecedented speed of development.|tofacitinib|JAK|28|27.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|491
11134654|Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.|almotriptan|5-HT receptor|4|8.0|Arg1:T26|Arg2:T40|CHEMICAL|GENE-N|AGONIST|492
23591777|On the other hand, MSM raised SOD and CAT activities as well as CYP2E1 level in liver tissues.|MSM|SOD|6|8.0|Arg1:T17|Arg2:T42|CHEMICAL|GENE-N|ACTIVATOR|493
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|(5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione|PPAR|3|52.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR|494
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|ZD6474|tyrosine kinase|25|21.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|495
7511163|  5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone (MET-CAMO) and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone (N-CPM-MET-CAMO) were tested in opioid receptor binding assays and in the mouse tail-flick test in order to characterize the affinity, selectivity and antinociceptive properties of these two compounds.|N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone|opioid receptor|17|31.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR|496
23435916|The underlying mechanism of the anti-inflammatory action of pristimerin was correlated with down-regulation of nuclear factor-κB and the mitogen-activated protein kinase signal pathway.|pristimerin|nuclear factor-κB|9|15.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|497
15554912|Eplerenone competed strongly for [(3)H]-dexamethasone binding to a MR/GR chimera containing amino acids 804-874 of the MR and weakly to a chimera containing amino acids 672-803 of the MR.|amino acids|MR|30|35.0|Arg1:T18|Arg2:T44|CHEMICAL|GENE-Y|PART-OF|498
12470615|Here, we characterize the activation of human pDC with the TLR7 agonists imiquimod and resiquimod.|resiquimod|TLR7|16|12.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|AGONIST|499
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|homochlorcyclizine|histamine H1-receptor|45|13.0|Arg1:T29|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST|500
12850267|Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs.   Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors.|KA|ionotropic glutamate receptors|16|31.0|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST|501
16973761|This suggests that Asn2.65(101) recognizes Gly10NH2 of GnRH II.|Gly10NH2|GnRH II|9|11.0|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|PART-OF|502
17408613|Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats.|irbesartan|AT1 receptor|9|6.0|Arg1:T21|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|503
23386704|This study in patients with highly variable serum levels of 25-hydroxyvitamin D could not reveal any relationship between vitamin D and 4β-hydroxycholesterol, an endogenous biomarker of CYP3A activity.|4β-hydroxycholesterol|CYP3A|22|28.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|504
11470741|  Cerivastatin is used in the treatment of hypercholesterolemia to inhibit 3-hydroxy 3-methylglutaryl coenzyme A reductase and thus prevent the synthesis of cholesterol precursors, such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), responsible, respectively, for translocation of Ras and Rho to the cell membrane, a step required for their cell signaling, leading to cell proliferation and migration.|GGPP|3-hydroxy 3-methylglutaryl coenzyme A reductase|36|11.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF|505
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|camphor|TRPA1|6|19.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR|506
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|desipramine|F316C|32|19.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|DIRECT-REGULATOR|507
15478125|An impressing number of inhibitors of STSs of the sulfamate type have been reported in the last years, with several compounds, such as 667COUMATE among others, progressing to clinical trials for the treatment of hormone-dependent tumors (breast and prostate cancers).|sulfamate|STSs|10|7.0|Arg1:T28|Arg2:T49|CHEMICAL|GENE-N|INHIBITOR|508
17228780|  Adult-onset citrullinemia (CTLN2) is a rare hereditary metabolic disorder characterized by highly increased concentration of citrulline and ammonia in the plasma, which is ascribed to a deficiency of argininosuccinate synthetase (ASS), one of the urea cycle enzymes mainly located in the liver.|citrulline|ASS|18|35.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE|509
14626653|Inhibition of PDE5 blocks the hydrolysis of cyclic guanosine monophosphate (GMPc) and results in increased arterial blood flow leading to enlargement of the corpus cavernosum and resulting in erection.|cyclic guanosine monophosphate|PDE5|8|3.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE|510
19531491|Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of GDH are inhibited by the green tea polyphenols, epigallocatechin gallate and epicatechin gallate.|epigallocatechin gallate|GDH|19|10.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|511
9374794|Under voltage-clamp conditions, cisapride block of HERG is dose dependent with a half-maximal inhibitory concentration of 6.5 nM at 22 degrees C (n = 25 cells).|cisapride|HERG|5|8.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|512
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|pyruvate|(L-serine dehydratase|22|2.0|Arg1:T2|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF|513
23391631|The results showed that Pb(2+) significantly induced cardiotoxicity and heart failure as evidenced by increase cardiac enzymes, lactate dehydrogenase and creatine kinase and changes in histopathology in vivo.|Pb(2+)|lactate dehydrogenase|5|22.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|514
10567199|RIHP and fractional excretion of sodium (FE(Na)) were measured before and after direct renal interstitial volume expansion in control rats (n=7), rats infused with the COX-1 inhibitor piroxicam (n=6, 1.5 mg/kg), and rats infused with the COX-2 inhibitors NS-398 (n=5, 1.5 mg/kg) and meloxicam (n=6, 0.3 mg/kg).|meloxicam|COX-2|59|49.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|515
23515287|These results indicate that 3β-diol induces OT promoter activity via ER-β-cHRE interactions.|3β-diol|cHRE|5|12.0|Arg1:T7|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR|516
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|PGE1|EP3|31|2.0|Arg1:T32|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR|517
9486667|Thus, our results indicate that important determinants of dofetilide binding are localized to the pore region of HERG.|dofetilide|HERG|10|19.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|518
16245075|Effects of granulocyte colony-stimulating factor (G-CSF) and neutrophil elastase inhibitor (ONO-5046) on acid-induced lung injury in rats.|ONO-5046|neutrophil elastase|14|10.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|519
15936988|Simvastatin, an HMG-CoA reductase inhibitor with mild inhibition of LFA-1, induced the production of interleukin (IL)-18, tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma in human peripheral blood mononuclear cells (PBMC).|Simvastatin|interleukin (IL)-18|1|17.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|520
23339663|Also, the inhibition of AChE by CBDP is unexpected, from a structural standpoint, i.e., considering the narrowness of AChE active site and the bulkiness of CBDP.|CBDP|AChE|30|23.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|521
12582227|db/db mice treated with DRF 2655 showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase, respectively.|DRF 2655|phosphoenolpyruvate carboxykinase|5|13.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|522
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|IL-6|30|24.0|Arg1:T15|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|523
1712335|In anesthetized spontaneously hypertensive rats, the antihypertensive activity of carvedilol was nearly abolished by combined pretreatment of the rats with high doses of the alpha 1 adrenoceptor antagonist, prazosin (1 mg/kg, iv), and the nonselective beta adrenoceptor antagonist, propranolol (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by carvedilol may be accounted for by blockade of beta and alpha 1 adrenoceptors.|prazosin|alpha 1 adrenoceptor|31|26.0|Arg1:T15|Arg2:T40|CHEMICAL|GENE-N|ANTAGONIST|524
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|24R, 25-(OH)(2)D(3)|PKC|10|26.0|Arg1:T7|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|525
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|nortriptyline|G400L|28|25.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR|526
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|lenalidomide|CRBN|7|20.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|527
23249624|Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases.|dabrafenib|V600E|13|10.0|Arg1:T15|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|528
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|lanreotide|SSTR2|16|20.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|529
17427197|TGF-beta1 and high D-glucose increased p42/44(mapk) and Smad2 phosphorylation, an effect blocked by PD-98059 (MEK1/2 inhibitor).|PD-98059|Smad2|18|11.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|530
23042953|Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.|amino acids|5A apolipoprotein|2|10.0|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|PART-OF|531
22878908|TZDs also inhibited alkaline phosphatase activity (58-75%, p<0.046) and osteocalcin production (52-75%, p<0.031).|TZDs|alkaline phosphatase|1|4.0|Arg1:T15|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|532
14626653|Contra-indications (co-administration with drugs increasing nitric oxide) and side-effects (headache and flushing due to vasodilatation) of vardenafil are similar to those of other PDE5 inhibitors.|vardenafil|PDE5|21|28.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|533
8836655|These results suggest that epinastine, although identified as a 5-HT antagonist, acts as a 5-HT1 agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional 5-HT1-like receptor, located to sensory nerves.|epinastine|5-HT1|5|17.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|AGONIST|534
12183670|To eliminate the interaction of bupropion with DAT or NET, nomifensine or desipramine, respectively, was included in the superfusion buffer.|bupropion|DAT|6|8.0|Arg1:T30|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|535
2226440|The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.|L-noradrenaline|phenylalanine hydroxylase|5|7.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|536
12085361|In complementary RNA (cRNA)-injected Xenopus laevis oocytes, rifamycin SV (10 micromol/L) cis-inhibited human organic anion transporting polypeptide C (SLC21A6) (OATP-C), human organic anion transporting polypeptide 8 (SLC21A8) (OATP8), human organic anion transporting polypeptide B (SLC21A9) (OATP-B), and human organic anion transporting polypeptide A (SLC21A3) (OATP-A) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes.|rifamycin SV|human organic anion transporting polypeptide 8|12|32.0|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|537
17884974|Ex vivo IC(50) values (COX-1: 105.2 micromol/L; COX-2: 26.3 micromol/L) of acetaminophen compared favorably with its in vitro IC(50) values.|acetaminophen|COX-1|20|9.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|538
16690332|NO rebinding in HNS from Staphylococcus aureus (SA-HNS) is faster than that measured for either Bacillus anthracis (BA-HNS) or for eNOS(HD) in both oxidized and reduced forms in the presence of arginine.|NO|SA-HNS|1|9.0|Arg1:T20|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|539
23454149|Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and p-Akt.|DMBT|p-Akt|5|18.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|540
23547652|  Small molecules bearing hydroxamic acid as the zinc binding group (ZBG) have been the most effective histone deacetylase inhibitors (HDACi) to date.|zinc|histone deacetylase|8|19.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|541
17308037|These data support the conclusion that renal ecto-phosphodiesterase activity is not mediated by PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7, PDE9, PDE10, or PDE11 and is inhibited by high concentrations of dipyridamole.|dipyridamole|phosphodiesterase|41|9.0|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|542
17553661|  4-Hydroxynonenal (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (GST) isoforms.|alpha,beta-unsaturated aldehyde|glutathione S-transferase|8|21.0|Arg1:T24|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE|543
9873034|The N-terminal oxygenase domain (amino acids 1-498; iNOSox) in each subunit binds heme, L-Arg, and tetrahydrobiopterin (H4B), is the site of NO synthesis, and is responsible for the dimeric interaction, which must occur to synthesize NO.|amino acids|iNOSox|6|10.0|Arg1:T16|Arg2:T51|CHEMICAL|GENE-Y|PART-OF|544
17125913|In conclusion, our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.|Cd|c-jun|8|29.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|545
23293300|The inhibitory potency of BOC was lower than known inhibitors of CYP3A (ketoconazole), OATP1B (rifampin), or both (telaprevir).|telaprevir|OATP1B|25|17.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|546
12837382|1,7-Heptylene-bis-N,N'-syn-2-pyridiniumaldoxime, the most potent of the alkylene-linked dimeric reactivators, was readily synthesized using bistriflate and is 100 times more potent than 2-PAM in reactivating hAChE poisoned by isoflurophate.|bistriflate|hAChE|18|29.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|547
23583259|Results from mechanistic studies indicated that rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, bound to the ligand-binding domain of hPXR, as assessed by a transactivation assay and by a competitive ligand-binding assay using time-resolved fluorescence resonance energy transfer; triggered nuclear translocation of a green fluorescence protein-tagged hPXR, as visualized by confocal imaging; and recruited steroid receptor coactivator-1 (SRC-1), SRC-2, and SRC-3 to hPXR, as demonstrated by mammalian two-hybrid assays.|rilpivirine|hPXR|7|77.0|Arg1:T28|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR|548
23605050|Our study revealed that high glucose/Fe concentrations in MIN6 cells induced an increase of the Bcl2/Bax ratio, an indicator of increased cell apoptosis.|glucose|Bax|6|17.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|549
12842269|Unlike OFQ II(1-17), high concentrations of its C-terminal extension, OFQ II(1-28), stimulated [35S]-GTPgammaS binding in a mu (mu) opioid receptor-like distribution and the effect was blocked by naloxone.|naloxone|mu (mu) opioid receptor|42|29.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|550
11488610|Changes in the accessibility of Trp residues upon pyridoxal-P binding strongly supported a significant conformational change in GAD.|pyridoxal-P|GAD|9|18.0|Arg1:T27|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|551
10365684|Exposure to MMI (1 microM and 10 microM) or PTU (10 microM and 100 microM) for 2 days caused a significant increase in cellular TPO activity; 100 microM MMI inhibited cellular TPO activity.|PTU|TPO|12|29.0|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR|552
23353701|Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.|AdOx|adenosylhomocysteine (SAH) hydrolase|6|13.0|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|553
17234158|Here, we report that the antifibrotic drug 5-methyl-1-phenyl-2-(1H)-pyridone (pirfenidone, PFD) elicits growth-inhibitory effects and reduces TGF-beta2 protein levels in human glioma cell lines.|PFD|TGF-beta2|17|24.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|554
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|carnitine|Carnitine acetyltransferases|13|1.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|555
16543605|We have cloned and characterized a CYP51 from MAC that functions as a lanosterol 14alpha-demethylase.|lanosterol|CYP51|14|7.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|556
11489456|Pre-treatment with the selective 5-HT2C receptor antagonist, SB-242084 (0.3-3 mg/kg), dose-dependently inhibited both d-fenfluramine- (3 mg/kg) and d-norfenfluramine-induced (2 mg/kg) hypophagia.|d-fenfluramine|5-HT2C|18|5.0|Arg1:T16|Arg2:T31|CHEMICAL|GENE-Y|AGONIST|557
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|dronedarone|ion channel|10|2.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|558
23551063|UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-glucuronic acid than the other UGTs. 5.|HFC|UGTs|12|19.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE|559
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|(5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione|peroxisome proliferator-activated receptor|3|48.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR|560
23416065|About 99% of a dose of diflunisal is unavailable for reaction with the target enzyme, because diflunisal strongly binds to human serum albumin (HSA).|diflunisal|HSA|19|27.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|561
12697717|All-trans-retinoic acid did not affect 17 beta HSDXI expression or activity, but addition of the retinoid together with cAMP significantly decreased activity over cAMP alone (32% vs.|cAMP|17 beta HSDXI|20|6.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|562
23339625|We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively.|DEX-P|CYP3A|39|53.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|563
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|dipeptidyl peptidase-4|1|5.0|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|564
23246867|Taken together, these data suggest that glucose-mediated activation of Cdc42 leads to activation of PAK1 and prompts activation of its downstream targets Raf-1, MEK1/2 and ERK1/2 to elicit F-actin remodeling and recruitment of insulin granules to the plasma membrane to support the sustained phase of insulin release.|glucose|Cdc42|8|11.0|Arg1:T6|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR|565
8827452|Thus, PHBP was a heterodimer composed of 50-kDa and 17-kDa subunits, bridged by a disulfide linkage.|disulfide|PHBP|17|3.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|PART-OF|566
12227806|  A streamlined and high-yielding synthesis of aprepitant (1), a potent substance P (SP) receptor antagonist, is described.|aprepitant|substance P (SP) receptor|7|14.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|ANTAGONIST|567
15843826|In addition, VEGF-induced formation of tube-like structures in vitro and neovascularization in mouse corneas were significantly inhibited by Am80.|Am80|VEGF|20|4.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|568
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|ibuprofen|PGH synthase-2|18|36.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|569
23047912|Nevertheless, low L-BMAA concentrations (≥ 0.1mM, 48 h) increased protein ubiquitination, 20S proteasomal and caspase 12 activity, expression of the endoplasmic reticulum (ER) stress marker CHOP, and enhanced phosphorylation of elf2α in SH-SY5Y cells.|L-BMAA|20S proteasomal|4|17.0|Arg1:T15|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|570
19930708|Exemestane increased EGFR activation 15 min after its application in H23 cells.|Exemestane|EGFR|1|3.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|571
22349823|They display sensitivity to TK inhibitors, including gefitinib and erlotinib.|gefitinib|TK|9|5.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|572
10727523|Probenecid and furosemide inhibited, whereas under certain conditions sulfinpyrazone, penicillin G, and indomethacin greatly stimulated, MRP2-mediated NEM-GS uptake.|penicillin G|MRP2|12|20.0|Arg1:T18|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR|573
23357361|β-Asarone regulates p15 expression by regulation of Oct-1 binding.|β-Asarone|p15|1|3.0|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|574
23416191|The most potent compound 5 (HJC0123) has demonstrated to inhibit STAT3 promoter activity, downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values.|HJC0123|STAT3|7|20.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR|575
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|oxysterols|liver X receptor|8|14.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR|576
23169610|  3-Methylcholanthrene (MC) is a readily metabolized aryl hydrocarbon receptor (AHR) agonist.|3-Methylcholanthrene|aryl hydrocarbon receptor|1|9.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|577
23448346|These results provide an example that attachment of a bulky side chain to the C-7α position of E2 can produce ER antagonists with ER affinity comparable to that of ICI-182,780.|ICI-182,780|ER|30|24.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|578
12188035|The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with rat GR, whereas BM and esterified-DEX had full transactivation agonistic activity.|DEX|rat GR|23|16.0|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR|579
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|fananserin|5-HT receptor|78|1.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST|580
22982445|LTD4 also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and NF-κB p65 in the hippocampus and cortex.|LTD4|CysLT(1)R|1|11.0|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|581
23567956|Compounds JL40 and JL432 presenting higher lipoxygenase inhibitory activity among the tested derivatives, were found to present a promising anti-inflammatory in vivo result, as well as antioxidant and LOX inhibitory profile.|JL432|lipoxygenase|4|7.0|Arg1:T21|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|582
10373224|In both vascular preparations, candesartan caused a marked decrease in the maximal contractile response of the angiotensin II (Ang II) concentration-response curve.|candesartan|Ang II|6|21.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|583
23303191|Transfected Has2 and particularly Has3 consumed enough UDP-sugars to reduce their content in COS-1 cells.|sugars|Has3|9|5.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|584
23159329|Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.|methamphetamine|CREB|4|21.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR|585
23455323|We demonstrate that activation of STAT3 serine-727 and tyrosine-705 phosphorylations is promoted by B-RAF(V600E) activity and that the Mcl-1 promoter is dependent on a STAT consensus-site for B-RAF-mediated activation.|serine|STAT3|7|6.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|PART-OF|586
19057128|MMP-2 and MMP-9 expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and captopril inhibited them.|captopril|MMP-9|16|3.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|587
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|acetyl-CoA|FAS|11|5.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|588
23306790|We found that VA upregulated the DNA binding activity of NF-κB, but that the antioxidants glutathione and N-acetyl-l-cysteine, as well as NF-κB inhibitor MG132, and mutant-IκB (m-IκB) transfection, significantly downregulated VA/TRAIL-induced cell death by inhibiting caspase-3 and NF-κB activities.|MG132|caspase-3|26|42.0|Arg1:T4|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|589
23547652|Subsequent optimization led to several novel 3HPT-based HDACi that are selective for HDAC 6 and HDAC 8.|3HPT|HDAC 8|7|16.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|590
23028140|During long-term treatment with imatinib 400 mg once or twice daily, up to 65 or 75% of its hepatic elimination was predicted to occur via CYP2C8, and only about 35 or 25% by CYP3A4, due to dose- and time-dependent autoinactivation of CYP3A4 by imatinib.|imatinib|CYP2C8|5|28.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|591
23643631|Melamine activates NFκB/COX-2/PGE2 pathway and increases NADPH oxidase-dependent ROS production in macrophages and human embryonic kidney cells.|Melamine|NFκB|1|3.0|Arg1:T16|Arg2:T33|CHEMICAL|GENE-N|ACTIVATOR|592
10475242|Here, we report the characterization of a PPARgamma specific monoclonal antibody (MAb), PgammaA53.25, and its use to monitor PPARgamma expression in the noncommitted pluripotent murine mesenchymal stem cell line, C3H10T1/2, treated with TZDs. MAb PgammaA53.25 was raised against a region in the N-terminal domain of human PPARgamma shared by splice variants PPARgamma1 and PPARgamma2.|N|human PPARgamma|51|54.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|PART-OF|593
20089905|Ibuprofen activates PPARgamma in neuron-like PC12 and B104 cells.|Ibuprofen|PPARgamma|1|3.0|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR|594
23558747|We analysed the role of the MBD in MeCP2-chromatin associations in vivo using an MeCP2 mutant Rett syndrome mouse model (Mecp2(tm)(1)(.)(1)(Jae)) in which exon 3 deletion results in an N-terminal truncation of the protein, including most of the MBD.|N|Mecp2|47|22.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|PART-OF|595
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|risperidone|5-HT2A|11|1.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST|596
23376120|Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-κB and MAPKs activation via the phosphatidylinositol 3-kinase signaling.|Gastrodin|NF-κB|1|13.0|Arg1:T15|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR|597
10421446|With DEPQ-inhibited wild-type mouse acetylcholinesterase (AChE), the reactivation kinetic profile demonstrated one-phase exponential association only when 2-[hydroxyimino methyl]-1-methylpyridinium chloride (2-PAM) and 1-(2-hydroxy-iminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridi nium)-dimethyl ether hydrochloride (HI-6) were used as reactivators.|DEPQ|AChE|2|7.0|Arg1:T18|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|598
23220609|The in vivo estrogenicity of BzP was supported by in vitro results from the human estrogen receptor α (hERα)-coactivator recruiting assay and in silico molecular docking analysis performed in this study.|BzP|hERα|6|20.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR|599
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|EP1|10|7.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|600
23296101|Furthermore, sensitization to FITC is also enhanced by menthol, which activates TRPA1 and TRPM8.|FITC|TRPM8|5|16.0|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR|601
23435916|Similarly, pristimerin inhibited the release of pro-inflammatory cytokines, namely, tumor necrosis factor-α and interleukin-6, induced by LPS.|pristimerin|interleukin-6|3|17.0|Arg1:T9|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|602
9497025|The three D4-selective compounds, CP-293,019 (5.6-17.8 mg/kg), U-101,387 (3-30 mg/kg) and L-745,870 (1-10 mg/kg), also significantly blocked the losses in PPI produced by apomorphine.|U-101,387|D4|12|3.0|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|603
23526814|  Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (HDAC) inhibitors.|pyrrole|HDAC|5|33.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR|604
23568856|  The dopamine transporter (DAT) is a sodium-coupled symporter protein responsible for modulating the concentration of extraneuronal dopamine in the brain.|dopamine|DAT|19|5.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|605
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|dasatinib|ABL|8|23.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|606
16899342|The drugs gabapentin and pregabalin interact with the alpha2delta subunit of the P/Q-type VDCCs. Gabapentin and pregabalin slow the rate of inactivation in recombinant P/Q-type VDCCs, expressed in Xenopus oocytes.|Gabapentin|P/Q-type VDCCs|16|26.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR|607
15771438|Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II.|sulfamide|human CA-II|17|26.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|608
23284002|Human immortalized corneal fibroblasts were treated with TGF-β in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) activator sulforaphane, or small interfering RNA.|diphenyleneiodonium|NAD(P)H oxidase|23|16.0|Arg1:T15|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR|609
12470615|Results indicate that imiquimod and resiquimod induce IFN-alpha and IFN-omega from purified pDC, and pDC are the principle IFN-producing cells in the blood.|imiquimod|IFN-alpha|4|8.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|610
23085979|Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced Cx43 protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner.|TCDD|Cx43|15|27.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|611
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|Bax|30|26.0|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|612
15892618|Other promising new drugs currently under preclinical and clinical evaluation, are VEGFR2 inhibitor PTK787/ZK 222584, thalidomide, farnesyl transferase inhibitor R115777 (tipifarnib, Zarnestra(TM)), matrix metalloproteinase inhibitors, proteasome inhibitor bortezomib (Velcade(TM)), mammalian target of rapamycin (mTOR) inhibitors, cyclooxygenase-2 (COX-2) inhibitors, platelet derived growth factor receptor (PDGF-R) inhibitors, protein kinase C (PKC) inhibitors, mitogen-activated protein kinase kinase (MEK) 1/2 inhibitors, Rous sarcoma virus transforming oncogene (SRC) kinase inhibitors, histondeacetylase (HDAC) inhibitors, small hypoxia-inducible factor (HIF) inhibitors, aurora kinase inhibitors, hedgehog inhibitors, and TGF-beta signalling inhibitors.|bortezomib|proteasome|39|37.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|613
19683471|  Insulin receptor substrates (IRS) serine phosphorylation is a time-controlled physiological feedback mechanism in insulin signaling that is hijacked by metabolic and inflammatory stresses to promote insulin resistance.|serine|IRS|7|5.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|PART-OF|614
23064031|NFD abrogated EGF-induced phosphorylation of EGF receptor (EGFR) and phosphatidylinositol 3-kinase (PI3K)/Akt.|NFD|PI3K|1|15.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|615
15887238|Imatinib stimulated the rapid release of soluble HB-EGF and the subsequent induction of membrane-bound HB-EGF, which correlated with biphasic MAPK activation.|Imatinib|HB-EGF|1|15.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|616
23291559|Here, we have determined the molecular mechanism of this male-specific activation of the Kcnk1 gene and characterized KCNK1 as a phenobarbital-inducible antihyperplasia factor.|phenobarbital|KCNK1|22|19.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|617
23064031|Furthermore, the EGFR inhibitor AG1478 inhibited EGF-induced MMP-9 expression, cell migration and invasion, as well as the activation of PI3K/Akt, suggesting that PI3K/Akt activation occur downstream of EGFR activation.|AG1478|PI3K|6|27.0|Arg1:T10|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|618
12842269|Unlike OFQ II(1-17), high concentrations of its C-terminal extension, OFQ II(1-28), stimulated [35S]-GTPgammaS binding in a mu (mu) opioid receptor-like distribution and the effect was blocked by naloxone.|C|OFQ II(1-17)|12|2.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|PART-OF|619
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|efavirenz|CYP3A4|6|19.0|Arg1:T5|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|620
23535287|A luciferase reporter assay also demonstrated that CSA-activated signaling resulted in the increased transcriptional activity of Nrf2 through binding to the antioxidant response element (ARE) enhancer sequence.|CSA|antioxidant response element|8|22.0|Arg1:T11|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|621
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|BMS-354825|SRC|10|20.0|Arg1:T19|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|622
22982776|  Human liver prolidase, a metal-dependent dipeptidase, is being tested as a potential catalytic bioscavenger against organophosphorus (OP) chemical warfare nerve agents.|organophosphorus|dipeptidase|18|7.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|SUBSTRATE|623
23434506|WS-CoQ10 did not alter the mRNA expression levels of Tp53 (at a concentration of 1.0μgmL(-1)) and exhibited neuroprotective activity by stimulating cisplatin-inhibited neurite outgrowth in nerve growth factor (NGF)-differentiated PC12 cells (at a concentration of 0.1μgmL(-1)).|cisplatin|NGF|27|35.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|624
20204178|Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed PTH mRNA expression and serum PTH effectively in the 5/6 NX rats, but paricalcitol was less potent in raising serum Ca than doxercalciferol.|doxercalciferol|PTH|35|12.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|625
17194716|Validation of this pharmacophore was performed by predicting the IC(50) of a test set of commercially available (n = 19) and CP-320626-related (n = 48) CYP51 inhibitors.|CP-320626|CYP51|27|33.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|626
11444497|Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.|irbesartan|AT1-receptor|8|4.0|Arg1:T16|Arg2:T28|CHEMICAL|GENE-N|ANTAGONIST|627
10340919|METHODS: COX-1 inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).|meloxicam|COX-1|30|3.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|628
12569076|  1 The principal aim of the present study was to determine whether long-term treatment of human lung mast cells (HLMC) with the clinically-relevant beta(2)-adrenoceptor agonists, salbutamol and terbutaline, leads to desensitization of beta(2)-adrenoceptor-mediated responses in these cells.|salbutamol|beta(2)-adrenoceptor|33|26.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|629
18773878|RTX treatment also induced foci of RAD51, gamma-H2AX, phospho-Chk1, and phospho-NBS1, although the extent of co-localization with RPA2 foci varied.|RTX|gamma-H2AX|1|9.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|630
17645691|Melatonin or silymarin also reduced OCP-induced signs of apoptosis (increased caspase-3 activity and Bax-alpha upregulation) in all the organs assayed.|Melatonin|caspase-3|1|12.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|631
23322164|Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.|acylcarnitines|Carnitine palmitoyltransferase 2|16|1.0|Arg1:T23|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF|632
10381000|To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase (TPH), the rate-limiting enzyme in 5-HT biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR).|5-HT|tryptophan hydroxylase|26|16.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF|633
17075268|Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats.|Dexamethasone|HDC|1|12.0|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|634
11695891|A small-molecule inhibitor of NOS (3-Br-7-nitroindazole, 7-NIBr) is profoundly neuroprotective in mouse models of stroke and Parkinson's disease.|3-Br-7-nitroindazole|NOS|7|5.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|635
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|PDGFR|1|17.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|636
15655513|In a human whole blood assay, IC(50) values for lumiracoxib were 0.13 microM for COX-2 and 67 microM for COX-1 (COX-1/COX-2 selectivity ratio 515).|lumiracoxib|COX-1|14|26.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|637
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|benzamidine|plasmin|12|8.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|638
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AKR1B10|24|18.0|Arg1:T6|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|639
23261524|The reduction of BiFC signal mediated by nutlin-3 was correlated with an increase in Puma transactivation, PARP cleavage, and cell death.|nutlin-3|PARP|8|18.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|640
23524313|Elevated levels of total cholesterol and LDL-cholesterol, along with hepatic cholesterol content in a high fat group were found to be significantly reduced by fisetin.|fisetin|LDL|26|7.0|Arg1:T12|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|641
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kushenol H|DGAT|24|52.0|Arg1:T19|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|642
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|1,2,3,7,8-pentachlorodibenzo-p-dioxin|vtg3|10|20.0|Arg1:T11|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|643
22815248|A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after CCl4 and PC administration alone.|CCl4|LDH|35|14.0|Arg1:T22|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|644
23526814|  Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (HDAC) inhibitors.|tert-butylcarbamate|histone deacetylase|23|30.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|645
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|diclofenac|COX|27|6.0|Arg1:T12|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR|646
7665369|Ergovaline inhibition of the binding of the D2-specific radioligand, [3H]YM-09151-2, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas dopamine was much less potent (370 +/- 160 nM).|[3H]YM-09151-2|D2|11|8.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|647
23475432|Glutathione-S-transferase, a phase II enzyme, was inhibited by both arsenic and nicotine but no such inhibition was noted in arsenic-treated animals pre-exposed to nicotine.|nicotine|Glutathione-S-transferase|14|1.0|Arg1:T22|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|648
23071106|Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca(2+) channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells.|gliclazide|Insulin|12|1.0|Arg1:T21|Arg2:T48|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|649
12213059|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (54) was found to bind and activate the SUR1/Kir6.2 K(ATP) channels in the low nanomolar range and to be at least 1000 times more potent than the reference compound diazoxide with respect to inhibition of insulin release from rat islets.|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|insulin|1|51.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|650
1929324|Strain JR4 (erg3 erg11), which produces 14-methylfecosterol [14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol) as the major sterol in the presence or absence of fenpropimorph, was also found to be resistant to the drug.|14-methylfecosterol|erg3|10|4.0|Arg1:T23|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF|651
16230360|At micromolar concentrations, procainamide was found to be a partial competitive inhibitor of DNMT1, reducing the affinity of the enzyme for its two substrates, hemimethylated DNA and S-adenosyl-l-methionine.|procainamide|DNMT1|5|15.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|652
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|RAGE|1|37.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|653
12646997|The potencies of selectivity of icariin and papaverine on PDE5 (PDE4/PDE5 of IC(50)) were 167.67 times and 4.54 times, respectively.|icariin|PDE5|6|13.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|654
23561191|In this study, we investigated if ω- and β-oxidation mediate catabolism of the AR homologue C19:0 to form 3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), using 3 in vitro platforms, human cytochrome P450 4F2 (CYP4F2), human liver S9, and HepG2 cells.|DHPPA|CYP4F2|30|44.0|Arg1:T5|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF|655
23333834|The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.|YR-11|TRAP|3|36.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|656
17253779|Unlike mouse RetSat (mRetSat), zRetSat A had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or all-trans-7,8-dihydroretinol, respectively.|all-trans-7,8-dihydroretinol|zRetSat A|30|8.0|Arg1:T3|Arg2:T47|CHEMICAL|GENE-Y|PRODUCT-OF|657
23446230|Moreover, overexpressed CYP2J2 and EETs inhibited Ang II-induced macrophage migration in a VSMC-macrophage coculture system.|EETs|Ang II|6|8.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|658
16926278|Truncated proteins with a complete GAF-B were dimers, but those lacking the N-terminal 46 amino acids of GAF-B were monomers, indicating that these residues are vital for GAF-B-mediated PDE5 dimerization.|amino acids|GAF-B|16|19.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-N|PART-OF|659
23632005|Our results showed that cisplatin increased the levels of oxidant parameters such as lipid peroxidation (thio barbituric acid reactive substance (TBARS)) and myeloperoxidase (MPO) in brain tissue and suppressed the effects of antioxidants such as total glutathione (GSH) and superoxide dismutase (SOD).|cisplatin|SOD|5|51.0|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|660
23142547|Deletion analysis revealed that the C-terminal 21-amino acid sequence of Rev1 is uniquely required for its interaction with Rad5 and is essential for its non-catalytic function.|C|Rev1|6|11.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|PART-OF|661
16627864|Blockade of the HO pathway after preconditioning and the combined pretreatment with dobutamine and esmolol decreased PDR(ICG) (Dob/SnMP/Shock: 12.6 +/- 4.24%/min, p = 0.011; Dob/Esmolol/Shock: 10.2 +/- 4.34%/min, p = 0.008).|esmolo|HO|15|4.0|Arg1:T6|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|662
9399970|In pigeons trained to discriminate 1.7 mg/kg dezocine from saline, a series of opioids with activity at the mu opioid receptor substituted completely for the dezocine stimulus with a rank order of potency similar to that obtained in other assays sensitive to the effects of mu agonists (i.e., fentanyl >[-]-cyclazocine >buprenorphine = butorphanol >l-methadone >nalbuphine >[-]-metazocine >morphine).|morphine|mu opioid receptor|72|20.0|Arg1:T34|Arg2:T47|CHEMICAL|GENE-N|AGONIST|663
23388095|We examined the effects of PHD inhibiton by dimethyloxalylglycine on the vasomotor responses of isolated rat aorta and aortic vascular smooth muscle cells (VSMCs) in a model of cold ischemia/warm reperfusion.|dimethyloxalylglycine|PHD|9|6.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|664
10898598|Most importantly, POCl(3)-induced electric eel AChE inhibition prevents postlabeling with [(3)H]diisopropyl phosphorofluoridate; i.e., both compounds phosphorylate at Ser-200 in the catalytic triad.|POCl(3)|electric eel AChE|4|9.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|665
17337452|Taken together, these results demonstrate that for hHint1; 1) the efficiency (k(cat)/K(m)) of acylated AMP hydrolysis, but not maximal catalytic turnover (k(cat)), is dependent on homodimerization and 2) the hydrolysis of lysyl-AMP generated by LysRS is not dependent on homodimerization if the monomer structure is similar to the wild-type structure.|lysyl-AMP|LysRS|52|55.0|Arg1:T7|Arg2:T33|CHEMICAL|GENE-Y|PRODUCT-OF|666
23086198|Cell homogenates prepared from human embryonic kidney (HEK)293 cells overexpressing wild-type UGT2A2 (termed UGT2A2_i1) exhibited glucuronidation activity, as observed by reverse-phase ultra-pressure liquid chromatography, against 1-hydroxy-(OH)-pyrene, 1-naphthol, and hydroxylated benzo(a)pyrene metabolites, whereas homogenates prepared from HEK293 cells overexpressing UGT2A3 only showed activity against simple PAHs like 1-OH-pyrene and 1-naphthol.|hydroxylated benzo(a)pyrene|UGT2A2|42|15.0|Arg1:T4|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|667
23297412|In cultured cardiomyocytes, cardiomyocyte hypertrophy induced by the α(1)-agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol, both of which down-regulated p300 protein levels but not p300 mRNA levels.|resveratrol|p300|26|32.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|668
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-isopropylamino|K(ATP) channels|11|51.0|Arg1:T16|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|669
9614060|Increased Cat3-mediated cationic amino acid transport functionally compensates in Cat1 knockout cell lines.|amino acid|Cat3|4|2.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE|670
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-serine|L-serine dehydratase|24|1.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|671
10449190|Only 1R,2S-ephedrine showed significant agonist activity on human beta3-AR with an EC50 = 45 betaM and a maximal response of 31%.|1R,2S-ephedrine|human beta3-AR|2|8.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|AGONIST|672
1472079|In addition, in rat microsome incubations, the net amount of 4-OHCIPC glucuronide was also indirectly increased by cadmium through a reduction in the activity of beta-glucuronidase.|4-OHCIPC glucuronide|beta-glucuronidase|13|28.0|Arg1:T22|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE|673
11578145|PAD is an inhibitor of S-adenosylhomocysteinase (EC 3.3.1.1), which is necessary for conversion of SeMet to SeCyH.|SeMet|EC 3.3.1.1|18|8.0|Arg1:T1|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE|674
17513393|Because Cu deficiency results in upregulation of Gclc and an increase in the biosynthesis of glutathione, it is plausible that the net flux of homocysteine through the transsulfuration pathway is increased.|homocysteine|Gclc|26|8.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|675
8676079|IL-1, TNF alpha, PGE2, parathyroid hormone (PTH) and 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) similarly induced production of IL-11 by osteoblasts, but IL-6, IL-4, and TGF beta did not.|1 alpha,25-dihydroxyvitamin D3|IL-11|14|29.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|676
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|bepridil|NCX|12|25.0|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|677
1327384|The affinities derived for these antagonists against [3H]-RS-15385-197 were similar to the values obtained for the displacement of [3H]-yohimbine indicating the alpha 2-adrenoceptor nature of the binding site.|[3H]-yohimbine|alpha 2-adrenoceptor|22|28.0|Arg1:T3|Arg2:T39|CHEMICAL|GENE-N|DIRECT-REGULATOR|678
17334413|(2) Does in vivo administration of (R)-(alpha)-(-)-methylhistamine dihydrobromide (RAMH) (H3R agonist), thioperamide maleate (H3R antagonist) or histamine, in the absence/presence of thioperamide maleate, to bile duct ligated (BDL) rats regulate cholangiocyte proliferation?|(R)-(alpha)-(-)-methylhistamine dihydrobromide|H3R|9|26.0|Arg1:T20|Arg2:T48|CHEMICAL|GENE-Y|AGONIST|679
23583931|MRS2179, a P2Y1R blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles ATP activates P2Y1 but not P2X receptors.|ATP|P2Y1|22|24.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|680
23220614|While SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by ISO.|SB203580|p38|9|12.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|681
18055877|Carbimazole inhibited NF-kappaB via the small GTPase Rac-1, whereas propylthiouracil inhibited the phosphorylation of IkappaBalpha by its kinase inhibitor of kappaB kinase alpha.|propylthiouracil|IkappaBalpha|11|16.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|682
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|alpha 2-macroglobulin receptor|30|13.0|Arg1:T2|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR|683
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-(S)-sec-butylamino|K(ATP) channels|16|51.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|684
8646863|The pharmacologic properties of fluticasone propionate-including high lipophilicity, high selectivity and affinity for the glucocorticoid receptor, low systemic absorption, and rapid metabolism and clearance-combine to give fluticasone propionate a high therapeutic index.|fluticasone propionate|glucocorticoid receptor|5|16.0|Arg1:T2|Arg2:T5|CHEMICAL|GENE-Y|DIRECT-REGULATOR|685
23345579|After aging and digestion with pepsin at pH 2, peptide FGES198AGAAS from Sp-tabun thiocholine had a mass of 902.2 m/z in negative mode, indicating that it had aged by deamination, whereas peptide FGES198AGAAS from Rp-tabun thiocholine had a mass of 874.2 m/z in negative mode, indicating that it had aged by O-dealkylation.|Rp-tabun thiocholine|pepsin|38|6.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|686
23229509|Exchange of domains between the two isoforms indicates that the C1b domain and the N-terminus of the C1a domain are important for directing selective regulation of AC7 by the G(13) pathway.|N|C1a domain|15|18.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PART-OF|687
23394205|Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.|4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole|ATR protein kinase|3|33.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|688
1403790|Other serotonergic compounds failed to produce substantial clozapine-appropriate responding: the 5-HT3 antagonist, ondansetron; the 5-HT1A agonists, (+-)-8-hydroxy-2-(di-n-propylamino)tetralin and BMY 14802; the 5-HT1A/1B agonist, RU24969; the 5-HT1A partial agonist, NAN190; the 5-HT1C/2 antagonist, mesulergine; the 5-HT1 agonist, I-5-hydroxytryptophane; and the 5-HT1C/2 agonist, quipazine.|ondansetron|5-HT3|15|12.0|Arg1:T38|Arg2:T58|CHEMICAL|GENE-N|ANTAGONIST|689
11006278|However, inter-helical distances calculated and determined by EPR for PGHS-2 complexed with arachidonic acid, flurbiprofen, and SC-58125 were in close agreement with those obtained from the cognate crystal structures.|flurbiprofen|PGHS-2|17|11.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|690
9563368|The resulting half-life of the FP active steroid-receptor complex is >10 hours, compared with approximately 5, 7.5, and 4 hours for budesonide, 17-BMP, and triamcinolone acetonide, respectively.|triamcinolone acetonide|steroid-receptor|31|8.0|Arg1:T3|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR|691
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFP|COX-1|7|17.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|692
23086748|We found that Ag NPs were highly cytotoxic to hepatocytes (LC(50) lactate dehydrogenase: 2.5 μg/cm(2)) and affected hepatocyte homeostasis by reducing albumin release.|Ag|albumin|4|31.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|693
23353698|ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.|quercetin|pleiotropic kinase|22|19.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|694
1687367|At beta 1-adrenoceptors, the affinity of the compound RR-SR was about 3 times that of labetalol.5. As labetalol is a mixture of active (RR and SR) and inactive (SS and SR) enantiomers (in terms of alpha and beta receptor actions), the combination of RR and SR may be a valuable substitute for labetalol in the treatment of systemic hypertension.|labetalol|beta 1-adrenoceptors|17|2.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|695
23384446|Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.|CPA|SERCA|43|58.0|Arg1:T22|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|696
11118042|Sulindac sulfide inhibits cyclooxygenase (COX) enzyme activities and has been reported to suppress ras-dependent signaling.|Sulindac sulfide|ras|1|16.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|697
12183691|Several organic anions such as valproate, as well as organic cations, significantly inhibited carnitine and TEA uptake by OCTN2, and valproate showed Na(+)-dependent inhibition of OCTN2-mediated TEA uptake.|valproate|OCTN2|24|33.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|698
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|3β-hydroxyl|estrogen receptor-α|25|39.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|699
12110374|It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.|indomethacin|cyclooxygenase|14|8.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|700
1712335|We therefore conclude that carvedilol, at antihypertensive doses, is an antagonist of beta 1, beta 2, and alpha 1 adrenoceptors, and also of calcium channels in vascular smooth muscle.(ABSTRACT TRUNCATED AT 400 WORDS)|carvedilol|calcium channels|5|29.0|Arg1:T19|Arg2:T44|CHEMICAL|GENE-N|ANTAGONIST|701
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|acetazolamide|MCA|12|51.0|Arg1:T6|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|702
12063169|These results indicate that hOAT4 mediates the high-affinity transport of OTA on the apical side of the proximal tubule, whereas the transport characteristics of OTA are distinct from those by basolateral OATs.|OTA|hOAT4|26|5.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|703
1407010|  Radioligand binding studies were performed in membranes of rabbit whole brain and striatum using the novel iodinated radioligand for 5-hydroxytryptamine 5-HT1B and 5-HT1D sites, Serotonin-5-O-Carboxymethyl-Glycyl[125I]Tyrosinamide ([125I]GTI).|[125I]GTI|5-hydroxytryptamine 5-HT1B|34|21.0|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|704
17038304|Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT).|Biotin|sodium-dependent multivitamin transporter|1|11.0|Arg1:T24|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|705
7853212|Histamine H1 receptor antagonists (mepyramine, diphenhydramine, chlorpheniramine and triprolidine) inhibited the lidocaine 3-hydroxylation activity catalyzed by P450 2D1 but did not inhibit the testosterone hydroxylation activities catalyzed by P450s other than P450 2D forms.|testosterone|P450 2D|28|36.0|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|SUBSTRATE|706
23434506|WS-CoQ10 did not alter the mRNA expression levels of Tp53 (at a concentration of 1.0μgmL(-1)) and exhibited neuroprotective activity by stimulating cisplatin-inhibited neurite outgrowth in nerve growth factor (NGF)-differentiated PC12 cells (at a concentration of 0.1μgmL(-1)).|CoQ10|NGF|2|35.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR|707
23319419|ICA-105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels.|ICA-105574|ERG|1|18.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR|708
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|diethylstilbestrol|estrogen receptor|9|34.0|Arg1:T6|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|709
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT3|61|49.0|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|710
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|fulvestrant|ER|4|24.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|711
12141946|Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin.|flavin|spermine oxidase|7|8.0|Arg1:T29|Arg2:T47|CHEMICAL|GENE-N|PART-OF|712
11393267|Reactivation potentials of BuChE (the difference between oxime-reactivated and -unreactivated enzyme activity) declined significantly with time after organophosphate ingestion.|oxime|BuChE|9|4.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|713
17498508|Incretin-receptor activation leads to glucose-dependent insulin secretion, induction of beta-cell proliferation, and enhanced resistance to apoptosis.|glucose|insulin|5|6.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|714
9760035|Both carbetocin, carbetocin metabolite I and carbetocin metabolite II displayed binding affinities to the myometrial oxytocin receptor of a similar magnitude as oxytocin.|carbetocin|oxytocin receptor|8|17.0|Arg1:T26|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|715
9138687|A-61603, a selective agonist at alpha 1A adrenoceptors behaved as a full agonist relative to NA and yielded monophasic E/[A] curves with a p[A50] of 7.59 +/- 0.04 (n = 15).||alpha 1A adrenoceptors|17|7.0|Arg1:T32|Arg2:T43|CHEMICAL|GENE-Y|AGONIST|716
3094574|Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.|3,4-dihydroxymandelate|Tyrosinase|8|1.0|Arg1:T26|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|717
16702329|GW9662, a PPARgamma antagonist, prevented (P < 0.01) the lutein-induced iNOS mRNA downregulation in HD11 cells.|GW9662|iNOS|1|15.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|718
23604717|Furthermore, SAL-2 inhibited HNE-induced activation of mitogen-activated protein kinases.|SAL-2|mitogen-activated protein kinases|3|8.0|Arg1:T21|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR|719
11481271|The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), ARC239 (alpha(2B)- and alpha(2C)-selective), and prazosin (alpha(2B)- and alpha(2C)-selective).|ARC239|alpha(2B)|21|23.0|Arg1:T21|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST|720
12531805|SU11248 is a recently described selective inhibitor with selectivity for split kinase domain RTKs, including platelet-derived growth factor receptors, vascular endothelial growth factor receptors, and KIT.|SU11248|vascular endothelial growth factor receptors|1|22.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|721
10381787|In contrast, the administration of 7.5 and 15 mg of meloxicam caused dose-dependent reductions in monocyte COX-2 activity by 51% and 70%, respectively, and in platelet COX-1 activity by 25% and 35%, respectively.|meloxicam|COX-1|12|32.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|722
23122161|Rosemary extract and its hexane fraction are important for the prevention of phosphorylation of MAPKs, thereby blocking NF-kB activation, which in turn leads to decreased expression of iNOS and COX-2, thus preventing inflammation.|hexane|NF-kB|5|19.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|723
23444386|Studies on the kinetics of the hSULT2A1-catalyzed sulfation of dehydroepiandrosterone (DHEA) showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme.|DHEA|hSULT2A1|12|7.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|724
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|GST|4|49.0|Arg1:T27|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|725
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|L-deprenyl|MAO-B|15|26.0|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|726
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|beta-alanine|GAT3|5|23.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|727
8986981|Peripheral intravenous injections of WB 4101 (a competitive alpha 1A-adrenoceptor antagonist), but not clorethylclonidine (CEC, an alpha 1B-adrenoceptor antagonist), significantly blunted (P < .05, ANOVA) the mesenteric vasoconstrictor responses to methoxamine.|WB 4101|alpha 1A-adrenoceptor|5|10.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ANTAGONIST|728
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|Raf|1|10.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|729
23194750|Compounds bearing the thiazolidinedione structure have also been shown to inhibit phosphoinositide 3-kinase (PI3K).|thiazolidinedione|phosphoinositide 3-kinase|4|12.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|730
23288144|Our results showed that SUN induced the CYP1A1 mRNA, protein, and activity levels in a concentration-dependent manner in MCF7 cells.|SUN|CYP1A1|5|8.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|731
15840408|ONO-AE1-259-01 a prostanoid EP2-receptor agonist, ONO-AE1-329, a prostanoid EP4-receptor agonist, and ONO-1301 inhibited TNF-alpha production and T-cell proliferation.|ONO-AE1-259|prostanoid EP2-receptor|1|3.0|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|732
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|V654A|24|11.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR|733
11078056|Selective COX-2 inhibitors, such as meloxicam, celecoxib (SC-58635), and rofecoxib (MK-0966), are NSAIDs that have been modified chemically to preferentially inhibit COX-2 but not COX-1.|SC-58635|COX-2|11|2.0|Arg1:T13|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|734
1407010|The pharmacological profile of [125I]GTI binding was fully comparable to that reported previously in human and other brain preparations known to possess 5-HT1D sites (using either [3H]5-HT or [125I]GTI) and displayed a characteristic rank order of affinity: 5-carboxamido-tryptamine greater than 5-HT = dihydroergotamine greater than or equal to ergotamine greater than or equal to sumatriptan greater than or equal to CGS 12066 greater than or equal to metergoline greater than yohimbine greater than or equal to methysergide greater than ICYP greater than 8-OH-DPAT greater than or equal to CP 93129 greater than (-)pindolol greater than ketanserin greater than isamoltane greater than mesulergine greater than corynanthine greater than buspirone greater than MDL 72222.|CGS 12066|5-HT1D|74|27.0|Arg1:T28|Arg2:T41|CHEMICAL|GENE-N|DIRECT-REGULATOR|735
23478802|Electrophilic chemicals activate both insect and vertebrate TRPA1 via covalent modification of cysteine residues in the amino-terminal region.|cysteine|TRPA1|13|8.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|PART-OF|736
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|AXL|3|47.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|737
12615691|Anesthetized rabbits were treated with the selective P2Y12 antagonists AR-C69931 MX (3 microg x kg x min(-1) IV) or clopidogrel (25 mg/kg orally).|clopidogrel|P2Y12|25|8.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST|738
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|erlotinib|tyrosine kinase|37|31.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|739
23567241|Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent ERα and ERβ agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.|parabens|ERβ|3|31.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|AGONIST|740
18393142|This overview focuses on the indirect antithrombin dependent pentasaccharide derivatives of idraparinux and on the most advanced oral direct inhibitors to factor Xa (rivaroxaban and apixaban) and IIa (dabigatran).|rivaroxaban|factor Xa|25|22.0|Arg1:T4|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|741
12601049|RESULTS: At concentrations devoid of cytotoxicity, budesonide inhibited VEGF secretion as well as mRNA expression in ARPE-19 cells in a dose-dependent manner.|budesonide|VEGF|9|11.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|742
23229512|Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis.|Vitamin K2|Bak|1|9.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|743
10683249|The mNQO activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 2,6-dichlorophenolindophenol and menadione.|2,6-dichlorophenolindophenol|mNQO|19|2.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE|744
1744096|Studies with 14 different Cbl analogues with alterations in various portions of the corrin ring and the nucleotide showed that all of the analogues were able to fully activate human methionine synthase when they were reduced with 2-mercaptoethanol.|Cbl|human methionine synthase|5|30.0|Arg1:T2|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR|745
23632082|This conductance was suppressed by nonselective TRPC channel blockers 2-APB, flufenamic acid and ML204, enhanced by La(3+) in a subpopulation of cells, and unchanged by the TRPV1 antagonist capsazepine or a Na(+) /Ca(2+) exchanger blocker KB-R7943.|flufenamic acid|TRPC|12|7.0|Arg1:T3|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|746
23416002|Amino acid derived quinazolines as Rock/PKA inhibitors.|quinazolines|Rock|4|6.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|747
12085361|Inhibition of human liver OATPs can explain the previously observed effects of rifamycin SV and rifampicin on hepatic organic anion elimination.|rifamycin SV|human liver OATPs|13|3.0|Arg1:T12|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR|748
3917545|Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone.|phenylbutazone|prostaglandin H synthase|10|3.0|Arg1:T34|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR|749
10548525|Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.|rosiglitazone|peroxisome proliferator-activated receptor gamma|14|9.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR|750
17349707|The specific activity of bGlcNAc 2-epimerase (124Umg(-1) protein) for the conversion of N-acetyl-d-glucosamine to N-acetyl-d-manosamine was about four-fold higher than that of porcine N-acetyl-d-glucosamine 2-epimerase.|N-acetyl-d-manosamine|bGlcNAc 2-epimerase|20|5.0|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|751
11861317|In contrast, pregnanolone sulphate (3alpha5betaS), a negative modulator of the NMDA receptor that acts at a distinct site from PS, inhibited all four subtypes, but was approximately 4 fold more potent at NR1/NR2C and NR1/NR2D than at NR1/NR2A and NR1/NR2B receptors.|pregnanolone sulphate (3alpha5betaS)|NR2B|4|47.0|Arg1:T22|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|752
23287710|In conclusion our in vitro results demonstrate that exposure to high doses of glycidamide/acrylamide - exceeding the dietary exposure of the general population by far - can induce genes with growth promoting potential like the oncogene cMYC and genes involved in the MAPK pathway.|acrylamide|MAPK|15|43.0|Arg1:T6|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|753
23001627|SOD levels of serum and hippocampus tissue were significantly increased and MDA levels were significantly decreased in the PTU + Vit E and PTU + L-T4 + Vit E groups than the PTU and PTU + L-T4 groups.|Vit E|SOD|21|1.0|Arg1:T11|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|754
2112956|Since four other human acyl-CoA dehydrogenases did not dehydrogenate isobutyryl-CoA, 2-methylbutyryl-CoA (obligatory intermediates from valine and isoleucine, respectively) nor valproyl-CoA, it is reasonable to assume that valproyl-CoA is dehydrogenated by 2-methyl-branch-chain acyl-CoA dehydrogenase in man as well.|valproyl-CoA|2-methyl-branch-chain acyl-CoA dehydrogenase|32|36.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|755
10405348|Cytokines, such as interleukin 6 (IL-6) and tumour necrosis factor alpha (TNFalpha) or prostaglandin E(2) (PGE(2)), can stimulate aromatase activity.|PGE(2)|aromatase|25|33.0|Arg1:T8|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR|756
12898700|We found that TR-MUL5 cells exhibited [(14)C]L-cystine uptake activity and expressed xCT and 4F2hc, which involve system x(c) (-).|[(14)C]L-cystine|4F2hc|7|20.0|Arg1:T9|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE|757
23220413|Treatment with TDCPP also significantly increased transcription of genes involved in thyroid hormone synthesis (tshβ, slc5a5 and tg) and thyroid development (hhex, nkx2.1 and pax8) as a compensatory mechanism for decreased T4 concentrations.|TDCPP|pax8|3|30.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|758
9399970|In pigeons trained to discriminate 1.7 mg/kg dezocine from saline, a series of opioids with activity at the mu opioid receptor substituted completely for the dezocine stimulus with a rank order of potency similar to that obtained in other assays sensitive to the effects of mu agonists (i.e., fentanyl >[-]-cyclazocine >buprenorphine = butorphanol >l-methadone >nalbuphine >[-]-metazocine >morphine).|butorphanol|mu opioid receptor|61|20.0|Arg1:T30|Arg2:T47|CHEMICAL|GENE-N|AGONIST|759
15646817|In Experiment 2, TT-235 induced a significant decrease (p<0.05) in oxytocin receptor number and binding affinity at both 0.5 and 4 hours compared with controls.|TT-235|oxytocin receptor|5|16.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR|760
15192023|Thus, hydralazine activates the HIF pathway through inhibition of PHD activity and initiates a pro-angiogenic phenotype.|hydralazine|PHD|3|11.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|761
10027835|The data thus suggest that selective MAO-A inhibitors such as esuprone may be an interesting new approach for the treatment of epilepsy.|esuprone|MAO-A|11|7.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|762
10909982|4-chloro-6-[(2,3-xylidine)-pirimidinylthio] acetic acid (WY-14,643), a specific ligand of the PPAR-alpha subtype, causes the most dramatic increase in UCP-3 mRNA, whereas troglitazone, a specific activator of PPAR-gamma, also significantly increases UCP-3 mRNA abundance in skeletal muscle of lactating mice.|WY-14,643|UCP-3|11|28.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|763
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|4-methoxybenzyl ester|SERT|14|48.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|764
9631585|A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide.|mitoxantrone|DNA-topoisomerase II|29|23.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|765
23415904|Thus, in mouse, 11βHSD1 influenced the abundance and balance of circulating and tissue levels of 7βOHC and 7KC, promoting reduction of 7KC.|7βOHC|11βHSD1|18|6.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF|766
8469910|We report that the phospholipase A2 and diacylglycerol lipase inhibitor quinacrine (1-10 mumol l-1) inhibited the thyroliberin stimulated prolactin (rPRL) production in a dose-dependent way in a rat pituitary tumour cell line (GH4Cl cells).|quinacrine|phospholipase A2|11|5.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|767
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|nucleotide|EPAC|29|49.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|768
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|flavonolignans|OATP2B1|22|12.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|769
10490901|The proliferative effects of TGF-alpha (1.0 ng/ml) were not affected significantly by a monoclonal antiepidermal growth factor receptor antibody (1-100 ng/ml) and were almost completely blocked by specific inhibitors of signal transducers such as genistein (10(-5) M), 1-6[[17beta-3methoxyestra-1,3, 5(10)-trien-17-yl]amino]hexyl]-1H-pyrrol2,5-dione (U-73122; 0(-5) M), wortmannin (5 x 10(-7) M), sphingosine (5 x 10(-6) M), 2'-amino-3'-methoxyflavone (PD98059; 5 x 10(-5) M), and rapamycin (10 ng/ml).|PD98059|TGF-alpha|98|5.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|770
17513393|Real-time RT-PCR was used to determine the expression of the subunits of glutamate-cysteine ligase (Gcl) in liver that catalyzes the rate-limiting step in glutathione biosynthesis.|glutathione|glutamate-cysteine ligase|26|13.0|Arg1:T15|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF|771
11689471|Salicylates inhibited ATPase activity stimulated by this specific heptapeptide but did not block ATP binding or induce BiP expression.|ATP|ATPase|14|3.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR|772
17138652|Immunohistochemical assays showed that in tumors from parental and CMV xenografts, estradiol decreased estrogen receptor-alpha expression and induced progesterone receptor expression and Akt phosphorylation, effects that were inhibited by tamoxifen, AG825, and R25C-Akt1 by 89, 82, and 77% for progesterone receptor expression and 48, 66, and 73% for pAkt expression, respectively.|AG825|progesterone receptor|34|47.0|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|773
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-AE3-240|EP(1)|14|1.0|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|774
15169831|These findings indicate that VTA GABA neurons are coupled electrically via gap junctions and that the inhibitory effect of ethanol on electrical transmission is primarily via inhibition of NMDA receptor-mediated excitation, not via enhancement of GABA receptor-mediated inhibition.|ethanol|GABA receptor|20|37.0|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|775
8799556|The quinazoline antagonists, prazosin, doxazosin and alfuzosin displayed high affinity but were non selective for the three cloned human alpha 1 adrenoceptors.|quinazoline|human alpha 1 adrenoceptors|2|21.0|Arg1:T29|Arg2:T52|CHEMICAL|GENE-N|DIRECT-REGULATOR|776
7929150|The two NH2-terminal truncated vectors deleted, respectively, 1) the 29-amino acid putative targeting sequence and 2) 51 amino acids, yielding a protein equivalent to a carbonic anhydrase (CA) V isolated from mouse liver mitochondria; and both vectors produced homogeneous protein fractions.|NH2|carbonic anhydrase (CA) V|3|31.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|PART-OF|777
17513393|Hepatic betaine-homocysteine methyltransferase (Bhmt), which catalyzes one of the two ways that homocysteine can be remethylated to methionine, was downregulated by Cu deficiency.|methionine|betaine-homocysteine methyltransferase|21|2.0|Arg1:T20|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF|778
23065141|However, exposure to 6OH-DCA and NOH-DCA reduces IL-2 secretion and NFAT activity but has no effect on calcium flux.|6OH-DCA|IL-2|5|9.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|779
20624440|  Rasagiline is a propargylamine and irreversible monoamine oxidase (MAO) B inhibitor used for the treatment of Parkinson's disease (PD).|propargylamine|monoamine oxidase (MAO) B|4|7.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|780
23292655|We show that UAAs inserted in the N-terminal domain of N-methyl-D-aspartate receptors (NMDARs) serve as photo-crosslinkers that lock the receptor in a discrete conformational state in response to UV photo treatment.|N|NMDARs|8|14.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF|781
15016471|GTK also catalyzes the transamination of cystathionine, lanthionine, and thialysine to the corresponding alpha-keto acids, which cyclize to ketimines.|alpha-keto acids|GTK|16|1.0|Arg1:T38|Arg2:T72|CHEMICAL|GENE-Y|PRODUCT-OF|782
2889803|Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.|triazolobenzodiazepines|Benzodiazepine receptor|5|1.0|Arg1:T19|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|783
9486667|Molecular determinants of dofetilide block of HERG K+ channels.|dofetilide|HERG|4|7.0|Arg1:T16|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|784
2248058|Here again moclobemide preferentially inhibited MAO-A; it was equipotent to clorgyline and brofaromine in these tests, and 2-4 times as potent as cimoxatone and harmaline.|clorgyline|MAO-A|12|6.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|785
18055877|Taken together, our data demonstrate that thioureylenes with a common, heterocyclic structure inhibit inflammation and immune function via the NF-kappaB pathway.|thioureylenes|NF-kappaB|8|22.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|786
23402371|This study demonstrates, for the first time, that inhibition of CDCF uptake in MDCKII-ABCC2 vesicles not only provides a screening assay to assess MRP2 drug-drug interaction potential, but is also predictive of human MRP2-mediated biliary excretion.|CDCF|MRP2|13|26.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE|787
18055877|Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.|Thionamides|nuclear factor-kappaB|1|6.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|788
20566645|Mutations in the Ca(2+) sensor, troponin C (TnC), were generated to increase/decrease the Ca(2+) sensitivity of cardiac skinned fibers to create the characteristic effects of DCM, HCM, and RCM.|Ca(2+)|TnC|4|13.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|789
12974388|The AdoMetDC of the filarial parasite Onchocerca volvulus, however, is not only stimulated by putrescine but also by the naturally occuring polyamines spermidine and spermine.|polyamines|AdoMetDC|24|2.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|ACTIVATOR|790
12213053|The 4',7,8-trichloro analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).|mazindol|DAT|8|20.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|791
23589499|Docking experiments for the most active compounds into the MAO-B and MAO-A binding pockets highlighted different interactions between the derivative classes (2-arylbenzofurans and 3-arylcoumarins), and provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of these scaffolds.|2-arylbenzofurans|MAO-B|23|10.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|792
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|Δ(9)-tetrahydrocannabinol|CB(1)|34|29.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|AGONIST|793
23468189|Based on our previously published work on CXCR4 antagonists, we have synthesized a series of aryl sulfonamides that inhibit the CXCR4/CXCL12 interaction.|aryl sulfonamides|CXCL12|17|23.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|794
23073075|  Fingolimod (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (S1PR) subtypes.|Fingolimod|sphingosine-1-phosphate receptor|1|20.0|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR|795
11772142|  UNLABELLED: Rabeprazole is an inhibitor of the gastric proton pump.|Rabeprazole|gastric proton pump|3|9.0|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|796
23551329|Results of RT-PCR analysis showed decrease of p53 mRNA level and no significant difference in Bcl-2 and Bax mRNA expressions in DEX-treated rats.|DEX|p53|22|8.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|797
20497523|As seen in the AA model, the selective ERbeta agonist ERB-79 did not suppress inflammation.|ERB-79|ERbeta|12|10.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|798
23401472|Treatment with 5-aza-2'-deoxycytidine (5-Aza-dC), an inhibitor of DNA methylation, resulted in an increase of UGT1A1 mRNA expression in both cell types, but the increase was much larger in HK-2 cells than in HuH-7 cells.|5-aza-2'-deoxycytidine|UGT1A1|3|19.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|799
11350858|The stimulation of AChE synthesis induced by CGRP was mimicked by direct activation of AC with 3 - 30 microM forskolin.|forskolin|AC|21|15.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR|800
12188035|The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with rat GR, whereas BM and esterified-DEX had full transactivation agonistic activity.|BM|rat GR|20|16.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR|801
17315258|  Mammalian mitochondrial dihydrolipoamide dehydrogenase (DLDH, EC 1.8.1.4) catalyzes NAD(+)-dependent oxidation of dihydrolipoamide in vivo and can also act as a diaphorase catalyzing in vitro nicotinamide adenine dinucleotide (reduced form) (NADH)-dependent reduction of electron-accepting molecules such as ubiquinone and nitroblue tetrazolium (NBT).|nitroblue tetrazolium|Mammalian mitochondrial dihydrolipoamide dehydrogenase|51|1.0|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|802
12409268|It is caused by a deficiency of propionyl-CoA carboxylase (PCC, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to D-methylmalonyl-CoA.|D-methylmalonyl-CoA|PCC|27|11.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|803
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride|beta(2)-adrenoceptor|48|74.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|804
10518812|The survey reveals that mometasone furoate, a new inhaled steroid with topical activity, has the greatest binding affinity for the glucocorticoid receptor, followed by fluticasone propionate, budesonide, triamcinolone acetonide, and dexamethasone.|budesonide|glucocorticoid receptor|31|23.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|805
23435615|Additionally, there was a significant difference in plasma concentrations of (R)-5-hydroxyomeprazole among CYP2C19 genotype groups, whereas no significant differences were observed in that of (S)-5-hydroxyomeprazole.|(S)-5-hydroxyomeprazole|CYP2C19|30|17.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE|806
15563582|Indomethacin, sulindac sulfide, and zomepirac displaced [3H]PGD2 binding at the mouse CRTH2 receptor (mCRTH2) with comparable affinity (Ki = 1.5 +/- 0.1, 2.5 +/- 0.4, and 3.3 +/- 0.3 microM, respectively).|zomepirac|mouse CRTH2 receptor|7|16.0|Arg1:T28|Arg2:T46|CHEMICAL|GENE-Y|DIRECT-REGULATOR|807
23619284|  Tandutinib is a novel inhibitor of tyrosine kinases FLT3, PDGFR and KIT.|Tandutinib|FLT3|1|9.0|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|808
23294566|Androgen treatment also induced p300 and RNA Pol II recruitment to androgen receptor enhancers of AGR2 and initiated local chromatin remodelling and the formation of RNA Pol II-containing androgen receptor transcription complexes.|Androgen|RNA Pol II|1|26.0|Arg1:T13|Arg2:T37|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|809
15755648|Regioisomers having a 2,4-difluorophenyl substituent attached to the C-4 (COX-2 IC(50)=0.087microM; COX-2 S.I. >1149), or C-5 (COX-2 IC(50)=0.77microM, SI>130), position of 11 exhibited the most potent and selective COX-2 inhibitory activity relative to the reference drug celecoxib (COX-1 IC(50)=33.1microM; COX-2 IC(50)=0.07microM; COX-2 S.I.=472).|2,4-difluorophenyl|COX-2|4|11.0|Arg1:T26|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|810
23454208|Notably, the activated caspases that appeared with luteolin treatment cleaved Beclin-1, and the expression of LC3II remained the same even after cells were challenged with Beclin-1 siRNA, demonstrating that luteolin induces Beclin-1-independent autophagy.|luteolin|caspases|9|5.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR|811
23349208|Both fatty acids, but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)γ-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.|fatty acids|cytokine|2|22.0|Arg1:T12|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|812
17611697|Am-80, Tamibarotene, binds to retinoic acid receptor alpha (RARalpha) more specifically than all-trans retinoic acid.|Tamibarotene|retinoic acid receptor alpha|3|7.0|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|813
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|amino acids|ERG|10|21.0|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|PART-OF|814
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|penicillin|flanking conserved motifs|36|6.0|Arg1:T10|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|815
23059626|Our results showed that bone remodeling was significantly decreased in CCL3(-/-) and CCR1(-/-) mice and in animals treated with Met-RANTES (an antagonist of CCR5 and CCR1).|Met|CCR1|26|33.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|ANTAGONIST|816
15161930|Comparison of the ligand-bound LBDs of ERRgamma and ERalpha reveals small but significant differences in the architecture of the ligand binding pockets that result in a slightly shifted binding position of diethylstilbestrol and a small rotation of 4-hydroxytamoxifen in the cavity of ERRgamma relative to ERalpha.|diethylstilbestrol|ERRgamma|32|7.0|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|817
11489456|In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).|d-norfenfluramine|5-HT2A|10|37.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|AGONIST|818
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|pyruvate|Monocarboxylate transporters|20|1.0|Arg1:T6|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE|819
12142814|However, those for P4-H activity remained uniformly elevated after one hundred days on NTBC, the PIIINP biomarker even increasing above its grossly abnormal, initial level.|NTBC|P4-H|15|5.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|ACTIVATOR|820
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|MEK|3|15.0|Arg1:T12|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|821
12942109|  Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma.|acetylenic retinoid|retinoid receptors|4|18.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-N|DIRECT-REGULATOR|822
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|isocarboxazid|MAO-B|3|12.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|823
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|rosiglitazone|PPARgamma|3|26.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|824
23247010|  Monomeric carbonyl reductase 1 (CBR1, SDR21C1) is a member of the short-chain dehydrogenase/reductase superfamily and is involved in the metabolism of anthracycline anti-cancer drugs, prostaglandins, and isatin, which is an endogenous inhibitor of monoamine oxidases.|anthracycline|dehydrogenase|25|16.0|Arg1:T3|Arg2:T36|CHEMICAL|GENE-N|SUBSTRATE|825
17253779|zRetSat A also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (vitamin A2), a second endogenous form of vitamin A in zebrafish.|all-trans-3,4-didehydroretinol|zRetSat A|12|1.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|826
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|PDGFR|3|23.0|Arg1:T12|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|827
15664409|As thiamine metabolism deficiencies have been seen in placental infarcts previously, these indicate that PP20/hTPK may have a role in placental diseases.|thiamine|hTPK|2|17.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|828
12660248|  In mammals, methionine adenosyltransferase (MAT), the enzyme responsible for S-adenosylmethionine (AdoMet) synthesis, is encoded by two genes, MAT1A and MAT2A.|S-adenosylmethionine|MAT|14|7.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF|829
11511086|The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel.|sertindole|human brain K(+) channel|4|11.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|830
10502685|EPR studies on the photo-induced intermediates of ferric NO complexes of rat neuronal nitric oxide synthase trapped at low temperature.|ferric NO|rat neuronal nitric oxide synthase|8|12.0|Arg1:T24|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|831
23430162|CONCLUSIONS: The present study demonstrated that chronic treatment with ethanol enhanced the rewarding effects of morphine by up-regulating functional changes in μ-opioid receptor, mediated by GRK2.|ethanol|GRK2|11|28.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|832
17545671|RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by rosiglitazone treatment of adipocytes.|rosiglitazone|cAspAT|25|6.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|833
11520216|Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase.|Ellagitannins|squalene epoxidase|1|9.0|Arg1:T17|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|834
23523101|HSYA was able to effectively inhibit oxidative stress mediated hepatic injury by increasing the activities of antioxidant enzymes, up regulating the expression of PPARγ and MMP-2, and down regulating the expression of TGF-β1 and TIMP-1, and reducing α-SMA level.|HSYA|TGF-β1|1|35.0|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|835
16773504|Molecular genetic studies revealed a heterozygote missense mutation, MCCA-R385S, converting arginine to serine in a highly conserved region of the MCCA gene.|serine|MCCA|15|23.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|PART-OF|836
11511086|We conclude that erg3 can be blocked by certain antipsychotic drugs like sertindole and pimozide.|pimozide|erg3|15|4.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|837
23229510|We identified one compound, E235 (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide), that activated the ISR and dose-dependently increased levels of ATF4 in transformed cells.|(N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide)|ATF4|7|36.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|838
23261757|Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats.|gentamicin|hemopexin|17|7.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|839
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|Cl-|( Glu1]Pg|31|10.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|840
2907566|At 10(-7) M, labetalol, dilevalol, amosulalol and KF-4317 were beta 2-adrenoceptor antagonists as they inhibited the relaxant responses of rat aorta to procaterol.|labetalol|beta 2-adrenoceptor|8|16.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST|841
12646997|The inhibitory effects of icariin on PDE5 and PDE4 activities were investigated by the two-step radioisotope procedure with [(3)H]-cGMP/[(3)H]-cAMP.|[(3)H]-cGMP|PDE5|19|7.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|842
11319222|  Inhibition by triacsins and troglitazone of long chain fatty acid incorporation into cellular lipids suggests the existence of inhibitor-sensitive and -resistant acyl-CoA synthetases (ACS, EC ) that are linked to specific metabolic pathways.|troglitazone|acyl-CoA synthetases|5|22.0|Arg1:T25|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|843
10933891|The induction in UCP-3 expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after bezafibrate or Wy-14,643 treatment.|bezafibrate|UCP-3|21|4.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|844
23537701|  Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family.|Tetrahydrocannabinol|CB2|1|31.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|845
10670413|It was concluded that PGE1 selectively reduces both N- and R-type Ca2+ currents by activating a G-protein probably through the EP3 receptor in paratracheal ganglion cells.|PGE1|G-protein|5|17.0|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|ACTIVATOR|846
17308037|Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.|8-methoxymethyl-3-isobutyl-1-methylxanthine|PDE1|5|3.0|Arg1:T23|Arg2:T57|CHEMICAL|GENE-N|INHIBITOR|847
10839333|A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.|quetiapine|dopamine D2 receptor|7|22.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|848
2270485|Mutational analysis showed that a cluster of three residues (His18, His21, and Glu174) in hGH and His188 from the hPRLbp (conserved in all PRL receptors but not GH receptors) are probable Zn2+ ligands.|Zn2+|hPRLbp|38|24.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|849
16292755|Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.|vitamin E|ACAT|9|2.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|850
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|ampicillin|PBP|24|19.0|Arg1:T24|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR|851
17273750|We also found that the cimetidine-mediated down-regulation of NCAM expression in HSG cells did not occur via blocking of the histamine receptor, even though H2R expression was observed on HSG cells, as two other H2R antagonists, famotidine and ranitidine, did not show similar effects.|famotidine|H2R|40|37.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST|852
6621777|From these results, it is proposed that tyrosine hydroxylase activity determines p-HPAA concentrations by regulating p-tyrosine availability.|p-tyrosine|tyrosine hydroxylase|17|9.0|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|853
23028140|In the beginning of imatinib treatment, the fractions of its hepatic clearance mediated by CYP2C8 and CYP3A4 were predicted to approximate 40 and 60%, respectively.|imatinib|CYP3A4|5|18.0|Arg1:T17|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|854
9836297|Mutation of Ser165 to alanine had no significant effect (less than 2-fold) on the affinity of any of the catecholamines for the alpha 2a-adrenoceptor, and in particular, the ratios of affinities between the corresponding (-)- and (+)-enantiomers of the catecholamines were not altered by the point mutation at Ser165.|alanine|alpha 2a-adrenoceptor|5|25.0|Arg1:T25|Arg2:T41|CHEMICAL|GENE-Y|PART-OF|855
23264615|Cortisol and IFNT stimulated endometrial HSD11B1 expression and activity, increased endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium.|Cortisol|HSD11B1|1|6.0|Arg1:T18|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|856
23146691|Emodin-6-O-β-D-glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo.|Emodin-6-O-β-D-glucoside|HMGB1|1|3.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|857
3917545|Most reducing cofactors for the peroxidase protect PHS and prostacyclin synthase from inactivation by hydroperoxides.|hydroperoxides|PHS|15|8.0|Arg1:T19|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR|858
15866500|These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5-fluoro-2'-deoxyuridine monophosphate (FdUMP).|5-fluoro-2'-deoxyuridine monophosphate|TS|25|18.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|859
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|carnitine octanoyltransferase|39|17.0|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|860
15106733|Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.|Salicylate|NF-kappaB|1|9.0|Arg1:T9|Arg2:T48|CHEMICAL|GENE-N|ACTIVATOR|861
2897127|All compounds inhibited histamine-stimulated adenylate cyclase and H+ secretion in a concentration-dependent manner.|histamine|adenylate cyclase|4|5.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|862
15736931|The kinetic parameters indicate that the main effect of the mutation of Arg228 to lysine is on the k(cat) of Glc-T, which increases 3-4-fold, both in the absence and in the presence of LA; simultaneously, the k(cat) for the Gal-T reaction is reduced 30-fold.|lysine|Glc-T|15|24.0|Arg1:T1|Arg2:T39|CHEMICAL|GENE-N|PART-OF|863
23229509|  Regulation of multiple adenylyl cyclases (AC) provides unique inputs to mediate the synthesis of cAMP, a ubiquitous second messenger that controls many aspects of cellular function.|cAMP|adenylyl cyclases|17|4.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|PRODUCT-OF|864
22818713|Based on our results, silibinin may attenuate the phenylephrine-induced hypertrophic response of H9c2 cells via antioxidant mechanisms involving mainly the inhibition of the intracellular signaling pathways mediated by ERK1/2 MAPKs and Akt.|phenylephrine|MAPKs|10|31.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR|865
23512537|Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes.|Beclomethasone Dipropionate|Cytochrome P450 3A|3|6.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|866
10874136|It is also converted to hydroquinone by the soluble two-electron reductase, DT-diaphorase, and is conjugated with GSH by glutathione S-transferase.|hydroquinone|DT-diaphorase|6|13.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF|867
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|N|PDE5Delta1-465|17|46.0|Arg1:T18|Arg2:T56|CHEMICAL|GENE-Y|PART-OF|868
23122079|These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.|phillyrin|LKB1|5|21.0|Arg1:T15|Arg2:T21|CHEMICAL|GENE-Y|ACTIVATOR|869
8344937|Thin sections of rabbit renal proximal tubules bound 125I-labeled uPA.PAI-1 and rRAP in the apical part of proximal tubules corresponding to the localization of gp330.|125I|PAI-1|9|12.0|Arg1:T5|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|870
15240345|Mitochondria, which produce glyoxylate from hydroxyproline metabolism, contained both alanine:glyoxylate aminotransferase (AGT)2 and glyoxylate reductase activities, which can convert glyoxylate to glycine and glycolate, respectively.|glycine|alanine:glyoxylate aminotransferase (AGT)2|30|12.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|871
23063590|Furthermore, cAMP production and protein kinase A (PKA) activity were suppressed by artemisinic acid.|artemisinic acid|protein kinase A|16|6.0|Arg1:T13|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|872
23368743|These results underscore a role for TRPML1 in zinc metabolism.|zinc|TRPML1|9|7.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|873
17353078|CONCLUSIONS: Pre-treatment with fluvastatin suppresses the release of plasma TNF-alpha, increases plasma IL-10, and NO production, and decreases the levels of markers of organ injury associated with endotoxic shock, so ameliorating LPS-induced organ damage amongst conscious rats.|fluvastatin|TNF-alpha|5|11.0|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|874
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|norepinephrine|OAT3|11|22.0|Arg1:T20|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|875
23085435|Furthermore, N-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.|BPs|Bim|4|24.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|876
6687626|Here we report the amino acid sequence of the bovine oxytocin-neurophysin I (OT-NpI) precursor which was derived from sequence analysis of the cloned cDNA.|amino acid|bovine oxytocin-neurophysin I (OT-NpI) precursor|5|10.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|PART-OF|877
23466342|These results suggest that mollugin treatment enhanced suppression of P-gp expression by inhibiting the NF-κB signaling pathway and COX-2 expression, as well as attenuating CRE transcriptional activity through AMPK activation.|mollugin|AMPK|5|30.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|878
8836617|  We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.|(4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate)|histamine H1 receptor|53|77.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST|879
12177684|In vivo flibanserin binds equally to 5-HT(1A) and 5-HT(2A) receptors.|flibanserin|5-HT(1A)|3|7.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR|880
19663609|  Conivaptan, the first vasopressin receptor antagonist approved by the FDA, is available for the treatment of hyponatremia in euvolemic and hypervolemic patients.|Conivaptan|vasopressin receptor|1|5.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|ANTAGONIST|881
15740719|In contrast, the binding of barusiban was significantly improved when the transmembrane domains 1 and 2 were transferred from the oxytocin receptor to the vasopressin V2 receptor.|barusiban|vasopressin V2 receptor|7|26.0|Arg1:T11|Arg2:T46|CHEMICAL|GENE-Y|DIRECT-REGULATOR|882
22552008|Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBN(YW/AA).|Lenalidomide|CRBN|1|7.0|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|883
23273517|Docking of nilotinib and of analogues 2a-c to the binding pocket of Abl and of Kit showed that the lack of shape complementarity in Kit is compensated by the stabilizing effect from its juxtamembrane region.|nilotinib|Kit|3|16.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|884
15123288|Herein we utilize a library of SRC2 peptidomimetics to select for specific inhibitors of the interaction of SRC2 with the two estrogen receptor (ER) isoforms, ERalpha and ERbeta, in the presence of three different ligands: 17beta-estradiol, diethylstilbesterol, and genistein.|genistein|ER|46|25.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|885
21262851|Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists.|dihydropyridine|L-VGCC|23|27.0|Arg1:T3|Arg2:T38|CHEMICAL|GENE-N|ANTAGONIST|886
23468426|To investigate this and solution-phase results with other tripeptides δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-Xaa, we have crystallised AhCV and δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-S-methylcysteine (AhCmC) with IPNS and solved crystal structures for the resulting complexes.|δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-S-methylcysteine|IPNS|21|30.0|Arg1:T29|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|887
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|rizatriptan|human 5-HT1B|10|16.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|888
1438284|The mutant W279A displayed strongly reduced inhibition by the peripheral site-specific ligand propidium relative to wild-type Torpedo AcChoEase, whereas inhibition by the catalytic-site inhibitor edrophonium was unaffected.|edrophonium|Torpedo AcChoEase|26|17.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|889
11980628|It is important to note that the inhibitory effect of SOM230 was relatively selective for GH and IGF-I in that insulin and glucagon secretion was inhibited only at higher doses of SOM230.|SOM230|IGF-I|11|18.0|Arg1:T15|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|890
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|polyamine|spermidine/spermine N(1)-acetyltransferase|2|12.0|Arg1:T21|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|891
23404443|Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of insulin (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).|glucose|insulin|85|73.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|892
10460702|  Activation of endothelial nitric oxide synthase (eNOS) results in the production of nitric oxide (NO) that mediates the vasorelaxing properties of endothelial cells.|nitric oxide|endothelial nitric oxide synthase|15|3.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|893
23568856|DAT ligands have traditionally been divided into two categories: cocaine-like inhibitors and amphetamine-like substrates.|cocaine|DAT|11|1.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|894
11054378|RESULTS: NF-kappaB/Rel activity induced by tumor necrosis factor alpha, 12-O-tetradecanoylphorbol-13-acetate, or overexpression of NF-kappaB-inducing kinase, IKK-alpha, IKK-beta, or constitutively active IKK-alpha and IKK-beta mutants was inhibited dose dependently by sulfasalazine.|sulfasalazine|NF-kappaB-inducing kinase|36|17.0|Arg1:T17|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|895
23623838|Adult NIC offspring showed more intense NPY staining in the paraventricular nucleus (PVN) (+21%) and increased number of POMC-positive cells in the: arcuate nucleus (+33%), as an increase in fiber density of α-MSH in PVN (+85%).|NIC|α-MSH|2|43.0|Arg1:T7|Arg2:T9|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|896
15736931|Comparison of the crystal structures of UDP-Gal- and UDP-Glc-bound beta4Gal-T1 reveals that the O4 hydroxyl group in both Gal and Glc moieties forms a hydrogen bond with the side chain carboxylate group of Glu317.|carboxylate|beta4Gal-T1|31|10.0|Arg1:T25|Arg2:T50|CHEMICAL|GENE-Y|PART-OF|897
16609060|For some, pharmacologic inhibitors are available, including sorafenib for BRAF, farnesyltransferase inhibitors for NRAS, PD-0325901 for mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, rapamycin analogues for mammalian target of rapamycin, and agents that inhibit either vascular endothelial growth factor or its receptors.|sorafenib|BRAF|10|12.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|898
23547652|Subsequent optimization led to several novel 3HPT-based HDACi that are selective for HDAC 6 and HDAC 8.|3HPT|HDAC 6|7|13.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|899
11237340|Both the spectrophotometric and the radiometric methods are based on the conversion of 5-methyltetrahydrofolate to tetrahydrofolate by methionine synthase.|tetrahydrofolate|methionine synthase|16|18.0|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF|900
15982930|Thalidomide reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.|Thalidomide|VEGF|1|15.0|Arg1:T11|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|901
23248236|Ebselen [2-phenyl-1,2 benzisoselenazol-3(2H)-one], a well-known antioxidant and a substrate for mammalian TrxR and Trx, is rapidly bacteriocidal for methicillin-resistant Staphylococcus aureus by an unknown mechanism.|Ebselen|mammalian TrxR|1|18.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|902
14737100|Increased phosphorylation of p95ErbB2 and AKT in response to HRG was abrogated to varying degrees by GW572016.|GW572016|p95ErbB2|17|4.0|Arg1:T1|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|903
11350858|To assess the effect of CGRP on AChE synthesis, myotubes were pre-exposed to the irreversible AChE inhibitor diisopropyl fluorophosphate (DFP) and treated with CGRP or forskolin, an adenylyl cyclase (AC) activator.|diisopropyl fluorophosphate|AChE|19|17.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|904
15814851|  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P450 enzyme complex called aromatase.|estrogen|aromatase|7|20.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|905
23554428|The present study characterized the kinetics of the separate R- and S- enantiomers of lorazepam by human liver microsomes (HLM) and by a panel of recombinant human UDP-glucuronosyltransferase (UGT) enzymes.|lorazepam|UGT|15|32.0|Arg1:T16|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|906
14654525|SU11248 is an oral multitargeted kinase inhibitor with selectivity for fms-related tyrosine kinase 3/Flk2 (FLT3), platelet-derived growth factor receptor alpha/beta, vascular endothelial growth factor receptor 1/2, and KIT receptor tyrosine kinases.|SU11248|kinase|1|6.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|907
23142558|The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.|17-β-oestradiol|cannabinoid CB2 receptor|2|9.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|908
15942707|Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF-1alpha, VEGF, BNP, and NGF-beta in the hypertrophic myocardium.|carvedilol|BNP|3|17.0|Arg1:T8|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|909
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|GDP|AdSS|31|4.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF|910
17979301|  The molecular bases for phosphodiesterase 5 (PDE5) catalytic-site affinity for cyclic guanosine monophosphate (cGMP) and potency of inhibitors are poorly understood.|cGMP|phosphodiesterase 5|17|5.0|Arg1:T3|Arg2:T52|CHEMICAL|GENE-Y|DIRECT-REGULATOR|911
12646997|The potencies of selectivity of icariin and papaverine on PDE5 (PDE4/PDE5 of IC(50)) were 167.67 times and 4.54 times, respectively.|icariin|PDE5|6|10.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|912
15261283|Two compounds with benztriazole group had a 5-HT(2A)/D(2) binding ratio characteristic for atypical neuroleptics (>1, pK(i) values).|benztriazole|D(2)|4|13.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|913
6703688|Alanine:glyoxylate aminotransferase (AGT) in the liver catalyzes most of the glyoxylate transamination in mammalian tissues (E.|glyoxylate|Alanine:glyoxylate aminotransferase|15|1.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|SUBSTRATE|914
16319075|Because ASIC1b and -3 subunits are mainly expressed in peripheral neurons, our data identified ASIC1a-containing Ca2+-permeable ASIC as a novel central target of Pb2+ action, which may contribute to Pb2+ neurotoxicity.|Ca2+|ASIC1a|17|16.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|915
23587660|Therefore, Korean pear juice may alleviate alcohol-hangover and its detoxification of alcohol seems to be modified by the genetic variation of ALDH2.|alcohol|ALDH2|13|23.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE|916
10658902|Loffler, Species-related inhibition of human and rat dihyroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives, Biochem.|isoxazol|human and rat dihyroorotate dehydrogenase|13|6.0|Arg1:T16|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|917
21631396|NFAT cooperates with c-Jun, a compound of the AP-1 complex, to activate target genes, and we also found that PSE inhibited both JNK activation and AP-1 transcriptional activity.|PSE|JNK|23|26.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|918
15219414|Inhibition was not overcome by increased cortisol concentration, and no inhibition by oxandrolone was observed in cells expressing GR alone, confirming that non-competitive mechanisms were involved.|cortisol|GR|7|20.0|Arg1:T16|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR|919
8263811|Affinities for the major nonadrenergic [125I]PIC binding site were highly comparable to human subtype-I1 imidazol(in)e receptor sites in the brain stem (rank order: moxonidine > clonidine > cirazoline > IDX > amiloride).|IDX|human subtype-I1 imidazol(in)e receptor|39|16.0|Arg1:T7|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR|920
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|Rilpivirine|hPXR|1|19.0|Arg1:T10|Arg2:T47|CHEMICAL|GENE-Y|AGONIST|921
23528299|As a potent synthetic APN inhibitor (IC50=850nM, versus bestatin of 8.1μM), LB-4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin.|LB-4b|APN|16|5.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|922
16735460|In [14C]succinate uptake and TEVC experiments performed simultaneously on the same oocytes, uptake was similar to or higher than WT, whereas succinate-induced currents were either comparable (K114R) to, or considerably smaller (K114E, K114I, K114Q) than, those evoked by WT.|[14C]succinate|K114E|2|41.0|Arg1:T6|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE|923
23423713|Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h.|TCDD|Cyp1a2|18|24.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|924
15128769|DBA/2J-mated CBA/J female mice were randomized in three groups: 1) control females, 2) mice exposed to stress on gestation day 5.5, and 3) mice exposed to stress and substituted with dydrogesterone, a progestogen with a binding profile highly selective for the progesterone receptor on gestation day 5.5. On gestation days 7.5, 9.5, and 10.5, mice of each group were sacrificed, and the frequency of CD8(+) cells and cytokine expression (IL-4, IL-12, TNF-alpha, IFN-gamma) in blood and uterus cells was evaluated by flow cytometry.|dydrogesterone|progesterone receptor|37|49.0|Arg1:T8|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|925
23371965|  Phenethylisothiocyanate (PEITC), a naturally occurring isothiocyanate and potent cancer chemopreventive agent, works by multiple mechanisms, including the inhibition of cytochrome P450 (P450) enzymes, such as CYP2E1, that are involved in the bioactivation of carcinogens.|isothiocyanate|CYP2E1|9|34.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|926
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H1R|1|14.0|Arg1:T1|Arg2:T57|CHEMICAL|GENE-Y|DIRECT-REGULATOR|927
12411515|In conclusion, halothane, isoflurane and sevoflurane inhibit complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain.|sevoflurane|complex I|8|10.0|Arg1:T11|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR|928
17263187|Prescription medications targeting chronic constipation currently include polyethylene glycol, lactulose and tegaserod, a serotonin type 4 receptor partial agonist.|tegaserod|serotonin type 4 receptor|13|16.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|AGONIST|929
23307549|Ruxolitinib is a small-molecule inhibitor of JAK1 and JAK2 and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis.|Ruxolitinib|JAK1|1|7.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|930
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|cerivastatin|HMG-CoA reductase|10|26.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|931
16540317|Human methionine aminopeptidase type 2 in complex with L- and D-methionine.|L- and D-methionine|Human methionine aminopeptidase type 2|9|1.0|Arg1:T5|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|932
15456329|This has been attributed mainly to the non-acidic chemical properties of nabumetone but also to its COX-1/COX-2 inhibitor profile.|nabumetone|COX-1|12|17.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|933
18061638|Dienogest activate PR (EC50=3.4 or 10.5 nmol/l) with antagonistic activity on AR (EC50=420.6 or 775.0 nmol/l) but not agonistic nor antagonistic action on GR, MR (3000 nmol/l).|Dienogest|AR|1|14.0|Arg1:T17|Arg2:T48|CHEMICAL|GENE-Y|ANTAGONIST|934
9406449|Molecular weight and isoelectric point of both purified enzymes were determined to be 60 KDa and pH 4, while optimum temperature and pH to yield the maximal activity were about 37 degrees C and pH 8.5. Metallic ions, NaCl and protamine sulfate reduced, and heparin increased, both LPL activities.|sulfate|LPL|45|53.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR|935
8986981|Activation of alpha 1-adrenoceptors was documented by observing dose-dependent increases in mesenteric perfusion pressure after intramesenteric arterial injection of methoxamine; alpha 2-adrenoceptor activity was confirmed by finding similar increases in mesenteric perfusion pressure after intramesenteric arterial injections of BHT 933.|BHT 933|alpha 2-adrenoceptor|40|22.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|ACTIVATOR|936
16547010|HQL-79 selectively inhibited PGD2 production by H-PGDS-expressing human megakaryocytes and rat mastocytoma cells with an IC50 value of about 100 microm but only marginally affected the production of other prostanoids, suggesting the tight functional engagement between H-PGDS and cyclooxygenase.|HQL-79|H-PGDS|1|7.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|937
10907719|  UNLABELLED: Apparent muscarinic acetylcholine (mAch) receptor occupancy in mouse cerebral cortex, hippocampus, and striatum by scopolamine, an antagonist, and biperiden, a relatively selective M1 antagonist, was estimated with competitive binding studies using two different radioligands: 3H-N-methyl piperidyl benzilate (3H-NMPB) and 3H-quinuclidinyl benzilate (3H-QNB).|scopolamine|muscarinic acetylcholine (mAch) receptor|21|4.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|ANTAGONIST|938
23295229|As the Mg(2+) ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 μM Mg(2+)) to 0.050 s(-1) (6000 μM Mg(2+)) and a distinct shift in steady-state conformational population from one that favors the ALDH1-NADH complex with the shorter fluorescence lifetime (33% excess) in the absence of magnesium ion to one that favors the ALDH1-NADH complex with the longer fluorescence lifetime (13% excess) at 6000 μM Mg(2+).|NADH|ALDH1|64|63.0|Arg1:T11|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|939
10530931|Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.|2-carbonyl|muscarinic receptor|11|6.0|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|ANTAGONIST|940
1438284|Modeling showed that two such residues, Phe-288 and Phe-290, replaced by leucine and valine, respectively, in BtChoEase, may prevent entrance of butyrylcholine into the acyl-binding pocket.|Phe|BtChoEase|10|21.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|941
23277230|Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.|Fisetin|IL-1β|1|28.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|942
12646997|The inhibitory effects of icariin on PDE5 and PDE4 activities were investigated by the two-step radioisotope procedure with [(3)H]-cGMP/[(3)H]-cAMP.|[(3)H]-cAMP|PDE4|26|9.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|DIRECT-REGULATOR|943
10697523|Thymidylate synthase is inhibited by 5-fluorodeoxyuridine monophosphate, forming an inactive ternary complex with intracellular folate.|5-fluorodeoxyuridine monophosphate|Thymidylate synthase|6|1.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|944
16855072|  Sitagliptin (MK-0431) is an oral, potent, and selective dipeptidyl peptidase-IV (DPP-4) inhibitor developed for the treatment of type 2 diabetes.|Sitagliptin|dipeptidyl peptidase-IV|1|13.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|945
23291050|The present investigation was undertaken to explore the in vivo inhibition of the freshwater gastropod snail Planorbarius corneus cholinesterase (ChE) and carboxylesterases (CES) activities by the organophosphorus pesticides azinphos-methyl (AZM) and chlorpyrifos (CPF).|organophosphorus|Planorbarius corneus cholinesterase|31|17.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|946
7678677|Alprenolol and BAAM also caused surmountable antagonism of isoprenaline responses, and this beta 1-adrenoceptor antagonism was slowly reversible.|Alprenolol|beta 1-adrenoceptor|1|14.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST|947
17006762|The distribution of LDH isozymes in primary cultures of cortical neurons does not directly reflect the kinetics of LDH and the capacity for lactate oxidation.|lactate|LDH|24|19.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE_PRODUCT-OF|948
23512787|Taken together, our data demonstrate that puerarin attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.|MPTP|Lamp 2A|28|34.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|949
7909690|Atovaquone, a naphthoquinone, is a moderate inhibitor of dihydroorotate dehydrogenase in vitro (Ki = 27 microM) but induces major accumulations of CA-asp and DHO.|naphthoquinone|dihydroorotate dehydrogenase|4|11.0|Arg1:T33|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|950
12388412|These findings suggest that RhBG and RhCG may play important and cell-specific roles in ammonium transport and signaling in these regions of the kidney.|ammonium|RhBG|15|5.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|951
18996527|Nicotinic acid (NA), a widely used drug to lower elevated plasma lipid levels, induced NNMT enzyme activity in white adipose tissue of mice.|Nicotinic acid|NNMT|1|19.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|952
22982445|These results suggest that LTD4 increases Aβ peptide burden via activation of CysLT(1)R, which further affects APP levels and activity of β- and γ-secretases via the NF-κB pathway.|LTD4|CysLT(1)R|5|13.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|ACTIVATOR|953
16533791|YM-359445 had greater antitumor activity than other VEGFR2 tyrosine kinase inhibitors.|YM-359445|tyrosine kinase|1|9.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|954
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|dofetilide|IKr|26|2.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|955
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|LU 43839|MAO-A|78|76.0|Arg1:T19|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|956
23353901|Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.|mCPP|5-HT2C|14|2.0|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|AGONIST|957
11331292|We now report the identification of two phenylalanine residues in transmembrane domain 7 of the alpha(1a)-adrenergic receptor (Phe-312 and Phe-308) that are a major site of antagonist affinity.|Phe|alpha(1a)-adrenergic receptor|23|16.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|PART-OF|958
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|ESI-09|Rap1|23|40.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|959
23305444|Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.|6-Hydroxy-benzofuran-5-carboxylic acid|mycobacterium protein tyrosine phosphatase B|15|8.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|960
11455568|The effects of Cox inhibition were not rate limiting, based on experiments in which PLA(2) was activated with melittin or inhibited with quinacrine.|quinacrine|PLA(2)|27|16.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|961
16543605|The cytochrome P450 enzyme, CYP51, catalyzes an essential early step in sterol metabolism, removing a methyl group from lanosterol in animals and fungi, or from obtusifoliol in plants.|sterol|cytochrome P450|14|2.0|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE|962
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|malonyl-CoA|FAS|13|5.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|963
15133083|SL-11158 inhibited SSAT activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine.|spermine|SSAT|28|3.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|DIRECT-REGULATOR|964
16757355|Thus, sorafenib may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling).|sorafenib|Raf|3|23.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|965
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|TGF-β1|1|22.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|966
1472079|Cadmium did not increase the breakdown of UDPGA by microsomal UDPGA pyrophosphatase but strongly decreased (30-66%) the synthesis of the cofactor in the cytosol by inhibiting UDP-glucose dehydrogenase (UDPGDH).|UDPGA|pyrophosphatase|8|12.0|Arg1:T1|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|967
21600945|The increasing effect of TPM on O(2)((-)) level was not significantly affected by the B1R antagonist SSR240612.|SSR240612|B1R|25|23.0|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|ANTAGONIST|968
23019138|In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].|capsazepine|vanilloid receptor type I|49|44.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|969
12650833|On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block PP1, and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception.|cantharidin|PP1|19|31.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|970
23000442|In the present study, a cocktail probe assay was performed for determination of the selective inhibitory effect of mollugin on cytochrome P450 (CYP) enzymes in human liver microsomes (HLM).|mollugin|cytochrome P450|20|22.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR|971
23157629|  The serotonin (5-HT) receptors of type 6 (5-HT6) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long C-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.|C|serotonin (5-HT) receptors|33|2.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF|972
7853212|The Ki values of these antagonists for the catalytic activity of P450 2D1 were low and were similar to those of quinine and quinidine, which are specific inhibitors of P450 2D forms.|quinidine|P450 2D|24|31.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|973
23432061|The functional significance of cardiac TRP channels is likely connected to the alteration of membrane potential or Ca2+ entry into a noncontractile compartment, where gene expression responsible for various cardiac diseases is induced.|Ca2+|TRP channels|18|6.0|Arg1:T2|Arg2:T3|CHEMICAL|GENE-N|SUBSTRATE|974
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|GW1843|TS|44|42.0|Arg1:T26|Arg2:T52|CHEMICAL|GENE-Y|INHIBITOR|975
10027835|Drugs inhibiting both MAO-A and MAO-B to a similar extent (tranylcypromine) or combinations of selective MAO-A and MAO-B inhibitors (esuprone plus LU 53439) had no advantage over MAO-A inhibition alone, but were less well tolerated.|esuprone|MAO-B|23|20.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|976
12535612|GAD67 exhibits a higher binding constant for PLP binding, making it more difficult to dissociate PLP from holoGAD67 than holoGAD65.|PLP|holoGAD65|17|21.0|Arg1:T10|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR|977
17869551|  Nitric oxide (NO) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by endothelial nitric oxide synthase (eNOS).|L-arginine|endothelial nitric oxide synthase|15|21.0|Arg1:T29|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|978
9710435|Based on these results, we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl- channels as well as basolateral membrane K+ channels.|salicylic acid|CFTR|13|30.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|979
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|SLC12A1|20|3.0|Arg1:T10|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|980
23116643|Furthermore, RA significantly inhibited the CCl(4)-induced apoptosis, which was evident from decreased cleavage of caspase-3.|CCl(4)|caspase-3|7|21.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|981
21600945|Stimulation of B1R with a selective agonist (des-Arg(9)-BK, 10 muM; 30 min) increased O(2)((-))production which was prevented by apocynin and diphenyleneiodonium (NADPH oxidase inhibitors).|des-Arg(9)-BK|B1R|9|3.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|AGONIST|982
10207608|Likewise, IL-2 steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM AACOCF3.|BPB|IL-2|25|3.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|983
23462886|In this phase IIb clinical trial, 258 patients with type 2 diabetes completed a 12-week protocol with 50, 100, or 150 mg of MSDC-0160 (an mTOT modulator), 45 mg pioglitazone HCl (a PPAR-γ agonist), or a placebo.|pioglitazone HCl|PPAR-γ|36|40.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|AGONIST|984
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|terlipressin|V(1a)|41|43.0|Arg1:T14|Arg2:T51|CHEMICAL|GENE-Y|AGONIST|985
15072849|Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro.|Imiquimod|Toll-like receptor-7|1|4.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|AGONIST|986
23261715|In this study, we found that the reductase activity of AKR1B19 was activated to about 5-fold immediately after the addition of 10 μM SH-reagents (p-chloromercuriphenylsulfonic acid and p-chloromercuribenzoic acid) in the absence or presence of NADPH.|p-chloromercuribenzoic acid|AKR1B19|30|12.0|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR|987
19344392|Sirolimus and second-generation mTOR inhibitors, such as temsirolimus and everolimus, are safe and relatively well-tolerated, making them potentially attractive as single agents or in combination with conventional cytotoxics and other targeted therapies.|everolimus|mTOR|11|4.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|988
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|TK|4|16.0|Arg1:T3|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|989
12970106|Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.|dihydroergotamine|5-HT2C|4|8.0|Arg1:T26|Arg2:T45|CHEMICAL|GENE-Y|AGONIST|990
23449197|  7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-β (TGF-β) type I receptor (also known as activin receptor-like kinase 5 or ALK5) inhibitor.|TASP0382088|ALK5|12|37.0|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|991
23621381|In rather short-term clinical trials with well-selected diabetic patients, no increased risk of acute pancreatitis has been observed with any of the five commercialized DPP-4 inhibitors: sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin.|alogliptin|DPP-4|35|26.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|992
17034761|Our results demonstrated that auranofin suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of COX-2, a pro-inflammatory enzyme.|auranofin|NF-kappaB|5|13.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|993
12181427|  To identify amino acid residues involved in PDE3-selective inhibitor binding, we selected eight presumed interacting residues in the substrate-binding pocket of PDE3A using a model created on basis of homology to the PDE4B crystal structure.|amino acid|PDE3A|3|23.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|PART-OF|994
8161345|At doses of 20 micrograms/kg, however, 5-ethynyl-2-pyrimidinone and 5-ethynyluracil produced equivalent inactivation of DPD.|5-ethynyluracil|DPD|11|16.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|995
15695169|The affinity of ramelteon for hamster brain MT3 binding sites was extremely weak (Ki: 2.65 microM) compared to melatonin's affinity for the MT3 binding site (Ki: 24.1 nM).|ramelteon|MT3|4|27.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|996
23289710|Incubation of in vitro transcribed tRNA[Ser]Sec with recombinant Trit1 transfers [(14)C]dimethylallyl pyrophosphate to tRNA([Ser]Sec).|[(14)C]dimethylallyl pyrophosphate|Trit1|15|13.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|997
23602989|The selective CaMKIIα inhibitor KN-62 reversed the blockade produced by ionomycin and K(+)-depolarization.|KN-62|CaMKIIα|5|3.0|Arg1:T22|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR|998
23318726|Treatment of HDP cells with a c-Jun NH2-terminal kinase (JNK) inhibitor also reduced butein-induced HO-1 expression, and butein treatment led to increased JNK phosphorylation.|butein|JNK|21|26.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR|999
16843091|However, several promising nonpeptide, vasopressin receptor antagonists have been described; these agents are VPA-985 (lixivaptan), YM-087 (conivaptan), OPC-41061 (tolvaptan), and SR-121463.|VPA-985|vasopressin receptor|17|7.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|ANTAGONIST|1000
15102890|Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide.|glyburide|SR-BI|14|3.0|Arg1:T13|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|1001
23482500|Results suggest that sorafenib uptake in human hepatocytes occurs via passive diffusion, and by OCT1 and a rifamycin-sensitive transporter.|sorafenib|OCT1|4|16.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|1002
11056242|RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on MCP-1 expression.|danazol|MCP-1|26|71.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|1003
10464780|The rate-limiting step of the BH4 synthesis is catalyzed by GTP cyclohydrolase I (GCH).|BH4|GTP cyclohydrolase I|6|11.0|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF|1004
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|arginine|Argininosuccinate synthetase|24|1.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF|1005
15236843|  To determine the role played by Tyr(356 (7.43)) in the rat beta(1)-adrenoceptor in binding the antagonists (+/-)cyanopindolol (4-[3-(t-butylamino]-3-(2'-cyano-indoloxy)-2-propanolol) and its iodinated analogue (+/-)[(125)Iodo]cyanopindolol (1-(t-butylamino]-3-(2'-cyano-3'-iodo-indoloxy)-2-propanolol), Tyr(356 (7.43)) was mutated to either Phe or Ala and binding affinities determined for wild type and mutant rat beta(1)-adrenoceptors.|(+/-)[(125)Iodo]cyanopindolol|rat beta(1)-adrenoceptor|47|16.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1006
17069932|This finding indicates that GAT-1 is an important GABA transporter in white matter and suggests that white matter GABA uptake is inhibited during tiagabine therapy.|GABA|GABA transporter|19|9.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE|1007
23394218|Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.|AZD5363|kinases|24|35.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|1008
19119014|Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with chlorthalidone, trichloromethiazide, and furosemide being efficient inhibitors against CA II (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).|trichloromethiazide|CA II|22|30.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|1009
10932681|Orlistat inhibits pancreatic lipase and can block 30% of triglyceride hydrolysis in subjects eating a 30% fat diet.|Orlistat|pancreatic lipase|1|3.0|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1010
10823899|With this mechanism of regulation, acute application of AMPH would reduce DA uptake not only by direct competition for uptake, but also by reducing the available cell-surface DAT.|DA|DAT|13|30.0|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|1011
23598363|While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the cisplatin-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.|cisplatin|c-Abl|24|28.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1012
23536517|Pancreatic tissues of rats and blood samples were obtained.Tau treatment significantly decreased serum amylase activity (p < 0.001), total injury score (p < 0.001), malondialdehyde levels (p < 0.001) and myeloperoxidase (MPO) activity (p < 0.001).|Tau|serum amylase|11|13.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|1013
7518029|In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).|haloperidol|prolactin|5|26.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1014
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kuraridin|DGAT|14|52.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1015
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|nipecotic acid|GAT2|10|21.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|1016
24365491|It lowered the production of tumour necrosis factor-alpha (TNF-alpha) in the beginning of acute liver failure induced by D-GalN/LPS.|D-GalN|TNF-alpha|21|10.0|Arg1:T1|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1017
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|5alpha-DHP|3alpha-HSDs|6|22.0|Arg1:T14|Arg2:T46|CHEMICAL|GENE-N|SUBSTRATE|1018
23432582|However, the involvement of the caspase-dependent pathway in the process of cell death induced by either BSC 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pancaspase inhibitor z-VAD-fmk.|z-VAD-fmk|caspase|37|36.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|1019
23397055|Adenosine and N(6)-cyclopentyl-adenosine (CPA, A1R agonist) constricted MVs but not MAs. Adenosine and CPA (0.001-10 µM) inhibited neurogenic constrictions and NE release in MAs and MVs. DOCA-salt arteries were resistant to adenosine and CPA-mediated inhibition of NE release and constriction.|N(6)-cyclopentyl-adenosine|A1R|3|11.0|Arg1:T24|Arg2:T27|CHEMICAL|GENE-Y|AGONIST|1020
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|38|18.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1021
12170055|CONCLUSION: Meperidine is a potent agonist at the alpha2 adrenoceptors at its clinically relevant concentrations, especially at the alpha(2B)-adrenoceptor subtype.|Meperidine|alpha2 adrenoceptors|3|10.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|AGONIST|1022
10735801|Inhibition of epsilon1/zeta1, epsilon2/zeta1, epsilon3/zeta1, and epsilon4/zeta1 channels by meperidine was dependent on pH, with more inhibition at acidic pH and less inhibition at alkaline pH.|meperidine|epsilon3/zeta1|13|7.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|1023
23219337|Wogonin had no effect on VEGF-C production in LM8 cells, or VEGFR-3 expression in human lymphatic endothelial cells (HLECs), however, it inhibited VEGF-C-induced VEGFR-3 phosphorylation in HLECs. The anti-tumor and anti-metastatic actions of wogonin may be associated with the inhibition of VEGF-C-induced lymphangiogenesis through a reduction in VEGF-C-induced VEGFR-3 phosphorylation by the inhibition of COX-2 expression and IL-1β production in TAMs.|wogonin|VEGFR-3|40|55.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1024
17979301|Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.|amino acids|phosphodiesterase-5|2|5.0|Arg1:T42|Arg2:T60|CHEMICAL|GENE-Y|PART-OF|1025
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|L-Arg|inducible nitric oxide synthase|24|2.0|Arg1:T9|Arg2:T58|CHEMICAL|GENE-Y|SUBSTRATE|1026
1647395|  Estramustine is a novel anti-microtubule drug shown to bind MAP-1 and MAP-2 (microtubule-associated proteins) in vitro.|Estramustine|MAP-2|1|12.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1027
23122079|Phillyrin strongly inhibited high glucose-induced fatty acid synthase (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.|Phillyrin|FAS|1|10.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1028
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|penicillin|PBP|22|19.0|Arg1:T22|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR|1029
17223000|Pranlukast hydrate (ONO-1078, 100 microM) downregulated the leukotriene D(4)-induced MUC2/5AC gene expression and mucin secretion.|leukotriene D(4)|mucin|11|21.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1030
17603555|  BACKGROUND AND PURPOSE: AMP-activated protein kinase (AMPK) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).|phenformin|AMP-activated protein kinase|16|5.0|Arg1:T42|Arg2:T55|CHEMICAL|GENE-Y|ACTIVATOR|1031
23132743|The VDR also has immunomodulatory actions that are dependent on its ligand, 1,25-dihydroxyvitamin D.|1,25-dihydroxyvitamin D|VDR|14|2.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1032
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFU|COX-2|5|18.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1033
23219337|Wogonin had no effect on VEGF-C production in LM8 cells, or VEGFR-3 expression in human lymphatic endothelial cells (HLECs), however, it inhibited VEGF-C-induced VEGFR-3 phosphorylation in HLECs. The anti-tumor and anti-metastatic actions of wogonin may be associated with the inhibition of VEGF-C-induced lymphangiogenesis through a reduction in VEGF-C-induced VEGFR-3 phosphorylation by the inhibition of COX-2 expression and IL-1β production in TAMs.|Wogonin|VEGFR-3|1|29.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1034
12110374|It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.|indomethacin|COX|14|10.0|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR|1035
23430162|CONCLUSIONS: The present study demonstrated that chronic treatment with ethanol enhanced the rewarding effects of morphine by up-regulating functional changes in μ-opioid receptor, mediated by GRK2.|morphine|GRK2|17|28.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1036
8161345|5-Ethynyl-2(1H)-pyrimidinone was rapidly oxidized to 5-ethynyluracil by aldehyde oxidase.|5-ethynyluracil|aldehyde oxidase|10|12.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|1037
17258485|Phorbol 12-myristate 13 acetate (PMA), the phorbol ester activator of protein kinase C, caused a 37% decrease in the I(SC) response to ASC.|phorbol ester|protein kinase C|10|14.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR|1038
23200255|N-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition.|pyridazinone|PDE3|4|13.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR|1039
23063590|The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by artemisinic acid treatment.|artemisinic acid|TRP-2|29|25.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1040
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|FAD synthetase|28|43.0|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1041
23281044|We identified benzo[e]pyridoindoles (BePI) as powerful aurora kinase inhibitors.|BePI|aurora kinase|9|13.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|1042
15287725|Using site-directed mutagenesis, we have identified the strong lysine-binding site present within apo(a) kringle IV type 10 as an important site within the C-terminal half of the molecule, which is involved in maintaining the closed conformation of apo(a).|lysine|apo(a) kringle IV type 10|10|14.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|PART-OF|1043
23354070|Moreover, molecular dynamics simulations have identified an allosteric mechanism by which binding of palinurin leads to GSK-3β inhibition.|palinurin|GSK-3β|15|18.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|1044
23288051|Mechanistic studies reveal that the NOGEL is dependent upon repair of O(6)-methylguanine (O(6)MeG) by the suicide enzyme O(6)MeG-DNA methyltransferase (MGMT).|O(6)MeG|MGMT|18|35.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1045
17604186|Compared with normal control group, PTZ-kindled mice had significantly higher levels of malondialdehyde, nitrite, myeloperoxidase but had lower levels of reduced glutathione in the whole brain homogenate.|PTZ|myeloperoxidase|7|18.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1046
23604717|We found that SAL-2 inhibited HNE-mediated IKK phosphorylation, IκBα degradation and nuclear translocation of p65 which are linked to NF-κB activation.|HNE|IKK|6|7.0|Arg1:T19|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR|1047
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|Nexavar|RAF|6|14.0|Arg1:T13|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR|1048
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|barusiban|oxytocin receptor|11|16.0|Arg1:T28|Arg2:T58|CHEMICAL|GENE-Y|ANTAGONIST|1049
15037867|Another 5-HT(2A) receptor polymorphism consists of the silent thymidine-cytosine substitution (102T>C), which has been controversially associated with schizophrenia.|cytosine|5-HT(2A)|13|2.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|PART-OF|1050
12183691|We previously found a single amino acid change in OCTN2, Ser467Cys (S467C), in the Japanese population and observed a decreased carnitine transport but unchanged organic cation transport compared with wild type.|carnitine|OCTN2|25|10.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|1051
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|cGMP|F786A|5|21.0|Arg1:T14|Arg2:T47|CHEMICAL|GENE-N|DIRECT-REGULATOR|1052
22951949|The mechanism of DEDTC-induced apoptosis in neuronal model cells is thought to occur through the death receptor signaling triggered by DEDTC-copper complex in low concentration that is associated with the activation of caspase 8.|DEDTC-copper|caspase 8|21|33.0|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|1053
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|dienestrol|estrogen receptor|13|42.0|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1054
11319222|These results, together with previous data showing that triacsin C and troglitazone strongly inhibit triacylglycerol synthesis compared with other metabolic pathways, suggest that ACS1 and ACS4 catalyze the synthesis of acyl-CoAs used for triacylglycerol synthesis and that lack of inhibition of a metabolic pathway by triacsin C does not prove lack of acyl-CoA involvement.|triacylglycerol|ACS1|36|26.0|Arg1:T21|Arg2:T50|CHEMICAL|GENE-Y|PRODUCT-OF|1055
23605695|  Pasireotide (Signifor(®)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of corticotropin from the pituitary adenoma in patients with Cushing's disease.|Pasireotide|corticotropin|1|24.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1056
23164673|Furthermore, we validated the inhibition of GSK-3β/NF-κB signaling following cinobufagin treatment.|cinobufagin|NF-κB|11|9.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1057
22750078|THPP-1 exhibits nanomolar potency on the PDE10A enzyme, demonstrates excellent pharmacokinetic properties in multiple preclinical animal species, and is selective for PDE10A over other PDE families of enzymes.|THPP-1|PDE10A|1|7.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|1058
10207608|Taken together, these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.|AACOCF3|PLA2|12|8.0|Arg1:T13|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|1059
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|AChE|38|4.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1060
23598363|Surprisingly, the conditional deletion of Trp63, but not ΔNp63, in oocytes inhibited apoptosis, as well as the accumulation of c-Abl and TAp73 caused by cisplatin.|cisplatin|c-Abl|29|24.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1061
17545671|Finally, the amounts of RORalpha and cAspAT mRNAs were similarly increased by TZD treatment of human adipose tissue explants, confirming coordinated regulation.|TZD|cAspAT|14|8.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1062
13129570|  2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid (1) is a potent AMPA receptor agonist with moderate affinity for native kainic acid (KA) receptors, whereas (S)-E-4-(2,2-dimethylpropylidene)glutamic acid (3) show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors.|2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid|AMPA receptor|1|17.0|Arg1:T1|Arg2:T31|CHEMICAL|GENE-N|AGONIST|1063
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|c-kit|4|32.0|Arg1:T3|Arg2:T53|CHEMICAL|GENE-Y|INHIBITOR|1064
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|NS-187|Src|27|16.0|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|1065
15661821|Glucose infusion increased mRNA expression for POMC, but not for the anorectic neuropeptide CART, or the orexigenic neuropeptides NPY and AGRP, in the arcuate nucleus of the fetal hypothalamus.|Glucose|POMC|1|7.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1066
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|rimonabant|CB(1)|45|29.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|AGONIST-INHIBITOR|1067
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol|CB(1)|15|9.0|Arg1:T22|Arg2:T47|CHEMICAL|GENE-Y|AGONIST|1068
21955206|Inhibition of the NF-kappaB pathway was responsible for this effect since the colchicoside inhibited RANKL-induced NF-kappaB activation, activation of IkappaB kinase (IKK) and suppressed inhibitor of NF-kappaBalpha (IkappaBalpha) phosphorylation and degradation, an inhibitor of NF-kappaB.|colchicoside|IkappaBalpha|13|32.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1069
7567987|Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of L-5-hydroxytryptophan to serotonin and that of L-3,4-dihydroxyphenylalanine to dopamine.|L-3,4-dihydroxyphenylalanine|Aromatic L-amino acid decarboxylase|15|1.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1070
20426763|These functional responses were blocked by selective 5HT(2) receptor antagonists with the 5HT(2A) antagonist, M-100970, exhibiting the highest potency.|M-100970|5HT(2)|22|8.0|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|ANTAGONIST|1071
23454149|Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and p-Akt.|DMBT|p-VEGFR-2|5|13.0|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1072
14626653|  Vardenafil (Levitra), recently launched in Belgium by Bayer and Glaxo-SmithKline, is a new drug that potently and selectively inhibits phosphodiesterase type 5 (PDE5) in the cavernosum tissue of the penis.|Levitra|PDE5|3|28.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1073
2891463|However, betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol.|levobunolol|beta 1-adrenergic receptor|19|11.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1074
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|ICI-118,5511|beta(2)-adrenoceptor|70|74.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|1075
9313928|16,16-dimethyl-PGE2 and two putative EP1 antagonists, AH6809 and SC-19220, did not show any significant binding to this receptor.|AH6809|EP1|8|5.0|Arg1:T8|Arg2:T76|CHEMICAL|GENE-Y|ANTAGONIST|1076
2453744|  Acebutolol is a relatively new beta-adrenoceptor blocking antagonist, possessing both beta 1-adrenoceptor selectivity and partial agonist activity (PAA).|Acebutolol|beta 1-adrenoceptor|1|12.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|AGONIST|1077
19057128|These findings indicate that captopril attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of MMP-2 and MMP-9 in rats.|captopril|MMP-2|5|19.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|1078
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide|5-HT1A|10|7.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|1079
17125913|Cd rapidly increased c-jun, c-fos and PDGFA expression.|Cd|c-fos|1|6.0|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1080
11319222|Troglitazone exhibited a mixed type inhibition of ACS4.|Troglitazone|ACS4|1|8.0|Arg1:T2|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|1081
23478800|The ROS scavenger N-acetyl l-cysteine and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of cucurbitacin I on Rac1 activation.|cucurbitacin I|Rac1|16|19.0|Arg1:T5|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|1082
1705633|  Enalkiren (A-64662), a potent, dipeptide renin inhibitor, mimics the transition state of the human renin substrate, angiotensinogen.|A-64662|human renin|3|19.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1083
23159986|The compound D-limonene induced a dose dependent increase in HDN severity and renal biomarker changes without altering BUN, creatinine or NAG: (1) minimal induction of HDN and no altered biomarkers at 10 mg/kg/day, (2) mild induction of HDN with increased αGST and μGST at 50 mg/kg/day and (3) marked induction of HDN with increased αGST, μGST and albumin at 300 mg/kg/day.|D-limonene|αGST|3|48.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1084
12927226|CONCLUSIONS: AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.|eprosartan|AT1|6|3.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ANTAGONIST|1085
23583910|A N,N-dimethylaminopropyl derivative showed promising inhibition of Trypanosoma cruzi OSC in combination with low cytotoxicity, and showed significant reduction of cholesterol biosynthesis in a human cell line.|cholesterol|Trypanosoma cruzi OSC|24|10.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|1086
23411280|  Histidine decarboxylase (HDC) catalyses the formation of histamine, a bioactive amine.|histamine|HDC|10|4.0|Arg1:T8|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF|1087
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|ICAM-1|7|12.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1088
23122161|Also, the methanol extract and the hexane fraction inhibited LPS-induced MAPKs and NF-kB activation associated with the inhibition of iNOS or COX-2 expression.|hexane|NF-kB|8|14.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|1089
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|haloperidol|preproenkephalin A|18|21.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1090
23238783|The bupropion metabolic ratio appears to detect known differences in CYP2B6 activity associated with genetic polymorphism, across different ethnic groups.|bupropion|CYP2B6|2|11.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1091
21194017|Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA(A)-R.|amino acids|bovine brain GABA(A)-R|21|29.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|PART-OF|1092
8441637|  All DNA (cytosine-5)-methyltransferases contain a single conserved cysteine.|cysteine|DNA (cytosine-5)-methyltransferases|11|2.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE|1093
23645248|In contrast, TSH-induced differentiation of progenitor cells, in particular the expression of the sodium iodide symporter, was significantly inhibited by 17beta-oestradiol.In conclusion, oestrogen stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells.|17beta-oestradiol|sodium iodide symporter|24|16.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|1094
10373451|The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.|amino acids|PDE|8|41.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-N|PART-OF|1095
10658902|With respect to the substrate dihydroorotate, atovaquone was an uncompetitive inhibitor of human dihydroorotate dehydrogenase (Kiu = 11.6 microM) and a non-competitive inhibitor of the rat enzyme (Kiu = 905/ Kic = 1,012 nM).|dihydroorotate|human dihydroorotate dehydrogenase|6|14.0|Arg1:T19|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR|1096
23605050|The Bcl2/Bax ratio increased and Mfn2 expression decreased in MIN6 cells after glucose stimulation.|glucose|Mfn2|13|6.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1097
10365684|  Methimazole (MMI) and propylthiouracil (PTU) are common antithyroid drugs for treating hyperthyroidism because the 2 drugs inhibit thyroid peroxidase (TPO)-catalyzed thyroid hormone formation.|Methimazole|thyroid peroxidase|1|22.0|Arg1:T1|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1098
7739347|  To find out the reason of weak addiction property of dihydroetorphine, we compared the affinities of dihydroetorphine to the type selective opioid receptor and inhibition effect on the adenylyl cyclase activity with those of etorphine.|etorphine|adenylyl cyclase|36|30.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|1099
15736931|In this study, we show that mutation of Arg228, a residue in the vicinity of Glu317, to lysine (R228K-Gal-T1) results in a 15-fold higher Glc-T activity, which is further enhanced by LA to nearly 25% of the Gal-T activity of the wild type.|lysine|Gal-T|21|45.0|Arg1:T31|Arg2:T55|CHEMICAL|GENE-N|PART-OF|1100
23527317|  A series of N-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [(3)H]dopamine uptake.|lobelane|vesicular monoamine transporter|5|24.0|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|1101
20512624|A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures.|GABA|GABA transporters|12|7.0|Arg1:T29|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE|1102
15353592|Lactisole inhibits the activity of the human T1R1/T1R3 receptor, and, as predicted, blocked the umami taste of l-glutamate in human taste tests.|Lactisole|T1R3|1|9.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|1103
23205634|Bile acids strongly decrease the basal ABCG2-ATPase activity both in the wild-type ABCG2 and in the mutant variant.|Bile acids|ABCG2|1|7.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1104
23589329|Thus, arsenic activates Nrf2 through a non-canonical mechanism (p62-dependent), leading to a chronic, sustained activation of Nrf2.|arsenic|Nrf2|3|5.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR|1105
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Asp|ALDH|13|21.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-N|PART-OF|1106
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|NO|iNOS|17|6.0|Arg1:T1|Arg2:T52|CHEMICAL|GENE-Y|PRODUCT-OF|1107
23583931|  During repetitive stimulation of skeletal muscle, extracellular ATP levels raise, activating purinergic receptors, increasing Ca(2+) influx, and enhancing contractile force, a response called potentiation.|ATP|purinergic receptors|9|14.0|Arg1:T15|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR|1108
17337452|Engineered monomeric human histidine triad nucleotide-binding protein 1 hydrolyzes fluorogenic acyl-adenylate and lysyl-tRNA synthetase-generated lysyl-adenylate.|lysyl|lysyl-tRNA synthetase|15|13.0|Arg1:T18|Arg2:T48|CHEMICAL|GENE-Y|PRODUCT-OF|1109
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|haem oxygenase 1|1|19.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1110
20188727|Phenformin but not metformin inhibits a number of variants of K(ATP) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (Kir6.1/SUR2B and Kir6.2/SUR2B) and pancreatic beta-cells (Kir6.2/SUR1).|Phenformin|K(ATP)|1|11.0|Arg1:T19|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR|1111
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|cGMP|Q817A|4|43.0|Arg1:T33|Arg2:T58|CHEMICAL|GENE-N|DIRECT-REGULATOR|1112
9256165|Sulfasalazine and CL 42A markedly inhibited extracellular release of sPLA2.|Sulfasalazine|sPLA2|1|10.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1113
2268554|4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM.|4-MA|5 alpha-reductase|1|6.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|1114
17088426|We propose a model whereby compartmentalized PDEs, rather than representing an enzymatic barrier to cAMP diffusion, act as a sink to drain the second messenger from discrete locations, resulting in multiple and simultaneous domains with different cAMP concentrations irrespective of their distance from the site of cAMP synthesis.|cAMP|PDEs|50|7.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|1115
17223000|Pranlukast hydrate (ONO-1078, 100 microM) downregulated the leukotriene D(4)-induced MUC2/5AC gene expression and mucin secretion.|ONO-1078|MUC2/5AC|4|17.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1116
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|SLPI|4|34.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1117
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|afatanib|EGFR|41|30.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1118
12085361|100 micromol/L rifampicin inhibited OATP-C- and OATP8-, OATP-B- and OATP-A-mediated BSP uptake by 66%, 96%, 25%, and 49%, respectively.|BSP|OATP-B|12|9.0|Arg1:T7|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1119
14504136|Interestingly, 5-CT-induced cardiac sympatho-inhibition was abolished by methiothepin, the cocktail of antagonists/inhibitors, GR 127935 or the combination of SB224289 (5-HT1B) plus BRL15572 (5-HT1D), but remained unchanged when SB224289 or BRL15572 were given separately.|SB224289|5-HT1B|22|24.0|Arg1:T13|Arg2:T47|CHEMICAL|GENE-Y|ANTAGONIST|1120
10639181|Derivatization of the carboxylate moiety in moderately selective COX-1 inhibitors, such as 5,8,11,14-eicosatetraynoic acid (ETYA) and arylacetic and fenamic acid NSAIDs, exemplified by indomethacin and meclofenamic acid, respectively, generated potent and selective COX-2 inhibitors.|indomethacin|COX-1|28|9.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1121
1407010|The pharmacological profile of [125I]GTI binding was fully comparable to that reported previously in human and other brain preparations known to possess 5-HT1D sites (using either [3H]5-HT or [125I]GTI) and displayed a characteristic rank order of affinity: 5-carboxamido-tryptamine greater than 5-HT = dihydroergotamine greater than or equal to ergotamine greater than or equal to sumatriptan greater than or equal to CGS 12066 greater than or equal to metergoline greater than yohimbine greater than or equal to methysergide greater than ICYP greater than 8-OH-DPAT greater than or equal to CP 93129 greater than (-)pindolol greater than ketanserin greater than isamoltane greater than mesulergine greater than corynanthine greater than buspirone greater than MDL 72222.|sumatriptan|5-HT1D|68|27.0|Arg1:T27|Arg2:T41|CHEMICAL|GENE-N|DIRECT-REGULATOR|1122
23273999|The most intensive stimulating DOAs were further investigated and compared with the known P-gp model substrates sertraline and verapamil.|verapamil|P-gp|19|14.0|Arg1:T13|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE|1123
9563368|The resulting half-life of the FP active steroid-receptor complex is >10 hours, compared with approximately 5, 7.5, and 4 hours for budesonide, 17-BMP, and triamcinolone acetonide, respectively.|budesonide|steroid-receptor|26|8.0|Arg1:T29|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR|1124
23589302|In the present report, we show that Fer associates with the activated PDGFbeta receptor (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and Tyr1021.|Tyr|PDGFRbeta|28|17.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|PART-OF|1125
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|norepinephrine|NET|6|20.0|Arg1:T27|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|1126
10768298|RESULTS: Topiramate Ki values for HCA I, HCA II, HCA IV, and HCA VI were approximately 100, 7, 10, and >100 microM, respectively.|Topiramate|HCA I|3|7.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|1127
15219414|Conversely, experiments in cell culture systems demonstrated significant antagonism of cortisol-induced transcriptional activation by oxandrolone in cells expressing both the AR and GR.|oxandrolone|GR|16|24.0|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST|1128
23583931|The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels.|ATP|pannexin|2|13.0|Arg1:T21|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE|1129
12213829|Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the ATP inhibition of K(IR)6.2/SUR1, but had no effect on homomeric K(IR)6.2 channels.|ATP|K(IR)6.2|25|28.0|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|1130
23315277|Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to SiO(2) NPs, the messenger RNA level of apoptotic genes (caspase-3 and caspase-9) were upregulated in a dose-dependent manner.|SiO(2)|caspase-9|15|31.0|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1131
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|pyridinium oximes|AChE|22|14.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|1132
23432586|Conclusions: We suggest that, among others, FKBP52 expression and function are altered in platelets from DM2 patients, contributing to the altered Ca(2+) entry and hyperaggregability in these cells.|Ca(2+)|FKBP52|26|10.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|1133
17471183|  New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their cytochrome P450 enzyme inhibition profiles, allow improved deductions concerning their effects and interactions and indicate which of the TCAs are the most useful.|tricyclic|cytochrome P450|7|22.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|1134
23301897|In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-κB (p65) inhibitory activity in an ELISA assay.|sesquiterpene|NF-κB|28|37.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|1135
14585280|For these reasons, the use of irreversible DNA methyltransferase inhibitors, such as 5-azacytidine and Decitabine, appears to be a promising option for the treatment of MDS and acute myeloid leukemia.|5-azacytidine|DNA methyltransferase|15|9.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|1136
14757700|In contrast, menthol- and icilin-activated TRPM8 currents were suppressed by low pH.|menthol|TRPM8|4|7.0|Arg1:T17|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR|1137
20007701|This expression system allowed identification of a new substrate, acriflavine, and isolation of mutants with modified affinity to tetrabenazine (TBZ), a non-competitive inhibitor of VMAT2 that is used in the treatment of various movement disorders including Tourette syndrome and Huntington chorea.|tetrabenazine|VMAT2|21|30.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1138
10579749|The mode of (functional) AT1 receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).|irbesartan|AT1|31|7.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST|1139
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|iron|transferrin|27|33.0|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|1140
23384967|  Bisphenol A (BPA) and diethylstilbestrol (DES) are endocrine-disrupting chemicals that interact with the human pregnane X receptor (PXR).|diethylstilbestrol|human pregnane X receptor|7|18.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1141
15106733|The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and PGE2 release.|PD098059|cytokine|11|14.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|1142
23201927|In addition, the PI3K inhibitor partially blocked the effects of Sal B on the upregulation of Bcl-2 and Bcl-xl protein expression, and downregulation of Bax protein expression.|Sal B|Bcl-xl|12|20.0|Arg1:T18|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1143
17046555|Treatment of the cells with the NADPH oxidase inhibitors, apocynin and diphenylene iodonium, inhibited these effects.|diphenylene iodonium|NADPH oxidase|13|7.0|Arg1:T15|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|1144
9614060|System y+ cationic amino acid transport is mediated by proteins encoded by a family of genes, Cat1, Cat2, and Cat3.|amino acid|System y+|4|1.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|1145
23486447|Amitriptyline, clomipramine, doxepin, imipramine, and trimipramine are demethylated by CYP2C19 to pharmacologically active metabolites.|clomipramine|CYP2C19|3|14.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE|1146
18604229|Specifically, B2-O-CH(2)-CH(2)-N-piperidine and B2-O-CH(2)-CH(2)-N-pyrrolidine revealed a higher affinity towards hERG channels than amiodarone.|B2-O-CH(2)-CH(2)-N-pyrrolidine|hERG|13|27.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1147
7905294|The inhibition was unaffected by the clamping-voltage and by a mutation [NR1-NR2A(N595Q)] that prevents the Mg(2+)-blockade of the channels, indicating that the mechanism of action of ethanol differs from that of Mg2+.|ethanol|NR2A|37|14.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1148
15840408|ONO-AE1-259-01 a prostanoid EP2-receptor agonist, ONO-AE1-329, a prostanoid EP4-receptor agonist, and ONO-1301 inhibited TNF-alpha production and T-cell proliferation.|ONO-AE1-329|TNF-alpha|7|17.0|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1149
10500149|10, 3beta-methylcarbonate-androst-5-ene-7,17-dione] that have no androgenic activity and could also block the Adiol-induced AR transactivation in prostate cancer PC-3 cells.|Adiol|AR|15|16.0|Arg1:T23|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR|1150
20204178|Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed PTH mRNA expression and serum PTH effectively in the 5/6 NX rats, but paricalcitol was less potent in raising serum Ca than doxercalciferol.|paricalcitol|PTH|26|12.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1151
15059893|Treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine for 5 days restored TIG1 expression in all eight silenced cell lines tested.|5-aza-2'-deoxycytidine|DNA methyltransferase|7|4.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1152
20497523|The selective ERbeta agonist ERB-79 had no effect on arthritis symptoms in this model.|ERB-79|ERbeta|5|3.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|AGONIST|1153
16980198|Ingestion of competitive inhibitors of 11beta-HSD2 such as liquorice and carbenoxolone result in a similar but milder clinical phenotype.|carbenoxolone|11beta-HSD2|11|6.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1154
23583910|A N,N-dimethylaminopropyl derivative showed promising inhibition of Trypanosoma cruzi OSC in combination with low cytotoxicity, and showed significant reduction of cholesterol biosynthesis in a human cell line.|N,N-dimethylaminopropyl|Trypanosoma cruzi OSC|2|10.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1155
10639181|Derivatization of the carboxylate moiety in moderately selective COX-1 inhibitors, such as 5,8,11,14-eicosatetraynoic acid (ETYA) and arylacetic and fenamic acid NSAIDs, exemplified by indomethacin and meclofenamic acid, respectively, generated potent and selective COX-2 inhibitors.|5,8,11,14-eicosatetraynoic acid|COX-1|14|9.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1156
15561708|  The molybdenum cofactor sulfurase ABA3 from Arabidopsis thaliana specifically regulates the activity of the molybdenum enzymes aldehyde oxidase and xanthine dehydrogenase by converting their molybdenum cofactor from the desulfo-form into the sulfo-form.|molybdenum|aldehyde oxidase|15|17.0|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|1157
9040115|There is, however, much information on the direct (acute and chronic) effects of alcohol on the binding properties of opioid receptors, as well as modulation of opioid peptide synthesis and secretion (e.g. a suggested increase in beta-endorphin release).|alcohol|beta-endorphin|18|44.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1158
2453744|  Acebutolol is a relatively new beta-adrenoceptor blocking antagonist, possessing both beta 1-adrenoceptor selectivity and partial agonist activity (PAA).|Acebutolol|beta-adrenoceptor|1|6.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ANTAGONIST|1159
23508685|We found that Egr1, a transcription factor whose promoter activity was positively regulated by the 5-HT2A receptor agonist TCB-2, binds less to the mGlu2 promoter in frontal cortex of 5-HT2A-KO as compared to wild-type mice.|TCB-2|5-HT2A|20|17.0|Arg1:T2|Arg2:T8|CHEMICAL|GENE-Y|AGONIST|1160
17260025|  A chemical biology approach identifies a beta 2 adrenergic receptor (beta2AR) agonist ARA-211 (Pirbuterol), which causes apoptosis and human tumor regression in animal models.|ARA-211|beta2AR|15|12.0|Arg1:T9|Arg2:T41|CHEMICAL|GENE-Y|AGONIST|1161
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|O2|iNOS|27|6.0|Arg1:T13|Arg2:T52|CHEMICAL|GENE-Y|SUBSTRATE|1162
23085120|All these results suggest that B12H substantially protected CGNs against glutamate-induced neuronal excitotoxicity via activating α7nAChR/PI3-K/Akt cascade.|B12H|PI3-K|6|17.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR|1163
23500772|Compared with DM8W group, SOD and ALDH2 in EtOH+DM8W group was increased, MDA was decreased.|EtOH|ALDH2|10|8.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1164
15985434|To understand this interaction, we determined the crystal structure of PDXK in complex with (R)-roscovitine, N6-methyl-(R)-roscovitine, and O6-(R)-roscovitine, the two latter derivatives being designed to bind to PDXK but not to CDKs. Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal-binding site of PDXK rather than in the anticipated ATP-binding site.|roscovitines|PDXK|55|63.0|Arg1:T21|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1165
2832297|After loperamide administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an ACTH increase; the pattern of ACTH response to CRH was slightly delayed.|loperamide|ACTH|2|4.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1166
18450949|Administration of chloroquine (50 mg/kg for 7 days po), a denaturant of lysosomes, increased the AQP5 protein level reduced by CTD.|chloroquine|AQP5|3|20.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1167
11120594|In the present study, we show that norepinephrine and terbutaline stimulate the beta2AR to decrease the level of IL-2 produced by freshly isolated murine splenic naive CD4+ T cells from either Balb/C or DO11.10 transgenic mice and activated polyclonally with anti-CD3 and anti-CD28 mAbs.|norepinephrine|beta2AR|9|14.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|1168
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|amino acids|EAG|10|25.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|PART-OF|1169
16018973|We present our studies to demonstrate that HM74A, but not HM74, binds niacin at high affinities and effectively mediates Gi signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing HM74A.|niacin|HM74A|15|8.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR|1170
23515287|The Androgen Metabolite, 5α-Androstane-3β,17β-Diol (3β-Diol), Activates the Oxytocin Promoter Through an Estrogen Receptor-β Pathway.|5α-Androstane-3β,17β-Diol|Oxytocin Promoter|5|12.0|Arg1:T19|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|1171
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|Procaine|norepinephrine transporter|1|17.0|Arg1:T26|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|1172
10841524|H(+) transport by NHE3 and the novel transporter is inhibited by cAMP, albeit to different extents.|cAMP|NHE3|15|7.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1173
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|tumor necrosis factor alpha|1|3.0|Arg1:T18|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1174
17185414|We have identified a highly potent and selective small-molecule ALK inhibitor, NVP-TAE684, which blocked the growth of ALCL-derived and ALK-dependent cell lines with IC(50) values between 2 and 10 nM.|NVP-TAE684|ALK|13|22.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR|1175
11980628|It is important to note that the inhibitory effect of SOM230 was relatively selective for GH and IGF-I in that insulin and glucagon secretion was inhibited only at higher doses of SOM230.|SOM230|GH|11|16.0|Arg1:T15|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR|1176
9610840|  Sesamin (a non-fat portion of sesame seed oil) inhibits delta-5 desaturase activity resulting in an accumulation of dihomo-gamma-linolenic acid (DGLA) which can displace arachidonic acid (AA) and decrease the formation of pro-inflammatory mediators.|DGLA|delta-5 desaturase|23|12.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|1177
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|Ser|phospho-Rb|43|42.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|1178
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|ARE|10|13.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|1179
8788445|Co-administration of haloperidol shifts the dose-response curve to the left and elevates the maximal response to 70% through a blockade of sigma 1 receptors, but the curve remains biphasic.|haloperidol|sigma 1 receptors|3|23.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1180
10208549|Following a single oral administration, both bis(7)-tacrine and tacrine produced dose-dependent inhibitions of AChE in rat brain, but bis(7)-tacrine exhibited higher efficacy and AChE/BChE selectivity than tacrine.|bis(7)-tacrine|AChE|8|19.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1181
15771438|Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.|sulfamide|carbonic anhydrase-II|5|11.0|Arg1:T16|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1182
19549602|Amitriptyline binds the extracellular domain of both TrkA and TrkB and promotes TrkA-TrkB receptor heterodimerization.|Amitriptyline|TrkA|1|8.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1183
15730717|0 approximately 400 micromol/L of IN could down-regulate the expression of p-STAT1 or p-STAT5 in a dose-response manner, p-STATs were distributed mainly in the nucleus as scattering spots.|IN|p-STAT1|6|12.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1184
23611809|These are drugs that were previously reported to be substrates for UGT1A4 or UGT1A3 and that contain in their structure either tertiary aliphatic amines, cyclic amines, or an imidazole group.|cyclic amines|UGT1A3|26|14.0|Arg1:T21|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE|1185
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W|VEGF|23|38.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1186
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hCNT2|11|22.0|Arg1:T12|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1187
17692905|Similarly, the tube formation induced by standard VEGF, FGF-2, or TNF-alpha was 100% inhibited by enoxaparin, and 70-90% by dalteparin, whereas minor or no inhibition was observed with UFH.|dalteparin|FGF-2|26|11.0|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR|1188
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|methyl|ERβ|29|45.0|Arg1:T15|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1189
19928382|At doses that produced equal increases in wake, DA-releasing (amphetamine, methamphetamine, phentermine) and several DAT-inhibiting agents (cocaine, bupropion, and methylphenidate) produced RHS during the first few hours after the onset of sleep recovery.|methylphenidate|DAT|28|20.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1190
12213829|The L0 linker has been reported to be required for glibenclamide binding, and DeltaNK(IR)6.2/SUR1 channels exhibit reduced labeling of K(IR) with (125)I-azidoglibenclamide, implying that the K(IR) N terminus and L0 of SUR1 are in proximity.|N|K(IR)|42|38.0|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|PART-OF|1191
23050902|It was reported previously that FVII gene (F7) expression was up-regulated by ribavirin treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.|ribavirin|F7|15|9.0|Arg1:T6|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1192
10381508|An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.   Factor IXR94S is a naturally occurring hemophilia B defect, which results from an Arg 94 to Ser mutation in the second epidermal growth factor (EGF)-like module of factor IX.|Ser|factor IX|53|67.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|PART-OF|1193
23566269|We identified a series of 4-hydroxypyridazin-3(2H)-one derivatives as novel DAAO inhibitors with high potency and substantial cell permeability using fragment-based drug design.|4-hydroxypyridazin-3(2H)-one|DAAO|6|14.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1194
23603004|Results showed that naringin of 60 and 120mg/kg significantly reduced PQ-induced upregulations of TNF-α, TGF-β1, MMP-9 and TIMP-1, levels of pulmonary malonaldehyde and hydroxyproline, as well as pulmonary fibrosis deposition, while increased activities of SOD, GSH-Px and HO-1.|naringin|MMP-9|4|18.0|Arg1:T14|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1195
23505344|  Pathways are computed for transport of H2O and CO in myoglobin (Mb), using the single sweep and zero-temperature string methods in a fully atomistic, explicitly solvated model system.|CO|myoglobin|9|11.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE|1196
1327384|alpha 2A-Adrenoceptor selective compounds, oxymetazoline and BRL 44409, showed high affinity for [3H]-RS-15385-197 binding in the human platelet and lower affinity in the neonate lung, while the alpha 2B-selective compounds, prazosin and imiloxan, showed high affinity for [3H]-RS-15385-197 binding in the neonate lung.This suggests that [3H]-RS-15385-197 labels both alpha2A- and alpha2B-adrenoceptor subtypes.4. Prazosin and methysergide inhibited the binding of [3H]-RS-15385-197 in the rat cerebral cortex in a simple manner consistent with an interaction at a single site.|oxymetazoline|alpha 2A-Adrenoceptor|6|1.0|Arg1:T4|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1197
18237195|In the absence of Cl-, melatonin served as a 1e- substrate for MPO compound I, but at higher concentration it limited the reaction by its dissociation from the corresponding complex.|melatonin|MPO|7|14.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|1198
23543737|In the current study, we extend these findings to show that the ability of astrocytes to buffer extracellular glutamate is reduced when CaMKII is inhibited.|glutamate|CaMKII|20|24.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|1199
10913016|In the presence of the beta(2)-adrenoceptor antagonist ICI-118551 (ICI, 10 microM), Iso caused an increase in [(14)C]phenylalanine incorporation, protein and RNA mass, cell volume, and cross-sectional area.|ICI-118551|beta(2)-adrenoceptor|12|6.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST|1200
15206110|Even though its inability to shift between the trivalent and a divalent oxidation state precludes that gallium behaves as an iron analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with transferrin and transferrin receptor-mediated endocytosis.|gallium|transferrin receptor|17|43.0|Arg1:T24|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR|1201
22982773|Rate constants for reactivation of OP-inhibited AChE by even the best oximes, such as HI-6 and obidoxime, can vary >100-fold between OP-AChE conjugates that are easily reactivated and those that are difficult to reactivate.|obidoxime|AChE|18|7.0|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR|1202
2901134|Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.|Cysteamine|somatostatin|1|5.0|Arg1:T17|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1203
23485615|CK significantly inhibited DMN-induced increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content.|DMN|AST|4|17.0|Arg1:T11|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|1204
10611634|In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT(1A) sites versus marked antagonist actions at halpha(2)-ARs. While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.|fluparoxan|halpha(2)-ARs|6|24.0|Arg1:T50|Arg2:T59|CHEMICAL|GENE-N|ANTAGONIST|1205
23063590|Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by artemisinic acid.|artemisinic acid|macrophage migration inhibitory factor|31|20.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1206
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|carnitine octanoyltransferase|32|17.0|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|1207
14633707|The observation that Ras-transformed cells can be sensitized to killing by ionizing radiation with GW572016 demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.|GW572016|EGFR|15|18.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|1208
23046389|The domestic animals also showed marked species differences in the AO activity and affinity toward zoniporide.|zoniporide|AO|16|11.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR|1209
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|sulpiride|preproenkephalin A|12|21.0|Arg1:T10|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1210
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|rofecoxib|COX|15|6.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR|1211
2855105|In all patients loperamide induced a significant fall in plasma ACTH levels.|loperamide|ACTH|4|11.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1212
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|hyperforin|beta2-AR|29|24.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1213
23142425|Subjects carrying the UGT2B7 268 His/Tyr or Tyr/Tyr genotype had significantly lower total NNAL than those carrying His/His genotype.|Tyr|UGT2B7|7|4.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|PART-OF|1214
17369473|In hearts treated with phenformin for 18 min and then perfused for 20 min with Krebs-Henseleit buffer, [AMP] began to increase at 26 min and AMPK activity was elevated at 36 min.|phenformin|AMPK|5|29.0|Arg1:T38|Arg2:T58|CHEMICAL|GENE-N|ACTIVATOR|1215
9765513|  We examined the effects of the calcium channel blockers nitrendipine, diltiazem, verapamil, bepridil, and mibefradil on the cloned HERG and KvLQT1/IsK K+ channels.|nitrendipine|calcium channel|10|7.0|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|1216
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|T432S|4|9.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|1217
15695169|Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.|ramelteon|MT1|4|11.0|Arg1:T18|Arg2:T37|CHEMICAL|GENE-Y|AGONIST|1218
22659408|Purified synaptosomes were selectively prelabeled with [(3)H]glycine through the neuronal transporter GlyT2 and subsequently depolarized by superfusion with 12 mM KCl. The selective mGluR2/3 agonist LY379268 inhibited the K(+)-evoked overflow of [(3)H]glycine in a concentration-dependent manner (EC(50) about 0.2 nM).|[(3)H]glycine|GlyT2|7|18.0|Arg1:T11|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1219
23423713|In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.|V(5+)|Cyp1a1|4|13.0|Arg1:T19|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1220
17606858|Furthermore, in aldosterone-untreated hearts, fenofibrate decreased transforming growth factor-beta, collagen type III (P<0.05 for both), and collagen type I (P<0.01) protein expression.|fenofibrate|collagen type I|7|25.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1221
10670413|Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.|17-phenyl-trinor-PGE2|EP1|16|19.0|Arg1:T14|Arg2:T48|CHEMICAL|GENE-Y|AGONIST|1222
16278927|In conclusion, of the seven NSAIDs investigated, niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4-MUG in a competitive manner.|niflumic acid|UGT1A9|10|19.0|Arg1:T1|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|1223
17202804|Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.|testosterone|human androgen receptor|5|9.0|Arg1:T26|Arg2:T69|CHEMICAL|GENE-Y|ACTIVATOR|1224
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|tripelennamine|histamine H1-receptor|30|13.0|Arg1:T22|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST|1225
15627430|The excellent correlation between in vitro antagonist activities of antipsychotics at muscarinic M2 receptors and their in vivo potencies to increase acetylcholine release, suggests that olanzapine, clozapine, as well as thioridazine and chlorpromazine, increase acetylcholine release via blockade of terminal muscarinic M2 autoreceptors.|olanzapine|muscarinic M2 autoreceptors|27|45.0|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|1226
23583884|In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and NF-κB activation induced by TCDD can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.|TCDD|NF-κB|20|16.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR|1227
14596599|Formation of pyruvate by SDH is a two-step reaction in which the hydroxyl group of serine is cleaved to produce aminoacrylate, and then the aminoacrylate is deaminated by nonenzymatic hydrolysis to produce pyruvate.|hydroxyl|SDH|13|5.0|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|PART-OF|1228
23339663|The series of crystallographic snapshots reveals that AChE and BChE react with the opposite enantiomers and that an induced-fit rearrangement of Phe297 enlarges the active site of AChE upon CBDP binding.|Phe|AChE|22|28.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|1229
23643752|As seen with phagocytotic microglia, the CB2 antagonist, AM630, increased Iba-1 positive microglia in the absence of URB597 treatment.|AM630|CB2|11|8.0|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST|1230
12213829|We hypothesize that L0 interacts with the K(IR) N terminus in ligand-inhibited K(ATP) channels and put forward a model, based on the architecture of BtuCD, MsbA, and the KcsA channel, in which TMD0-L0 links the MDR-like core of SUR with the K(IR) pore.|N|K(IR)|12|8.0|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|PART-OF|1231
8600944|Dexamethasone (DEX) inhibited the anti-CD3-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.|Dexamethasone|IL-5|1|12.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1232
17980251|AZD6140 is a reversible oral P2Y(12) receptor antagonist that has been studied in ACS patients in comparison with clopidogrel (DISPERSE-2 study).|clopidogrel|P2Y(12)|22|6.0|Arg1:T21|Arg2:T29|CHEMICAL|GENE-Y|ANTAGONIST|1233
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Nucleotide|nucleotide-binding domains|1|21.0|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|1234
23591125|The induced 'ischemic depression' was lasting and sensitive to an acute administration of brain-derived neurotrophic factor or bryostatin-1, a relatively selective activator of protein kinase Cε, during the induction phase.|bryostatin-1|protein kinase Cε|19|26.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR|1235
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|mitoxantrone|TOP2|38|29.0|Arg1:T17|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|1236
23200901|Bidirectional transport assays of the Aconitum alkaloids were performed with or without P-gp (cyclosporine A and verapamil), BCRP (Ko143) and MRP2 (MK571) inhibitors.|Ko143|BCRP|23|21.0|Arg1:T22|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|1237
2521824|We conclude that androgens can stimulate human and murine osteoblastic cell proliferation in vitro, and induce expression of the osteoblast-line differentiation marker ALP, presumably by an androgen receptor mediated mechanism.|androgens|osteoblast-line differentiation marker|4|21.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1238
9145928|Both the hydroxyl and the ether oxygen atoms of the oxypropanol moiety seem to be required for binding at wild-type 5-HT1A receptors.|oxypropanol|5-HT1A|11|21.0|Arg1:T23|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1239
23066988|Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by co-incubation with the AMPK inhibitor compound C.|compound C|proghrelin|22|7.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1240
8301142|Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.|Retinoic acid|IL-6|1|6.0|Arg1:T21|Arg2:T48|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1241
23093496|This study showed that, in addition to ADP and ATP, other ATP derivatives are not only ligands of P2Y(12) but also agonists.|ATP|P2Y(12)|14|21.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1242
17373776|The E1013D variant showed coupling between glutamine hydrolysis at the glutaminase site and 2-oxoglutarate-dependent L-glutamate synthesis at the synthase site, but a sigmoid dependence of initial velocity on L-glutamine concentration.|L-glutamate|E1013D|15|2.0|Arg1:T20|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF|1243
17645691|These included, biliverdin-IX alpha reductase and the sodium-dependent vitamin C transport proteins SVCT1 and SVCT2, whose expression levels were enhanced in maternal and fetal liver by melatonin treatment.|vitamin C|SVCT1|10|14.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|1244
12388748|Culture of HepG2 cells with griseofulvin has now been shown to induce both the formation of intracellular aggregates containing K18 as well as an increase in the abundance of K18 mRNA.|griseofulvin|K18|6|30.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1245
23256625|This study provides a mechanistic understanding of the in vivo inhibition of transporters and enzymes by GSK1292263.|GSK1292263|transporters|17|13.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|1246
10567921|  The N-terminus of the type 1 interferon receptor subunit, IFNAR1, has high amino acid sequence similarity to the receptor binding B subunit of the Escherichia coli-derived verotoxin 1, VT1.|N|type 1 interferon receptor subunit|2|5.0|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|PART-OF|1247
23085435|  Nitrogen-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small G-proteins.|bisphosphonates|G-proteins|2|17.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|1248
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|JNK|11|35.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|1249
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|efavirenz|hPXR|6|19.0|Arg1:T12|Arg2:T47|CHEMICAL|GENE-Y|AGONIST|1250
22815248|In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and cytochrome P450, compared to the CCl4 only group.|CCl4|cytochrome P450|30|24.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR|1251
23639801|CID16020046 concentration-dependently inhibited LPI-induced activation of nuclear factor of activated T-cells (NFAT), nuclear factor kappa of activated B cells (NF-κB) and serum response element (SRE), translocation of NFAT and NF-κB, and GPR55 internalization.|LPI|nuclear factor of activated T-cells|4|7.0|Arg1:T12|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR|1252
18794803|The CRAF inhibitor sorafenib was found to induce a time-dependent reduction in both BAD phosphorylation and Bcl-2 expression in the D594G/G469E lines only.|sorafenib|CRAF|4|2.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|1253
16395286|Minocycline showed more potent inhibition on MMP-9 mRNA expression, starting at 1 (P<0.005) and further at more than 30 (P<0.001) mg/kg/day.|Minocycline|MMP-9|1|7.0|Arg1:T12|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1254
23470629|Measurement of Transport Activities of 3β-Hydroxy-Δ(5)-bile Acids in Bile Salt Export Pump and Multidrug Resistance-Associated Proteins Using LC-MS/MS.|3β-Hydroxy-Δ(5)-bile Acids|Multidrug Resistance-Associated Proteins|6|18.0|Arg1:T10|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE|1255
12170055|Meperidine inhibited the production of forskolin-stimulated cyclic adenosine monophosphate mediated by all receptor subtypes but was most effective at the alpha(2B) adrenoceptor (alpha(2B), 0.6 microm; alpha(2A), 1.3 mm; alpha(2C), 0.3 mm), reaching the same level of inhibition (approximately 70%) as achieved with the alpha2-adrenoceptor agonist dexmedetomidine.|Meperidine|alpha(2B) adrenoceptor|1|21.0|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR|1256
17611273|In hippocampal dentate gyrus, MPH-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of neural cell adhesion molecule).|MPH|NET|6|14.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1257
12085361|100 micromol/L rifampicin inhibited OATP-C- and OATP8-, OATP-B- and OATP-A-mediated BSP uptake by 66%, 96%, 25%, and 49%, respectively.|BSP|OATP-A|12|11.0|Arg1:T7|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|1258
17308037|Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.|BRL-50481|PDE7|65|63.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|1259
23193181|Based on animal and in vitro studies, resveratrol reverts these risk factors via stimulation of silent mating type information regulation 2 homolog 1 (SIRT1), but data in human subjects are scarce.|resveratrol|SIRT1|9|26.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|ACTIVATOR|1260
16010590|CONCLUSIONS: The combination of TFT with the antifolates AG337, ZD1694 and GW1843 is mainly additive when the drugs are given simultaneously and this is mediated by an additive TS inhibition and DNA damage.|TFT|TS|6|31.0|Arg1:T19|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR|1261
12668769|The ratio between the GDC/SHMT and C1-THF synthase/SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.|[(13)C]formate|C1-THF synthase|23|7.0|Arg1:T12|Arg2:T57|CHEMICAL|GENE-Y|SUBSTRATE|1262
12697717|Collectively, these results suggest a role for 17 beta HSDXI in androgen metabolism during steroidogenesis and a possible role in nonsteroidogenic tissues including paracrine modulation of 5 alpha-androstane-3 alpha, 17 beta-diol levels.|androgen|17 beta HSDXI|13|9.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|1263
15814851|The potent and selective third-generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were introduced into the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.|anastrozole|aromatase|9|6.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1264
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|GRE|4|14.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|1265
17553661|HepG2 cells transfected with an hGSTA4 vector construct exhibited high steady-state hGSTA4 mRNA, high GST-4-HNE catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells.|4-HNE|GST-4|17|16.0|Arg1:T27|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE|1266
15133856|Ang II level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in irbesartan group and lower in imidapril group.|imidapril|Ang II|32|1.0|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1267
23541125|The fine particulate (PM < 2.5 μm) of wood smoke were the most potent TRPA1 agonists and several chemical constituents of wood smoke particulate, 3,5-ditert-butylphenol, coniferaldehyde, formaldehyde, perinaphthenone, agathic acid, and isocupressic acid, were TRPA1 agonists.|agathic acid|TRPA1|36|44.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|AGONIST|1268
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|benzolamide|hCA VI|31|35.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1269
16926278|GAF-B contributes to dimerization of PDE5, inhibition of cGMP binding to GAF-A, and sequestration of the phosphorylation site.|cGMP|GAF-A|10|13.0|Arg1:T17|Arg2:T49|CHEMICAL|GENE-N|DIRECT-REGULATOR|1270
6150080|Positive staining of mitochondria was achieved in the presence of the MAO substrate, tryptamine.|tryptamine|MAO|15|12.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE|1271
15650315|The aim of this study was to determine the mechanism of pranlukast-induced interleukin-5 (IL-5) inhibition in allergic inflammation.|pranlukast|interleukin-5|12|13.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1272
7739347|Dihydroetorphine and etorphine have almost the same binding affinities to all types (mu, delta, and kappa) of opioid receptors and antagonist binding sites, and have similar inhibition activities to forskolin stimulated adenylyl cyclase.|etorphine|adenylyl cyclase|3|37.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|1273
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|amino acids|LAT3|21|11.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|1274
23382458|Ketoconazole decreased the P-gp-mediated apixaban efflux in Caco-2 and the P-gp-cDNA-transfected cell monolayers, but did not affect the apixaban efflux to a meaningful extent in the BCRP-cDNA-transfected cell monolayers.|apixaban|P-gp|20|11.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|1275
25225185|In the lateral geniculate nucleus, brexpiprazole displayed alpha1B-adrenoceptor antagonistic action.|brexpiprazole|alpha1B-adrenoceptor|7|9.0|Arg1:T10|Arg2:T37|CHEMICAL|GENE-Y|ANTAGONIST|1276
23380305|Here we report that systemic administration of the non-imidazole histamine H3 receptor antagonist 4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile (ABT-239, 3 mg/kg) increased c-Fos expression dose-dependently in rat cortex and nucleus basalis magnocellularis (NBM) but not in the nucleus accumbens (NAcc) nor striatum, and augmented acetylcholine and histamine release from rat prefrontal cortex.|ABT-239|c-Fos|31|37.0|Arg1:T13|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1277
22878908|We have previously reported that TZDs reduce estrogen synthesis by inhibiting aromatase activity in human granulosa cells (HGC).|estrogen|aromatase|8|12.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|1278
23357361|β-Asarone appeared to increase expression of lamin B1, p53, p21, but not lamin A/C.|β-Asarone|p53|1|10.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1279
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|hydroxyl|dopamine transporter|45|56.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR|1280
14720519|In the present work, we found for the first time that uPAR stimulation with the amino-terminal fragment (ATF) of urokinase devoid of proteolytic activity transactivates the EGFR in mammary MCF-7 cells through a mechanism involving Src and a metalloproteinase, as indicated by its sensitivity to selected inhibitors.|amino|urokinase|17|23.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|PART-OF|1281
15650315|RESULTS: Pretreatment of lung tissues with pranlukast alone significantly decreased the amount of IL-5 protein in the culture medium by 40%.|pranlukast|IL-5|8|15.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1282
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|epsilon-aminocaproic acid|tissue plasminogen activator|40|22.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR|1283
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|IL-1RI|6|29.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1284
10224140|When expressed in Xenopus laevis oocytes, OAT3 mediated the uptake of organic anions, such as p-aminohippurate (Km = 65 microM), ochratoxin A (Km = 0.74 microM), and estrone sulfate (Km = 2.3 microM) and a cationic compound, cimetidine.|estrone sulfate|OAT3|36|8.0|Arg1:T26|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE|1285
16469680|Selective COX-2 inhibition with nimesulide and COX-1 inhibition with low-dose aspirin appear to be well-tolerated in the short-term.|aspirin|COX-1|11|7.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|1286
23284002|In conclusion, this study provides the first evidence implicating that TSA inhibits TGF-β-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-ARE signaling.|TSA|Nrf2|12|22.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1287
23267011|DNA polymerase minor groove interactions modulate mutagenic bypass of a templating 8-oxoguanine lesion.|8-oxoguanine|DNA polymerase minor groove|12|1.0|Arg1:T22|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|1288
10626810|In this report, we evaluated the growth-inhibitory effects of sulindac sulfide, a COX-1 and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines.|NDGA|lipoxygenase|41|45.0|Arg1:T27|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|1289
12411515|Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria.|isoflurane|complex I|3|12.0|Arg1:T41|Arg2:T57|CHEMICAL|GENE-Y|INHIBITOR|1290
12652111|  We investigated the basis for the difference in the cardiotonic effects of the PDE3 inhibitors cilostazol and milrinone in the rabbit heart.|cilostazol|PDE3|16|14.0|Arg1:T34|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR|1291
17603759|  L-2-hydroxyglutaric aciduria is a metabolic disorder in which L-2-hydroxyglutarate accumulates as a result of a deficiency in FAD-linked L-2-hydroxyglutarate dehydrogenase, a mitochondrial enzyme converting L-2-hydroxyglutarate to alpha-ketoglutarate.|L-2-hydroxyglutarate|L-2-hydroxyglutarate dehydrogenase|9|19.0|Arg1:T20|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|1292
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|TFT|TS|36|28.0|Arg1:T25|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|1293
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|oxymorphone|CYP2D6|33|24.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|1294
20497523|In the TT-specific DTH model, EE and the selective ERalpha agonist ERA-63 suppressed the TT-specific swelling response in WT and ERbetaKO mice but not in ERalphaKO mice.|ERA-63|ERalpha|13|11.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|1295
16982784|  Among the TEM-type extended-spectrum beta-lactamases (ESBLs), an amino acid change at Ambler position 104 (Glu to Lys) results in increased resistance to ceftazidime and cefotaxime when found with other substitutions (e.g., Gly238Ser and Arg164Ser).|Lys|ESBLs|21|7.0|Arg1:T3|Arg2:T40|CHEMICAL|GENE-N|PART-OF|1296
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|C|PDE5Delta1-534|53|59.0|Arg1:T20|Arg2:T58|CHEMICAL|GENE-Y|PART-OF|1297
2877081|  Nizatidine (LY139037), a selective histamine H2-receptor antagonist, is a potent inhibitor of gastric acid secretion.|LY139037|histamine H2-receptor|3|8.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|ANTAGONIST|1298
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|2,3,7,8-tetrachlorodibenzodioxin|CYP1A1|25|8.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1299
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|brinzolamide|hCA VI|18|35.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1300
23256625|This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the HMG-coA reductase inhibitors simvastatin and rosuvastatin.|GSK1292263|GPR119|9|13.0|Arg1:T14|Arg2:T37|CHEMICAL|GENE-Y|AGONIST|1301
8760245|beta 2-Adrenoceptor activation results in increases in Na-K-ATPase and Na transport as a consequence of increased apical sodium entry.|sodium|Na-K-ATPase|18|8.0|Arg1:T19|Arg2:T42|CHEMICAL|GENE-N|SUBSTRATE|1302
23266269|Moreover, ganodermanondiol increased cellular glutathione levels and the expression of the glutamine-cysteine ligase gene in a dose-dependent manner.|ganodermanondiol|glutamine-cysteine ligase|3|13.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1303
10658902|With respect to the quinone co-substrate of the dihydroorotate dehydrogenase, atovaquone (Kic = 2.7 microM) and dichloroally-lawsone (Kic = 9.8 nM) were shown to be competitive inhibitors of human dihydroorotate dehydrogenase.|atovaquone|human dihydroorotate dehydrogenase|12|34.0|Arg1:T6|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|1304
23583884|In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and NF-κB activation induced by TCDD can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.|TCDD|cytokine|20|14.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR|1305
20605094|  We investigated the inhibitory activity of several 1,3,4-thiadiazole-sulfonamides against all catalytically active CA (EC 4.2.1.1), CA I-XV.|1,3,4-thiadiazole-sulfonamides|CA|8|13.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR|1306
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|matrix metalloproteinase-13|17|20.0|Arg1:T16|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1307
23384446|Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.|ACh|G protein-coupled receptor|36|30.0|Arg1:T20|Arg2:T38|CHEMICAL|GENE-N|AGONIST|1308
22708686|The agonist activity was antagonized by the selective kappa-opioid blocker nor-binaltorphimine (nor-BNI).|nor-BNI|kappa-opioid|13|9.0|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|1309
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|alpha 2MR|30|21.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1310
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|leptin|1|25.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1311
23611809|In conclusion, this study expands the understanding of the substrate specificity of UGT2B10, highlighting its preference for tertiary amines with higher affinities and clearance values than those of UGT1A4 and UGT1A3.|tertiary amines|UGT2B10|20|14.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1312
12488248|Probenecid-sensitive uptake of p-aminohippurate (PAH, an Oat1 and Oat3 substrate) and estrone sulfate (ES, an Oat3 substrate) in rat Oat3-expressing oocytes was significantly trans-stimulated by preloading the oocytes with the dicarboxylate glutarate (GA).|Probenecid|Oat1|1|9.0|Arg1:T23|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|1313
11426832|The Ki values of betamipron, cilastatin, KW-3902 and probencid for human-OAT1 were 23.6, 1470, 7.82 and 12.1 microM, whereas those for human-OAT3 were 48.3, 231, 3.70 and 9.0 microM.|cilastatin|human-OAT3|7|27.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1314
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|AM4054|CB(1)|72|29.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|AGONIST|1315
23319419|ICA is a mixed agonist of mutant EAG and EAG/ERG chimera channels that inactivate by a combination of slow and fast mechanisms.|ICA|ERG|1|11.0|Arg1:T17|Arg2:T22|CHEMICAL|GENE-Y|AGONIST|1316
17168665|Other FASN inhibitors such as the cerulenin derivative C75, the beta-lactone orlistat, the green tea polyphenol epigallocatechin-3-gallate (EGCG) and other naturally occurring flavonoids (i.e., luteolin, quercetin, and kaempferol), as well as the antibiotic triclosan, have been identified and have been shown to limit cancer cell growth by inducing apoptotic cell death.|cerulenin|FASN|7|2.0|Arg1:T10|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|1317
8799556|(+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned human alpha 1D adrenoceptors.|Rec 15/2739|human alpha 1D adrenoceptors|14|46.0|Arg1:T4|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1318
23273999|ATPase stimulation kinetics could be modeled for the entactogen 3,4-methylenedioxy-α-ethylphenethylamine (3,4-BDB), the hallucinogen 2,5-dimethoxy-4-iodoamphetamine (DOI), the abused alkaloid glaucine, the opioid-like drugs N-iso-propyl-1,2-diphenylethylamine (NPDPA), and N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA), with K(m) and V(max) values within the same range as for verapamil or sertraline.|3,4-BDB|ATPase|12|1.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|1319
23473803|With this objective, we utilised a high-throughput computational approach that identified moexipril, a well tolerated and safe angiotensin-converting enzyme (ACE) inhibitor, as a PDE4 inhibitor.|moexipril|angiotensin-converting enzyme|13|20.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|1320
23228696|Overall, our results suggest that inhibition of the p38 MAPK signaling by metformin coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination, which however will require further validation.|metformin|MAPK|14|11.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|1321
9059856|In order to perform a pharmacological characterization of these receptors, competition binding experiments were carried out using the muscarinic receptor antagonists pirenzepine, (11(2-diethyl-amino)methyl)-1-piperidinylacetyl-5-11-dihydro-6H-py rido(14) benzodiazepine (AF-DX 116), himbacine, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), dicyclomine and hexahydro-sila-difenidol (HHSD).|HHSD|muscarinic receptor|55|20.0|Arg1:T27|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST|1322
15866500|These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5-fluoro-2'-deoxyuridine monophosphate (FdUMP).|FdUMP|TS|28|18.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1323
22552008|Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a reduction in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.|lenalidomide|CRBN|4|17.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1324
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|bepridil|ion channel|12|2.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|1325
1407010|Autoradiographic studies were performed on rabbit brain slices using [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and mesulergine (in order to mask 5-HT1A and 5-HT1C binding sites) and [125I]CYP (iodocyanopindolol) in the presence of 3 mumol/l isoprenaline and 100 nmol/l 8-OH-DPAT (in order to mask beta adrenoceptor and 5-HT1A binding sites).|8-OH-DPAT|5-HT1C|21|31.0|Arg1:T9|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR|1326
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|Akt1|3|10.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1327
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|5-methylurapidil|alpha 1-adrenoceptor|18|3.0|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|1328
17929831|AdSS from the thermophilic archaea, Methanocaldococcus jannaschii (MjAdSS) is 345 amino acids long against an average length of 430-457 amino acids for most mesophilic AdSS.|amino acids|MjAdSS|14|10.0|Arg1:T14|Arg2:T24|CHEMICAL|GENE-Y|PART-OF|1329
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|NIS|hNET|79|74.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1330
9059856|In brush-border membranes, the receptor found match in terms of affinity for the antagonists with the muscarinic M1 receptor subtype (Ki pirenzepine, 13.6 +/- 8.2 nM; Ki AF-DX 116, 1680 +/- 271 nM; Ki himbacine, 212 +/- 6.5 nM; Ki 4-DAMP.|AF-DX 116|muscarinic M1 receptor subtype|32|18.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST|1331
10598120|BIO TO-2 cardiomyopathic hamsters (CMHs) in the early stages of dilated heart failure were treated with vehicle or maximal ACE inhibitory doses of captopril (750 micromol/kg/day) or omapatrilat (200 micromol/kg/day).|captopril|ACE|26|22.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1332
23229511|In addition, 17-AAG treatment reduced cell viability, CDK2, CDK4, cyclin E, cyclin D1, and phosphorylated Rb levels in AhR-expressing lung AD cells.|17-AAG|cyclin E|4|14.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1333
23367873|Progression in the field has taken a recent step forward with the approval of ruxolitinib (Jakafi), a selective inhibitor of JAK1/2 and very recently tofacitinib (Xeljanz), a pan-JAK inhibitor.|tofacitinib|JAK|28|35.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1334
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|Phenelzine|MAO-A|1|10.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1335
23604722|FBP suppressed the production of reactive oxygen species (ROS) but did not affect cyclooxygenase-2 expression and prostaglandin E2 production in endothelial cells stimulated with LPS.|prostaglandin E2|cyclooxygenase-2|19|16.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|PRODUCT-OF|1336
23291050|ChE activity was measured with acetylthiocholine as substrate and CES activity was measured with four substrates: p-nitrophenyl acetate, p-nitrophenyl butyrate, 1- and 2-naphthyl acetate.|p-nitrophenyl acetate|CES|18|10.0|Arg1:T18|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE|1337
16781459|Both H(2)S solution prepared by bubbling pure H(2)S gas and NaSH, a H(2)S donor, dose dependently induced HO-1 expression through the activation of the extracellular signal-regulated kinase (ERK).|H(2)S|ERK|2|43.0|Arg1:T25|Arg2:T64|CHEMICAL|GENE-N|ACTIVATOR|1338
11920914|Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates.|organophosphates|acetylcholinesterase|10|7.0|Arg1:T16|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1339
23473805|Rp1 and actinomycin D reduced Src activity, and overexpression of active Src decreased the synergistic effect of Rp1 with actinomycin D.|Rp1|Src|1|6.0|Arg1:T7|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|1340
17632548|10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref.|glutathione|microsomal prostaglandin E synthase 1|22|37.0|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|1341
9059856|In brush-border membranes, the receptor found match in terms of affinity for the antagonists with the muscarinic M1 receptor subtype (Ki pirenzepine, 13.6 +/- 8.2 nM; Ki AF-DX 116, 1680 +/- 271 nM; Ki himbacine, 212 +/- 6.5 nM; Ki 4-DAMP.|himbacine|muscarinic M1 receptor subtype|41|18.0|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1342
20372850|  Thymidine kinase-1 (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo pyrimidine synthesis, respectively.|pyrimidine|thymidylate synthase|20|7.0|Arg1:T16|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF|1343
18045203|Compounds 1 and 2 potently displaced (3)H-NMS binding at m1, m3 and m4 receptors, but were less potent at the m2 and m5 subtypes.|(3)H-NMS|m5|7|28.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1344
23639626|The induction of IGFBP-4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP-4 mRNA indicating that IGFBP-4 is a previously unknown transcriptional target of TCDD in 5L cells.|TCDD|IGFBP-4|37|25.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1345
23611809|These are drugs that were previously reported to be substrates for UGT1A4 or UGT1A3 and that contain in their structure either tertiary aliphatic amines, cyclic amines, or an imidazole group.|imidazole|UGT1A3|31|14.0|Arg1:T22|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE|1346
2882965|Interference with lipoxygenase enzymes, rather than a steroid-like inhibition of arachidonic acid release from intracellular phospholipids, seems to be the mode of action.|arachidonic acid|lipoxygenase|12|3.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE|1347
23178380|In contrast to parenteral delivery of rBChE, which currently requires posttranslational modification for good plasma stability, an unmodified aer-rBChE pretreatment given 1-40h prior to >1 LD50 of aer-paraoxon (Px) was able to prevent inhibition of circulating cholinesterase in a dose-dependent manner.|paraoxon|cholinesterase|32|42.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR|1348
17602574|Moreover, the CDO active site is essentially unreactive toward NO in the absence of substrate, suggesting an obligate ordered binding of l-cysteine prior to NO.|NO|CDO|27|4.0|Arg1:T40|Arg2:T57|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1349
23429263|  The pro-apoptotic BCL-2 family member BOK is widely expressed and resembles the multi-BH domain proteins BAX and BAK based on its amino acid sequence.|amino acid|BAK|22|18.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|PART-OF|1350
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFP|COX-2|7|13.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1351
22614004|We have previously shown that the inhibitor of pyruvate dehydrogenase kinase (PDK) dichloroacetate (DCA) activates glucose oxidation and induces apoptosis in cancer cells in vitro and in vivo.|dichloroacetate|pyruvate dehydrogenase kinase|15|9.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|1352
23612487|These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.|S1P|osteoptotegerin|5|29.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1353
21413019|The rate-limiting polyamine biosynthetic enzymes, ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase, are essential for mammalian development, with knockout of the genes encoding these enzymes, Odc1 and Amd1, causing early embryonic lethality in mice.|polyamine|S-adenosylmethionine decarboxylase|3|13.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|PRODUCT-OF|1354
10460702|These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the eNOS selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).|L-Nomega -monomethyl-L-arginine|eNOS|31|23.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST|1355
23620436|MNU-induced lesions presented markers indicative of an aggressive phenotype: lack of basal cells, rupture of the smooth muscle cell layer, loss of E-cadherin, and high MGMT staining.|MNU|E-cadherin|1|26.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1356
23229512|Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for VK2-induced cytochrome c (cyt c) release and cell death.|VK2|cytochrome c|33|34.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1357
12227806|Practical asymmetric synthesis of aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction.|aprepitant|NK-1 receptor|5|10.0|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|ANTAGONIST|1358
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|Rivastigmine|AChE|1|15.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|1359
23466488|The objective of the present investigation was to evaluate l-glutamine increases glucagon like peptide-1 (GLP-1) (7-36) amide secretion in streptozotocin-nicotinamide (STZ-NTM) induced diabetic Sprague Dawley rats.|l-glutamine|GLP-1|10|16.0|Arg1:T18|Arg2:T55|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1360
17067304|Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, BDNF and ChAT that was eliminated by olanzapine treatment.|quinpirole|ChAT|7|19.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1361
16782438|The concentration of imatinib necessary to inhibit RET in vitro, however, makes it impossible to conclude that imatinib monotherapy will be a good option for systemic therapy of MTC.|imatinib|RET|4|8.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1362
22815248|A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after CCl4 and PC administration alone.|CCl4|alanine aminotransferase|35|8.0|Arg1:T22|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|1363
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|citrulline|AS|20|13.0|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1364
17324065|Repeated cocaine resulted in CREB phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine, but rats challenged after 2 drug-free days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell.|cocaine|CREB|28|43.0|Arg1:T9|Arg2:T12|CHEMICAL|GENE-N|ACTIVATOR|1365
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kushenol H|diacylglycerol acyltransferase|24|49.0|Arg1:T19|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1366
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|acenaphthene|P450 2A13|23|6.0|Arg1:T29|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|1367
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|Raf-1|4|16.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1368
23512537|CYP3A4 and CYP3A5 metabolized BDP via hydroxylation ([M4] and [M6]) and dehydrogenation ([M5]) at similar rates; CYP3A7 did not metabolize BDP.|BDP|CYP3A4|5|1.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|1369
23220590|At therapeutic drug levels (0.015 mM) and physiologically relevant concentrations of ethanol (10 mM) and acetaldehyde (10 μM) in target tissues, cimetidine could weakly inhibit (<5%) the activities of ADH1B2 and ADH1B3 in liver, ADH2 in liver and small intestine, ADH4 in stomach, and ALDH1A1 in the three tissues, but not significantly affect ADH1A, ADH1B1, ADH1C1/2, or ALDH2.|ethanol|ADH4|14|54.0|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|1370
10500149|  Our earlier report suggested that androst-5-ene-3beta,7beta-diol (Delta(5)-androstenediol or Adiol) is a natural hormone with androgenic activity and that two potent antiandrogens, hydroxyflutamide (Eulexin) and bicalutamide (Casodex), fail to block completely the Adiol-induced androgen receptor (AR) transactivation in prostate cancer cells.|Adiol|AR|44|48.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR|1371
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W dihydrochloride|E-selectin|20|36.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1372
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|choline|flavin mono-oxygenase|26|5.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|1373
16326016|Given that glutamine is the predominant precursor for releasable pools of glutamate, our observation that estradiol increases glutamine synthetase gene and protein expression suggests that hormonal regulation of glutamate neurotransmission involves hormonally responsive glia.|glutamate|glutamine synthetase|30|19.0|Arg1:T9|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE|1374
23414802|In this study, a novel series of 2-hydroxydiarylamide derivatives were synthesized and evaluated for inhibiting TMPRSS4 serine protease activity and suppressing cancer cell invasion.|2-hydroxydiarylamide|serine protease|9|18.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR|1375
10879806|Flutamide administration decreased body weight gain, serum IGF-I levels, hepatic IGF-I mRNA, and GH receptor mRNA content.|Flutamide|IGF-I|1|9.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1376
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|ethynylestradiol|Mrp2|24|40.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1377
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|glutathione|DIC|38|16.0|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1378
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H3R|1|18.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1379
8697470|After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received aurintrycarboxilic acid (ATA), an inhibitor of platelet glycoprotein Ib/von Willebrand factor interaction (10 mg/kg i.v. bolus).|aurintrycarboxilic acid|glycoprotein Ib|97|107.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|1380
17403374|Furthermore, the enzymatic activity of alanine aminotransferase (ALT), which converts the critical gluconeogenic amino acid alanine into pyruvate, is decreased (approximately 50%) in KLF15-/- hepatocytes.|alanine|alanine aminotransferase|20|7.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE|1381
17604186|With this background, the present study was designed to explore the possible effect of nimesulide (a preferential COX-2 inhibitor) against pentylenetetrazol (PTZ)-induced kindling epilepsy in mice.|nimesulide|COX-2|16|20.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1382
23274898|Electrical Stimuli Release ATP to Increase GLUT4 Translocation and Glucose Uptake via PI3Kγ-Akt-AS160 in Skeletal Muscle Cells.|Glucose|GLUT4|10|7.0|Arg1:T24|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE|1383
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|desoxypeganine|acetylcholinesterase|19|10.0|Arg1:T13|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|1384
19997047|Inhibition of interferon gamma and TNF-alpha production increased from 7% (+/-1%) and 31% (+/-6%) (PTX alone) to 49% (+/-2%) and 69% (+/-6%), respectively.|PTX|TNF-alpha|24|6.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1385
1327384|The selective alpha 2-adrenoceptor antagonists, idazoxan, yohimbine, rauwolscine and WY 26703 displaced [3H]-RS-15385-197 binding to rat cerebral cortex in a simple manner with Hill slopes close to unity.|idazoxan|alpha 2-adrenoceptor|7|3.0|Arg1:T33|Arg2:T46|CHEMICAL|GENE-N|ANTAGONIST|1386
23146758|Direct assessment of aromatase activity by dibenzylfluorescein assay and indirect assessment of aromatase activity by measurement of the conversion of testosterone to estradiol confirmed that 5-OH-BDE-47 and 6-OH-BDE-47 stimulate aromatase activity.|testosterone|aromatase|21|13.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE|1387
23074173|We demonstrated that deferasirox increased expression of the metastasis suppressor protein N-myc downstream-regulated gene 1 and upregulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1) while decreasing cyclin D1 levels.|deferasirox|cyclin-dependent kinase inhibitor p21|4|19.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1388
23223023|  Metabolic profiling of plasma nonesterified fatty acids discovered that palmitic acid (PA), a natural peroxisome proliferator-activated receptor γ (PPARγ) ligand, is a reliable type 2 diabetes biomarker.|palmitic acid|PPARγ|10|23.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1389
23247009|  Aldose reductase (AR) catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).|aldehydes|AR|12|4.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|1390
23271742|Here we found that arsenic trioxide, a frontline agent for acute promyelocytic leukemia, inhibits ΔNp63 but not TAp63 expression in time- and dose-dependent manners.|arsenic trioxide|ΔNp63|5|17.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1391
16860312|Administration of dimaprit (1-10 mg/kg x 2), an H2/H4 agonist, mimicked the protective effect of histamine, and the effect of dimaprit is reversed by thioperamide, whereas neither H1 nor H2 antagonists altered the outcome caused by dimaprit.|thioperamide|H4|30|13.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|1392
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|phenethylamine|TA1|20|27.0|Arg1:T9|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR|1393
23339682|Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively.|caffeine|CYP1A2|44|19.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1394
17603555|  BACKGROUND AND PURPOSE: AMP-activated protein kinase (AMPK) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).|AICAR|AMPK|25|9.0|Arg1:T27|Arg2:T57|CHEMICAL|GENE-Y|ACTIVATOR|1395
17606858|Conversely fenofibrate increased peroxisome proliferator-activated receptor-alpha, peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression, and acetyl coenzyme A carboxylase phosphorylation (P<0.05 for all) in aldosterone-infused hearts; uncoupling protein-3 and medium-chain acyl coenzyme A dehydrogenase protein expression decreased with fenofibrate (P<0.05 and P<0.01, respectively, versus aldosterone-infused), suggesting that improved myocardial remodeling is independent of fatty acid oxidation.|fenofibrate|acetyl coenzyme A carboxylase|2|15.0|Arg1:T10|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|1396
10373451|Of the PDE inhibitors tested, dipyridamole was most effective, with IC50 values of 1.2 and 0.45 microM for inhibition of cAMP and cGMP hydrolysis, respectively.|dipyridamole|PDE|7|3.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|1397
14642426|Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of IL-6 level in macrophage rather than in the brain.|ginseng saponins|IL-6|12|41.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1398
23261705|Furthermore, insulin-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins CDK4, CCND3 and PCNA were also blocked by rapamycin.|rapamycin|cell cycle regulatory proteins|24|11.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1399
23357976|  Type 2 11β-hydroxysteroid dehydrogenase encoded by the HSD11B2 gene converts cortisol to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.|cortisol|Type 2 11β-hydroxysteroid dehydrogenase|11|1.0|Arg1:T7|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|1400
17369473|Metformin and phenformin, which are biguanides, have been reported to increase AMPK activity without increasing AMP/ATP.|phenformin|AMPK|3|14.0|Arg1:T25|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|1401
11426832|Organic anion transport inhibitors including betamipron, cilastatin, KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine) and probenecid significantly inhibited human-OAT1- and human-OAT3-mediated organic anion uptake in a dose-dependent manner.|cilastatin|human-OAT3|8|24.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1402
16860312|Neither mepyramine (3 mg/kg x 2), an H1 antagonist, nor cimetidine (15 mg/kg x 2), an H2 antagonist, affected the outcome in histamine-treated rats.|cimetidine|H2|15|24.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|1403
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|tumor necrosis factor-α|1|18.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1404
16305240|2004, 126, 8167-8180.) showed that when AdoCbl is bound to the MMCM active site, no enzymatic perturbation of the Co3+ Cbl electronic structure occurs, even in the presence of substrate (analogues).|AdoCbl|MMCM|11|16.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1405
17124432|Neuronal NE reuptake may be impaired in individuals with renal disease and/or hypertension due to dysfunction of the NE transporter.|NE|NE transporter|2|19.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE|1406
17321471|The selective A(2A) receptor antagonist ZM241385 (30 nM), but not the selective A(2B) receptor antagonist MRS1754 (30 nM), blocked the inhibitory effect of NECA and CGS21680 on TNF-alpha release.|ZM241385|TNF-alpha|9|40.0|Arg1:T29|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1407
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|SKF 89976-A|GAT3|5|30.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|1408
17929114|The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias.|imatinib|tyrosine kinase|6|3.0|Arg1:T34|Arg2:T56|CHEMICAL|GENE-N|INHIBITOR|1409
15871445|  Intolerance reactions to acetyl salicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) are common and caused by inhibition of COX-1 enzyme.|acetyl salicylic acid|COX-1|4|24.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|1410
21600945|TPM-increased B1R mRNA was prevented by co-treatments with N-acetyl-l-cysteine (potent antioxidant), diphenyleneiodonium (NADPH oxidase inhibitor), IL-1Ra (interleukin-1R antagonist) and SN-50 (specific inhibitor of NF-kB activation) but not by pentoxifylline (TNF-alpha release inhibitor), indomethacin and niflumic acid (COX-1 and -2 inhibitors).|pentoxifylline|TNF-alpha|39|41.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1411
23353902|In both females and males, FLU reversed the nuclear levels of GR and pGR246 without affecting CORT and GR mRNA levels.|FLU|pGR246|7|15.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1412
15814851|Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.|imidazole|aromatase|14|2.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1413
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|acyl-CoAs|CrAT|11|4.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|1414
23066988|Our results show that Metformin directly inhibits stomach ghrelin production and secretion through AMPK.|Metformin|ghrelin|5|9.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1415
23368743|The recent identification of zinc permeability of the lysosomal ion channel TRPML1 (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1 in zinc transport.|zinc|transient receptor potential mucolipin 1|5|14.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|1416
9059856|1.5 +/- 0.4 nM; Ki dicyclomine, 5.1 +/- 0.8 nM; Ki HHSD, 34.3 +/- 7.3 nM), whereas the receptor in basal plasma membrane seems to be of the muscarinic M2 receptor subtype (Ki pirenzepine, 202 +/- 48 nM; Ki AF-DX 116, 124 +/- 60 nM; Ki himbacine, 20.6 +/- 4.8 nM; Ki 4-DAMP, 4.5 +/- 1.2 nM; Ki dicyclomine, 54.6 +/- 22 nM; Ki HHSD, 89.2 +/- 15.8 nM).|pirenzepine|muscarinic M2 receptor subtype|41|35.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|1417
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|isoflurane|NADH:ubiquinone oxidoreductase|7|20.0|Arg1:T27|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR|1418
23567241|These results indicate that parabens are selective agonists for ERβ over ERα; their interactions with ERα/β are dependent on the size and bulkiness of the alkyl groups; and they are metabolized by carboxylesterases, leading to attenuation of their estrogenic activity.|parabens|ERβ|5|10.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|AGONIST|1419
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|c-Jun N-terminal protein kinase|11|30.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|1420
23395669|Moreover, compared with the model group, sophocarpine could significantly increase P-AMPKα (>5.82-fold), AMPKα (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and HNF-4α (<0.20-fold) protein expression.|sophocarpine|ACC|9|25.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1421
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|acetylcarnitine|Carnitine acetyltransferases|15|1.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|1422
23248200|Interestingly, several oral antidiabetics (glyburide, glimepiride, troglitazone, pioglitazone, glipizide, gliclazide, and tolbutamide), but not metformin, were identified as significant inhibitors of the OATP1B1-mediated transport of rosuvastatin.|glyburide|OATP1B1|7|34.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1423
15899831|Concordant with this activity, in human umbilical vein endothelial cells, AZD2171 inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 values of 0.4 and 0.5 nmol/L, respectively.|AZD2171|KDR|13|18.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1424
17553661|The alpha class human GSTA4-4 enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward 4-HNE conjugation.|4-HNE|human GSTA4-4|17|4.0|Arg1:T22|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE|1425
23385959|These findings are the first to show that long-term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38(MAPK) phosphorylation and caspase activity in the striatum.|Mn|caspase|12|37.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR|1426
2828423|Immunological titration of opioid binding activity from rat brain showed that the antibody was able to displace specific binding of [3H]etorphine (universal opioid) and [3H]dihydromorphine (mu opioid) from rat membranes, but was ineffective against the binding of [3H]ethylketocyclazocine (kappa [3H]D-Ala2,D-Leu5-enkephalin (delta opioid) or [3H]phencyclidine (phencyclidine/sigma receptor ligand).|[3H]dihydromorphine|mu opioid|30|35.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1427
14610216|hOAT1, hOAT3, and hOAT4 but not hOAT2, mediated the uptake of bumetanide.|bumetanide|hOAT4|15|6.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|1428
17315049|Like other DPP-4 inhibitors, sitagliptin reduces hemoglobin A1c (HbA1c), fasting and postprandial glucose by glucose-dependent stimulation of insulin secretion and inhibition of glucagon secretion.|sitagliptin|DPP-4|6|3.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1429
7665369|Ergovaline inhibition of the binding of the D2-specific radioligand, [3H]YM-09151-2, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas dopamine was much less potent (370 +/- 160 nM).|Ergovaline|D2|1|8.0|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1430
18056045|The inhibitory effects of the nitrogen-containing BPs (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their inhibition of farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.|zoledronate|farnesyl pyrophosphate synthase|17|28.0|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1431
23500387|Our study demonstrated that curcumin inhibited OVA-induced increases in eosinophil count; interleukin (IL)-17A level were recovered in bronchoalveolar lavage fluid increased IL-10 level in bronchoalveolar lavage fluid.|curcumin|interleukin (IL)-17A|5|13.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|1432
22815312|When the E(max) and EC(50) values were compared with those for carbamazepine and rifampin, estradiol was found to be as potent an inducer of CYP2B6 as rifampin and carbamazepine.|rifampin|CYP2B6|34|32.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR|1433
17097861|In the present study, glucose-stimulated insulin secretion was significantly increased in GalN-treated rats compared to controls.|GalN|insulin|13|7.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1434
20557886|ICI 182780, an estrogen receptor antagonist and R,R-THC, an estrogen receptor beta antagonist, counteracted the effect of 3beta-Adiol while bicalutamide, an androgen receptor antagonist, had minor effects.|bicalutamide|androgen receptor|25|28.0|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|1435
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|Akt|3|15.0|Arg1:T9|Arg2:T34|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1436
23000451|This prompted the design of variants of BChE which exhibit significantly improved catalytic activity against (-)-cocaine.|(-)-cocaine|BChE|16|8.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE|1437
23148920|Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells.|nitric oxide|endothelial nitric oxide synthase|4|11.0|Arg1:T36|Arg2:T47|CHEMICAL|GENE-Y|PRODUCT-OF|1438
10667230|Suramin inhibited the anchorage-independent growth induced by IGF-1 or TGF alpha only at an IC50 of 100 micrograms/ml.|Suramin|IGF-1|1|8.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|1439
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|E3174|AT1|30|4.0|Arg1:T32|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST|1440
23046524|Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal AChE expression and activity - was significantly higher following exposure to paraoxon concentrations as low as 31.2 nM.|paraoxon|AChE|32|21.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR|1441
15694390|Expression of monocyte chemotactic protein-1 and interferon-gamma inducible protein-10 mRNA in response to IFN-gamma was significantly suppressed in the presence of NDGA, as was tyrosine-phosphorylation of JAK and STAT.|NDGA|STAT|22|30.0|Arg1:T11|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR|1442
10517265|The CCK receptor antagonists blocked, in a dose-dependent manner, the response to 5-HT and to the selective agonists at 5-HT3 and 5-HT4 receptors, 2-methyl-5-hydroxytryptamine (2-Me-5-HT) and 5-methoxytryptamine (5-MeOT), respectively.|2-methyl-5-hydroxytryptamine|5-HT3|27|22.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|AGONIST|1443
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|mazindol|hNET|81|74.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1444
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|flavin mononucleotide|Riboflavin kinase|25|1.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|1445
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|Cabozantinib|RET|1|43.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1446
14633707|Thus, Ras utilizes autocrine signaling through EGFR to increase radioresistance, and the EGFR KI GW572016 acts as a radiosensitizer.|GW572016|Ras|17|3.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1447
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|17 alpha-hydroxy pregnenolone|Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase|23|1.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE|1448
11716850|Binding experiments on mitiglinide, nateglinide, and repaglinide to SUR1 expressed in COS-1 cells revealed that they inhibit the binding of [3H]glibenclamide to SUR1 (IC50 values: mitiglinide, 280 nM; nateglinide, 8 microM; repaglinide, 1.6 microM), suggesting that they all share a glibenclamide binding site.|repaglinide|SUR1|43|28.0|Arg1:T6|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1449
1328609|  Etorphine, a potent opioid agonist, has been reported to bind to both mu and epsilon opioid receptors.|Etorphine|epsilon opioid receptors|1|17.0|Arg1:T1|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|1450
16547651|Glufosinate inhibits glutamine synthetase and blocks biosynthesis of glutamine.|glutamine|glutamine synthetase|9|3.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|PRODUCT-OF|1451
23291630|The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.|navitoclax|BCL-2-like 1|15|24.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1452
23604717|SAL-2 also downregulated COX-2 and iNOS expression induced by HNE, but salicylate did not.|HNE|COX-2|10|4.0|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1453
12445705|However, 5-HT(1A) agonism may be important only for quetiapine-induced ACh release.|quetiapine|5-HT(1A)|13|3.0|Arg1:T22|Arg2:T56|CHEMICAL|GENE-Y|AGONIST|1454
10485486|Likewise, the catalytic activity of the G2 checkpoint kinase, hChk1, was only marginally suppressed by caffeine but was inhibited potently by the structurally distinct radiosensitizer, UCN-01.|UCN-01|checkpoint kinase|30|9.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|1455
11799102|Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.|Aliskiren|Ang II receptor|1|21.0|Arg1:T14|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST|1456
23214926|  An effective method for the total synthesis of 1 (AMF-26), a potentially promising new anticancer drug that disrupts the Golgi system by inhibiting the ADP-ribosylation factor 1 (Arf1) activation, has been developed for the first time.|AMF-26|Arf1|11|32.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|1457
7944828|The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).|spiroxatrine|5-HT1A|44|41.0|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|1458
19996149|In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans.|BMS-512148|sodium-glucose cotransporter type II|9|14.0|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1459
1315825|  OBJECTIVE: Candoxatril (UK79,300) is an orally available inhibitor of the neutral endopeptidase (E.C.3.4.24.11) which degrades atrial natriuretic factor (ANF).|Candoxatril|E.C.3.4.24.11|3|17.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1460
23200945|  Previous studies showed that fitter yeast (Saccharomyces cerevisiae) that can grow by fermenting glucose in the presence of allyl alcohol, which is oxidized by alcohol dehydrogenase I (ADH1) to toxic acrolein, had mutations in the ADH1 gene that led to decreased ADH activity.|acrolein|alcohol dehydrogenase I|36|28.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF|1461
2886573|Exercise as well as isoprenaline infusion caused 100% increases in lymphocyte beta 2-adrenoceptor density; these increases were completely abolished by ICI 118,551, but not affected by bisoprolol.|isoprenaline|beta 2-adrenoceptor|5|13.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1462
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|dopamine|phenylalanine 4-monooxygenase|7|13.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|1463
23103565|To demonstrate whether PDGF-BB induced ROS formation affects PKA dependent pathways, the effects of PDGF-BB on phosphorylation of serine 157 of vasodilator stimulated protein (VASP) a classical target of PKA were analysed.|serine|VASP|20|27.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|PART-OF|1464
8842678|MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imipramine, maprotiline, amitriptyline, zimeldine, nomifensine, and viloxazine.|zimeldine|MAO-B|24|1.0|Arg1:T5|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|1465
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|nipecotic acid|GAT2|12|28.0|Arg1:T23|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|1466
23056222|Finally, DMF suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and alpha-SMA, fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of Nrf2 and phospho-Smad3, respectively.|DMF|fibronectin|3|17.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1467
15102535|The present results showed that the cyclooxygenase-2 inhibitor, parecoxib, when administered parenterally, has potent antihyperalgesic, anti-inflammatory, antipyretic effects and has a better safety profile than with ketorolac, with sparing of cyclooxygenase-1 in the stomach in these animal models.|ketorolac|cyclooxygenase-1|32|37.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1468
23393127|We hypothesized that CREB is activated by a distinct signaling pathway in response to pulsatile GnRH in a frequency-dependent manner to dictate the FSHβ transcriptional response.|GnRH|CREB|16|4.0|Arg1:T7|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|1469
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|betamipron|human-OAT1|5|11.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1470
12513997|Interestingly, the allele of PRO1 was shown to enhance the activities of gamma-glutamyl kinase and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of L-proline synthesis from L-glutamate and which together may form a complex in vivo.|L-proline|gamma-glutamyl kinase|30|14.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF|1471
8836655|Pretreatment of the tissues with combined 5-HT1/5-HT2 antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.|methysergide|5-HT1|10|7.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST|1472
2146972|  We have previously shown that human placental estradiol-17 beta dehydrogenase (EC 1.1.1.62; 17 beta-EDH) catalyzes the conversion of estradiol-17 beta to estrone and stereospecifically reduces NAD+ to [4-pro-S]NADH, [( 4-B]NADH).|NAD+|human placental estradiol-17 beta dehydrogenase|29|6.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|1473
23497867|Considering apoptosis-related factors, the polysaccharides suppressed AKT activity through the inhibition of AKT phosphorylation at Thr(308) and/or Ser(473).|Ser|AKT|22|14.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF|1474
15161930|Although no natural ligand is known, ERRgamma is deactivated by the estrogen receptor (ER) agonist diethylstilbestrol and the selective ER modulator 4-hydroxytamoxifen but does not significantly respond to estradiol or raloxifene.|diethylstilbestrol|estrogen receptor|19|13.0|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|1475
23561191|In this study, we investigated if ω- and β-oxidation mediate catabolism of the AR homologue C19:0 to form 3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), using 3 in vitro platforms, human cytochrome P450 4F2 (CYP4F2), human liver S9, and HepG2 cells.|3,5-dihydroxybenzoic acid|CYP4F2|20|44.0|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF|1476
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|prazosin|adrenoceptor|11|40.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|ANTAGONIST|1477
23643094|Although it has been shown that NDGA induces Nrf2 nuclear translocation in renal epithelial LLC-PK1 cells in culture, it is unknown if NDGA may induce Nrf2 translocation in vivo.|NDGA|Nrf2|7|9.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|1478
23073075|Neuroprotection was attenuated by pertussis toxin, and inhibited by the selective type-1 S1PR (S1P1R) antagonist, W146, and by inhibitors of the mitogen associated protein kinase (MAPK) and the phosphatidylinositol-3-kinase (PtdIns-3-K) pathways.|W146|S1P1R|20|16.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|1479
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|sulfonylureas|PPARgamma|11|24.0|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|1480
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|cGMP|Y612A|4|31.0|Arg1:T33|Arg2:T57|CHEMICAL|GENE-N|DIRECT-REGULATOR|1481
23295227|Structural analysis of the V301L AKR1B10-fidarestat complex displayed enzyme-inhibitor interactions similar to those of the AR-fidarestat complex.|fidarestat|AKR1B10|7|6.0|Arg1:T23|Arg2:T54|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1482
23562928|  The purpose of this study is to investigate the effects of n-hexane extracts from bones and internal organs of Japanese eel, Anguilla japonica (HEE), on cyclooxygenase-2 (COX-2)-dependent prostaglandin D2 (PGD2) generation in stem cell factor (SCF), IL-10, plus LPS-induced mouse bone marrow-derived mast cells (BMMCs) and on passive cutaneous anaphylaxis (PCA) in mice.|PGD2|COX-2|38|32.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|1483
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|c-Kit|24|28.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1484
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|TEA|S467C|8|16.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|1485
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|AG013736|VEGFRs|31|36.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|1486
1983158|CD1 mice were used, treated with saline, morphine CHl (5 mg/kg), and 1 or 10 mg/kg of the H1-antihistaminics tripelennamine, chlorpheniramine, diphenhydramine and cyclizine and the H2-antihistaminics ranitidine and cimetidine, all compounds by s.c. route.|cimetidine|H2|37|34.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1487
23607712|Therefore, in addition to its previously described functions, synaptotagmin-1 is involved in a rapid vesicular Ca(2+) sequestration through a Ca(2+) /H(+) antiport.|H(+)|synaptotagmin-1|30|11.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1488
10773011|Similar results were obtained with the specific COX-2 inhibitor NS-398 (10-30 microM) but not with the selective COX-1 inhibitor valeryl salicylate (10-300 microM).|NS-398|COX-2|10|8.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|1489
23154533|Her MPO-ANCA titer was 21 ELISA units (EUs) before PTU treatment but increased to 259 EUs at 22 days after PTU treatment.|PTU|MPO|23|2.0|Arg1:T14|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1490
23086198|  UDP-glucuronosyltransferase A1 (UGT2A1) is expressed in the lung and exhibits activity against polycyclic aromatic hydrocarbons (PAHs), suggesting UGT2A1 involvement in the local metabolism of PAH tobacco carcinogens.|PAHs|UDP-glucuronosyltransferase A1|19|1.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|1491
11455568|The membrane-associated signaling pathways include rapid production of diacylglycerol and activation of protein kinase C (PKC), as well as activation of phospholipase A(2) (PLA(2)), increased production of arachidonic acid, and increased production of prostaglandins.|prostaglandins|PLA(2)|47|31.0|Arg1:T14|Arg2:T37|CHEMICAL|GENE-N|PRODUCT-OF|1492
8755512|Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.|thalidomide|alpha1-acid glycoprotein|3|5.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-N|DIRECT-REGULATOR|1493
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|HQL-79|H-PGDS|34|16.0|Arg1:T8|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1494
12177684|Flibanserin seems to act via direct or indirect stimulation of 5-HT(1A), DA, and opioid receptors in those animal models.|Flibanserin|5-HT(1A)|1|11.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR|1495
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|arginine|EC 6.3.4.5|24|6.0|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF|1496
2362440|  We have copurified human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase, which synthesize progesterone from pregnenolone and androstenedione from fetal dehydroepiandrosterone sulfate, from microsomes as a homogeneous protein based on electrophoretic and NH2-terminal sequencing data.|dehydroepiandrosterone sulfate|human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase|25|4.0|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|1497
14530799|Moreover, recent in vitro studies suggest that memantine abrogates beta-amyloid (Abeta) toxicity and possibly inhibits Abeta production.|memantine|Abeta|9|19.0|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1498
23254196|Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).|Ser|myosin light chain|23|16.0|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|PART-OF|1499
23512537|It is possible that variations in cytochrome P450 3A enzyme-mediated metabolism of BDP may contribute to this phenomenon.|BDP|cytochrome P450 3A|13|7.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE|1500
16876889|  Serine hydroxymethyltransferase (SHMT) catalyses the reversible conversion of serine and tetrahydrofolate to glycine and methylene-tetrahydrofolate.|tetrahydrofolate|SHMT|13|4.0|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE|1501
22966070|Tub tyrosine phosphorylation (Tub-p-tyr) is modulated by nutritional status.|tyrosine|Tub|2|1.0|Arg1:T5|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|1502
23415833|  Profenofos is a direct acting phosphorothioate organophosphorus (OP) pesticide capable of inhibiting β-esterases such as acetylcholinesterase, butyrylcholinesterase, and carboxylesterase.|Profenofos|acetylcholinesterase|1|18.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1503
23270965|Meanwhile, the serum level of KC (a functional homolog of IL-8 and the main proinflammatory alpha chemokine in mice) in apoE(-/-) mice was up to 357pg/ml in SFO-HD treated group.|SFO|alpha chemokine|34|18.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1504
16199482|This reduction of late Ca2+ signals also appeared after >72 h of treatment with subnanomolar 5alpha-androstane-3beta,17beta-diol (3beta-Adiol), an endogenous dihydrotestosterone metabolite with ER-beta binding activity.|dihydrotestosterone|ER-beta|24|27.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1505
23325562|Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3β at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.|ursolic acid|AMPK|3|9.0|Arg1:T13|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR|1506
10207608|Taken together, these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.|AACOCF3|IL-2|12|17.0|Arg1:T13|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1507
10076535|Analogous to the antiandrogens, bicalutamide and hydroxyflutamide, binding of estramustine phosphate metabolites to the androgen receptor was observed.|bicalutamide|androgen receptor|6|17.0|Arg1:T2|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1508
16781459|Interestingly, the inhibitory effect of H(2)S on NF-kappaB activation was reversed by the transient transfection with HO-1 siRNA, but was mimicked by either HO-1 gene transfection or treatment with carbon monoxide (CO), an end product of HO-1.|carbon monoxide|HO-1|36|46.0|Arg1:T11|Arg2:T53|CHEMICAL|GENE-Y|PRODUCT-OF|1509
10933891|Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the UCP-3 induction achieved after bezafibrate and Wy-14, 643 treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.|bezafibrate|UCP-3|29|25.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1510
17194761|  Aspartoacylase catalyzes hydrolysis of N-acetyl-l-aspartate to aspartate and acetate in the vertebrate brain.|N-acetyl-l-aspartate|Aspartoacylase|5|1.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE|1511
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|alpha-linolenic acid|D6D|23|5.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|1512
18568240|CONCLUSION: PTX-mediated phosphodiesterase inhibition occurs partially through a Protein kinase A-independent pathway and may serve as a useful tool in the attenuation of LPS-induced inflammation.|PTX|phosphodiesterase|3|4.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|1513
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|carbetocin|vasopressin V1A/oxytocin receptor|35|25.0|Arg1:T21|Arg2:T45|CHEMICAL|GENE-N|AGONIST|1514
15561708|Besides mitochondrial AtNFS1 and plastidial AtNFS2, which are both proposed to be involved in iron-sulfur cluster formation, ABA3 is proposed to be a third and cytosolic NifS-like cysteine desulfurase in A.|iron-sulfur|AtNFS2|16|6.0|Arg1:T9|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|1515
10839989|N(5)-Substituted H(4)biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and N(5)-hydroxymethyl H(4)biopterin inhibited phenylalanine hydroxylase, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect.|N(5)-Substituted H(4)biopterin|dihydropteridine reductase|1|21.0|Arg1:T8|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE|1516
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W dihydrochloride|VEGF|20|38.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1517
12213829|These effects resemble those seen with N-terminal deletions (DeltaN) of K(IR)6.0, and application of Ntp to DeltaNK(ATP) channels decreased their P(O(max)) and apparent IC(50) for ATP in the absence of Mg(2+).|ATP|DeltaNK(ATP) channels|45|24.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|1518
17034761|The results suggest that the suppression of TLR4 activity by auranofin may be the molecular mechanism through which auranofin exerts anti-rheumatic activity.|auranofin|TLR4|11|8.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1519
10368299|RESULTS: Our experimental structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.|E2020|TcAChE|8|9.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1520
10405348|2-MeOE2 also reduced basal and TNFalpha-stimulated aromatase activities by 46% and 56% respectively.|2-MeOE2|aromatase|1|7.0|Arg1:T19|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1521
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK receptors|27|45.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR|1522
23295227|Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.|Val|AR|24|30.0|Arg1:T20|Arg2:T52|CHEMICAL|GENE-Y|PART-OF|1523
14508322|CONCLUSIONS: These results indicate that etomidate acts as an agonist at alpha2-adrenoceptors, which appears in vivo primarily as an alpha2B-receptor-mediated increase in blood pressure.|etomidate|alpha2-adrenoceptors|7|13.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|AGONIST|1524
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|R 24571|calmodulin|27|57.0|Arg1:T5|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|1525
15975002|  Irinotecan (CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I (Topo I).|Irinotecan|DNA topoisomerase I|1|27.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|1526
17125913|Cd rapidly increased c-jun, c-fos and PDGFA expression.|Cd|c-jun|1|4.0|Arg1:T10|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1527
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|5-HT(1B)|6|31.0|Arg1:T56|Arg2:T81|CHEMICAL|GENE-Y|AGONIST|1528
16722247|An increasing number of studies concerning the identification of single nucleotide polymorphisms in the hNET gene and their potential association with disease as well as the functional investigation of naturally occurring or induced amino acid variations in hNET have contributed to a better understanding of NET function, regulation and genetic contribution to disorders.|nucleotide|hNET|11|15.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|PART-OF|1529
2120879|The smooth muscle relaxant, W-7, which is believed relatively specific in inhibiting the Ca2(+)-calmodulin interaction, depressed hyposmolarity-induced PRL secretion in a dose-dependent manner (r = -0.991, p less than 0.01).|W-7|PRL|6|25.0|Arg1:T9|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1530
23085120|  Bis(12)-hupyridone (B12H), derived from the Chinese medicinal component huperzine A, was originally designed as a novel acetylcholinesterase (AChE) inhibitor.|Bis(12)-hupyridone|acetylcholinesterase|1|25.0|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1531
16472148|  Cilostazol was developed as a selective inhibitor of cyclic nucleotide phosphodiesterase 3 (PDE3).|Cilostazol|cyclic nucleotide phosphodiesterase 3|1|9.0|Arg1:T1|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|1532
22944069|Furthermore treatment of the cells with MG132, an inhibitor of the 26S proteasome, prevented the destabilizing effect of lithium on AChE-S.|MG132|26S proteasome|7|13.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|1533
12527923|It is especially effective against MMP-2 and -9 more so than other MMP inhibitors such as Marimastat, Ro 32-3555 and D-2163.|Ro 32-3555|MMP|19|13.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|1534
23339663|TOCP is metabolized to cresyl saligenin phosphate (CBDP), a potent irreversible inhibitor of butyrylcholinesterase (BChE), a natural bioscavenger present in the bloodstream, and acetylcholinesterase (AChE), the off-switch at cholinergic synapses.|cresyl saligenin phosphate|BChE|5|19.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1535
23548896|Here we report the solution structure of the SH2 domain of C-terminal Src kinase (Csk) in complex with a longer phosphopeptide from Csk-binding protein (Cbp).|C|Csk|12|16.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|PART-OF|1536
15740719|The binding domain of barusiban differs from the binding domain of the agonists and the nonselective oxytocin receptor antagonist d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin that has been used in previous studies.|d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin|oxytocin receptor|20|17.0|Arg1:T17|Arg2:T47|CHEMICAL|GENE-Y|ANTAGONIST|1537
16690332|NO rebinding in HNS from Staphylococcus aureus (SA-HNS) is faster than that measured for either Bacillus anthracis (BA-HNS) or for eNOS(HD) in both oxidized and reduced forms in the presence of arginine.|NO|HNS|1|4.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|DIRECT-REGULATOR|1538
16964330|The sordarins group are protein synthesis inhibitors that work by blocking the function of fungal translation elongation factor 2.|sordarins|fungal translation elongation factor 2|2|15.0|Arg1:T7|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|1539
15204055|The patients were divided into two groups according to the 5HT-2A affinity of the individual medications (high 5HT-2A affinity--clozapine, olanzapine, risperidone vs.|olanzapine|5HT-2A|24|19.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1540
15133856|Ang II level in plasma and mesenteric arteries in imidapril group was significantly lower than that in irbesartan group (P<0.05).|irbesartan|Ang II|18|1.0|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1541
16319075|Moreover, Pb2+ inhibited the ASIC-mediated membrane depolarization and the elevation of intracellular Ca2+ concentration.|Pb2+|ASIC|3|6.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|1542
8600944|Dexamethasone (DEX) inhibited the anti-CD3-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.|DEX|IL-5|3|12.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1543
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|Fe|Tf|29|35.0|Arg1:T14|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1544
15106733|The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and PGE2 release.|PD098059|ERK|11|5.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|1545
10365684|The presence of cyclic adenosine monophosphate (cAMP)-generating system (forskolin) in TSH-free medium increased MMI-mediated TPO activity.|forskolin|TPO|13|20.0|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR|1546
17168665|Though the exact mode of action of these FASN inhibitors is under discussion, it has been revealed that depletion of end-product fatty acids, toxic intracellular accumulation of supra-physiological concentrations of the FASN substrate malonyl-CoA and/or limited membrane synthesis and/or functioning by altered production of phospholipids partitioning into detergent-resistant membrane microdomains (lipid raft-aggregates), can explain, at least in part, the cytostatic, cytotoxic as well as the apoptotic effects occurring upon pharmacological inhibition of FASN activity in cancer cells.|fatty acids|FASN|23|9.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|1547
11451212|In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist.|olmesartan medoxomil|angiotensin II type AT1 receptor|8|12.0|Arg1:T17|Arg2:T27|CHEMICAL|GENE-Y|ANTAGONIST|1548
23557993|The h-OB were 10-100 fold more sensitive to DPHD than transformed osteoblasts: DPHD increased h-OB proliferation at 10nM and, at 100nM, activated MAP kinase signaling within 30min.|DPHD|MAP kinase|14|26.0|Arg1:T18|Arg2:T31|CHEMICAL|GENE-N|ACTIVATOR|1549
23473803|Experimentally we showed that moexipril and two structurally related analogues acted in the micro molar range to inhibit PDE4 activity.|moexipril|PDE4|5|19.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|1550
18450949|Administration of cevimeline hydrochloride, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one.|cevimeline hydrochloride|AQP1|3|43.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1551
1472079|In addition, in rat microsome incubations, the net amount of 4-OHCIPC glucuronide was also indirectly increased by cadmium through a reduction in the activity of beta-glucuronidase.|cadmium|beta-glucuronidase|20|28.0|Arg1:T23|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|1552
23050902|These data suggest that ribavirin-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, AFF4 and ELL3, to F7, and modulates FVII mRNA transcription elongation.|ribavirin|F7|5|22.0|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1553
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|Pristimerin|inducible NO synthase|1|22.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1554
23434829|Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.|paclitaxel|P-gp|15|27.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|1555
23336565|To determine if the up-regulation of PDGFβ receptors is neuroprotective, primary hippocampal neurons were incubated with the 5-HT7 receptor agonist, LP 12, for 24 h.|LP 12|5-HT7|23|19.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|1556
15661821|Glucose infusion increased circulating glucose and insulin concentrations, mean lipid locule size (532.8 +/- 3.3 microm2 versus 456.7 +/- 14.8 microm2) and total unilocular fat mass (11.7 +/- 0.6 g versus 8.9 +/- 0.6 g) of the perirenal fat depot.|Glucose|insulin|1|7.0|Arg1:T6|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1557
23486447|Amitriptyline, clomipramine, doxepin, imipramine, and trimipramine are demethylated by CYP2C19 to pharmacologically active metabolites.|doxepin|CYP2C19|5|14.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE|1558
10494028|Under serum conditions allowing apo CIII secretion, treatment with the peroxisome-proliferator activated receptor (PPAR)alpha activators fenofibrate, gemfibrozil and Wy-14643 result in a marked lowering of apo CIII secretion and gene expression, this effect being most pronounced with Wy-14643.|gemfibrozil|apo CIII|22|31.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1559
10368299|CONCLUSIONS: Our study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE).|E2020|AChE|14|36.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1560
23234246|The in vitro binding affinity of the benzenesulfonamide rhenium complexes yielded IC(50) values ranging from 3 to 116 nM in hypoxic CA-IX expressing HeLa cells.|benzenesulfonamide rhenium|CA-IX|8|25.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1561
19852528|Oral palonosetron is likely to be a useful addition to oral formulations of other 5-HT3 receptor antagonists in preventing CINV in patients receiving MEC.|palonosetron|5-HT3 recepto|2|15.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST|1562
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|bisindolylmaleimide I|PKC|24|22.0|Arg1:T10|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR|1563
14508322|In membranes from HEK293 cells transfected with alpha2-receptors, etomidate inhibited binding of the alpha2-antagonist, [3H]RX821002, with higher potency from alpha2B- and alpha2C-receptors than from alpha2A-receptors (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm).|etomidate|alpha2A-receptors|10|31.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1564
15671155|Also, prophylactic, as well as therapeutic, treatment with the CSE inhibitor, DL-propargylglycine (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (MPO) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; PAG, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.|PAG|CSE|18|13.0|Arg1:T22|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|1565
23478800|Here we found that the anticancer agent cucurbitacin I, a Jak2 inhibitor, reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells.|cucurbitacin I|Jak2|8|12.0|Arg1:T9|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|1566
23234812|CM from PFF-treated osteocytes without SrRan enhanced Ki67 expression but reduced Runx2 and Ocn expression in osteoblasts.|SrRan|Ocn|6|14.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1567
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|l-isoleucine|LAT3|27|11.0|Arg1:T14|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|1568
23259865|  Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents.|camptothecin|topoisomerase I|26|20.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR|1569
23266270|Furthermore, DPEP inhibited the LPS-induced phosphorylation of inhibitor κB (IκB)-α and NF-κB p50.|DPEP|p50|3|17.0|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|1570
23229509|On stimulation by G(s), the activities of ACs can be further selectively modulated by other pathways to ensure precise control of intracellular cAMP responses to specific stimuli.|cAMP|ACs|27|12.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PRODUCT-OF|1571
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|Eletriptan|5-HT1D|1|19.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1572
18073378|METHODS: Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 6a is an extension of ABCSG Trial 6, in which hormone receptor-positive postmenopausal patients received 5 years of adjuvant tamoxifen, with or without the aromatase inhibitor aminoglutethimide, for the first 2 years of therapy.|aminoglutethimide|aromatase|42|40.0|Arg1:T9|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1573
16230360|By doing so, procainamide significantly decreased the processivity of DNMT1 on hemimethylated DNA.|procainamide|DNMT1|5|11.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1574
23059626|mRNA levels of receptor activator of nuclear factor kappa-B (RANK), its ligand RANKL, tumor necrosis factor alpha (TNF-α) and RANKL/osteoprotegerin (OPG) ratio were diminished in the periodontium of CCL3(-/-) mice and in the group treated with Met-RANTES.|Met|RANKL|48|16.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1575
17234158|PFD leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.|PFD|pro-protein convertase|1|26.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1576
17355958|Human Grx1 and Grx2 contain Cys-Pro-Tyr-Cys and Cys-Ser-Tyr-Cys active sites and have three and two additional structural Cys residues, respectively.|Cys-Pro-Tyr-Cys|Grx2|6|4.0|Arg1:T18|Arg2:T34|CHEMICAL|GENE-Y|PART-OF|1577
23201180|The paraoxonase 1 from human serum (PON1) is a phosphotriesterase (PTE) that hydrolyses several xenobiotics including drugs and organophosphorus compounds (OPs).|organophosphorus|phosphotriesterase|23|12.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE|1578
16982784|  Among the TEM-type extended-spectrum beta-lactamases (ESBLs), an amino acid change at Ambler position 104 (Glu to Lys) results in increased resistance to ceftazidime and cefotaxime when found with other substitutions (e.g., Gly238Ser and Arg164Ser).|Lys|TEM-type extended-spectrum beta-lactamases|21|3.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|PART-OF|1579
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|AKT|10|46.0|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR|1580
9059856|1.5 +/- 0.4 nM; Ki dicyclomine, 5.1 +/- 0.8 nM; Ki HHSD, 34.3 +/- 7.3 nM), whereas the receptor in basal plasma membrane seems to be of the muscarinic M2 receptor subtype (Ki pirenzepine, 202 +/- 48 nM; Ki AF-DX 116, 124 +/- 60 nM; Ki himbacine, 20.6 +/- 4.8 nM; Ki 4-DAMP, 4.5 +/- 1.2 nM; Ki dicyclomine, 54.6 +/- 22 nM; Ki HHSD, 89.2 +/- 15.8 nM).|AF-DX 116|muscarinic M2 receptor subtype|49|35.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|1581
2087492|The suppressive effect of ceruletide on barrel rotation could be partially countered by MK-329, a selective peripheral CCK (CCK-A) receptor antagonist.|MK-329|CCK|14|19.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|ANTAGONIST|1582
8827452|The amino acid sequence deduced from the nucleotide sequence of the cloned PHBP cDNA exhibited significant homology to that of hepatocyte growth factor activator (HGFA).|nucleotide|PHBP|8|13.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|PART-OF|1583
10917903|Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of eicosapentaenoic acid (EPA) blocked Delta-5-desaturase activity, the terminal enzymatic step in AA synthesis.|EPA|Delta-5-desaturase|16|19.0|Arg1:T22|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|1584
23183084|Similarly favorable effects were seen for dienogest, which promoted significant reduction of AKR1C1 and AKR1C2 expression and also showed no effect on PR-B protein levels.|dienogest|AKR1C2|7|16.0|Arg1:T6|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1585
15192023|Hydralazine dose-dependently inhibited PHD activity and induced nonhydroxylated HIF-1alpha, evidence for HIF stabilization specifically by inhibition of PHD enzyme activity.|Hydralazine|PHD|1|4.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|1586
3004501|Similar concentrations also inhibited the formation of leukotriene C4 (LTC4) by LTC synthetase, a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling LTA4 to glutathione.|leukotriene C4|LTC synthetase|8|14.0|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF|1587
16014042|Moreover, uptake of l-cystine also increased (about tenfold) in Xenopus oocytes expressing hxCT and h4F2hc.|l-cystine|hxCT|5|16.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|1588
23470287|To study the molecular mechanism, results from luciferase assay, nuclear translocation of NF-κB, and Western blot indicated that the mechanism of the anti-inflammatory effects of SA9 might be suppression of intracellular generation of ROS and inhibition of NF-κB activation in ECs. SA9 is a prototype of a novel class of antioxidant with anti-inflammatory effects in ECs. It may represent a new therapeutic approach for preventing endothelial activation in cardiovascular disorders.|SA9|NF-κB|29|41.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|1589
23147415|HZ mice are also more sensitive to the peripheral application of the selective AChE inhibitor donepezil or the mixed inhibitor physostigmine; extracellular ACh levels rise significantly after administration of both drugs; also glucose levels are moderately increased indicating potentially non-cholinergic effects of donepezil.|donepezil|AChE|16|14.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|1590
16982809|ATRA regulates gene expression via the activation of the retinoic acid receptor (RAR)alpha in human DCs, and RARalpha acutely regulates CD1d expression.|ATRA|CD1d|1|25.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1591
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|alanine aminotransferase|8|47.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1592
23468082|Ridaforolimus is a selective inhibitor of mTOR that has demonstrated positive clinical activity in endometrial cancer.|Ridaforolimus|mTOR|1|7.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1593
2922761|In contrast, serum alkaline phosphatase was elevated in animals dosed with 13cisRA or 4HPR but not in those dose with ROAc. For this enzyme, the electrophoretic pattern on agarose gel showed a decrease, compared to controls, in the major isozyme in serum of ROAc-dosed animals.|13cisRA|alkaline phosphatase|13|5.0|Arg1:T15|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1594
23337567|Additionally, these effects of ATO on γ-H2AX, Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.|ATO|cip1|6|20.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1595
23541436|FCEO significantly inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2, respectively.|prostaglandin E2|cyclooxygenase (COX)-2|10|29.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1596
14672731|  The specific pharmacological profile of the 19-norprogestin nomegestrol acetate (NOMAC) is, at least in part, defined by its pattern of binding affinities to the different steroid hormone receptors.|19-norprogestin|steroid hormone receptors|7|30.0|Arg1:T29|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|1597
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT1|60|64.0|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|1598
20007701|  The vesicular neurotransmitter transporter VMAT2 is responsible for the transport of monoamines into synaptic and storage vesicles.|monoamines|vesicular neurotransmitter transporter|12|2.0|Arg1:T15|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|1599
10485486|These data suggest that the radiosensitizing effects of caffeine are related to inhibition of the protein kinase activities of ATM and ATR and that both proteins are relevant targets for the development of novel anticancer agents.|caffeine|ATM|9|20.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1600
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|D6D|26|8.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF|1601
10229494|Previous studies have indicated that PLMs occur in the rat brain synaptosomal and retinal membranes, and they are activated under halothane anesthesia.|halothane|PLMs|22|6.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR|1602
23179775|  Adrenal insufficiency may be caused by the destruction or altered function of the adrenal gland with a primary deficit in cortisol secretion (primary adrenal insufficiency) or by hypothalamic-pituitary pathologies determining a deficit of ACTH (secondary adrenal insufficiency).|cortisol|ACTH|21|36.0|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF|1603
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|receptor tyrosine kinases|1|41.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|1604
11799102|In conclusion, the renin inhibitor Aliskiren dose-dependently decreases Ang II levels in humans following oral administration.|Aliskiren|renin|7|5.0|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|1605
23583258|This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and IL-8, caused by a mixture of oxysterols representative of a high cholesterol diet.|cholesterol|interleukins|33|17.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1606
23183084|Different effects were seen for progesterone, which significantly decreased SRD5A1, PR-B and HSD17B2 protein levels.|progesterone|HSD17B2|6|15.0|Arg1:T7|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1607
8740147|Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.|Amezinium|uptake1|1|7.0|Arg1:T32|Arg2:T57|CHEMICAL|GENE-N|SUBSTRATE|1608
7769797|Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans.|remikiren|renin|9|6.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1609
23544613|The highest DPmax of 15 was achieved in a one-step and two-step synthesis of oligo(p-xylylene sebacamide) catalyzed by CLEA cutinase.|oligo(p-xylylene sebacamide)|CLEA cutinase|15|22.0|Arg1:T8|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE|1610
23482500|[(14)C]Sorafenib (0.5 to 5 μM) uptake was significantly higher in hOCT1-transfected CHO cells compared to mock cells, and inhibited by the general OCT inhibitor, MPP(+).|MPP(+)|OCT|35|32.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|1611
23639801|Here we show that the compound CID16020046 ((4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo [3,4-c] pyrazol-5-yl] benzoic acid) is a selective GPR55 antagonist.|CID16020046|GPR55|7|32.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST|1612
16940412|Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin.|E7389|tubulin|14|28.0|Arg1:T23|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR|1613
17016511|Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin.|quercetin|R1623Q|16|10.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1614
23591110|Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part I).|aryl amides|histamine H3 receptor|6|12.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|ANTAGONIST|1615
17442055|  The tryptophan metabolite kynurenic acid (KYNA), which is produced enzymatically by the irreversible transamination of l-kynurenine, is an antagonist of alpha7 nicotinic and NMDA receptors and may thus modulate cholinergic and glutamatergic neurotransmission.|KYNA|alpha7 nicotinic and NMDA receptors|7|25.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|ANTAGONIST|1616
15840408|Both prostaglandins inhibited tumor necrosis factor (TNF)-alpha production and T-cell proliferation of lipopolysaccharide-treated human peripheral blood mononuclear cells (PBMC).|prostaglandins|tumor necrosis factor (TNF)-alpha|2|4.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1617
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|Procaine|NET|1|20.0|Arg1:T26|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|1618
12200198|Long-term administration of propargylamines to rats increased the activities of antioxidative enzymes superoxide dismutase (SOD) and catalase in the brain regions containing dopamine neurons.|propargylamines|catalase|4|19.0|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR|1619
23591044|Oviduct ER-α, ER-β and uterine ER-β were down-regulated by either ethanol or melatonin.|melatonin|ER-β|14|7.0|Arg1:T28|Arg2:T50|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1620
18506437|This report reviews the recent advances in the knowledge of the mechanism of action as well as the molecular basis and interethnic variations of TPMT and inosine triphosphate pyrophosphatase (ITPase; EC 3.6.1.19), another enzyme implicated in thiopurine toxicity.|thiopurine|inosine triphosphate pyrophosphatase|41|27.0|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|1621
9313928|The two receptors were discriminated by butaprost, AH-13205 and AH-6809 that bound to the EP2 receptor but not to the EP4 receptor, and by 1-OH-PGE1 that bound to the EP4 but not to the EP2 receptor.|butaprost|EP2|7|16.0|Arg1:T19|Arg2:T83|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1622
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|SKI-606|Abl|9|17.0|Arg1:T31|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|1623
2270485|Zinc mediation of the binding of human growth hormone to the human prolactin receptor.|Zinc|human growth hormone|1|7.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1624
16298345|[3H]-maraviroc bound with high affinity to CCR5 from macaque (K(d) = 1.36+/-0.07 nM) and human (K(d) = 0.86 +/- 0.08 nM), but was found to dissociate approximately 10-fold more quickly from macaque CCR5.|[3H]-maraviroc|CCR5|1|10.0|Arg1:T10|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|1625
10823899|Conversely, DAT inhibitors, such as cocaine, mazindol, and nomifensine, when administered with AMPH, blocked the reduction in [(3)H]DA uptake and the redistribution of DAT immunofluorescence to the cytosol.|nomifensine|DAT|13|3.0|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|1626
17088426|By using pharmacological and genetic manipulation of phosphodiesterases (PDEs), we demonstrate that compartmentalized PDE4B and PDE4D are responsible for selectively modulating the concentration of cAMP in individual subcellular compartments.|cAMP|PDE4B|28|17.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|1627
23086198|These data suggest that, although UGT2A1 is the only UGT2A enzyme active against PAH proximate carcinogens (including PAH diols), both UGTs 2A1 and 2A2 play an important role in the local detoxification of procarcinogenic monohydroxylated PAH metabolites.|PAH|UGT2A1|15|7.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|1628
23318726|Butein also increased heme oxygenase-1 (HO-1) protein expression and HO activity.|Butein|heme oxygenase-1|1|4.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1629
11885959|  Non-steroidal anti-inflammatory drugs (NSAIDs) are competitive inhibitors of cyclooxygenase (COX), the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid.|steroidal|COX|2|13.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|1630
17929831|  Adenylosuccinate synthetase (AdSS) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate, in a reaction driven by the hydrolysis of GTP to GDP.|adenylosuccinate|AdSS|20|4.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF|1631
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|guvacine|GAT2|13|21.0|Arg1:T15|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|1632
15367040|Levetiracetam binds selectively and with high affinity to a synaptic vesicle protein known as SV2A, thought to be involved with synaptic vesicle exocytosis and presynaptic neurotransmitter release.|Levetiracetam|synaptic vesicle protein|1|10.0|Arg1:T1|Arg2:T4|CHEMICAL|GENE-N|DIRECT-REGULATOR|1633
23642478|  A series of benzenesulfonamides incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the β-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.|cyanoacrylamide|ScCA|6|30.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1634
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|cilastatin|human-OAT3|21|25.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1635
2857786|Ambenonium was a less potent antagonist of tissue responses to acetylcholine, and the underestimation in the pKB (as compared to that obtained with bethanechol) could be eliminated by prior treatment of tissues with the acetylcholinesterase inhibitor neostigmine.|neostigmine|acetylcholinesterase|40|38.0|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1636
16298345|Maraviroc inhibited binding of [125I]-MIP-1beta to CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM, respectively) and antagonised MIP-1beta induced intracellular calcium release mediated through CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89, respectively).|125I|CCR5|6|10.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|1637
23643730|Take together, our results demonstrated that juglone might induce the apoptosis in LNCaP cell via down-regulation of AR expression.|juglone|AR|8|19.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1638
23542513|Taken together, our findings indicate that 5HHMF suppresses NO production through modulation of iNOS, consequently suppressing NF-κB activity and induction of Nrf2-dependent HO-1 activity.|5HHMF|NF-κB|8|19.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1639
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|Mg2+|human hematopoietic prostaglandin (PG) D synthase|28|7.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1640
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|iron|Tf|27|35.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1641
16418149|  Leptin is a 167 amino acid protein encoded by the obesity gene that is synthesized in adipose tissue and interacts with receptors in the hypothalamus linked to the regulation of appetite and metabolism.|amino acid|Leptin|5|1.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PART-OF|1642
23277230|Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.|Fisetin|p65|1|21.0|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1643
23178381|Western blot analysis revealed that aspidin PB inhibited PI3K expression, phosphorylation of Ser473 Akt and Ser9 GSK3β followed by up-regulation of nonsteroidal anti-inflammatory drugs activated gene-1 (NAG-1) expression.|aspidin PB|PI3K|6|9.0|Arg1:T15|Arg2:T31|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1644
11723241|To gain further insight into the binding site, we examined the minimal structural changes necessary to transform low-affinity binding of dofetilide by the related bovine ether a-go-go channel bEAG to high-affinity binding of HERG.|dofetilide|bovine ether a-go-go channel|22|26.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1645
23246867|Similar to MIN6 β cells, human islets elicited glucose-stimulated PAK1 activation that was sensitive to the PAK1 inhibitor, IPA3.|IPA3|PAK1|21|18.0|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|1646
10768100|Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes.|Troglitazone|plasminogen activator inhibitor-1|1|3.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1647
11979347|These results indicate that MTHFR genotype influences the correlation of Hcy level with vitamin B12 and folate levels in HD patients.|folate|MTHFR|17|5.0|Arg1:T23|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE|1648
14744615|This response was: (1) partly blocked in dogs pretreated intravenously with the antagonists SB224289 (5-HT(1B); 2,3,6,7-tetrahydro-1'-methyl-5-[2'-methyl-4' (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl]furo[2,3-f]indole-3-spiro-4'-p iperidine hydrochloride), rauwolscine (alpha(2)), BRL44408 (alpha(2A); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole) or MK912 (alpha(2C); (2S,12bS)-1'3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2Hbenzo[b]furo[2,3-a]q uinazoline)-2,4'-pyrimidin-2'-one); (2) markedly blocked after SB224289 plus rauwolscine; and (3) unaffected after BRL15572 (5-HT(1D); 1-(3-chlorophenyl)-4-[3,3-diphenyl (2-(S,R) hydroxypropanyl) piperazine] hydrochloride) or imiloxan (alpha(2B)).|rauwolscine|alpha(2)|42|44.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|ANTAGONIST|1649
14761877|In contrast to their opposing actions on cell growth, both activin A and DHT upregulated PSA gene expression and increased PSA secretion by LNCaP cells.|DHT|PSA|15|22.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1650
23361846|  Methadone N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.|Methadone|CYP3A4|1|24.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|1651
8799556|RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes.|RS 17053|alpha 1D|1|26.0|Arg1:T39|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1652
23643744|Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.|phencyclidine|metabotropic glutamate receptor 5|25|5.0|Arg1:T21|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR|1653
16801455|  Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and mitochondrial arginase II.|L-arginine|arginase I|22|36.0|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|1654
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|batracylin|TOP2|64|57.0|Arg1:T21|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|1655
23583258|This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and IL-8, caused by a mixture of oxysterols representative of a high cholesterol diet.|oxysterols|interleukins|28|17.0|Arg1:T11|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1656
23468082|CONCLUSIONS: These encouraging preclinical findings suggest the inhibition of both FGFR2 and mTOR by the ponatinib-ridaforolimus combination may provide a new therapeutic strategy to treat advanced endometrial cancers with dual pathway dysregulation.|ponatinib|FGFR2|17|12.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1657
23643744|We wanted to determine whether behavioural and GABAergic functional deficits induced by the NMDA receptor channel blocker, phencyclidine (PCP), could be reversed by repeated administration of two drugs known to enhance GABAergic transmission: the positive allosteric modulator (PAM) of the metabotropic glutamate receptor 5 (mGluR5), ADX47273, and the partial agonist of the α7 nicotinic acetylcholine receptor (α7 nAChR), SSR180711.|SSR180711|α7 nicotinic acetylcholine receptor|73|64.0|Arg1:T17|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|1658
23219525|  The combinations of the endothelin-1 receptor antagonists bosentan or ambrisentan with the phosphodiesterase 5 inhibitors sildenafil or tadalafil are current standard therapies of advanced pulmonary arterial hypertension.|ambrisentan|endothelin-1 receptor|10|5.0|Arg1:T24|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST|1659
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|amiodarone|NCX|8|25.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1660
23211523|Furthermore, knockdown of Brms1L significantly attenuated GnRH-induced FSHβ expression.|GnRH|FSHβ|8|9.0|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1661
15674236|Because minocycline inhibits matrix metalloprotease-9 (MMP-9), we also compared minocycline's protective effect in wild type (wt) and MMP-9 knock-out (ko) mice.|minocycline|matrix metalloprotease-9|2|4.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1662
23053666|Cu-dependent tyrosinase activity was also markedly reduced in both types of CLDN knockdown cells when incubated with the substrate l-DOPA.|l-DOPA|tyrosinase|20|2.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|1663
10947967|In contrast, 2, 4-dioxo-5-acetamido-6-phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopamine-beta-hydroxylase.|ascorbate|PAM|29|33.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1664
11006272|Three LTB(4) receptor antagonists, 14,15-dehydro-LTB(4), LTB(4)-3-aminopropylamide, and U-75302, had high affinity for LTB(4)-R1 but not for LTB(4)-R2.|LTB(4)-3-aminopropylamide|LTB(4)-R1|14|27.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1665
9387868|Cocaine significantly decreased the abundance of the SERT mRNA within the dlDR and DAT mRNA abundance within the SNc and the PBP, and increased the abundance of the NET mRNA within the LC.|Cocaine|NET|1|30.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1666
17289088|  Lymphocytes possess the essential components of a cholinergic system, including acetylcholine (ACh); choline acetyltransferase (ChAT), its synthesizing enzyme; and both muscarinic and nicotinic ACh receptors (mAChRs and nAChRs, respectively).|ACh|choline acetyltransferase|14|17.0|Arg1:T11|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF|1667
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|VEGF|1|29.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1668
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline alphoscerate|acetylcholinesterase|10|13.0|Arg1:T20|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1669
23356880|Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase (LOX)-pathway (one having as precursors the polyunsaturated fatty acids containing a cis-cis-1,4-pentadiene system).|polyunsaturated fatty acids|LOX|29|20.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE|1670
23292752|FXa inhibitors, e.g. rivaroxaban and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa. Both agents have a rapid onset of action, a wide therapeutic window, little or no interaction with food and other drugs, minimal inter-patient variability, and display similar pharmacokinetics in different patient populations.|apixaban|FXa|8|22.0|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1671
15975002|  Irinotecan (CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I (Topo I).|Irinotecan|Topo I|1|31.0|Arg1:T1|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1672
10580458|Rofecoxib specifically inhibits COX-2 and has demonstrated a low potential for causing upper GI injury.|Rofecoxib|COX-2|1|4.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1673
14587496|  BACKGROUND: Rivastigmine is a carbamate drug designed to inhibit both acetylcholinesterase and butyrylcholinesterase by reversibly covalently bonding to these enzymes.|carbamate|acetylcholinesterase|6|12.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1674
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|1-m-chlorophenylpiperazine|5-HT2A|17|12.0|Arg1:T8|Arg2:T61|CHEMICAL|GENE-Y|AGONIST|1675
23639738|  Cholesterol esterase (CE) induced surface erosion of poly(ethylene carbonate) (PEC) and drug release from PEC under mild physiological environment was investigated.|PEC|Cholesterol esterase|16|1.0|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|1676
10727523|These results indicate that MRP1 is a more efficient transporter of glutathione conjugates and free glutathione than MRP2, whereas several anions are preferred substrates for MRP2.|glutathione|MRP2|12|18.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|1677
23313376|Furthermore, PTE treatment directly inhibited the phosphorylation of JAK2 at Tyr 1007 and the downstream activation of STAT3.|Tyr|JAK2|12|10.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|PART-OF|1678
21631396|Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways.|Pseudoephedrine|NF-kappaB|1|7.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|1679
11723241|Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.|dofetilide|EAG-related K(+) channels|6|16.0|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|1680
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|bisdioxopiperazines|DNA topoisomerase II|2|18.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1681
11920914|  The rates of inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) by paraoxon, haloxon, DDVP and enantiomers of neutral alkyl methylphosphonyl thioates and cationic alkyl methylphosphonyl thiocholines were measured in the presence and absence of AChE peripheral site inhibitors: gallamine, d-tubocurarine, propidium, atropine and derivatives of coumarin.|alkyl methylphosphonyl thioates|EC 3.1.1.7|24|11.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1682
22967140|Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol, a selective ERα agonist-PPT [4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol], a selective ERβ agonist-DPN [2,3-bis(4-hydroxyphenyl)-propionitrile], a selective ERα antagonist-MPP [1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride] or a selective ERβ antagonist-PHTPP (4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol).|1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol|ERα|54|51.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1683
16293341|  MELANOTAN (NDP-MSH) binds the MC1 receptor to significantly increase the eumelanin content of human skin cells.|MELANOTAN|MC1 receptor|1|7.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1684
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|dasatinib|SRC|8|20.0|Arg1:T18|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1685
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|epinephrine|OAT3|9|22.0|Arg1:T19|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|1686
11444497|Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.|losartan|AT1-receptor|6|4.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-N|ANTAGONIST|1687
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|betamipron|human-OAT3|5|13.0|Arg1:T12|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1688
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|LYSO-7|PPAR|19|52.0|Arg1:T8|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR|1689
23561166|In addition, fisetin supplementation significantly reduced hepatic mRNA abundance of FAS, ATPCL and G6Pase compared to the control group.|fisetin|G6Pase|4|16.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1690
11270983|Dazoxiben (inhibitor of thromboxane synthase) inhibited, to the same extent as indometacin and ridogel, the response to higher concentrations of endothelin-1.|indometacin|thromboxane synthase|15|5.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1691
11986668|Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.|Minocycline|cytochrome c|1|3.0|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1692
1475066|  Male Sprague-Dawley rats when administered sc a sublethal dose of organophosphorus cholinesterase inhibitors such as the nerve agents, soman (100 micrograms/kg, sc), sarin (110 micrograms/kg, sc), tabun (200 micrograms/kg, sc), or VX (12 micrograms/kg, sc), developed seizures and severe muscle fasciculations within 15-20 min, lasting for 4-6 hr.|VX|cholinesterase|45|12.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1693
7518029|Haloperidol decreased the amount of SP mRNA by 20% while sulpiride increased it by 20%.|sulpiride|SP|12|6.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1694
10398211|We topically applied the nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine, on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet.|NG-nitro-L-arginine|nitric oxide synthase|13|5.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|1695
12904467|Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.|topiramate|GluR5|9|4.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|1696
14596599|The holo-SDH contained PLP-OMS aldimine in the active site, indicating that OMS can form the Schiff base linkage with PLP, but the subsequent dehydration did not occur.|OMS|holo-SDH|13|2.0|Arg1:T33|Arg2:T50|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1697
17369473|Metformin and phenformin, which are biguanides, have been reported to increase AMPK activity without increasing AMP/ATP.|biguanides|AMPK|7|14.0|Arg1:T26|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|1698
2270485|Scatchard analysis indicated a stoichiometry of one Zn2+ per hGH.hPRLbp complex.|Zn2+|hGH|8|10.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1699
23642478|Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase.|cyanoacrylamide|Saccharomyces cerevisiae β-carbonic anhydrase|4|8.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1700
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|Nexavar|MEK|6|15.0|Arg1:T13|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|1701
11971019|NO derived from inducible NO synthase (iNOS) can activate macrophage apoptosis.|NO|inducible NO synthase|1|4.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|1702
10611634|In guinea pigs, antagonist actions of yohimbine at 5-HT(1B) receptors are revealed by blockade of hypothermia evoked by the 5-HT(1B) agonist, GR46,611.|yohimbine|5-HT(1B)|8|10.0|Arg1:T44|Arg2:T77|CHEMICAL|GENE-Y|ANTAGONIST|1703
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|ketone|MCTs|25|4.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE|1704
12445705|Although only clozapine and ziprasidone are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and D(2) blockade.|clozapine|5-HT(1A)|3|9.0|Arg1:T27|Arg2:T57|CHEMICAL|GENE-Y|AGONIST|1705
11969359|The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and milrinone, reduced the GM-CSF release in a concentration dependent manner.|amrinone|PDE3|15|13.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|1706
23001627|SOD levels of serum and hippocampus tissue were significantly increased and MDA levels were significantly decreased in the PTU + Vit E and PTU + L-T4 + Vit E groups than the PTU and PTU + L-T4 groups.|L-T4|SOD|26|1.0|Arg1:T13|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1707
9480923|Consistent with these results, the translocation of cPLA2 protein as well as the release of arachidonic acid, a principal product of phospholipase A2, was rapidly induced by the addition of C2-ceramide in a Rac-dependent manner.|arachidonic acid|phospholipase A2|17|24.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|PRODUCT-OF|1708
17008880|Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane.|vitamin C|SVCT-1|13|20.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF|1709
23537701|  Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family.|THC|CB1|3|29.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|ACTIVATOR|1710
8589992|The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.|DNQX|EAA3a|28|14.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1711
22983118|Moreover, 24h exposure to DOI promoted an increase in cytochrome c in the cytoplasmatic fraction of neurons.|DOI|cytochrome c|6|11.0|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1712
22841397|Insulin secretion increased from the islets of biotin-supplemented mice, together with the messenger RNA (mRNA) expression of several transcription factors regulating insulin expression and secretion, including forkhead box A2, pancreatic and duodenal homeobox 1 and hepatocyte nuclear factor 4α.|biotin|pancreatic and duodenal homeobox 1|8|35.0|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1713
12085361|Rifampicin (10 micromol/L) inhibited OATP8-mediated BSP uptake by 50%, whereas inhibition of OATP-C-, OATP-B-, and OATP-A-mediated BSP transport was below 15%.|BSP|OATP-A|23|22.0|Arg1:T4|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|1714
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|Akt|47|20.0|Arg1:T14|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|1715
23401473|OATP1B1-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 µM, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 µM, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 µM, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 µM, respectively).|silychristin|OATP1B3|61|3.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1716
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Nucleotide|SUR|1|24.0|Arg1:T16|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR|1717
23028140|Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.|imatinib|CYP2C8|11|9.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE|1718
10430100|  We studied the antitumor activity and toxicity of ZD1694 (tomudex), a specific inhibitor of thymidylate synthase (TS), in nude mice bearing human head and neck squamous cell carcinoma A253 and FaDu xenografts.|tomudex|thymidylate synthase|11|18.0|Arg1:T23|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|1719
17513393|Because Cu deficiency results in upregulation of Gclc and an increase in the biosynthesis of glutathione, it is plausible that the net flux of homocysteine through the transsulfuration pathway is increased.|glutathione|Gclc|16|8.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF|1720
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|risperidone|5-HT2C|11|3.0|Arg1:T4|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1721
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|PD166326|Abl|12|17.0|Arg1:T32|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|1722
23368743|The recent identification of zinc permeability of the lysosomal ion channel TRPML1 (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1 in zinc transport.|zinc|TRPML1|40|38.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|1723
14610216|hOAT1 and hOAT3, but not hOAT2 and hOAT4 mediated the uptake of furosemide.|furosemide|hOAT3|14|3.0|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|1724
23161664|Cadmium (Cd), an inducer of reactive oxygen species, inhibited HIF-1α mRNA expression and HIF-1α binding to the LO gene in Co-treated cells as revealed by RT-PCR and ChIP assays, respectively.|Cadmium|HIF-1α|1|18.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|1725
23261757|Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats.|gentamicin|VDBP|17|11.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1726
2083404|Although the precise mechanism of the protective action of trilisate is unknown, our data support the possibility of interaction between salicylate and ASA on cyclo-oxygenase locus in the respiratory tract in ASA-intolerant patients.|ASA|cyclo-oxygenase|24|26.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|1727
23340651|Our results demonstrate that 3% O(2) augmented proliferation of BMSC, as well as the formation of colonies in the colony-forming unit assay (CFU-A), the percentage of quiescent cells, and the expression of stemness markers Rex-1 and Oct-4, thereby suggesting an increase in the stemness of culture when exposed to hypoxia.|O(2)|Oct-4|7|46.0|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1728
23466229|PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency.|pyrazole|KAT II|13|17.0|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|1729
9231746|We have examined the effect of dihydropyridine Ca2+-channel blockers felodipine and nicardipine on CaMPDE.|dihydropyridine|Ca2+-channel|7|8.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|1730
23581876|The effect of sex and cytochrome P450 (P450) enzyme induction on the enantioselective metabolism of PCB 136 was studied using liver tissue slices prepared from naïve control (CTL), phenobarbital (PB; CYP2B inducer) or dexamethasone (DEX; CYP3A inducer) pretreated adult Sprague-Dawley rats.|PCB 136|cytochrome P450|18|6.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE|1731
23528300|  A series of benzoxazole compounds containing oxamic acid were synthesized and screened for the PTP1B inhibition.|benzoxazole|PTP1B|4|15.0|Arg1:T1|Arg2:T4|CHEMICAL|GENE-Y|INHIBITOR|1732
23220614|While SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by ISO.|SP600125|JNK|2|5.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|1733
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|Androstanol|CARs|1|20.0|Arg1:T8|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|1734
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|ammonia|EC 4.3.1.17|24|6.0|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF|1735
2386945|Pimozide and thioridazine had no effect on the estradiol binding properties of the MCF-7 ER, nor did pimozide interfere with the induction of progesterone receptors by estradiol.|estradiol|ER|9|15.0|Arg1:T29|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1736
11430635|In view of the role of CA in acid-base balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra- and extracellular pH, our results suggest that: firstly, CA activation induced by indomethacin might cause changes in COX activity; secondly, PGs are synthetized as a consequence of the changes in COX activity, a hypothesis that requires further study.|indomethacin|CA|48|44.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR|1737
15730717|CONCLUSIONS: IN could significantly inhibit the proliferation of CML cells, the mechanism of which might be related to the suppression of STATs/Bcl-X(L) signal transduction pathway.|IN|STATs|3|24.0|Arg1:T8|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|1738
23471964|These findings establish a novel mechanism by which maspin utilizes its cysteine thiols to inhibit oxidative stress and cell growth.|cysteine thiols|maspin|12|9.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|PART-OF|1739
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|collagen type I|1|8.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1740
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|lovastatin|HMG-CoA reductase|14|26.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1741
23465614|Of the compounds active in the present assay system, the most potent compound 7, platyphyllonol-5-O-β-d-xylopyranoside, significantly suppressed the induction of peroxisome proliferator activated receptor γ (PPARγ and CCAAT/enhancer binding protein α (C/EBPα) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPARγ agonist.|platyphyllonol-5-O-β-d-xylopyranoside|C/EBPα|17|37.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1742
23292752|Although parenteral oral direct thrombin inhibitors (DTIs), such as argatroban and bivalirudin, have been on the market for years, DTIs such as dabigatran are novel synthetic thrombin antagonists.|dabigatran|thrombin|28|32.0|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1743
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|Wy-14643|PPARalpha|19|34.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|1744
17537429|ANP increased glucose uptake in both adult and neonatal myocytes, under oxygenation and hypoxia, and GLUT4 favored this increase.|glucose|GLUT4|3|18.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|1745
23453071|Furthermore, BRN-250 inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.|BRN-250|VEGF receptor 2|3|14.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1746
10411647|On phosphorylation of Ser40 by protein kinase A, the affinity for H4biopterin increased ([S]0.5 = 11 +/- 2 microM) and the negative cooperativity was amplified (h = 0.27 +/- 0.03).|Ser40|protein kinase A|4|6.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE|1747
12840797|  Erlotinib HCl (Tarceva; Genentech, Inc, South San Francisco, CA) is an orally available, highly selective, reversible inhibitor of epidermal growth factor receptor (HER1/EGFR) tyrosine kinase.|Tarceva|epidermal growth factor receptor|4|27.0|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1748
23371965|Liquid chromatography mass spectroscopy analysis of the inactivated CYP2E1 apo-protein suggests that a reactive sulfur atom generated during desulfurization of PEITC is involved in the inactivation of CYP2E1.|PEITC|CYP2E1|21|28.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|1749
23396419|Uptake of dioscin by rat liver slices and isolated rat hepatocytes was inhibited significantly by Oatp modulators, such as ibuprofen (Oatp1a1 inhibitor), digoxin (Oatp1a4 substrate), and glycyrrhizic acid (Oatp1b2 inhibitor), but not by TEA or p-aminohippurate.|dioscin|Oatp|3|16.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|SUBSTRATE|1750
23479389|[6]-Gingerol derived from Zingiber officinale Roscoe (ginger) was identified as a novel angiotensin II type 1 receptor antagonist, with an IC50 value of 8.173 µM.|[6]-Gingerol|angiotensin II type 1 receptor|1|18.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|ANTAGONIST|1751
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|lanreotide|SSTR5|16|29.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1752
23159986|The compound D-limonene induced a dose dependent increase in HDN severity and renal biomarker changes without altering BUN, creatinine or NAG: (1) minimal induction of HDN and no altered biomarkers at 10 mg/kg/day, (2) mild induction of HDN with increased αGST and μGST at 50 mg/kg/day and (3) marked induction of HDN with increased αGST, μGST and albumin at 300 mg/kg/day.|D-limonene|αGST|3|64.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1753
23229511|Although treatment with 17-AAG reduced AhR levels and AhR-regulated gene expression in lung AD cells, AhR expression increased anticancer activity of 17-AAG.|17-AAG|AhR|4|6.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1754
23416173|For example, organophosphates, which inhibit acetylcholinesterase as do the drugs used in treating AD symptoms, have also been shown to lead to microtubule derangements and tau hyperphosphorylation, a hallmark of AD.|organophosphates|tau|4|29.0|Arg1:T1|Arg2:T2|CHEMICAL|GENE-Y|ACTIVATOR|1755
23201003|Moreover, 1,25(OH)(2)D(3) decreased expression of Oat1 and Oat3 in rat kidney.|1,25(OH)(2)D(3)|Oat1|3|17.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1756
2833901|Again, inhibition of the actin-activated myosin Mg2+-ATPase and myosin filament assembly by felodipine and the p-chloro analogue could be reversed by raising the calmodulin concentration.|p-chloro|myosin|17|7.0|Arg1:T20|Arg2:T62|CHEMICAL|GENE-N|INHIBITOR|1757
23396419|(-)-Epigallocatechin gallate, cyclosporin A, rifampicin, and telmisartan inhibited transport of dioscin in OATP1B3-HEK293 cells.|cyclosporin A|OATP1B3|7|19.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1758
10693877|  OBJECTIVE: This randomized, double-blind study tested the hypothesis that rofecoxib, a drug that specifically inhibits cyclooxygenase 2, would cause fewer gastroduodenal ulcers than ibuprofen (in a multicenter trial), and its side effects would be equivalent to those of placebo (in a prespecified analysis combining the results with another trial of identical design).|rofecoxib|cyclooxygenase 2|12|19.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1759
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|methazolamide|hCA VI|10|35.0|Arg1:T22|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1760
15627430|Since thioridazine binds with similar high affinities to muscarinic receptors as olanzapine and clozapine, muscarinic autoreceptor blockade was ruled out as a primary mechanism [Neuropsychopharmacology 26 (2002) 583].|olanzapine|muscarinic receptors|12|9.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR|1761
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|SR 59230A|beta-adrenoceptor|31|2.0|Arg1:T8|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST|1762
23473805|Rp1 treatment resulted in an accumulation of doxorubicin or rhodamine 123 by decreasing MDR-1 activity in doxorubicin-resistant cells.|doxorubicin|MDR-1|8|14.0|Arg1:T23|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE|1763
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|acylated sulfanilamide|CA V|26|4.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1764
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|tasosartan|AT1|40|4.0|Arg1:T2|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST|1765
15478125|The X-ray crystal structure of the best-studied isozyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.|sulfamates|CA II|15|10.0|Arg1:T3|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|1766
15639300|  Inhibitors of phosphodiesterase type 4 (PDE4) act by increasing intracellular concentrations of cyclic AMP, which has a broad range of anti-inflammatory effects on various key effector cells involved in asthma and chronic obstructive pulmonary disease (COPD).|cyclic AMP|PDE4|15|7.0|Arg1:T13|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|1767
18559268|Insight into the structural basis for this improvement was gained with molecular modeling and NMR data obtained for microtubule-bound docetaxel.|docetaxel|microtubule|20|19.0|Arg1:T4|Arg2:T9|CHEMICAL|GENE-N|DIRECT-REGULATOR|1768
23583884|TCDD also caused a fast (within 30min as judged by the increase in its mRNA level) activation of cytosolic phospholipase A2 (cPLA2).|TCDD|cytosolic phospholipase A2|1|21.0|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1769
20188727|Phenformin but not metformin inhibits a number of variants of K(ATP) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (Kir6.1/SUR2B and Kir6.2/SUR2B) and pancreatic beta-cells (Kir6.2/SUR1).|Phenformin|Kir6.1|1|29.0|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|1770
8469910|The lipoxygenase inhibitor nafazatrom (5-50 mumol-1) also dose-dependently inhibited the thyroliberin stimulated rPRL production, while the cyclo-oxygenase inhibitor indomethacin had no such effect on rPRL production.|nafazatrom|rPRL|4|15.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1771
23256625|In vitro, GSK1292263 demonstrated little/weak inhibition (IC50 values >30 μM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), Pgp, OATP1B3, or OCT2.|GSK1292263|OCT2|4|34.0|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|1772
11669456|S2 hOAT1 and S2 hOAT3 exhibited a time- and dose-dependent, and a saturable increase in uptake of [3H]-OTA, with apparent Km values of 0.42 microM (hOAT1) and 0.75 microM (hOAT3).|[3H]-OTA|hOAT3|19|38.0|Arg1:T3|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|1773
23317165|This review will summarize the developments of small molecule p38α MAP kinase inhibitors based on the imidazole core scaffolds in recent 10 years.|imidazole|MAP kinase|17|11.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|1774
23537747|In conclusion, nobiletin attenuates HGF-induced HepG2 cells metastasis involving both ERK and PI3K/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.|nobiletin|HGF|4|6.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1775
23466232|  Several members of a new family of non-sugar-type α-glycosidase inhibitors, bearing a 5-(p-toluenesulfonylamino)phthalimide moiety and various substituent at the N2 position, were synthesized and their activities were investigated.|5-(p-toluenesulfonylamino)phthalimide|α-glycosidase|14|9.0|Arg1:T3|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|1776
23583603|Both ICI treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ERα) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.|ICI|ERα|2|20.0|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1777
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|meclofenamate|PGH synthase-2|23|36.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|1778
12137927|Chronic treatment with the NET inhibitor, desipramine (DMI), reduced NET levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.|desipramine|NET|8|5.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1779
15982930|These results demonstrated that thalidomide might inhibit growth of tumors through COX-2 degradation independent of antiangiogenesis.|thalidomide|COX-2|5|12.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|1780
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|riboflavin|flavokinase|19|9.0|Arg1:T7|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|1781
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|parkin|14|33.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1782
8589992|The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.|L-glutamate|EAA3a|22|14.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1783
10611634|In [(35)S]GTPgammaS binding protocols, yohimbine exerts antagonist actions at halpha(2A)-AR, h5-HT(1B), h5-HT(1D), and hD(2) sites, yet partial agonist actions at h5-HT(1A) sites.|yohimbine|hD(2)|12|34.0|Arg1:T39|Arg2:T74|CHEMICAL|GENE-Y|ANTAGONIST|1784
17352516|As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved HbA(1c) to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin.|metformin|HbA(1c)|42|17.0|Arg1:T5|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1785
6150080|Staining around the edges of the brown fat cells was observed with the SSAO substrates, tyramine and benzylamine.|benzylamine|SSAO|19|14.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1786
23569176|However, until future studies elucidate the magnitude of functional change, caution is warranted in rare instances of extensive metabolism by catechol-O-methyltransferase in Bcrp-knockouts and intestinal carboxylesterase in Mdr1a-knockout rats, specifically for molecules with free catechol groups and esters subject to gut wall hydrolysis.|catechol|catechol-O-methyltransferase|38|23.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|1787
18604229|Specifically, B2-O-CH(2)-CH(2)-N-piperidine and B2-O-CH(2)-CH(2)-N-pyrrolidine revealed a higher affinity towards hERG channels than amiodarone.|amiodarone|hERG|30|27.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1788
23144001|Real-time fluorescence turn-on detection of alkaline phosphatase activity with a novel perylene probe.|perylene|alkaline phosphatase|12|6.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR|1789
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|pindolol|human beta-adrenergic receptors|51|73.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST|1790
23085435|  Nitrogen-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small G-proteins.|N|G-proteins|4|17.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|1791
24261583|  INTRODUCTION: Macitentan is a novel dual endothelin receptor antagonist (ERA) showing sustained receptor occupancy.|Macitentan|endothelin receptor|3|8.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ANTAGONIST|1792
9730867|Concanavalin A (Con A)-induced IFN-gamma, GM-CSF, and IL-3 mRNAs are dose-dependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol.|fenoterol|IL-3|30|13.0|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1793
10401556|The potency of the selective alpha 1D-adrenoceptor antagonist BMY 7378 against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective alpha 1A-adrenoceptor antagonist RS-17053 against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement.|BMY 7378|alpha 1D-adrenoceptor|9|6.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST|1794
23611809|Using recombinant UGT2B10, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.|tamoxifen|UGT2B10|25|3.0|Arg1:T17|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|1795
11785774|COX-1 and COX-2 inhibitor, piroxicam (0.02 and 0.2 microg) and compound NS-398 (0.01 and 0.1 microg), respectively, were given intracerebroventricularly (i.c.v.) 15 min prior to i.c.v. adrenergic receptor agonists: phenylephrine (30 microg) and clonidine (10 microg), an alpha1- and alpha2-adrenergic agonist, and isoprenaline (20 microg) a non-selective beta-adrenergic agonist and clenbuterol (10 microg) a selective beta2-adrenergic agonist.|clonidine|adrenergic receptor|48|38.0|Arg1:T12|Arg2:T39|CHEMICAL|GENE-N|AGONIST|1796
1472079|In contrast, in native rat liver microsomes, glucuronidation of 4-OHCIPC was increased by cadmium through activation of microsomal 4-OHCIPC glucuronosyl transferase.|cadmium|glucuronosyl transferase|16|22.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|ACTIVATOR|1797
9669506|The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter.|paroxetine|5-HT transporter|6|17.0|Arg1:T14|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1798
15787205|  Bupropion has an antidepressant effect through blocking the dopamine transporter.|Bupropion|dopamine transporter|1|9.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|1799
12713596|Expression of cyclooxygenase-1, prostaglandin synthases, and prostaglandin E2/D2 production were colocalized in new tissue at the margin of the wound.|prostaglandin E2/D2|cyclooxygenase-1|9|3.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF|1800
1434122|  Ketotifen, a histamine H1-receptor antagonist and mast cell stabilizer, significantly protected the rat gastric mucosa against lesions induced by necrotizing agents, histamine or compound 48/80.|Ketotifen|histamine H1-receptor|1|4.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ANTAGONIST|1801
16651698|  Multiple exposure to theophylline, a phosphodiesterase (PDE) inhibitor, induces acinar hypertrophy in the salivary gland.|theophylline|phosphodiesterase|4|7.0|Arg1:T2|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR|1802
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|PD166326|Src|12|16.0|Arg1:T32|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|1803
1666931|In addition, platelet alpha 2-adrenergic receptor densities (and binding affinities), measured with 3H-labelled yohimbine, and adrenaline-induced suppression of cyclic AMP contents did not differ among the three groups.|3H-labelled yohimbine|alpha 2-adrenergic receptor|17|5.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-N|DIRECT-REGULATOR|1804
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine|AChE|69|4.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|1805
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|breast cancer resistance protein|43|10.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|1806
23386702|  Carboxylesterases hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.|esters|Carboxylesterases|3|1.0|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|1807
8836655|Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.|thioperamide|histamine H3|23|30.0|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST|1808
23499662|However, it is now evident that pannexins function as unapposed membrane channels and the major role of Panx1 is that of an ATP release channel.|ATP|Panx1|24|19.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|1809
22846225|Furthermore, we demonstrate the standard concentrations of ZIP, but not scrambled ZIP, inhibit the ability of PKMζ to potentiate AMPAR responses at postsynaptic sites, the physiological function of the kinase.|ZIP|PKMζ|9|20.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1810
23238299|Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA.|chelidonine|CYP3A4|13|34.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1811
1327384|alpha 2A-Adrenoceptor selective compounds, oxymetazoline and BRL 44409, showed high affinity for [3H]-RS-15385-197 binding in the human platelet and lower affinity in the neonate lung, while the alpha 2B-selective compounds, prazosin and imiloxan, showed high affinity for [3H]-RS-15385-197 binding in the neonate lung.This suggests that [3H]-RS-15385-197 labels both alpha2A- and alpha2B-adrenoceptor subtypes.4. Prazosin and methysergide inhibited the binding of [3H]-RS-15385-197 in the rat cerebral cortex in a simple manner consistent with an interaction at a single site.|BRL 44409|alpha 2A-Adrenoceptor|8|1.0|Arg1:T5|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1812
23404505|We report for the first time that VEGF-D binds heparin, and that the C-terminal propeptide significantly enhances this interaction (removal of this propeptide from full-length VEGF-D completely prevents heparin binding).|C|VEGF-D|15|28.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|PART-OF|1813
22846225|(2012) had also claimed that staurosporine, a general kinase inhibitor that does not effectively inhibit PKMζ biochemically in vitro, nonetheless indirectly blocked the PKMζ fusion protein overexpressed in cultured cells by inhibiting phosphoinositide-dependent protein kinase-1 (PDK1).|staurosporine|PKMζ|8|28.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1814
8073394|The present study utilized blood from normal volunteers and 125I-fibrinogen in a dilute whole blood clot assay to determine the relative concentrations of lysine analogues required for inhibition of clot lysis induced by exogenous t-PA.|125I|fibrinogen|10|11.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR|1815
2268554|Cyproterone acetate, a progestin used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit 3 beta-HSD activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.|Cyproterone acetate|3 beta-HSD|1|32.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|1816
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|3-ethynylphenanthrene|P450 2A13|35|6.0|Arg1:T3|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|1817
12904467|Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.|topiramate|kainate-receptor|9|5.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST|1818
12067524|  BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (GABA).|gamma-aminobutyric acid|GAD|20|9.0|Arg1:T1|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF|1819
12141946|In attempting to clone the PAO involved in this back-conversion pathway, we encountered an oxidase that preferentially cleaves spermine in the absence of prior acetylation by SSAT.|spermine|SSAT|20|28.0|Arg1:T16|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE|1820
23578993|Serum markers of liver damage (AST, ALT, ALP and Bilirubin) were increased by CCl4 and TAA intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).|TAA|ALT|20|9.0|Arg1:T4|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1821
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HEP|GST-P|33|14.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1822
8384226|RESULTS: Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF/IL-8 of GM-CSF primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of IL-3 primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L).|Nedocromil sodium|IL-8|3|13.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|1823
23583931|Phosphorylation on Ser and Thr residues of pannexin1 was increased during potentiation, possibly mediating HC opening.|Thr|pannexin1|5|8.0|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|PART-OF|1824
23284002|Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.|Trichostatin A|antioxidant response element|1|19.0|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1825
23160941|The aforementioned peptides were much less efficacious at mFpr2, which responded better to the synthetic hexapeptide WKYMVm, the synthetic agonists Quin-C1 (a substituted quinazolinone), and compound 43 (a nitrosylated pyrazolone derivative).|quinazolinone|mFpr2|27|9.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|AGONIST|1826
23050902|In the present study, we investigated the molecular mechanism of ribavirin-induced up-regulation of F7 expression in HepG2 (human hepatoma cell line).|ribavirin|F7|12|15.0|Arg1:T8|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1827
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|pimozide|human ether-a-go-go-related gene|6|34.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1828
23353698|ABT-737 is a BH3 mimetic agent which binds Bcl-2, Bcl-XL and Bcl-w with high affinity, while weakly interacts with Mcl-1 and Bfl-1.|ABT-737|Bcl-w|1|13.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1829
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|sulpiride|PPA|12|24.0|Arg1:T10|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1830
15554912|In contrast with results with the MR antagonists eplerenone and spironolactone, amino acids 820-844 are sufficient in themselves to confer high-affinity aldosterone binding to the MR, suggesting that the binding determinants of the two antagonists are similar to each other but differ from those of aldosterone.|eplerenone|MR|9|7.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|1831
20089905|Elucidation of the novel molecular mechanisms linking ibuprofen to RhoA inhibition may provide additional therapeutic targets to the disorders characterized by RhoA activation, including spinal cord injuries and Alzheimer's disease.|ibuprofen|RhoA|8|10.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1832
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|aspartate aminotransferase|8|53.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1833
17389249|Furthermore, the D439N mutation converted l-glutamate, THA, and PDC, which are activating substrates for the wild-type anion conductance, but not l-aspartate, into transient inhibitors of the EAAC1(D439) anion conductance.|l-glutamate|D439N|7|4.0|Arg1:T5|Arg2:T28|CHEMICAL|GENE-N|SUBSTRATE|1834
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|IFN-gamma|7|25.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1835
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|14.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|1836
10740137|  BACKGROUND: Statins are the most effective agents currently available for lowering plasma levels of low-density lipoprotein cholesterol (LDL-C) and are the mainstay of therapy for hyperlipidemia.|Statins|low-density lipoprotein|3|16.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1837
12709047|Depending on arginine utilization, location and regulation of ASS are quite different.|arginine|ASS|3|10.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE|1838
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|N|Bim|6|26.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1839
14506273|These studies indicate that multiple domains of the OCTN2 transporter are required for carnitine transport and identify transmembrane residues important for carnitine recognition.|carnitine|OCTN2|14|9.0|Arg1:T10|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|1840
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS1|4|8.0|Arg1:T32|Arg2:T61|CHEMICAL|GENE-Y|INHIBITOR|1841
12177684|In vitro and in microiontophoresis, flibanserin behaves as a 5-HT(1A) agonist, a very weak partial agonist on dopamine D(4) receptors, and a 5-HT(2A) antagonist.|flibanserin|5-HT(2A)|7|32.0|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|1842
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|GSH|OGC|40|23.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE|1843
10709635|  gamma-Butyrobetaine hydroxylase catalyse the last step in carnitine biosynthesis, the formation of L-carnitine from gamma-butyrobetaine, a reaction dependent on Fe2+, alpha-ketoglutarate, ascorbate and oxygen.|L-carnitine|gamma-Butyrobetaine hydroxylase|14|1.0|Arg1:T12|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF|1844
2262902|  To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v. adenosine agonists, N6-(R-phenylisopropyl)adenosine (R-PIA), N6-(S-phenylisopropyl)adenosine, 5'-(N-cyclopropyl)-carboxamidoadenosine, antagonists, theophylline and 8-p-(sulfophenyl)theophylline as well as enprofylline on ethanol-(i.p.)-induced motor incoordination was evaluated by rotorod.|enprofylline|adenosine|64|28.0|Arg1:T19|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST|1845
16449355|In cirrhotic rats, Western blot analysis revealed a 170% increase in renal neutral endopeptidase protein content (P < 0.03), mainly in the proximal nephron and macula densa, and both candoxatrilat dosages increased plasma ANP levels, urinary volume, and urinary excretion of sodium, ANP, and cGMP compared with vehicle alone (all P < 0.03).|candoxatrilat|ANP|36|52.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1846
23416173|For example, organophosphates, which inhibit acetylcholinesterase as do the drugs used in treating AD symptoms, have also been shown to lead to microtubule derangements and tau hyperphosphorylation, a hallmark of AD.|organophosphates|acetylcholinesterase|4|8.0|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR|1847
23146690|Taken together, the data provide evidence that the synergistic antiproliferative effect of resveratrol and clofarabine is linked to the inhibition of Akt and Sp1 activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.|resveratrol|Akt|14|23.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|1848
17092971|  Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine D(2) receptor partial agonists based largely on their activity in second messenger-based assays of dopamine D(2) receptor signalling.|(-)3-PPP|dopamine D(2) receptor|10|18.0|Arg1:T21|Arg2:T50|CHEMICAL|GENE-Y|AGONIST|1849
23295224|Three of the AKRs used (AKR1B1, AKR1B10 and AKR3C1) could produce 2,3-butanediol from acetoin.|2,3-butanediol|AKR3C1|15|11.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|PRODUCT-OF|1850
13679187|Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors.|ambenonium|AChE|8|11.0|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1851
10381508|Recombinant factor IXR94S was activated by factor XIa/calcium with an approximately 50-fold reduced rate and by factor VIIa/tissue factor/phospholipid/calcium with an approximately 20-fold reduced rate compared with wild-type factor IX.|calcium|R94S|9|4.0|Arg1:T4|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR|1852
17210712|They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of arginine with rhArg, to citrulline, which is converted back to arginine via ASS.|ornithine|OTC|18|11.0|Arg1:T12|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE|1853
7832763|  The enzyme cyclo-oxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of prostaglandins.|arachidonic acid|cyclo-oxygenase|8|3.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|1854
10891536|When DLD-1/FdUrd cells expressing increased TS mRNA were treated with FdUrd and F3(d)Thd for only 4 h, the resistance ratios of DLD-1/FdUrd cells to parental DLD-1 cells were markedly different for FdUrd and F3(d)Thd, suggesting that the cytotoxicity with short-time exposure to F3(d)Thd is due to a mechanism other than TS inhibition, although the cytotoxicity of F3(d)Thd in the short-time is low compared to that of long-time exposure.|F3(d)Thd|TS|53|65.0|Arg1:T20|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|1855
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|3,4-methylenedioxyamphetamine|human recombinant 5-HT2B receptors|32|42.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1856
15860753|We observed dose-dependent GR activation with 100- and 500-microg doses of FP, and to a lesser extent with 50 microg salmeterol alone.|FP|GR|12|4.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|1857
23604720|From the 10 isolated compounds, methyl-3,5-di-O-caffeoylquinate showed the most potent inhibition, with IC50 values of 0.30 and 0.67 μM for rAR and rhAR, respectively.|methyl-3,5-di-O-caffeoylquinate|rAR|7|23.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1858
23270965|Furthermore, compared with control groups, the plaque endothelium level of p75(NTR) was 3-fold increased and the liver level of p75(NTR) was 17.4-fold increased by SFO-HD.|SFO|p75(NTR)|33|25.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1859
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|TCDD|STAT3|62|79.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|ACTIVATOR|1860
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|entecavir|hOAT3|9|4.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|1861
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|tyrosine kinase|1|14.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR|1862
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFU|COX-1|5|10.0|Arg1:T12|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|1863
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|TNF-alpha|7|23.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1864
20566645|Steady-state fluorescence was utilized to assess Ca(2+) affinity in isolated cardiac (c)TnCs containing F27W and did not necessarily mirror the fiber Ca(2+) sensitivity.|Ca(2+)|cardiac (c)TnCs|7|14.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1865
11509829|A variety of stimuli such as aldosterone, cell shrinkage, insulin or TGF-beta1 stimulate transcription and activate the SGK1 kinase.|aldosterone|SGK1|7|20.0|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR|1866
23473803|With this objective, we utilised a high-throughput computational approach that identified moexipril, a well tolerated and safe angiotensin-converting enzyme (ACE) inhibitor, as a PDE4 inhibitor.|moexipril|PDE4|13|29.0|Arg1:T12|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|1867
9117115|At the alpha 1B-adrenoceptor of the rat spleen and rabbit corpus cavernosum penis, tamsulosin again acted as a competitive antagonist but with a significantly lower affinity (pKB = 8.9-9.2).|tamsulosin|alpha 1B-adrenoceptor|15|3.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR|1868
15175324|When coexpressed with the m(2) acetylcholine (ACh) receptor in Xenopus oocytes, agonist-activated GIRK1(F137S)- and GIRK2-mediated currents are inhibited by halothane, whereas in the absence of ACh, high concentrations of halothane induce GIRK1(F137S)-mediated currents.|halothane|F137S|42|46.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|1869
11578145|PPG is an effective inhibitor of the pyridoxal 5'-phosphate (PLP)-containing enzyme bacterial L-methionine gamma-lyase (EC 4.4.1.11) contributing to the alpha,gamma-elimination reaction of SeMet and cystathionine gamma-lyase (EC 4.4.1.1) relating to conversion of SeMet to SeCyH.|SeMet|cystathionine gamma-lyase|42|32.0|Arg1:T9|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE|1870
23478800|Interestingly, disruption of the RhoA-ROCK pathway prevented the inhibitory effect of cucurbitacin I on Rac1 activation by heregulin.|cucurbitacin I|Rac1|13|16.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|1871
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|glycine|ALAS|23|5.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE|1872
12589193|Arginase also induces nitric oxide synthase activity by competing for arginine availability in the extracellular environment, and producing polyamines, which may modulate macrophage activation.|arginine|Arginase|11|1.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|1873
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|5-methylurapidil|alpha(1D)|7|30.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|1874
15072849|In peripheral lymphocytes of healthy and diseased subjects, IMQ induced a significant increase of perforin(+) CTLs within 12h in all experiments performed.|IMQ|perforin|10|16.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1875
11319232|Troglitazone, a second ACS4 inhibitor, inhibited ACS activity <10% in microsomes and mitochondria and 45% in MAM.|Troglitazone|ACS4|1|5.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|1876
17032653|Here we show that RDH12 localizes to the photoreceptor inner segments and that deletion of this gene in mice slows the kinetics of all-trans-retinal reduction, delaying dark adaptation.|all-trans-retinal|RDH12|24|5.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE|1877
17341305|PR isoform B levels were low in virgin control mice and increased after progestin treatment in both strains.|progestin|PR isoform B|14|1.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1878
23074173|We demonstrated that deferasirox increased expression of the metastasis suppressor protein N-myc downstream-regulated gene 1 and upregulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1) while decreasing cyclin D1 levels.|deferasirox|cyclin D1|4|28.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1879
23535185|Furthermore, galangin attenuated IgE-mediated passive cutaneous anaphylaxis and the expression of histamine receptor 1 at the inflamed tissue.|galangin|histamine receptor 1|3|13.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1880
16679384|Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes.|nomifensine|hemoglobin|3|13.0|Arg1:T26|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE|1881
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Mg-nucleotide|SUR|15|24.0|Arg1:T17|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR|1882
23388705|Pretreatment of mice with a phosphorylated prodrug of nitrobenzylmercaptopurine riboside, an inhibitor of mENT1, significantly decreased brain exposure to tecadenoson compared with that of the untreated (control) group, suggesting involvement of mENT1 in transport of tecadenoson across the blood-brain barrier (BBB).|nitrobenzylmercaptopurine|mENT1|9|15.0|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|1883
15229223|Melatonin acts as a calmodulin antagonist inducing conformational changes in the ERalpha-calmodulin (CaM) complex, thus impairing the binding of E(2).ERalpha.CaM complex to DNA and, therefore, preventing ERalpha-dependent transcription.|Melatonin|calmodulin|1|5.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-N|ANTAGONIST|1884
12842269|Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.|GTPgammaS|opioid receptors|3|15.0|Arg1:T9|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|1885
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|N|cardiac troponin C|14|18.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PART-OF|1886
23397055|The A2A adenosine receptor agonist CGS21680 (C23H29N7O6.HCl.xH2O) (0.001-0.1 μM) did not alter NE oxidation currents.|CGS21680|A2A adenosine receptor|6|2.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|1887
2120879|Removing medium Ca2+, blocking Ca2+ channels with 50 mumol/l verapamil, or inhibiting calmodulin activation with 20 mumol/l trifluoperazine, 10 mumol/l chlorpromazine or 10 mumol/l pimozide almost completely blocked hyposmolarity-induced secretion.|pimozide|calmodulin|28|15.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1888
2886573|  To characterize beta 1- and beta 2-adrenoceptor mediated effects in man the influence of the selective beta 1-adrenoceptor antagonist bisoprolol and the selective beta 2-adrenoceptor antagonist ICI 118,551 on changes in blood pressure, heart rate and lymphocyte beta 2-adrenoceptor density evoked by dynamic exercise or isoprenaline infusion was studied in 12 male normotensive volunteers.|bisoprolol|beta 1-adrenoceptor|20|17.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST|1889
11159707|It was also confirmed that the treatment of ADX rats with dexamethasone, PDTC or dexamethasone plus PDTC completely inhibit NF-kappaB activation caused by absence of endogenous glucucorticoid.|dexamethasone|NF-kappaB|12|21.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|1890
15016471|The roles of GTK in (a) brain nitrogen, sulfur, and aromatic amino acid/kynurenine metabolism, (b) brain alpha-keto acid metabolism, (c) bioactivation of certain electrophiles in brain, (d) prodrug targeting, and (e) maintenance of normal blood pressure deserve further study.|nitrogen|GTK|10|4.0|Arg1:T23|Arg2:T70|CHEMICAL|GENE-Y|SUBSTRATE|1891
23291630|The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.|navitoclax|BCL-X(L)|15|27.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1892
16595573|In addition, roxithromycin is an inhibitor of the drug transporter P-glycoprotein, possibly leading to accumulation of cyclophosphamide in endothelial cells.|roxithromycin|P-glycoprotein|4|12.0|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|1893
23639801|CID16020046 concentration-dependently inhibited LPI-induced activation of nuclear factor of activated T-cells (NFAT), nuclear factor kappa of activated B cells (NF-κB) and serum response element (SRE), translocation of NFAT and NF-κB, and GPR55 internalization.|LPI|NF-κB|4|38.0|Arg1:T12|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR|1894
20184869|We determined whether an angiotensin-converting enzyme (ACE) inhibitor, captopril, inhibits MMP-2 activity in peritoneal effluents from patients on CAPD, and simulated molecular models of the MMP-2-captopril complex.|captopril|angiotensin-converting enzyme|12|5.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|1895
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|p85alphaPI-3K|1|16.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1896
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|gramine|acetylcholinesterase|23|10.0|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|1897
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|VEGF receptor 2|3|16.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|1898
14504136|I.v. continuous infusions of the agonists 5-carboxamidotryptamine (5-CT; 5-HT1/7 and recombinant 5-ht5A/5B), CP 93129 (r5-HT1B), sumatriptan (5-HT1B/1D), PNU-142633 (5-HT1D) and ergotamine (5-HT1B/1D and recombinant 5-ht5A/5B) mimicked the above sympatho-inhibition to 5-HT.|PNU-142633|5-HT1D|29|31.0|Arg1:T5|Arg2:T42|CHEMICAL|GENE-Y|AGONIST|1899
23631463|In the current study, we show that systematic modification of an aminoalkylindole scaffold identifies two new compounds with dual CB1R antagonist/CB2R agonist activity.|aminoalkylindole|CB2R|13|23.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|AGONIST|1900
23604717|Collectively, SAL-2 inhibited COX-2 and iNOS gene expression through suppression of NF-κB leading to the inhibition of PGE2 synthesis.|SAL-2|COX-2|3|5.0|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1901
1438284|The mutated enzyme was also inhibited well by the bulky, BtChoEase-selective organophosphate inhibitor (tetraisopropylpyrophosphoramide, iso-OMPA).|organophosphate|BtChoEase|13|12.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1902
15673388|CONCLUSION: Oral quinidine is effective in suppressing the gain of function in IKr responsible for some cases of short QT syndrome with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardia/ventricular fibrillation noninducible.|quinidine|IKr|4|14.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1903
15381832|Both inhibitors, moreover, caused the reduction in the gastric mucosal cell phospholipid secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenyl cyclase activator, forskolin.|forskolin|adenyl cyclase|31|27.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR|1904
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|nortriptyline|S399P|28|24.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|1905
15655513|However, consistent with its low COX-1 inhibitory activity, lumiracoxib at a dose of 100 mg kg(-1) orally caused no ulcers and was significantly less ulcerogenic than diclofenac (P<0.05).|lumiracoxib|COX-1|11|7.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|1906
23435615|The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers.|(R)-omeprazole|CYP2C19|2|9.0|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|1907
21631396|However, phosphorylation of the p65/RelA subunit was clearly inhibited by PSE in stimulated cells.|PSE|RelA|12|7.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|1908
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|AZM|MCA|14|51.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|1909
23571427|Screening assays with 12 available human recombinant UDP-glucuronosyltransferases (UGTs) demonstrated that UGT1A9 was the predominant UGT isoform involved in R-ornidazole glucuronidation, whereas S-ornidazole glucuronidation was almost exclusively catalyzed by UGT2B7.|R-ornidazole|UGT|22|18.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-N|SUBSTRATE|1910
17207582|The GRIP1 reduction was inhibited by MK-801, an N-methyl-d-aspartate (NMDA) receptor antagonist, but not by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an AMPA receptor antagonist.|CNQX|AMPA receptor|22|26.0|Arg1:T15|Arg2:T51|CHEMICAL|GENE-N|ANTAGONIST|1911
17468175|Potential binding conformations of D1 and D2 receptors were obtained, and the D1-SPD and D2-SPD complexes were generated, which are in good agreement with most of experimental data.|SPD|D2|17|16.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1912
23542513|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-κB suppression and Nrf-2-dependent heme oxygenase-1 induction.|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone|heme oxygenase-1|1|17.0|Arg1:T22|Arg2:T52|CHEMICAL|GENE-Y|ACTIVATOR|1913
9013583|In this report, we show that indomethacin binds and activates peroxisome proliferator-activated receptor gamma (PPARgamma), a ligand-activated transcription factor known to play a pivotal role in adipogenesis.|indomethacin|peroxisome proliferator-activated receptor gamma|8|12.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|1914
16897483|Two highly divergent ADH genes (15% identity at the amino acid level) of Cantaloupe Charentais melon (Cucumis melo var.|amino acid|ADH|12|4.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-N|PART-OF|1915
22972179|2-Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2.|2-Deoxyglucose|TSC2|1|10.0|Arg1:T7|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR|1916
23624148|Sciadopitysin also decreased the production of tumor necrosis factor-a (TNF-α) induced by antimycin A, a mitochondrial electron transport inhibitor.|Sciadopitysin|TNF-α|1|11.0|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1917
23353901|Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.|PAT|5-HT2C|25|28.0|Arg1:T19|Arg2:T42|CHEMICAL|GENE-Y|AGONIST|1918
17114825|Tryptophan-dependent tRNAtrp aminoacylation catalyzed by TrpRS can be inhibited by its substrate tryptophan at physiological concentrations was demonstrated.|tryptophan|TrpRS|13|6.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|1919
14596599|Formation of pyruvate by SDH is a two-step reaction in which the hydroxyl group of serine is cleaved to produce aminoacrylate, and then the aminoacrylate is deaminated by nonenzymatic hydrolysis to produce pyruvate.|aminoacrylate|SDH|21|5.0|Arg1:T24|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|1920
23386703|Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.|apixaban|factor Xa|6|9.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|1921
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|TGF-alpha|1|18.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1922
2568212|  The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating histamine H1-receptor antagonists terfenadine, astemizole, loratadine, and acrivastine are reviewed.|terfenadine|histamine H1-receptor|22|19.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST|1923
23391631|In contrast, at the in vitro level, Pb(2+) treatment induced both β-MHC and α-MHC mRNA levels in time- and dose-dependent manner.|Pb(2+)|β-MHC|10|17.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1924
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|oxoglutaramic acid|KATI|27|16.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|1925
23645249|Herein, we report that post-weaning dietary exposure to soy protein isolate and its bioactive isoflavone genistein lowered mammary adiposity and increased mammary tumor suppressor PTEN and E-cadherin expression in female mice, relative to control casein diet.|isoflavone|E-cadherin|16|28.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1926
10598120|BIO TO-2 cardiomyopathic hamsters (CMHs) in the early stages of dilated heart failure were treated with vehicle or maximal ACE inhibitory doses of captopril (750 micromol/kg/day) or omapatrilat (200 micromol/kg/day).|omapatrilat|ACE|32|22.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1927
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|Co|hypoxia-inducible factor (HIF)-1α|21|9.0|Arg1:T13|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1928
20426763|These functional responses were blocked by selective 5HT(2) receptor antagonists with the 5HT(2A) antagonist, M-100970, exhibiting the highest potency.|M-100970|5HT(2A)|22|16.0|Arg1:T15|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST|1929
14716684|[(131)I]MIBG uptake in PC12 cells, which express the NET endogenously, was 20- to 28-fold lower than in transduced cells.|[(131)I]MIBG|NET|1|16.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|1930
23603339|In primary human hepatocytes, DHEA diminished the increase in CYP1A activities (7-ethoxyresorufin O-dealkylation and phenacetin O-dealkylation) and in CYP1A2 mRNA level induced by 3-methylcholanthrene, but did not alter the amount of CYP1A1 and CYP1B1 mRNA.|3-methylcholanthrene|CYP1A2|27|22.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1931
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|α-SMA|1|14.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1932
1665782|When delta-receptor binding was determined by using [3H]DPDPE, a 40-50% decrease in binding in the midbrain and cortex, and 25-35% decrease in binding in the striatum were observed after 3 or 4 days of DPDPE treatment.|[3H]DPDPE|delta-receptor|8|2.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1933
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|sildenafil|Q817A|8|43.0|Arg1:T35|Arg2:T58|CHEMICAL|GENE-N|DIRECT-REGULATOR|1934
23289710|Incubation of in vitro transcribed tRNA[Ser]Sec with recombinant Trit1 transfers [(14)C]dimethylallyl pyrophosphate to tRNA([Ser]Sec).|[(14)C]dimethylallyl pyrophosphate|tRNA([Ser]Sec)|15|24.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1935
23396419|Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans.|dioscin|organic anion-transporting polypeptides|11|3.0|Arg1:T20|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE|1936
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|3-NP|SDH|6|25.0|Arg1:T17|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|1937
22818713|Moreover, silibinin repressed the phenylephrine-induced phosphorylation of ERK1/2 kinases, while it appeared to inhibit the weakly activated by phenylephrine phosphorylation of Akt.|silibinin|Akt|3|24.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|1938
23412992|Previous data from our groups and from others point to the sodium/potassium pump (the Na+/K+-ATPase, i.e., NaK) with its highly specific ligands (i.e., cardiotonic steroids) as a new target for combating cancers associated with dismal prognoses, including gliomas, melanomas, non-small cell lung cancers, renal cell carcinomas, and colon cancers.|steroids|sodium/potassium pump|31|12.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR|1939
8600944|In vitro studies with blood-derived T cells, however, show inhibition of all three cytokines by GCS.|GCS|cytokines|18|16.0|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1940
23266270|DPEP inhibited LPS-induced phosphorylation of ERK, JNK, and p38.|DPEP|p38|1|11.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|1941
23402744|We previously demonstrated that developmental exposure to a mixture of polychlorinated biphenyls (PCBs) which was reconstituted according to the congener pattern found in human breast milk caused feminization of sweet preference as a sexually dimorphic behavior in adult male rats, following decreases in aromatase activity in the brain of newborn male pups.|PCBs|aromatase|14|47.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|1942
8760245|Both dimethylamiloride and monensin prevented metaproterenol activation of Na-K-ATPase.|dimethylamiloride|Na-K-ATPase|2|9.0|Arg1:T3|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR|1943
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|protein kinase A|4|7.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|1944
16297435|Choline alphoscerate or rivastigmine, but not choline increased acetylcholine levels as well as [(3)H]hemicholinium-3 binding used as a marker of high affinity cholinergic transporter.|[(3)H]hemicholinium-3|cholinergic transporter|15|30.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|DIRECT-REGULATOR|1945
15261283|Compound 2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole, expressed clozapine-like in vitro binding profile at D(2), 5-HT(2A) and alpha 1 receptors and a higher affinity for 5-HT(1A) receptors than clozapine.|clozapine|alpha 1 receptors|19|35.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR|1946
23376608|In the c-Myc siRNA-transfected and apigenin-treated cells, compared with the apigenin-treated control cells, apoptosis and phosphorylation of p38 and p53 were ameliorated.|apigenin|p53|6|22.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|1947
23000442|Incubation of isoform-specific substrate probes CYPs with mollugin (0-25μM) in HLM resulted in strong inhibition of CYP1A2-catalyzed phenacetin O-deethylation, showing IC(50) values of 1.03 and 3.55μM without and with pre-incubation, respectively.|phenacetin|CYP1A2|20|19.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|1948
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|L-serine|SDH|19|1.0|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|1949
17273750|Apaf-1 activity was also detected in HSG cells in a dose-dependent manner after treatment with cimetidine.|cimetidine|Apaf-1|16|1.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|1950
23454527|N-acetylcysteine (NAC, 33 mM) and the c-jun N-terminal kinase (JNK) inhibitor (SP600125, 33 μM) further decreased the viability in the presence of DEP (200 μg/ml) and 3.3% FCS.|SP600125|c-jun N-terminal kinase|18|10.0|Arg1:T4|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR|1951
23386703|BCRP appeared to play a more important role for absorption and intestinal and renal elimination of apixaban than P-gp in transporter-KO rats after oral and i.v. dosing, which led to a higher level of active renal excretion in rat than other species.|apixaban|P-gp|17|19.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE|1952
23340252|TF or Cort each increased insulin-stimulated lipogenesis, an effect resulting from increased lipogenic gene expression and enhanced insulin-stimulated dephosphorylation of acetyl-coenzyme A carboxylase.|Cort|insulin|3|6.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1953
11488610|  Cofactor and tryptophan accessibility of the 65-kDa form of rat brain glutamate decarboxylase (GAD) was investigated by fluorescence quenching measurements using acrylamide, I-, and Cs+ as the quenchers.|tryptophan|GAD|3|15.0|Arg1:T4|Arg2:T49|CHEMICAL|GENE-Y|PART-OF|1954
2268554|4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM.|4-MA|3 beta-HSD|1|16.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|1955
23317159|Many other JAK2 inhibitors such as TG101348 or SAR302503, SB1518, CEP701 and LY2784544 are now under investigation for MPN development.|SB1518|JAK2|11|3.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|1956
23625915|Activation of AMPK using AICAR resulted in STIM1 phosphorylation on serine residues and prevented PAR-1-induced Ca2+ entry.|AICAR|PAR-1|5|15.0|Arg1:T4|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1957
23537890|Additionally, quercetin treatment in d-GalN/LPS treated rats significantly increased HO-1 mRNA and its protein expressions.|quercetin|HO-1|3|11.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1958
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT3|21|35.0|Arg1:T8|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|1959
15963471|  Thiazolidinediones are a new class of anti-diabetic agents which increase insulin sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of insulin-responsive genes involved in glucose and lipid metabolism.|Thiazolidinediones|insulin|1|32.0|Arg1:T1|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1960
17429625|  PURPOSE: Dasatinib (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.|Dasatinib|BCR|3|17.0|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|1961
23194750|Analysis of phospho-Akt (ser 473) in lysates from rat arteries (by immunoblot) revealed that thiazolidinediones, LY294002 and 10-DEBC, at the same concentration and kinetics inhibiting vasoconstriction, produced a similar decrease of Akt phosphorylation.|thiazolidinediones|Akt|19|39.0|Arg1:T7|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|1962
11304699|To mechanistically evaluate this regional selectivity, we assessed cyclo-oxygenase-2 (COX-2) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and AOM-treated rats.|AOM|COX-2|39|12.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1963
12110374|Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent.|prostaglandin E(2)|COX-2|10|7.0|Arg1:T21|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE|1964
17181139|Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators.|carprofen|COX-2|9|6.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|1965
23376608|In conclusion, our results indicate that apigenin induces apoptosis mediated via c-Myc with concomitant phosphorylation of p53 and p38 in FRO ATC cells.|apigenin|p53|8|18.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|1966
23353736|  A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods.|methyl rosmarinate|MMP-1|12|4.0|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR|1967
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|X-linked inhibitor of apoptosis protein|47|34.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1968
11885959|  Non-steroidal anti-inflammatory drugs (NSAIDs) are competitive inhibitors of cyclooxygenase (COX), the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid.|arachidonic acid|COX|26|13.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE|1969
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|collagen type I|17|44.0|Arg1:T16|Arg2:T44|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|1970
23247009|In addition, BGG-mediated inhibition of AR prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.|BGG|p38|4|14.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|1971
10421446|With DEPQ-inhibited wild-type mouse acetylcholinesterase (AChE), the reactivation kinetic profile demonstrated one-phase exponential association only when 2-[hydroxyimino methyl]-1-methylpyridinium chloride (2-PAM) and 1-(2-hydroxy-iminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridi nium)-dimethyl ether hydrochloride (HI-6) were used as reactivators.|2-PAM|AChE|28|7.0|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|ACTIVATOR|1972
22080037|Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase.|Mercury|inducible nitric oxide synthase|1|8.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1973
22982445|The results demonstrated that intracerebral infusions of LTD4 (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of Aβ1-40 and Aβ1-42 in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of amyloid precursor protein (APP).|LTD4|Aβ1-40|8|34.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1974
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|MPTP|UCHL- 1|26|40.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1975
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|2,3,7,8-tetrachlorodibenzodioxin|AhR|25|35.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR|1976
11018726|  Tyrosine-175 located in the active site of human glyoxalase II was replaced by phenylalanine in order to study the contribution of this residue to catalysis.|phenylalanine|human glyoxalase II|14|8.0|Arg1:T10|Arg2:T14|CHEMICAL|GENE-Y|PART-OF|1977
23028140|In vitro, CYP2C8 inhibitors and CYP3A4 inhibitors inhibited the depletion of 0.1 µM imatinib by 45 and 80%, respectively, and the formation of the main metabolite of imatinib, N-desmethylimatinib, by >50%.|imatinib|CYP2C8|15|4.0|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|1978
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|(+)-[(3)H]isradipine|Ca(v)1.3|3|26.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|1979
23620199|The conjugate combines two strategies: the anti-HER2 activity of trastuzumab, and the targeted intracellular delivery of mertansine, a tubulin polymerisation inhibitor which interferes with mitosis and promotes apoptosis.|mertansine|tubulin|19|22.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|1980
23291264|Levels of both CCL2 and kidney injury molecule-1 (KIM-1) in the whole kidney increased after cisplatin administration.|cisplatin|CCL2|18|4.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|1981
23530019|Zebra finch liver microsomes metabolized nicotine and bupropion (CYP2B substrate) but not coumarin (CYP2A substrate).|nicotine|CYP2B|6|10.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE|1982
17321471|The selective A(2A) receptor antagonist ZM241385 (30 nM), but not the selective A(2B) receptor antagonist MRS1754 (30 nM), blocked the inhibitory effect of NECA and CGS21680 on TNF-alpha release.|MRS1754|A(2B) receptor|25|19.0|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|1983
17210712|Therefore, pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to arginine depletion with arginine-depleting enzymes.|arginine|arginine-depleting enzymes|19|22.0|Arg1:T3|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE|1984
17340133|These results demonstrate that the availability of L: -arginine can play a role in the control of gene expression by augmenting the DNA-binding activity of NF-kappaB, which can affect the initiation and progression of dermal inflammation.|L: -arginine|NF-kappaB|8|27.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR|1985
10727523|Both MRP1 and MRP2 actively transported leukotriene C(4) and N-ethylmaleimide glutathione (NEM-GS), although the relative affinity of MRP2 for these substrates was found to be significantly lower than that of MRP1.|leukotriene C(4)|MRP1|7|2.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|1986
17075268|Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and HDC mRNA induced by TDI in TDI-sensitized rats.|dexamethasone|HDC|3|18.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1987
23157629|  The serotonin (5-HT) receptors of type 6 (5-HT6) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long C-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.|C|5-HT6|33|11.0|Arg1:T2|Arg2:T8|CHEMICAL|GENE-Y|PART-OF|1988
15161930|In contrast to the complexes of the ERalpha LBD with 4-hydroxytamoxifen or raloxifene, helix 12 of antagonist-bound ERRgamma does not occupy the coactivator groove but appears to be completely dissociated from the LBD body.|raloxifene|ERalpha LBD|13|8.0|Arg1:T16|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR|1989
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|long-chain fatty acids|FAS|16|5.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|1990
16855178|Colonic cyclooxygenase-2 and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ATB-429, but not by mesalamine.|ATB-429|cyclooxygenase-2|15|2.0|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1991
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|LYSO-7|peroxisome proliferator-activated receptor|19|48.0|Arg1:T8|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR|1992
23449197|Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): a potent and selective transforming growth factor-β type I receptor inhibitor as a topical drug for alopecia.|7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole|transforming growth factor-β type I receptor|3|20.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|1993
10403635|In phosphotriesterase and physostigmine-treated mice, a 4- and 2-fold higher sarin dose, respectively, was needed to cause a 50% inhibition of brain AChE activity.|sarin|AChE|12|27.0|Arg1:T11|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|1994
23291050|In addition, results obtained when the snails were exposed sequentially to the pesticides showed that the sequence AZM/CPF produced at 48 h a higher ChE inhibition than the sequence CPF/CPF.|CPF|ChE|32|26.0|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|1995
23632082|This conductance was suppressed by nonselective TRPC channel blockers 2-APB, flufenamic acid and ML204, enhanced by La(3+) in a subpopulation of cells, and unchanged by the TRPV1 antagonist capsazepine or a Na(+) /Ca(2+) exchanger blocker KB-R7943.|ML204|TRPC|15|7.0|Arg1:T4|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|1996
9059856|Radioligand binding assay, using [3H]N-methyl-scopolamine as tracer, showed the existence of acetylcholine muscarinic receptors in brush-border (Kd 0.28 +/- 0.04 nM; Bmax 9.4 +/- 1.6 fmol/mg protein) and basal plasma membranes (Kd 0.24 +/- 0.05 nM; Bmax 34.3 +/- 6.3 fmol/mg protein).|[3H]N-methyl-scopolamine|acetylcholine muscarinic receptors|6|17.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|1997
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|BRL-49653|apo CIII|14|25.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|1998
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|33.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE|1999
2112956|Valproyl-CoA was dehydrogenated at a significant rate (0.167 mumol/min per mg protein) only by rat 2-methyl-branched-chain acyl-CoA dehydrogenase.|Valproyl-CoA|2-methyl-branched-chain acyl-CoA dehydrogenase|1|18.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE|2000
17959709|In addition, the molecular configuration of vardenafil differs from that of sildenafil when bound to PDE5.|sildenafil|PDE5|13|17.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2001
1881457|Phenelzine is a more potent monoamine oxidase inhibitor than is N2-acetylphenelzine.|Phenelzine|monoamine oxidase|1|6.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|2002
23562928|  The purpose of this study is to investigate the effects of n-hexane extracts from bones and internal organs of Japanese eel, Anguilla japonica (HEE), on cyclooxygenase-2 (COX-2)-dependent prostaglandin D2 (PGD2) generation in stem cell factor (SCF), IL-10, plus LPS-induced mouse bone marrow-derived mast cells (BMMCs) and on passive cutaneous anaphylaxis (PCA) in mice.|PGD2|cyclooxygenase-2|38|30.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|PRODUCT-OF|2003
23059626|The expression of the osteoblast markers runt-related transcription factor 2 (RUNX2) and periostin was decreased, while osteocalcin (OCN) was augmented in CCL3(-/-) and Met-RANTES-treated mice.|Met|OCN|32|22.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2004
21926191|Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.|Cabozantinib|VEGFR2|1|10.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|2005
11980628|The infusion of 10 microg/kg/h of SOM230 using subcutaneously implanted minipumps decreased plasma IGF-I levels far more effectively than SMS 201-995.|SOM230|IGF-I|7|14.0|Arg1:T9|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2006
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT1|61|47.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|2007
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|KIT|3|45.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2008
23231967|  The influence of diverse methoxyphenyl substitution patterns on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold is herein explored in order to modulate the A(3) adenosine receptor antagonistic profile.|N-(2,6-diarylpyrimidin-4-yl)acetamide|A(3) adenosine receptor|10|24.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|ANTAGONIST|2009
16232421|A double mutant of the two fumarate reductase isozyme genes (OSM1 and FRDS) showed a succinate productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.|succinate|fumarate reductase|18|7.0|Arg1:T6|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF|2010
9313928|M&B-28767, a putative EP3 agonist, and misoprostol, a putative EP2/EP3 agonist, also bound to this receptor with Ki values of 120 nM.|misoprostol|EP2|11|15.0|Arg1:T12|Arg2:T78|CHEMICAL|GENE-Y|AGONIST|2011
23220560|Moreover, we demonstrated that in utero exposure to low-level MeHg suppresses the expression of Rac1, Cdc42, and RhoA, which play key roles in the migration of cerebrocortical neurons during the early stage of brain development, suggesting that the MeHg-induced migratory disturbance of cerebrocortical neurons is likely associated with the Rho GTPases signal pathway.|MeHg|Rac1|11|16.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2012
19337422|  Tolvaptan is a selective arginine vasopressin (AVP) V(2) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia.|Tolvaptan|arginine vasopressin (AVP) V(2) receptor|1|5.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2013
17827008|From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.|AZD6140|P2Y12 receptor|4|13.0|Arg1:T5|Arg2:T8|CHEMICAL|GENE-Y|ANTAGONIST|2014
10076535|Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.|EMP|androgen receptor|8|15.0|Arg1:T46|Arg2:T63|CHEMICAL|GENE-Y|ANTAGONIST|2015
23643631|Furthermore, melamine-induced ROS production could be attenuated by apocynin, a NOX inhibitor.|apocynin|NOX|10|13.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|2016
23453071|Furthermore, BRN-250 inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.|BRN-250|VEGFR2|3|18.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2017
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|AM2389|CB1|42|2.0|Arg1:T20|Arg2:T29|CHEMICAL|GENE-Y|AGONIST|2018
15694390|However, the 5-LO products, leukotriene B(4) (LTB(4)) and leukotriene C(4), were not detected in cells treated with IFN-gamma, indicating that the effect of NDGA seemed to be independent of 5-LO inhibition.|LTB(4)|5-LO|13|4.0|Arg1:T14|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF|2019
23557840|Continuing our previous work, we take the first steps of structure-activity relationship exploration and show that 1,3,4-oxadiazol-2-ones can serve as scaffold for both selective FAAH and MAGL inhibitors, and also function as a dual FAAH/MAGL inhibitor at sub-micromolar IC50 values.|1,3,4-oxadiazol-2-ones|MAGL|18|38.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2020
12416991|Two-substrate kinetic analysis and dead-end inhibition studies for 5alpha-DHP reduction and allopregnanolone oxidation indicated that 3alpha-HSD type III utilized a ternary complex (sequential) kinetic mechanism, with nicotinamide adenine dinucleotide cofactor binding before steroid substrate and leaving after steroid product.|steroid|3alpha-HSD type III|41|16.0|Arg1:T11|Arg2:T41|CHEMICAL|GENE-Y|PRODUCT-OF|2021
23229510|E235 also activated DNA damage response signaling, resulting in increased levels of Ser15-phosphorylated p53, γ-H2AX, and phosphorylated checkpoint kinase 2 (Chk2), although E235 does not appear to cause physical DNA damage.|E235|phosphorylated p53|1|15.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2022
11146120|Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells; with maxima at 10 nM and at 8-12 h exposure.|Clenbuterol|NGF|1|7.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2023
22552008|Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBN(YW/AA).|pomalidomide|CRBN|3|15.0|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2024
12601049|Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.|corticosteroid|VEGF|12|16.0|Arg1:T24|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2025
18061638|Danazol activated PR and AR.|Danazol|PR|1|3.0|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR|2026
22370636|Whole-exome analysis of the Pik3ca(H1047R)-driven mammary tumors identified multiple mutations, including Trp53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors.|Trp|H1047R|17|7.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|PART-OF|2027
17315049|Sitagliptin, a DPP-4 inhibitor, is orally active and has been shown to be efficacious and safe in clinical studies.|Sitagliptin|DPP-4|1|4.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2028
15655513|Lumiracoxib inhibited purified COX-1 and COX-2 with K(i) values of 3 and 0.06 microM, respectively.|Lumiracoxib|COX-2|1|6.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2029
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|GW1843|TS|44|28.0|Arg1:T26|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|2030
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-8713|EP(1)|12|1.0|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|2031
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|17 alpha-hydroxy pregnenolone|3 beta-HSD|23|11.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE|2032
12563315|This anti-lipolytic effect of nicotinic acid involves the inhibition of cyclic adenosine monophosphate (cAMP) accumulation in adipose tissue through a G(i)-protein-mediated inhibition of adenylyl cyclase.|nicotinic acid|adenylyl cyclase|5|30.0|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2033
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|coumestrol|estrogen receptor|15|34.0|Arg1:T9|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2034
23500659|Testosterone significantly decreased ER-β and increased ER-α and AR expressions as compared to the control group and these effects were significantly ameliorated by SIL.|Testosterone|ER-α|1|7.0|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2035
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|citrulline|EC 6.3.4.5|13|6.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|2036
23424204|In conclusion, BPA has adverse effects on phosphorylation of Akt, GLUT4 translocation and (14)C-glucose oxidation.|BPA|GLUT4|4|13.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2037
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK-B|27|43.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2038
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|24R, 25-(OH)(2)D(3)|PKC|42|38.0|Arg1:T9|Arg2:T38|CHEMICAL|GENE-N|ACTIVATOR|2039
23515287|The dihydrotestosterone metabolite, 5α-androstane-3β,17β-diol (3β-diol), binds and activates estrogen receptor-β (ER-β), the predominant ER in the PVN.|5α-androstane-3β,17β-diol|ER-β|5|16.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2040
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester|hNET|61|2.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST|2041
12513997|L-proline accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding gamma-glutamyl kinase.|L-proline|gamma-glutamyl kinase|1|19.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|2042
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|epinephrine|human beta-adrenergic receptors|18|73.0|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|AGONIST|2043
8622118|Injection of in vitro-transcribed RNA from this clone into Xenopus laevis oocytes results in the robust expression of homo-oligomeric cation channels that can be gated by L-glutamate (EC50 = 1.2 +/- 0.3 micron) and several other glutamate receptor agonists; rank order of potency: glutamate >> kainate > ibotenate > AMPA.|ibotenate|glutamate receptor|53|39.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|AGONIST|2044
12141946|Substrate specificity using lysates of oxidase-transfected HEK-293 cells revealed that the newly identified oxidase strongly favoured spermine over N (1)-acetylspermine and that it failed to act on N (1)-acetylspermidine, spermidine or the preferred PAO substrate, N (1), N (12)-diacetylspermine.|spermine|oxidase|17|14.0|Arg1:T27|Arg2:T46|CHEMICAL|GENE-N|SUBSTRATE|2045
10905636|Michaelis-Menten constants and turnover numbers for PGH2 were 141 microM and 10.8 min(-1) for GSTM2-2 and 1.5 mM and 130 min(-1) for GSTM3-3, respectively.|PGH2|GSTM2-2|7|18.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE|2046
15478125|The X-ray crystal structure of the best-studied isozyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.|topiramate|CA II|20|10.0|Arg1:T5|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|2047
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|lactate|Monocarboxylate transporters|18|1.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE|2048
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|kinase|3|8.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|2049
17513393|The net effect of increased Gclc and decreased Bhmt would be a decrease in homocysteine as a result of Cu deficiency.|homocysteine|Bhmt|15|9.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|2050
8392199|  It was recently reported that acute cocaine pretreatment can reduce the (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced 5-hydroxytryptamine2 (5-HT2)-receptor mediated head-twitch response (HTR) in mice via indirect stimulation of adrenergic alpha 2- and serotonergic 5-HT1A-receptors.|cocaine|adrenergic alpha 2|7|41.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2051
10980326|Blood samples were taken from both alcohol-dependent and control subjects to determine 5-HTTLPR genotypes using PCR of lymphocyte DNA, and to perform platelet [3H]paroxetine binding (binding capacity: B(max); and dissociation constant: K(D)).|[3H]paroxetine|5-HTTLPR|25|13.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2052
23386702|  Carboxylesterases hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.|amines|Carboxylesterases|17|1.0|Arg1:T5|Arg2:T37|CHEMICAL|GENE-N|PRODUCT-OF|2053
22750078|THPP-1 exhibits nanomolar potency on the PDE10A enzyme, demonstrates excellent pharmacokinetic properties in multiple preclinical animal species, and is selective for PDE10A over other PDE families of enzymes.|THPP-1|PDE10A|1|24.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2054
23542513|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-κB suppression and Nrf-2-dependent heme oxygenase-1 induction.|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone|Nrf-2|1|16.0|Arg1:T22|Arg2:T51|CHEMICAL|GENE-Y|ACTIVATOR|2055
12411515|To test the hypothesis that complex I is a target of volatile anaesthetics, we examined the effects of these agents on NADH:ubiquinone oxidoreductase (EC 1.6.99.3) activity using the ubiquinone analogue DBQ (decylubiquinone) as substrate.|ubiquinone|NADH:ubiquinone oxidoreductase|34|23.0|Arg1:T37|Arg2:T54|CHEMICAL|GENE-N|SUBSTRATE|2056
10047461|The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.|Tomudex|cyclin E|15|19.0|Arg1:T2|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2057
17510465|Modulation of the function of CD36 (CD36-/- mice), p38(MAPK) (SB203580), COX-1 (indomethacin), and glycoprotein Ib alpha (Nk-protease, 6D1 antibody) induced approximately 50% inhibition.|indomethacin|COX-1|22|20.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2058
15814851|Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.|estrogens|aromatase|13|3.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|2059
11578145|The results of this study indicated that SeMet was directly metabolized to CH(3)SeH by an alpha,gamma-elimination enzyme analogous to bacterial L-methionine gamma-lyase, in addition to the generally acceptable pathway via SeCyH.|SeMet|bacterial L-methionine gamma-lyase|8|26.0|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|SUBSTRATE|2060
12566304|EGF-stimulated phosphorylation of ERK and Bad is blocked by pretreatment with U0126, a selective MAP kinase kinase (MKK)1/2 inhibitor.|U0126|ERK|12|4.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|2061
15814851|Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.|flavonoid|aromatase|18|2.0|Arg1:T18|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2062
6433001|The results suggest that calmodulin antagonists bind to a protein associated with the [3H]nitrendipine binding site that has a hydrophobic domain similar to that exposed on calmodulin by Ca++, but that this protein is not calmodulin itself.|[3H]nitrendipine|calmodulin|14|5.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-N|DIRECT-REGULATOR|2063
23353736|Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).|methyl rosmarinate|matrix metalloproteinase-1|5|12.0|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|2064
15730717|0 approximately 400 micromol/L of IN could down-regulate the expression of p-STAT1 or p-STAT5 in a dose-response manner, p-STATs were distributed mainly in the nucleus as scattering spots.|IN|p-STATs|6|20.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2065
23238299|Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA.|chelidonine|MRP1|13|30.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2066
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AKR1B10|23|18.0|Arg1:T5|Arg2:T33|CHEMICAL|GENE-Y|PART-OF|2067
12623106|These radiotracers are close analogues of reboxetine, a potent and selective ligand for the norepinephrine transporter (NET).|reboxetine|norepinephrine transporter|7|16.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2068
23353698|In this cell line, quercetin down-regulated Mcl-1 through the inhibition of PI3K/Akt signaling pathway, leading to Mcl-1 instability.|quercetin|PI3K|6|13.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|2069
17034761|IRF3 activation induced by MyD88-independent signaling components, TRIF and TBK1, was also downregulated by auranofin.|auranofin|TRIF|17|9.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2070
11736858|H1-receptor occupancies in cortex were approximately 10% by ebastine and > or = 50% by either dose of (+)-chlorpheniramine (95% confidence interval for difference in the mean receptor occupancies: 27%, 54% for 2 mg and 35%, 62% for 6 mg vs ebastine, respectively).|(+)-chlorpheniramine|H1-receptor|21|1.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2071
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|p-aminohippurate|hOAT1|22|2.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|2072
12358053|It was hypothesised that the nonselective COX inhibitor flunixin would retard repair of bile-injured colon by preventing production of reparative prostaglandins, whereas the selective COX-2 inhibitor, etodolac would not inhibit repair as a result of continued COX-1 activity.|etodolac|COX-2|29|26.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2073
22585533|β-eudesmol-induced apoptosis was accompanied by cleavage of caspase-3, caspase-9, and poly (ADP-ribose) polymerase; downregulation of Bcl-2 expression; release of cytochrome c from mitochondria; and decrease in mitochondrial membrane potential (MMP).|β-eudesmol|Bcl-2|1|21.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2074
12488248|Probenecid-sensitive uptake of p-aminohippurate (PAH, an Oat1 and Oat3 substrate) and estrone sulfate (ES, an Oat3 substrate) in rat Oat3-expressing oocytes was significantly trans-stimulated by preloading the oocytes with the dicarboxylate glutarate (GA).|Probenecid|rat Oat3|1|25.0|Arg1:T23|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR|2075
19427182|These results strongly suggest that ABCA1 is substantially involved in hepatic alpha-tocopherol secretion.|alpha-tocopherol|ABCA1|12|6.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF|2076
16223973|Here we report that the SA SOM230 can also act by a nonpituitary-mediated inhibition of IGF-I action.|SOM230|IGF-I|7|16.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2077
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|benzamidine|gp330|12|10.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2078
23376440|Arsenite-induced ROS generation and COX-2 expression were significantly attenuated by treatment with melatonin (a ROS scavenger), but enhanced by DL-buthionine-(S, R)-sulfoximine (BSO, an inhibitor of gamma-glutamylcysteine synthetase (γ-GCS) resulting in lower GSH and increased ROS levels).|melatonin|COX-2|13|5.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2079
15526107|The aim of this study was to characterize the ISA of the beta-adrenoceptor blocker carteolol in healthy volunteers.|carteolol|beta-adrenoceptor|15|13.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2080
18056045|The inhibitory effects of the nitrogen-containing BPs (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their inhibition of farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.|zoledronate|FPPS|17|32.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|2081
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|nicardipine|CaMPDE|24|17.0|Arg1:T13|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|2082
21600945|Stimulation of B1R with a selective agonist (des-Arg(9)-BK, 10 muM; 30 min) increased O(2)((-))production which was prevented by apocynin and diphenyleneiodonium (NADPH oxidase inhibitors).|apocynin|B1R|36|3.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2083
23542819|In a high-throughput screen for modulators of KCNQ2 channel, a fundamental player modulating neuronal excitability, Mancozeb, was found to significantly potentiate KCNQ2 activity.|Mancozeb|KCNQ2|18|25.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|2084
10494028|Under serum conditions allowing apo CIII secretion, treatment with the peroxisome-proliferator activated receptor (PPAR)alpha activators fenofibrate, gemfibrozil and Wy-14643 result in a marked lowering of apo CIII secretion and gene expression, this effect being most pronounced with Wy-14643.|Wy-14643|apo CIII|24|31.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2085
23339682|Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively.|tolbutamide|CYP2E1|48|23.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2086
7828655|The results showed that treatment with EEDQ, which blocked 80% to 85% of the dopamine D2 and dopamine D1 receptors in substantia nigra, increased the levels of dopamine D2 receptor mRNA in substantia nigra by about 27%.|EEDQ|dopamine D1 receptors|7|21.0|Arg1:T21|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|2087
23453039|The expression of regucalcin is stimulated through the action of insulin in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by streptozotocin administration in vivo.|streptozotocin|regucalcin|35|4.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2088
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|pralidoxime|AChE|25|14.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|2089
23294566|Both AGR genes were also transcriptionally activated by ≥ 5 nM oestradiol but not by isotype selective or nonselective oestrogen receptor agonists in DUCaP cells that harbour a high-level of wild-type androgen receptor.|oestradiol|AGR|12|2.0|Arg1:T21|Arg2:T47|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2090
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|zolmitriptan|5-ht1f|6|22.0|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2091
15606893|Dissociation of [3H]S-citalopram from a complex with the SERT double-mutant, N208Q/N217Q, which has been suggested to be unable to self-assemble into oligomeric complexes, is retarded to an extent similar to that found with the wild-type, raising the possibility that the allosteric mechanism is mediated within a single subunit.|[3H]S-citalopram|N208Q|3|15.0|Arg1:T18|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR|2092
17273750|  It has been reported that cimetidine, a histamine type-2 receptor (H2R) antagonist, inhibits the growth of glandular tumors such as colorectal cancer.|cimetidine|histamine type-2 receptor|6|9.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|2093
11728431|In the presence of alpha(2)-adrenoceptor antagonism, cannabinoid CB(1) receptor activation by WIN-55,212-2 was much more effective in inhibiting the release of [(3)H]noradrenaline.|WIN-55,212-2|cannabinoid CB(1) receptor|20|12.0|Arg1:T1|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR|2094
12538485|In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.|SU11248|platelet-derived growth factor receptors|6|19.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|2095
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|dacomitinib|tyrosine kinase|43|31.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|2096
23287710|In conclusion our in vitro results demonstrate that exposure to high doses of glycidamide/acrylamide - exceeding the dietary exposure of the general population by far - can induce genes with growth promoting potential like the oncogene cMYC and genes involved in the MAPK pathway.|acrylamide|cMYC|15|37.0|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2097
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|sertindole|cardiac K(+) channel|4|24.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2098
23586470|Although fluorescence intensities from S Kα level were much weaker than Ni Kα signals, we could detect the location of S atoms in recombinant Xcad-11 proteins.|S|Xcad-11|5|26.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|PART-OF|2099
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|glutathione reductase|4|35.0|Arg1:T27|Arg2:T54|CHEMICAL|GENE-Y|INHIBITOR|2100
23583258|Besides this direct activity, an excess of phenolic compounds detectable in red wine, may exert an additional indirect action by blocking oxysterol-related NOX1 induction, thus totally preventing the pro-oxidant and pro-inflammatory events triggered by dietary oxysterols.|phenolic|NOX1|9|25.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2101
23522834|  Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson's disease and this Letter describes the SAR of a series of dihydropteridinone based Plk-2 inhibitors.|dihydropteridinone|Plk-2|25|27.0|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR|2102
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|pyruvate|EC 4.3.1.17|22|6.0|Arg1:T2|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF|2103
14629008|Trimethoprim induces heat shock proteins and protein aggregation in E.|Trimethoprim|heat shock proteins|1|3.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR|2104
23303191|  Mammals have three homologous genes encoding proteins with hyaluronan synthase activity (Has1-3), all producing an identical polymer from UDP-N-acetylglucosamine and UDP-glucuronic acid.|glucuronic acid|hyaluronan synthase|25|9.0|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|2105
15126366|PKC-delta in particular showed a different pattern of translocation in response to I3A and PMA.|PMA|PKC-delta|15|1.0|Arg1:T21|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2106
17067304|Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, BDNF and ChAT that was eliminated by olanzapine treatment.|quinpirole|BDNF|7|17.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2107
23204517|Mutations in the acidic sequence of PEP-19 that inhibit or prevent it from modulating Ca(2+) binding to CaM greatly inhibit its effect on ATP-induced Ca(2+) release.|Ca(2+)|CaM|15|21.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2108
15736931|  Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from UDP-Gal to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.|UDP-Gal|Beta-1,4-galactosyltransferase I|10|1.0|Arg1:T30|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2109
7832763|Both NS-398 and Dup-697 exhibited time-dependent inactivation of hCOX-2, as did indomethacin on both enzymes.|NS-398|hCOX-2|2|9.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|2110
15942707|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|NGF-beta|3|17.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2111
21955206|Inhibition of the NF-kappaB pathway was responsible for this effect since the colchicoside inhibited RANKL-induced NF-kappaB activation, activation of IkappaB kinase (IKK) and suppressed inhibitor of NF-kappaBalpha (IkappaBalpha) phosphorylation and degradation, an inhibitor of NF-kappaB.|colchicoside|NF-kappaBalpha|13|30.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2112
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|guvacine|GAT3|13|23.0|Arg1:T15|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2113
1407010|  Radioligand binding studies were performed in membranes of rabbit whole brain and striatum using the novel iodinated radioligand for 5-hydroxytryptamine 5-HT1B and 5-HT1D sites, Serotonin-5-O-Carboxymethyl-Glycyl[125I]Tyrosinamide ([125I]GTI).|[125I]GTI|5-HT1D|34|24.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2114
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|flavonolignans|OATP1B1|22|6.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2115
15306222|The affinity rank order and pKi values of ARs for carvedilol were as follows: alpha1D-AR (8.9)>alpha1B-AR (8.6)>beta1-AR (8.4)>beta2-AR (8.0)>alpha1A-AR (7.9)?alpha2C-AR (5.9)>alpha2B-AR (5.5)>alpha2A-AR (5.3).|carvedilol|ARs|11|9.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR|2116
10460702|We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating eNOS activation.|[3H]L-arginine|eNOS|9|26.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|2117
20426763|Furthermore, quantitative autoradiography revealed a relatively high specific binding of [(3)H]-5HT and [(3)H]-ketanserin to 5HT(2) receptors in human CE and longitudinal ciliary muscle (CM).|[(3)H]-5HT|5HT(2)|12|28.0|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2118
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|Valdecoxib|COX-1|1|10.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2119
15860753|We initially demonstrated significant GR activation 60 minutes after inhalation of 800 microg beclomethasone dipropionate in six healthy subjects.|beclomethasone dipropionate|GR|14|5.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR|2120
10882160|Entacapone and tolcapone are new potent, selective and reversible nitrocatechol-type COMT inhibitors.|tolcapone|COMT|3|12.0|Arg1:T13|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|2121
9117115|At the alpha 1B-adrenoceptor of the rat spleen and rabbit corpus cavernosum penis, tamsulosin again acted as a competitive antagonist but with a significantly lower affinity (pKB = 8.9-9.2).|tamsulosin|alpha 1B-adrenoceptor|15|3.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|ANTAGONIST|2122
12177684|In vivo flibanserin binds equally to 5-HT(1A) and 5-HT(2A) receptors.|flibanserin|5-HT(2A)|3|12.0|Arg1:T16|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2123
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|8-pCPT-2'-O-Me-cAMP-AM|insulin|1|4.0|Arg1:T7|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2124
11243491|METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [buspirone (partial 5-HT1A agonist), anpirtoline (5-HT1B agonist)] in the mouse forced swimming test.|anpirtoline|5-HT1B|67|69.0|Arg1:T26|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|2125
23142559|Furthermore, TNF-α-induced CXCL8 secretion was (i) inhibited by the MR antagonist tiotropium and the M3R antagonist 4-DAMP and (ii) enhanced by the M1/M3R agonist pilocarpine and the cholinesterase inhibitor physostigmine.|4-DAMP|CXCL8|20|4.0|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2126
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|felodipine|PDE 1B1|22|8.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2127
19427182|First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased alpha-tocopherol secretion in a dose-dependent manner.|alpha-tocopherol|ATP-binding cassette transporter A1|27|16.0|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF|2128
8667211|Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II.|acetazolamide|CA I|7|9.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2129
16679384|Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes.|dihydroisoquinolinium|cytochrome P450|6|20.0|Arg1:T27|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF|2130
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|chemokines|47|11.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2131
17427197|D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium.|D-glucose|Smad2|1|19.0|Arg1:T20|Arg2:T58|CHEMICAL|GENE-Y|ACTIVATOR|2132
9765513|  We examined the effects of the calcium channel blockers nitrendipine, diltiazem, verapamil, bepridil, and mibefradil on the cloned HERG and KvLQT1/IsK K+ channels.|bepridil|calcium channel|16|7.0|Arg1:T23|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2133
14530799|Like other NMDA receptor antagonists, memantine at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory.|memantine|NMDA receptor|7|3.0|Arg1:T20|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST|2134
8566141|The distribution pattern of Fos induced by amantadine was more similar to those seen with dopaminomimetics than with N-methyl-D-aspartate (NMDA) receptor antagonists.|amantadine|Fos|8|5.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2135
23249626|Here, we leveraged protein engineering to modify the PK characteristics of the native molecule by fusing FST315 to a murine IgG(1) Fc and removing the intrinsic heparan sulfate-binding activity of follistatin.|sulfate|follistatin|32|35.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2136
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|alpha(2)-adrenergic receptors|6|12.0|Arg1:T56|Arg2:T84|CHEMICAL|GENE-N|ANTAGONIST|2137
23160941|When stably expressed in transfected rat basophilic leukemia (RBL-2H3) cells, mFpr1 was readily activated by N-formylated peptides derived from Listeria monocytogenes (fMIVTLF), Staphylococcus aureus (fMIFL), and mitochondria (fMMYALF).|N|mFpr1|19|14.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|2138
22552008|CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine production in T cells.|lenalidomide|cytokine|16|19.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2139
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|amiodarone|ion channel|8|2.0|Arg1:T6|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2140
10531013|Caffeine inhibits the checkpoint kinase ATM.|Caffeine|ATM|1|6.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|2141
12697717|A 17 beta HSDXI construct with a stretch of 20 adenosines was found to produce significantly more enzyme activity than constructs containing 15 or less adenosines (43% vs.|adenosines|17 beta HSDXI|11|2.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|PART-OF|2142
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|Co|LO|21|3.0|Arg1:T13|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2143
23353902|In both females and males, FLU reversed the nuclear levels of GR and pGR246 without affecting CORT and GR mRNA levels.|FLU|GR|7|13.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2144
23478802|We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted cysteines crucial for electrophile activation (C621S, C641S, C665S).|serine|C665S|19|30.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|PART-OF|2145
23557706|Inhibition of mTOR by low dose rapamycin decreases HG-induced Nox4 and Nox1, NADPH oxidase activity and podocyte apoptosis.|rapamycin|Nox1|7|12.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2146
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|propranolol|beta-adrenoceptor|54|2.0|Arg1:T12|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST|2147
16874462|To further investigate the molecular basis of POX-induced apoptosis, we utilized the DLD-1.POX cells to show that cells overproducing POX exhibit an L-proline-dependent apoptotic response.|L-proline|POX|24|21.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|2148
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|EE2|vtg3|13|20.0|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2149
23139020|  Cytochrome P450 (P450)-derived arachidonic acid (AA) metabolites serve pivotal physiological roles.|arachidonic acid|Cytochrome P450|7|1.0|Arg1:T3|Arg2:T5|CHEMICAL|GENE-N|PRODUCT-OF|2150
23254196|Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).|Ser|MLC|23|20.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|PART-OF|2151
15120421|At 10(-6)M in transcription assays, none of these compounds showed progestin agonist activity, whereas mifepristone and its monodemethylated metabolite manifested slight glucocorticoid agonist activity.|mifepristone|glucocorticoid|21|28.0|Arg1:T14|Arg2:T45|CHEMICAL|GENE-Y|AGONIST|2152
16857832|  The transsulfuration pathway, which aids in regulating homocysteine concentration and mediates cysteine synthesis, may be sensitive to vitamin B-6 status because cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CGL) require pyridoxal 5'-phosphate (PLP).|cysteine|CGL|13|33.0|Arg1:T25|Arg2:T33|CHEMICAL|GENE-Y|PRODUCT-OF|2153
14505791|  The potent histamine H(1)-receptor antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine.|Xyzal|histamine H(1)-receptor|26|3.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST|2154
23050902|We observed that ribavirin enhanced ELL3 recruitment to F7, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.|ribavirin|ELL3|4|6.0|Arg1:T16|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2155
23103562|TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.|cisplatin|JNK|7|9.0|Arg1:T16|Arg2:T47|CHEMICAL|GENE-N|ACTIVATOR|2156
23558747|We analysed the role of the MBD in MeCP2-chromatin associations in vivo using an MeCP2 mutant Rett syndrome mouse model (Mecp2(tm)(1)(.)(1)(Jae)) in which exon 3 deletion results in an N-terminal truncation of the protein, including most of the MBD.|N|MeCP2|47|9.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|PART-OF|2157
23552101|PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase β type I (pip5k1β), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].|PI(4,5)P2|PIP5K1B|36|1.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|PRODUCT-OF|2158
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|ICRF-154|DNA topoisomerase II|11|18.0|Arg1:T10|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2159
10567199|RIHP and fractional excretion of sodium (FE(Na)) were measured before and after direct renal interstitial volume expansion in control rats (n=7), rats infused with the COX-1 inhibitor piroxicam (n=6, 1.5 mg/kg), and rats infused with the COX-2 inhibitors NS-398 (n=5, 1.5 mg/kg) and meloxicam (n=6, 0.3 mg/kg).|NS-398|COX-2|51|49.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2160
23271742|Furthermore, we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression.|arsenic trioxide|Pirh2|6|15.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2161
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|inducible nitric oxide synthase|5|29.0|Arg1:T9|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2162
10422661|In order to investigate the role of cyclooxygenase (COX) isozymes, relatively selective COX1 (piroxicam) and COX2 N-[2-cyclohexyloxy-4-nitrophenyl] metanesulfonamide (NS-398) inhibitors were administered i.th.|N-[2-cyclohexyloxy-4-nitrophenyl] metanesulfonamide|COX2|22|21.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2163
10502685|Although the nitric oxide (NO) complex of the ferric heme was EPR-silent, photo-illumination at 5 K to the NO complex of the ferric nNOS in the substrate-free form produced a new high spin EPR signal similar to that of the ferric heme of N(omega)-nitro-L-arginine-bound nNOS, suggesting that the photo-dissociated NO might move away from the heme.|NO|nNOS|22|27.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2164
11741285|A 100:1 molar ratio of ribostamycin to PDI was almost sufficient to completely inhibit the chaperone activity of PDI.|ribostamycin|PDI|6|19.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2165
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|1,3,4-thiadiazole-2-sulfonamide|CA V|31|4.0|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2166
14506273|The progressive substitution of the N terminus of OCTN2 with OCTN1 resulted in a decrease in carnitine transport associated with a progressive increase in the Km toward carnitine from 3.9 +/- 0.5 to 141 +/- 19 microM.|N|OCTN1|6|11.0|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|PART-OF|2167
14508322|In alpha2B-receptor-expressing HEK293 cells, etomidate rapidly increased phosphorylation of the extracellular signal-related kinases ERK1/2.|etomidate|ERK1/2|6|15.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR|2168
10933891|Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes.|Wy-14,643|uncoupling protein-3|12|15.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2169
23046389|Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.|zoniporide|aldehyde oxidase|7|9.0|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|2170
23295386|Furthermore, a humanized CYP3A4/3A7 mouse model showed in vivo induction of CYP3A4 mRNA and protein by [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY14,643) in liver but not in intestine, whereas hepatic occupancy of PBRs by PPARα was ligand independent.|4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid|CYP3A4|19|13.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2171
12713596|Accordingly, wound tissue from SC-560-treated mice (selective cyclooxygenase-1 inhibitor) and diclofenac-treated mice (nonselective cyclooxygenase inhibitor), but not celecoxib-treated mice (selective cyclooxygenase-2 inhibitor), and wound tissue from cyclooxygenase-1-deficient animals exhibited a severe loss of prostaglandin E2/D2 at the wound site, and this change was associated with an impairment in the normal wound morphology.|prostaglandin E2/D2|cyclooxygenase|43|18.0|Arg1:T12|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF|2172
16819260|  Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of nuclear hormone receptor superfamily.|Retinoid|retinoic acid receptors|1|13.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|DIRECT-REGULATOR|2173
23200901|The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.|aconitine|efflux transporters|12|4.0|Arg1:T27|Arg2:T48|CHEMICAL|GENE-N|SUBSTRATE|2174
10421446|In experiments with D74N AChE, for which the inhibition potency of charged organophosphate (OP) was two to three orders less than wild-type enzyme, edrophonium had no effect on the reactivation by LuH6 and TMB4 and the time courses of reactivation were monophasic.|organophosphate|D74N|14|4.0|Arg1:T12|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR|2175
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|barusiban|oxytocin receptor|11|8.0|Arg1:T28|Arg2:T52|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2176
8799556|The affinity estimate for prazosin on human prostate was lower than the corresponding binding affinity determined at alpha 1A adrenoceptors and RS 17053 was a very weak antagonist on human prostate (pA2 = 6.0) relative to the high affinity (pKi = 8.6) determined at cloned human alpha 1A adrenoceptors.|RS 17053|human alpha 1A adrenoceptors|22|50.0|Arg1:T20|Arg2:T45|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2177
23473805|Rp1 treatment resulted in an accumulation of doxorubicin or rhodamine 123 by decreasing MDR-1 activity in doxorubicin-resistant cells.|Rp1|MDR-1|1|14.0|Arg1:T22|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2178
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine|STAT3|29|51.0|Arg1:T13|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2179
23211523|GnRH caused a sustained increase in nuclear β-catenin levels, which was significantly reduced by c-Jun N-terminal kinase (JNK) inhibition.|GnRH|β-catenin|1|8.0|Arg1:T5|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2180
22659088|This localization is in turn dependent on the Homer family of scaffolding proteins which bind to a small motif on the distal C-termini of mGluR1 and 5, localize the receptors near the PSD, strengthen coupling to post-synaptic effectors and simultaneously uncouple the mGluRs from extra-synaptic effectors such as voltage dependent ion channels.|C|mGluR1 and 5|23|25.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|PART-OF|2181
17259377|Sulfasalazine (also as a representative of the salicylates) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by NF-kappaB, including vascular cell adhesion molecule, intracellular adhesion molecule-1, inducible nitric oxide synthase, and cyclooxygenase-2 in whole-retinal lysate.|Sulfasalazine|cyclooxygenase-2|1|43.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2182
15917650|It is through inhibition of c-kit that imatinib is also used clinically in the treatment of gastrointestinal stromal tumours.|imatinib|c-kit|8|6.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2183
12213053|The 4',7,8-trichloro analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).|4',7,8-trichloro|NET|2|33.0|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2184
14757700|TRPM8 (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and icilin.|menthol|Ca(2+)-permeable channel|22|7.0|Arg1:T35|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|2185
17537429|Hypoxia increased glucose uptake in adult cardiomyocytes but not in neonatal cells and this increase in glucose uptake was mediated by GLUT4.|glucose|GLUT4|17|22.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|2186
15509185|The wide variability in the pharmacokinetic properties of tramadol can partly be ascribed to CYP polymorphism.|tramadol|CYP|9|15.0|Arg1:T12|Arg2:T41|CHEMICAL|GENE-N|SUBSTRATE|2187
9525919|We report here the use of Met methyl groups as site-specific structural markers to identify drug binding sites for trifluoperazine and bepridil on cTnC.|bepridil|cTnC|22|24.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2188
17341305|The expression of ER-alpha and PR isoform A in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands, and both receptors were downregulated in progestin-treated BALB/c mice (P < 0.05).|progestin|PR isoform A|30|6.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2189
21600945|TPM-increased B1R mRNA was prevented by co-treatments with N-acetyl-l-cysteine (potent antioxidant), diphenyleneiodonium (NADPH oxidase inhibitor), IL-1Ra (interleukin-1R antagonist) and SN-50 (specific inhibitor of NF-kB activation) but not by pentoxifylline (TNF-alpha release inhibitor), indomethacin and niflumic acid (COX-1 and -2 inhibitors).|diphenyleneiodonium|B1R|15|2.0|Arg1:T17|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2190
22732443|The LTD can be blocked by systemic application of the selective GluN2B antagonist Ro25-6981 (6 mg/kg, i.p.) or a synthetic peptide Tat-GluA2(3Y) (3 μmol/kg, i.p.) that interferes with the endocytosis of AMPA receptors.|Ro25-6981|GluN2B|14|12.0|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|ANTAGONIST|2191
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|EACA|t-PA|43|26.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|2192
23422569|SIRT1 co-precipitated with PPARα and nicotinamide increased the acetylation of the PPARα coactivator PGC-1α, which was suppressed by resveratrol.|nicotinamide|PGC-1α|6|14.0|Arg1:T5|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR|2193
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|AG013736|PDGFR-beta|31|40.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2194
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|Alexa532-NA|beta2-AR|10|14.0|Arg1:T17|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2195
12085361|Direct transport of rifampicin could be shown for OATP-C (apparent K(m) value 13 micromol/L) and OATP8 (2.3 micromol/L).|rifampicin|OATP-C|4|9.0|Arg1:T8|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE|2196
18574460|CONCLUSIONS AND IMPLICATIONS: Halogenated propofol analogues constitute a novel class of sodium channel-blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug lidocaine.|Halogenated propofol|sodium channel|5|13.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2197
23064031|NFD suppressed EGF-mediated protein levels of c-Jun and c-Fos, and reduced MMP-9 expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity.|NFD|MMP-9|1|13.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2198
23535185|Galangin decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8.|Galangin|IL-8|1|27.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2199
20387803|None were found to bind to ERalpha, but Rb1(S) and 20(S)-Rg3 were shown to bind to peroxisome proliferator-activated receptor gamma.|20(S)-Rg3|peroxisome proliferator-activated receptor gamma|15|25.0|Arg1:T10|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2200
14737100|  The expression of the NH2 terminally truncated ErbB2 receptor (p95ErbB2) in breast cancer correlates with metastatic disease progression compared with the expression of full-length p185ErbB2.|NH2|ErbB2|5|8.0|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|PART-OF|2201
22884520|Defects resulting in slowed release of cholesterol from late endosomes and lysosomes or reduction in sterol-27-hydroxylase activity lead to specific blocks in oxysterol production and impaired LXR-dependent gene activation.|oxysterol|sterol-27-hydroxylase|23|16.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF|2202
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|CGP20712A|beta(1)-adrenoceptor|36|40.0|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|2203
9732824|Both the 5 alpha-reductase inhibitor finasteride and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.|doxazosin|alpha 1-adrenoceptor|16|8.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|ANTAGONIST|2204
23482500|Hepatocyte uptake of [(14)C]sorafenib was not Na(+)-dependent or influenced by the organic anion transporter 2 (OAT2) inhibitor ketoprofen.|ketoprofen|organic anion transporter 2|30|22.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2205
23161217|Taken together, suramin improves the outcome of FPG transplantation, most likely by inhibition of TNF-α and TGF-β formation.|suramin|TNF-α|4|17.0|Arg1:T5|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|2206
23639249|Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis.|Indoxyl 3-sulfate|STAT3|1|11.0|Arg1:T14|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR|2207
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|NO|AS|21|13.0|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF|2208
23303191|Hyaluronan synthesis driven by HAS2 was less affected by glucosamine addition, and HAS3 was not affected at all.|glucosamine|HAS2|10|5.0|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2209
1400062|The 5-lipoxygenase-activating protein inhibitor MK886, administered orally 2-6 h before perfusion, also inhibited the pressor response to PAF as well as LT production, as did DEC.|MK886|5-lipoxygenase-activating protein|5|2.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2210
11078056|COX-2 produces prostaglandins that inhibit apoptosis and stimulate angiogenesis and invasiveness.|prostaglandins|COX-2|3|1.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF|2211
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|GDP|Adenylosuccinate synthetase|31|1.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF|2212
23643730|Moreover, we found that juglone significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).|juglone|PSA|6|22.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2213
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-8713|EP(3) receptor|12|6.0|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST|2214
1600046|Some 5-HT3 antagonists have 5-HT4 agonist activity (for example, renzapride, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.|renzapride|5-HT3|12|2.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|2215
10639181|Only the amide derivatives of ETYA and meclofenamic acid inhibit COX-2; the esters are either inactive or nonselective.|meclofenamic acid|COX-2|8|11.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2216
15787205|The average occupancy of bupropion on DAT was similar to the international findings at 20.84% in 9 depressed patients.|bupropion|DAT|5|7.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2217
23200945|The E67Q substitution near the catalytic zinc was shown previously to increase the Michaelis constant for acetaldehyde and to decrease turnover for ethanol oxidation.|zinc|E67Q|7|2.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|PART-OF|2218
14693528|  This study compared the plasma amprenavir pharmacokinetics of the human immunodeficiency virus (HIV) protease inhibitors amprenavir (Agenerase) 1,200 mg twice daily (BID) and the amprenavir prodrug GW433908, a formulation that substantially reduces the number of tablets per dose compared with amprenavir, at doses of 1,395 mg and 1,860 mg BID, in combination with abacavir 300 mg BID and lamivudine 150 mg BID in patients with HIV infection.|amprenavir|human immunodeficiency virus (HIV) protease|18|10.0|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|2219
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|bEAG|4|8.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|2220
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|tacrine|acetylcholinesterase|16|10.0|Arg1:T9|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR|2221
10735801|Any antinociceptive and neuroprotective benefit from the N-methyl-D-aspartate-receptor antagonist property of meperidine may be pH dependent.|meperidine|N-methyl-D-aspartate-receptor|12|8.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST|2222
23437843|6'-Sulfonyloxy derivatives exhibited outstanding affinities to MAO-A (7.0 nM < IC50 < 49 nM, much higher than moclobemide) and a pronounced MAO-A/B selectivity.|6'-Sulfonyloxy|MAO-A|1|7.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2223
8392199|The present results further support the previously suggested hypothesis that acute cocaine administration inhibits the 5-HT2-receptor function by increasing the synaptic concentration of norepinephrine and serotonin via inhibition of their uptake and therefore indirectly stimulating the respective inhibitory adrenergic alpha 2- and serotonergic 5-HT1A-receptors.|cocaine|5-HT2|12|16.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR|2224
1403790|Other reference compounds such as the typical antipsychotics, chlorpromazine and thioridazine; the selective dopamine D-2 antagonists, droperidol and sulpiride; the dopamine D-1 antagonist, SCH 23390; the antimuscarinics, atropine and scopolamine; the antihistamines, pyrilamine and diphenhydramine; the alpha-1 antagonist, prazosin; and the antidepressants, imipramine and chloromipramine also failed to produce clozapine-appropriate responding.|droperidol|dopamine D-2|20|16.0|Arg1:T4|Arg2:T48|CHEMICAL|GENE-N|ANTAGONIST|2225
23333834|The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.|YR-11|RANK|3|30.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2226
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|COX-2|37|26.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF|2227
16010590|TS inhibition (14.3%) and DNA damage (8%) were more pronounced than expected (P<0.05) when TFT was combined with GW1843 in WiDr/F cells, in contrast to AG337 and ZD1694, which showed inhibiting effects as expected (additive).|TFT|TS|25|1.0|Arg1:T15|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|2228
23473804|To this end, 158N murine oligodendrocytes were treated with 7KC or 7βOHC inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving Mcl-1, and caspase-3 activation.|7KC|caspase-3|11|40.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR|2229
17434872|Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.|lumiracoxib|cyclooxygenase-2|10|8.0|Arg1:T25|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|2230
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefuroxime|PBPs|44|52.0|Arg1:T14|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR|2231
23536521|A decrease in ADA activity was observed when the slices were exposed to organoselenium at the concentrations of 1, 10 and 30 µM.|organoselenium|ADA|14|4.0|Arg1:T13|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2232
23093023|Blood pressure was increased in rats exposed to IH, and treatment with the PDK-1 inhibitor OSU-03012 [2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide] (33 mg/day) lowered blood pressure in IH but not sham group rats.|OSU-03012|PDK-1|17|15.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|2233
12909199|Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing alpha3beta4 nicotinic cholinergic receptors.|Bupropion|alpha3beta4 nicotinic cholinergic receptors|1|24.0|Arg1:T14|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|2234
23238783|These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of CYP2B6 activity in women, when measured by the metabolism of bupropion.|bupropion|CYP2B6|29|5.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|2235
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|HERG|4|12.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2236
23462233|This is the first study to establish the in vivo relevance of AOX in neonicotinoid metabolism in mammals and one of the first for xenobiotics in general.|neonicotinoid|AOX|15|13.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE|2237
10370904|2) Radioligand and functional studies at the N-methyl-D-aspartate (NMDA) type glutamate receptor characterize budipine as a low-affinity, uncompetitive antagonist with fast kinetics and moderate voltage-dependency at the phencyclidine (PCP) binding site, comparable to that observed with amantadine, thereby counteracting an increased excitatory glutamatergic activity.|budipine|N-methyl-D-aspartate (NMDA) type glutamate receptor|17|9.0|Arg1:T25|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST|2238
17531267|Contrary to most of their counterparts in animal cells, the higher plant GPX homologues identified so far possess cysteine instead of selenocysteine in their active site.|cysteine|GPX|20|14.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|PART-OF|2239
10823899|Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.|Amphetamine|human dopamine transporter|1|4.0|Arg1:T24|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|2240
23479079|Both ROCK-1 and ROCK-2 (Rho kinases) were activated by sulfide, and sulfide-induced cell blebbing was suppressed by a ROCK inhibitor, suggesting that a Rho pathway is involved in sulfide-induced blebbing in lymphocytes.|sulfide|ROCK-2|12|4.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR|2241
23279865|Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.|anthra[1,2-d]imidazole-6,11-dione|telomerase|9|16.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|2242
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|cobalt|hypoxia-inducible factor (HIF)-1α|19|9.0|Arg1:T12|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2243
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Mg-nucleotide|nucleotide-binding domains|15|21.0|Arg1:T17|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|2244
9662053|Single strand conformational polymorphism analysis and nucleotide sequencing of the promoter and entire coding region of the CPE gene in 269 Japanese subjects with NIDDM, 28 nondiabetic obese subjects and 104 nonobese and nondiabetic controls revealed three nucleotide changes, a G-to-T substitution at nucleotide -53, a G-to-A substitution at nucleotide -144 (relative to start of transcription) in the promoter region and a silent G-to-A substitution in codon 219.|nucleotide|CPE|53|18.0|Arg1:T3|Arg2:T7|CHEMICAL|GENE-Y|PART-OF|2245
23183186|Finally, the Pak1(-/-) mice exhibited reduced brainstem gcg level and abolished β-cat Ser675 phosphorylation in brain neurons after insulin treatment.|Ser|β-cat|17|16.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|PART-OF|2246
23064031|The specific PI3K inhibitor, wortmannin, blocked significantly EGF-induced cell migration and invasion.|wortmannin|PI3K|6|3.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|2247
14718599|The L-proline uptake was saturable and mediated by a single transport system (hPAT1) with an affinity constant of 2.0 +/- 0.2 mM.|L-proline|hPAT1|2|14.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE|2248
1929324|Strain JR4 (erg3 erg11), which produces 14-methylfecosterol [14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol) as the major sterol in the presence or absence of fenpropimorph, was also found to be resistant to the drug.|14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol|erg3|12|4.0|Arg1:T24|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF|2249
23291050|ChE activity was measured with acetylthiocholine as substrate and CES activity was measured with four substrates: p-nitrophenyl acetate, p-nitrophenyl butyrate, 1- and 2-naphthyl acetate.|p-nitrophenyl butyrate|CES|21|10.0|Arg1:T19|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE|2250
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|losartan|AT1|36|4.0|Arg1:T1|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST|2251
23611809|  Recent observations revealed that human UDP-glucuronosyltransferase (UGT) 2B10 catalyzes N-glucuronidation of amine-containing compounds.|amine|human UDP-glucuronosyltransferase (UGT) 2B10|14|5.0|Arg1:T3|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE|2252
11689471|Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts.|Aspirin|ATPase|1|17.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|2253
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|BMY 7378|alpha 1-adrenoceptor|20|3.0|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|2254
23567243|Western blot assay demonstrated that DICO decreased Bcl-2 level and induced Bax translocation to cause cytochrome c release.|DICO|Bcl-2|6|8.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2255
11156594|[(3)H]-prazosin binds to alpha(1) adrenoceptors on these cells and is displaceable by unlabelled prazosin in concentrations up to 10(-7) M.|prazosin|alpha(1) adrenoceptors|23|10.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR|2256
23541637|Aldosterone-induced ENaC and basal Na(+)/K(+)-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells.|Aldosterone|ENaC|1|2.0|Arg1:T14|Arg2:T38|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2257
7567987|Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of L-5-hydroxytryptophan to serotonin and that of L-3,4-dihydroxyphenylalanine to dopamine.|L-5-hydroxytryptophan|Aromatic L-amino acid decarboxylase|9|1.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|2258
16819260|Among them, tamibarotene (Am80) is an RARalpha- and RARbeta-specific (but RARgamma- and RXRs-nonbinding) synthetic retinoid that is effective in the treatment of psoriasis patients and relapsed APL.|retinoid|RARalpha|20|10.0|Arg1:T9|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2259
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Caprelsa|epidermal growth-factor receptors|3|49.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2260
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|23|18.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2261
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol|CB1|54|2.0|Arg1:T23|Arg2:T29|CHEMICAL|GENE-Y|AGONIST|2262
23042728|  In utero exposure to valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, causes neural tube, heart, and limb defects.|valproic acid|histone deacetylase|5|12.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2263
1744096|Spectral studies employing CN-Cbl and Me-Cbl showed that both forms of Cbl must be converted to Cob(II)alamin before they can bind to human apomethionine synthase and convert it to its activated holoenzyme form.|Cob(II)alamin|human apomethionine synthase|17|27.0|Arg1:T41|Arg2:T55|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2264
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT3|17|10.0|Arg1:T22|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE|2265
14737100|GW572016, a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts.|GW572016|tyrosine kinases|1|12.0|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|2266
15967876|We found that although inactivation facilitated cisapride block of the HERG K+ current, it was not coupled with cisapride block of HERG when the Cs+ current was recorded.|cisapride|HERG|7|11.0|Arg1:T10|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2267
10334992|Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor.|bile acids|FXR|6|17.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2268
15887238|Together, these results suggested that imatinib affects EGFR activation and signaling pathways through rapid release and increased expression of endogenous EGFR-activating ligands.|imatinib|EGFR|7|22.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2269
12589193|RECENT FINDINGS: The metabolism of arginine is determined by the expression of the arginine metabolizing enzymes inducible nitric oxide synthase and two arginase isoforms (arginase I and II).|arginine|inducible nitric oxide synthase|15|18.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|2270
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|OTA|D6D|34|5.0|Arg1:T16|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF|2271
15606893|Dissociation of [3H]S-citalopram from SERT is most potently inhibited by S-citalopram followed by R-citalopram, sertraline, serotonin and paroxetine.|sertraline|SERT|19|8.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2272
23530018|These five CGPs also inhibited [(3)H]E217βG uptake by MRP4.|CGPs|MRP4|3|15.0|Arg1:T21|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|2273
23339663|TOCP is metabolized to cresyl saligenin phosphate (CBDP), a potent irreversible inhibitor of butyrylcholinesterase (BChE), a natural bioscavenger present in the bloodstream, and acetylcholinesterase (AChE), the off-switch at cholinergic synapses.|cresyl saligenin phosphate|acetylcholinesterase|5|31.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|2274
23566514|Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.|4-aminopyrrolopyrimidine|kinase|6|8.0|Arg1:T8|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR|2275
23619386|Rapamycin inhibits proteinase and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations.|Rapamycin|peptidase|1|6.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|2276
23422569|To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 (nicotinamide, sirtinol, EX527) in aorta segments isolated from young Wistar rats.|EX527|SIRT1|38|32.0|Arg1:T16|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|2277
23449197|  7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-β (TGF-β) type I receptor (also known as activin receptor-like kinase 5 or ALK5) inhibitor.|TASP0382088|transforming growth factor-β (TGF-β) type I receptor|12|19.0|Arg1:T6|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|2278
12826849|The mole fractions of recombinant Galpha(i1) bound to [35S]GTPgammaS were 0.49 +/- 0.02 and 0.60 +/- 0.02 at 10 and 20 min, respectively.|[35S]GTPgammaS|Galpha(i1)|12|6.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2279
15175324|Mutated GIRK channels showed normal currents when activated by ACh but exhibited different pharmacological properties toward halothane.|ACh|GIRK|10|2.0|Arg1:T15|Arg2:T46|CHEMICAL|GENE-N|ACTIVATOR|2280
17200663|Serum albumin and serum retinol-binding protein (sRBP), proteins capable of binding retinoids, have also been reported to be components of the IPM.|retinoids|serum retinol-binding protein|15|4.0|Arg1:T12|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2281
23337567|Additionally, these effects of ATO on γ-H2AX, Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.|ATO|p21|6|17.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2282
23085435|Furthermore, N-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.|N|phosphorylated extracellular signal-regulated kinase|3|8.0|Arg1:T10|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2283
23515287|The dihydrotestosterone metabolite, 5α-androstane-3β,17β-diol (3β-diol), binds and activates estrogen receptor-β (ER-β), the predominant ER in the PVN.|dihydrotestosterone|ER-β|2|16.0|Arg1:T10|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2284
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|COX-1|37|24.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF|2285
7824160|In all cases at both the 5-HT2A and 5-HT2C receptors, the affinities of the isomers of MDMA and MDA were at least 2-3 orders of magnitude less than 5-HT.|MDMA|5-HT2A|18|7.0|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2286
23411280|  Histidine decarboxylase (HDC) catalyses the formation of histamine, a bioactive amine.|amine|HDC|14|4.0|Arg1:T10|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF|2287
9614060|System y+ cationic amino acid transport is mediated by proteins encoded by a family of genes, Cat1, Cat2, and Cat3.|amino acid|Cat2|4|20.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|2288
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|isoflurane|complex I|7|17.0|Arg1:T27|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR|2289
15561708|Although different in its physiological function, the mechanism of ABA3 for sulfur mobilization was found to be similar to NifS proteins.|sulfur|NifS|13|21.0|Arg1:T22|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE|2290
23583884|Further, TCDD exposure could induce phosphorylation- and ubiquitination-dependent degradation of IкBα, and the translocation of NF-κB p65 from the cytosol to the nucleus in this microglial cell line.|TCDD|IкBα|3|12.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|ACTIVATOR|2291
18056711|Crystallographic data reveal that a conserved Gly residue (located at the juncture between the linker and C-terminal domains) is at one end of a short alpha-helix, which extends to the active site Tyr covalently linked to the DNA.|C|alpha-helix|18|28.0|Arg1:T24|Arg2:T38|CHEMICAL|GENE-N|PART-OF|2292
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS|4|2.0|Arg1:T32|Arg2:T60|CHEMICAL|GENE-N|INHIBITOR|2293
19119014|  Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.|Thiazide|carbonic anhydrase|1|15.0|Arg1:T1|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|2294
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|BRL49653|PPARgamma|5|38.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2295
15509185|The O-demethylation of tramadol to M1, the main analgesic effective metabolite, is catalysed by cytochrome P450 (CYP) 2D6, whereas N-demethylation to M2 is catalysed by CYP2B6 and CYP3A4.|tramadol|cytochrome P450 (CYP) 2D6|4|17.0|Arg1:T10|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2296
7911719|Following inactivation of alpha 1B-adrenoceptors by chloroethylclonidine treatment, alpha lA-adrenoceptors can fully compensate and mediate inotropic effects by promoting influx of extracellular Ca2+ at least partly via voltage-operated channels.Therefore, we speculate that alpha 1B-adrenoceptors exert a tonic inhibitory effect on alpha 1A-adrenoceptors.|Ca2+|voltage-operated channels|24|29.0|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE|2297
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|IκB-α|11|19.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2298
10891536|  5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (TS).|5-Fluorouracil|thymidylate synthase|1|36.0|Arg1:T1|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR|2299
23122079|Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/AMP-activated protein kinase-dependent signalling.|Phillyrin|AMP-activated protein kinase|1|16.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR|2300
11723241|HERG/I(Kr) channels are blocked selectively by class III antiarrhythmic methanesulfonanilide drugs such as dofetilide.|dofetilide|HERG|17|1.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2301
17234158|PFD leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.|PFD|TGF-beta2|1|14.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2302
23194750|Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.|thiazolidinediones|PI3K|6|9.0|Arg1:T23|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|2303
23552851|Treatment of A549 and H1299 cells with dioscin caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR.|dioscin|mTOR|8|31.0|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|2304
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|IKK|1|10.0|Arg1:T18|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|2305
18559268|Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.|taxane|microtubules|3|6.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR|2306
16803890|Interestingly, knockdown of endogenous AC by RNA interference attenuated cyclooxygenase 2 induction by TNFalpha and subsequent PGE(2) biosynthesis.|PGE(2)|cyclooxygenase 2|18|11.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|2307
23337530|In THP-1 cells, anagliptin reduced lipopolysaccharide-induced TNF-α production with inhibiting ERK phosphorylation and nuclear translocation of nuclear factor-κB.|anagliptin|nuclear factor-κB|5|18.0|Arg1:T10|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|2308
22406476|Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.|metformin|mTOR|3|13.0|Arg1:T10|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2309
23086198|These data suggest that, although UGT2A1 is the only UGT2A enzyme active against PAH proximate carcinogens (including PAH diols), both UGTs 2A1 and 2A2 play an important role in the local detoxification of procarcinogenic monohydroxylated PAH metabolites.|diols|UGT2A1|21|7.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|2310
23515287|Treatment of ovariectomized rats with estradiol benzoate or 3β-diol for 4 days increased OT mRNA selectively in the midcaudal, but not rostral PVN compared with vehicle-treated controls.|3β-diol|OT|9|14.0|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2311
23549262|In addition to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses.|lipoxin A4|FPR2|8|38.0|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|2312
14757700|TRPM8 (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and icilin.|icilin|Ca(2+)-permeable channel|26|7.0|Arg1:T7|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR|2313
15866114|In cases of chorioamnionitis regardless of betamethasone treatment, placental 11beta HSD-2 expression and activity was decreased compared to controls.|betamethasone|11beta HSD-2|7|11.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|2314
10681601|The production of [(3)H]-L-citrulline from [(3)H]-L-arginine in tissue extracts enriched in superficial layers indicated that nNOS specific activity is as high in the opossum as in the rat.|[(3)H]-L-citrulline|nNOS|4|28.0|Arg1:T8|Arg2:T11|CHEMICAL|GENE-N|PRODUCT-OF|2315
12416991|Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).|allopregnanolone|human 3 alpha-hydroxysteroid dehydrogenase type III|3|7.0|Arg1:T38|Arg2:T51|CHEMICAL|GENE-Y|PRODUCT-OF|2316
3440035|  Derivatives of 5-(dipentylamino)-5-oxo-pentanoic acid are a new class of non-peptide cholecystokinin (CCK) antagonists.|5-(dipentylamino)-5-oxo-pentanoic acid|CCK|3|17.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST|2317
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hCNT3|9|36.0|Arg1:T8|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2318
16014042|  BACKGROUND: System x(-) (c) is a heterodimeric transporter, comprised of a light chain, xCT, and heavy chain, 4F2hc, which mediates the sodium-independent exchange of cystine and glutamate at the plasma membrane.|glutamate|System x(-) (c)|38|3.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|2319
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|acetyl-CoA|CrAT|34|4.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|2320
23521080|One exception is tranexamic acid (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to fibrin.|TXA|plasminogen|7|20.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2321
16313925|The attenuated inflammatory and allergic responses from the potent and preferential PDE4 inhibition of ibudilast may have contributed significantly to its beneficial pharmacological responses and distinguishes ibudilast from the other ophthalmic solutions in the treatment of ocular allergy.|ibudilast|PDE4|15|12.0|Arg1:T15|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|2322
22967140|Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol, a selective ERα agonist-PPT [4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol], a selective ERβ agonist-DPN [2,3-bis(4-hydroxyphenyl)-propionitrile], a selective ERα antagonist-MPP [1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride] or a selective ERβ antagonist-PHTPP (4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol).|MPP|ERα|53|51.0|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|2323
12185406|The validity of this mechanism has been questioned because the affinity of bupropion for the DAT is quite low.|bupropion|DAT|13|16.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2324
8484964|Purification of nonantibiotic insulinase inhibitors from bacitracin.|bacitracin|insulinase|7|4.0|Arg1:T4|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR|2325
22552008|Overexpression of CRBN wild-type protein, but not CRBN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated reductions in c-myc and IRF4 expression and increases in p21(WAF-1) expression.|pomalidomide|IRF4|22|27.0|Arg1:T20|Arg2:T41|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2326
16686685|The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells.|RSD1235|Na channel|9|2.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2327
9288901|This indicates that the PH-20 hyaluronidases, like numerous enzymes that hydrolyze glycosidic bonds, have acidic amino acids in their active site.|acidic amino acids|PH-20 hyaluronidases|17|5.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|PART-OF|2328
23220614|ISO significantly inhibited the levels of ERK1/2 kinase and increased the expression of JNK and p38 kinases.|ISO|p38|1|16.0|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2329
23591777|On the other hand, MSM raised SOD and CAT activities as well as CYP2E1 level in liver tissues.|MSM|CAT|6|10.0|Arg1:T17|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR|2330
23636303|Local LC citalopram effect was abolished by LC presence of the 5-HT3 receptor antagonist MDL72222 (1 μM) but not the 5-HT1/2 receptor antagonist methiothepin (1 μM).|methiothepin|5-HT1/2|26|23.0|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|ANTAGONIST|2331
16472148|In this review, the novel action mechanism (s) of cilostazol are overviewed with the focus on the action of cilostazol in in vitro and in vivo studies as a maxi-K channel opener targeting anti-apoptotic signaling pathways.|cilostazol|maxi-K channel|23|33.0|Arg1:T12|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR|2332
23531031|Results: Our results demonstrate that treatment with LBH589 leads to NIS RNA expression as shown by RT-PCR and luciferase assay, and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors.|LBH589|NIS|9|12.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2333
12085361|Rifampicin (10 micromol/L) inhibited OATP8-mediated BSP uptake by 50%, whereas inhibition of OATP-C-, OATP-B-, and OATP-A-mediated BSP transport was below 15%.|BSP|OATP-B|23|19.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|2334
16973761|Mutating Asp2.61(97) to Glu or Ala, Asn2.65(101) to Ala, or Lys3.32(120) to Gln decreased potency of GnRH II-stimulated inositol phosphate production.|Ala|GnRH II|9|28.0|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|PART-OF|2335
11319222|The thiazolidinedione (TZD) insulin-sensitizing drugs and peroxisome proliferator-activated receptor gamma (PPARgamma) ligands, troglitazone, rosiglitazone, and pioglitazone, strongly and specifically inhibited only ACS4, with an IC(50) of less than 1.5 microm.|rosiglitazone|ACS4|20|30.0|Arg1:T36|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|2336
23623790|GABAA receptor modulation by piperine and a non-TRPV1 activating derivative.|piperine|TRPV1|5|9.0|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR|2337
15985434|  Pyridoxal kinase (PDXK) catalyzes the phosphorylation of pyridoxal, pyridoxamine, and pyridoxine in the presence of ATP and Zn2+.|pyridoxamine|Pyridoxal kinase|12|1.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|2338
23237828|These results imply the functional MEK1/ERK-mediated pathway is necessary for the cycloheximide stimulation of SOCS-3 gene expression.|cycloheximide|SOCS-3|12|15.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2339
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|17β-estradiol|CARs|7|20.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|2340
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline|AChE|8|15.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|2341
23313794|The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) PhIP (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.|PhIP|superoxide dismutase|23|31.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|2342
23543412|Challenge with nicotine triggered phosphorylation of the extracellular signal-regulated kinase (ERK) and the thymoma viral proto-oncogene (Akt) followed by activation of the mTORC1-dependent p70 ribosomal S6 protein kinase.|nicotine|Akt|3|20.0|Arg1:T16|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR|2343
11330337|Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.|[3H]-oxotremorine-M|muscarinic receptors|4|16.0|Arg1:T41|Arg2:T56|CHEMICAL|GENE-N|DIRECT-REGULATOR|2344
20590599|KEY RESULTS: Several agonists were found to be highly subtype selective because of selective affinity (e.g. salmeterol and formoterol, for the beta(2)-adrenoceptor over the beta(1) or beta(3)), while others (e.g. isoprenaline) had little affinity-selectivity.|salmeterol|beta(2)-adrenoceptor|20|26.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|AGONIST|2345
15114505|These data suggest that the lavandulyl side chain and the position of the hydroxy group are important for high DGAT inhibitory activity.|lavandulyl|DGAT|6|20.0|Arg1:T17|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2346
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|tamsulosin|alpha 1-adrenoceptor|16|3.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST|2347
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|N|human recombinant 5-HT2B receptors|30|42.0|Arg1:T16|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2348
17041099|Methylthioadenosine phosphorylase (MTAP) salvages purines by releasing adenine from methylthioadenosine and is often deleted in mesothelioma.|methylthioadenosine|MTAP|12|4.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|2349
10933891|  Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.|H(+)|UCPs|16|4.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|2350
12023686|Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.|valsartan|AT1|10|7.0|Arg1:T37|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|2351
2386945|Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide.|W-12|calmodulin|13|9.0|Arg1:T13|Arg2:T41|CHEMICAL|GENE-Y|ANTAGONIST|2352
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|survivin|47|29.0|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2353
23142789|The expression levels of Ca transport genes, TRPV5 and calbindin-D9k (CaBP-9k), in the kidney were decreased after treatment with OP and BPA.|Ca|TRPV5|5|9.0|Arg1:T7|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|2354
23485614|Both interventions restored the liver function markers (alanine transaminase: ALT, aspartate transaminase: AST, alkaline phosphatase: ALP, total bilirubin and total protein) and hepatic antioxidants (superoxide dismutase: SOD, catalase: CAT, reduced glutathione: GSH and glutathione peroxidase: GPx) to the normal levels than elevated levels noticed on paracetamol control at P<0.001.|paracetamol|GPx|62|51.0|Arg1:T17|Arg2:T37|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2355
18559268|Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.|paclitaxel|microtubules|19|6.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR|2356
15621150|It inhibits the inducible isoform of the enzyme inosine-monophosphate dehydrogenase (IMPDH II) via its active metabolite mycophenolic acid (MPA).|mycophenolic acid|IMPDH II|19|12.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2357
23371303|  Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes.|NXL104|Ambler class D|4|28.0|Arg1:T14|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR|2358
15199474|"These results demonstrate that this receptor corresponds to the previously called ""P2t"" platelet receptor and show that the active metabolite of clopidogrel binds in a covalent manner to this receptor, thus explaining how it blocks the aggregating effect of ADP on platelets."|clopidogrel|platelet receptor|24|15.0|Arg1:T11|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR|2359
22064666|Although genetic polymorphisms in the endothelial nitric oxide synthase (eNOS) gene may impair endogenous NO formation, there is little information about how eNOS polymorphisms and haplotypes affect the responses to sildenafil.|NO|eNOS|17|11.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|PRODUCT-OF|2360
8667211|Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II.|acetazolamide|CA II|7|12.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|2361
10381000|In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (GTPCH), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (BH4), the obligate cofactor for TPH.|BH4|GTP cyclohydrolase I|29|12.0|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|2362
16926278|All PDE5 constructs had similar affinities for 3-isobutyl-1-methylxanthine, sildenafil, tadalafil, and UK-122764, but mutants containing a complete GAF-B had 7- to 18-fold higher affinity for vardenafil-based compounds compared with those lacking a complete GAF-B.|3-isobutyl-1-methylxanthine|GAF-B|8|22.0|Arg1:T4|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR|2363
11401111|Carvedilol reduced mortality and heart failure in patients with higher pre-treatment plasma N-BNP and adrenomedullin.|Carvedilol|N-BNP|1|13.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2364
23419638|Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR.|pelargonidin|AhR|6|12.0|Arg1:T20|Arg2:T39|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2365
15671155|Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form H2S.|H2S|Cystathionine-gamma-lyase|16|1.0|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|2366
23314308|However, they were increased by nearly 40% in response to BAY K 8644 (10(-7)M) and were inhibited by nifedipine (10(-7)M), indicating that activation of the LTCCs was essential.|nifedipine|LTCCs|27|41.0|Arg1:T19|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|2367
14610216|hOAT1, hOAT3, and hOAT4 but not hOAT2, mediated the uptake of bumetanide.|bumetanide|hOAT1|15|1.0|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|2368
23093496|Molecular docking studies revealed a binding pocket for the ATP derivatives that is bordered by transmembrane helices 3, 5, 6, and 7 in human P2Y(12,) with Y(105), E(188), R(256), Y(259), and K(280) playing a particularly important role in ligand interaction.|ATP|human P2Y(12,)|10|27.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2369
22841391|Subsequently, we confirmed these proteins with the Western blotting approach, and found that methylselenol increased the expression of GADD 153 and p21 but reduced the level of c-Myc, E2F1 and Phos p38 MAP kinase.|methylselenol|p21|16|24.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2370
21262851|Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists.|pentobarbital|Ca(v)1.3|11|1.0|Arg1:T2|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2371
10208549|Following a single oral administration, both bis(7)-tacrine and tacrine produced dose-dependent inhibitions of AChE in rat brain, but bis(7)-tacrine exhibited higher efficacy and AChE/BChE selectivity than tacrine.|bis(7)-tacrine|BChE|25|35.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|2372
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|α-SMA|1|20.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2373
7912539|Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective beta 2-adrenoceptor agonist salbutamol 8 mg (SAL), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors.|SAL|beta 2-adrenoceptor|25|18.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|AGONIST|2374
23583510|Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors.|tetrahydrocurcuminoid dihydropyrimidinone|acetylcholinesterase|3|8.0|Arg1:T12|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|2375
23631499|The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity, CRP, NF-κB, and MCP-1 accompanied with a significant depletion in the Ach level.|AlCl3|NF-κB|7|22.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2376
23353698|ABT-737 is a BH3 mimetic agent which binds Bcl-2, Bcl-XL and Bcl-w with high affinity, while weakly interacts with Mcl-1 and Bfl-1.|ABT-737|Bcl-2|1|9.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2377
15991886|Lubiprostone activates a specific chloride channel (CLC2) on cells lining the gut, thereby naturally increasing intestinal fluid secretion.|Lubiprostone|CLC2|1|8.0|Arg1:T16|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR|2378
23339663|Also, the inhibition of AChE by CBDP is unexpected, from a structural standpoint, i.e., considering the narrowness of AChE active site and the bulkiness of CBDP.|CBDP|AChE|8|6.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2379
2362440|  We have copurified human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase, which synthesize progesterone from pregnenolone and androstenedione from fetal dehydroepiandrosterone sulfate, from microsomes as a homogeneous protein based on electrophoretic and NH2-terminal sequencing data.|progesterone|human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase|18|4.0|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF|2380
23557706|Inhibition of mTOR by low dose rapamycin decreases HG-induced Nox4 and Nox1, NADPH oxidase activity and podocyte apoptosis.|rapamycin|Nox4|7|10.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2381
11426832|The Ki values of betamipron, cilastatin, KW-3902 and probencid for human-OAT1 were 23.6, 1470, 7.82 and 12.1 microM, whereas those for human-OAT3 were 48.3, 231, 3.70 and 9.0 microM.|betamipron|human-OAT1|5|13.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2382
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|clozapine|5-HT2C|7|3.0|Arg1:T2|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|2383
9730867|Secretion of GM-CSF protein in the presence of increasing concentrations of isoproterenol followed a similar pattern as observed for GM-CSF mRNA.|isoproterenol|GM-CSF|12|3.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2384
11799102|Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.|Aliskiren|renin|1|11.0|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|2385
23411279|Aqueous ethanol (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 μg/ml), with moderate COX-1 (IC(50), 66 μg/ml) and COX-2 (IC(50), 119 μg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.|ethanol|15-LOX|2|19.0|Arg1:T8|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|2386
15887238|Western blot analysis of cells incubated with imatinib demonstrated activation of EGFR and downstream signaling that was reduced by inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase 1 (MEK1) and EGFR, but not Her2/ErbB2.|imatinib|EGFR|8|12.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|ACTIVATOR|2387
23142559|Western blot analysis revealed that pilocarpine and physostigmine enhanced the TNF-α-induced phosphorylation of ERK1/2 and p38 MAPK and the degradation of IκBα.|physostigmine|IκBα|8|22.0|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|2388
15866500|Clinical studies in cancer patients treated with the new fluoropyrimidine analogue capecitabine (N4-pentoxycarbonyl-5'-5-fluorocytidine) have shown that plasma 2'-deoxyuridine was significantly elevated after 1 week of treatment, consistent with inhibition of thymidylate synthase (TS).|2'-deoxyuridine|TS|20|37.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2389
10548525|Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.|BRL 49653|peroxisome proliferator-activated receptor gamma|16|9.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR|2390
11799102|There was a dose-dependent decrease in plasma renin activity, Ang I, and Ang II following single doses of Aliskiren starting with 40 mg.|Aliskiren|Ang I|21|11.0|Arg1:T26|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2391
11861317|Whereas PS potentiated NMDA-, glutamate-, and glycine-induced currents of NR1/NR2A and NR1/NR2B receptors, it was inhibitory at NR1/NR2C and NR1/NR2D receptors.|PS|NR2D|2|24.0|Arg1:T18|Arg2:T56|CHEMICAL|GENE-Y|INHIBITOR|2392
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|candesartan|AT1|24|4.0|Arg1:T30|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2393
11959556|Cefaclor and cefprozil showed decreased affinity of PRSP but not PISP for all three PBPs. Cefuroxime showed decreased affinity of PISP and PRSP for PBP1a and -2x but no change for PBP2b.|Cefaclor|PBPs|1|15.0|Arg1:T4|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR|2394
7832763|The competitive inhibitor of hCOX-1, mefenamic acid, also displayed competitive inhibition of hCOX-2.|mefenamic acid|hCOX-2|7|15.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|2395
23219339|Western blot analysis revealed that OMT decreased the expression of Bax and repaired the balance of pro- and anti-apoptotic proteins.|OMT|Bax|6|11.0|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2396
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|estradiol-17β-glucuronide|OATP1B3|9|8.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|2397
15102890|The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs. Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).|BLT|SR-BI|38|68.0|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2398
10913016|In the presence of the beta(2)-adrenoceptor antagonist ICI-118551 (ICI, 10 microM), Iso caused an increase in [(14)C]phenylalanine incorporation, protein and RNA mass, cell volume, and cross-sectional area.|[(14)C]phenylalanine|beta(2)-adrenoceptor|25|6.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2399
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|TCDD|AhR|27|35.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR|2400
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|Modafinil|TA1|1|27.0|Arg1:T7|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR|2401
15714982|Docetaxel is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of bcl-2 inactivation, which induce apoptosis.|Docetaxel|bcl-2|1|18.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2402
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|ethoxzolamide|hCA VI|12|35.0|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2403
23259865|Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).|indenoisoquinolines|Top1|6|20.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2404
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|tyrosine kinase|1|5.0|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|2405
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|CFT|rat dopamine transporter|29|40.0|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2406
17075268|Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and HDC mRNA induced by TDI in TDI-sensitized rats.|TDI|HDC|22|18.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2407
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Met|ALDH|46|64.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-N|PART-OF|2408
18505444|The Kv channel blockers amiodarone, tetraethylammonium and verapamil, as well as increased extracellular K+ levels, inhibited proliferation of cultured MSC.|verapamil|Kv channel|9|2.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2409
23151004|  A number of integral membrane G protein-coupled receptors (GPCRs) share common structural features (including palmytoilated aminoacid residues and consensus sequences specific for interaction with cholesterol) that allow them to interact with lipid rafts, membrane cholesterol-rich microdomains able to regulate GPCR signalling and functions.|palmytoilated aminoacid|GPCRs|18|10.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|PART-OF|2410
19029287|(+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) and Ca(v)-DM brains was reduced to 15.1 and 4.4% of wild type, respectively, indicating that Ca(v)1.3 accounts for 10.7% of brain LTCCs. qPCR revealed that Ca(v)1.1 and Ca(v)1.4 alpha(1) subunits comprised 0.08% of the LTCC transcripts in mouse whole brain, suggesting that they cannot account for the residual binding.|(+)-[(3)H]isradipine|LTCCs|1|55.0|Arg1:T7|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|2411
17427197|High D-glucose increases L-arginine transport and eNOS expression following TbetaRII activation by TGF-beta1 involving p42/44(mapk) and Smad2 in HUVEC.|D-glucose|eNOS|2|7.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2412
16782438|CONCLUSIONS: Imatinib inhibits RET-mediated MTC cell growth affecting RET protein levels in vitro in a dose-dependent manner.|Imatinib|RET|3|10.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2413
23229512|Moreover, VK2-2,3 epoxide, an intracellular metabolite of VK2, was shown to covalently bind to the cysteine-166 residue of Bak.|VK2|Bak|10|22.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2414
19302827|Treating VSMC with the prostacyclin analog iloprost induced differentiation (contractile protein expression and contractile morphology), and also up-regulated COX-2 expression, leading to prostacyclin release by VSMC.|iloprost|COX-2|7|22.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2415
8506307|These results demonstrate that the ability of CHO cells to modify glutamic acid residues to gamma-carboxyglutamic acid in secreted factor IX is not limited by the expression of the vitamin K-dependent gamma-carboxylase alone.|gamma-carboxyglutamic acid|factor IX|16|20.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|PART-OF|2416
17434872|Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.|lumiracoxib|human COX-2|30|14.0|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|2417
23019137|Reversal of inhibition by D2 agonist quinpirole was produced by serotonin (50 µM) and by neurotensin (5-10 nM).|quinpirole|D2|7|5.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|AGONIST|2418
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|AVM|P-gp|4|8.0|Arg1:T17|Arg2:T46|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2419
9631585|  A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia (t-AML) after chemotherapy consisting of treatment with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and an alkylating agent, cyclophosphamide.|etoposide|DNA-topoisomerase II|26|22.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR|2420
18381445|Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.|Statins|histone deacetylase|1|7.0|Arg1:T5|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|2421
15639300|"Ultimately, clinicians will want to know whether PDE4 inhibitors are anything more than expensive ""designer"" theophylline, the archetypal non-selective phosphodiesterase inhibitor."|theophylline|phosphodiesterase|19|24.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|2422
15975002|CPT-11 and SN-38 may also stimulate the production of pro-inflammatory cytokines and prostaglandins (PGs), thus inducing the secretion of Na(+) and Cl(-).|CPT-11|cytokines|1|11.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2423
23146758|The aromatase inhibitor CGS 16949A abolished this stimulatory activity and reduced estradiol levels in the control and treatment groups.|estradiol|aromatase|12|2.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-N|PRODUCT-OF|2424
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline alphoscerate|AChE|10|15.0|Arg1:T20|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|2425
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|D6D|46|8.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|2426
15206110|Even though its inability to shift between the trivalent and a divalent oxidation state precludes that gallium behaves as an iron analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with transferrin and transferrin receptor-mediated endocytosis.|iron|transferrin receptor|21|43.0|Arg1:T25|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR|2427
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|atosiban|vasopressin V1A/oxytocin receptor|29|25.0|Arg1:T19|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST|2428
10655292|  The feasibility of administering a relatively high dose of the gonadotrophin-releasing hormone (GnRH) antagonist ganirelix by means of a needle-free injection device, which could be useful in the long-term treatment of sex-steroid-dependent disorders, was evaluated in a randomized, crossover study in 16 healthy females.|ganirelix|GnRH|17|14.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|2429
15887238|Inhibitors and neutralizing antibodies against heparin-binding epidermal growth factor-like growth factor (HB-EGF), and to a lesser extent transforming growth factor-alpha, reduced imatinib-mediated mitogen activated protein kinase (MAPK) activation.|imatinib|mitogen activated protein kinase|26|27.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR|2430
1438284|The mutated enzyme was also inhibited well by the bulky, BtChoEase-selective organophosphate inhibitor (tetraisopropylpyrophosphoramide, iso-OMPA).|iso-OMPA|BtChoEase|18|12.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2431
17254025|The latter reaction, catalyzed by aspartoacylase (ASPA), produces acetyl groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter.|acetyl|aspartoacylase|13|7.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF|2432
16828882|The cholesterol-lowering drug simvastatin inhibits LFA-1 signaling by binding to an allosteric site on CD11a (LFA-1 alpha chain), which leads to immunomodulation.|simvastatin|LFA-1|4|6.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2433
23471769|Adenosine and dipyridamole are nonselective adenosine receptor agonists that have been associated with myocardial infarction (MI) during intravenous infusion.|Adenosine|adenosine receptor|1|6.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|AGONIST|2434
16232421|A double mutant of the two fumarate reductase isozyme genes (OSM1 and FRDS) showed a succinate productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.|succinate|FRDS|18|14.0|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|2435
23247009|  Aldose reductase (AR) catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).|aldehydes|Aldose reductase|12|1.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE|2436
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|meperidine|SERT|11|48.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2437
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|Δ(5)-androstenediol|ERα|7|42.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2438
23261589|This was confirmed on adding LY294002 the PI3K inhibitor which abolished the protection.|LY294002|PI3K|6|8.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR|2439
23391631|The direct evidence for the involvement of CYP1A1 in the induction of cardiotoxicity by Pb(2+) was evidenced by the ability of AhR antagonist, resveratrol, to significantly inhibit the Pb(2+)-modulated effect on β-MHC and α-MHC mRNAs. It was concluded that acute lead exposure induced cardiotoxicity through AhR/CYP1A1-mediated mechanism.|Pb(2+)|β-MHC|34|41.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2440
19029287|  The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.|DHP|Ca(v)1.3|24|15.0|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2441
7944828|The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).|(+/-)-pindolol|beta-adrenoceptor|62|51.0|Arg1:T6|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|2442
15561708|Besides mitochondrial AtNFS1 and plastidial AtNFS2, which are both proposed to be involved in iron-sulfur cluster formation, ABA3 is proposed to be a third and cytosolic NifS-like cysteine desulfurase in A.|iron-sulfur|AtNFS1|16|3.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF|2443
22080037|Here, we report biochemical evidence that mercury alone induces NF-κB activation, resulting in the induced expression of COX-2 and iNOS.|mercury|NF-κB|8|11.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|2444
12181427|We changed the residues to alanine using site-directed mutagenesis technique, expressed the mutants in a baculovirus/Sf9 cell system, and analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol, specific inhibitors of PDE3.|alanine|PDE3|6|40.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|PART-OF|2445
23625779|Amino-functionalized MCM-41 (AM-41) shows an effect on the amount of OVA binding, with 2.5-fold increase in binding capacity (72 mg OVA/g AM-41) compared to nonfunctionalized MCM-41 (29 mg OVA/g MCM-41).|MCM-41|OVA|2|25.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2446
8001268|  We compared the cardiac electrophysiological actions of two types of H1-receptor antagonists--the piperidines, astemizole and terfenadine, and the nonpiperidines, chlorpheniramine and pyrilamine-in vitro in guinea pig ventricular myocytes and in vivo in chloralose-anesthetized dogs.|piperidines|H1-receptor|15|11.0|Arg1:T21|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST|2447
23246867|IPA3 also ablated glucose-stimulated insulin granule accumulation at the plasma membrane, consistent with its role in sustained/second-phase insulin release.|glucose|insulin|4|5.0|Arg1:T13|Arg2:T52|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2448
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|Seliciclib|cyclin-dependent kinases|8|16.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2449
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|CYC202|cyclin-dependent kinases|6|16.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2450
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|propranolol|human beta-adrenergic receptors|39|73.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST|2451
15148258|6 In conclusion, these data demonstrate that the anticancer drug amsacrine is an antagonist of cloned HERG potassium channels, providing a molecular mechanism for the previously reported QTc interval prolongation during clinical administration of amsacrine.|amsacrine|HERG potassium channels|12|18.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST|2452
23393220|Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.|harmaline|CYP2D6|19|15.0|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|2453
10381508|Recombinant factor IXR94S was activated by factor XIa/calcium with an approximately 50-fold reduced rate and by factor VIIa/tissue factor/phospholipid/calcium with an approximately 20-fold reduced rate compared with wild-type factor IX.|calcium|R94S|20|4.0|Arg1:T5|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR|2454
10697523|  Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively.|pyrimidine nucleotide|thymidine kinase|18|4.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF|2455
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|dofetilide|HERG|26|1.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2456
23237733|  Isoliquiritigenin, a herbal ingredient with chalcone structure, has been speculated to be able to inhibit one of the most drug-metabolizing enzymes (DMEs) UDP-glucuronosyltransferase (UGT).|Isoliquiritigenin|UDP-glucuronosyltransferase|1|27.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|2457
9843368|Here we present the crystal structure of the dimeric catalytic domain (residues 117-424) of human phenylalanine hydroxylase (hPheOH), cocrystallized with various potent and well-known catechol inhibitors and refined at a resolution of 2.0 A.|catechol|hPheOH|30|21.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2458
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|Ru 24969|5-HT2C|22|14.0|Arg1:T10|Arg2:T62|CHEMICAL|GENE-Y|AGONIST|2459
9760035|All three compounds displayed antagonistic properties against oxytocin in vitro, with carbetocin being the strongest inhibitor (pA2 = 8.21) and carbetocin metabolite II (pA2 = 8.01) being stronger than carbetocin metabolite I (pA2 = 7.81).|carbetocin|oxytocin|35|8.0|Arg1:T5|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|2460
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|BCRP|43|15.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|2461
23334943|  BACKGROUND: Two clinical trials have shown that users of 5α-reductase inhibitors finasteride and dutasteride (5-ARIs) have reduced overall prostate cancer risk, while the proportion of high-grade tumors is increased.|dutasteride|5α-reductase|15|11.0|Arg1:T4|Arg2:T6|CHEMICAL|GENE-N|INHIBITOR|2462
17567713|Recently, it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfame-K.|acesulfame-K|T2R|27|12.0|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|2463
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|bumetanide-sensitive sodium potassium 2 chloride cotransporter|20|7.0|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|2464
22989705|The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-α), nuclear factor kappa B (NF-κB) genes expression in cisplatin injected rats.|pioglitazone|NF-κB|6|34.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2465
16735460|K114I, located within transmembrane helix 4, showed [14C]succinate uptake similar to WT but relatively small inward currents.|[14C]succinate|K114I|10|1.0|Arg1:T29|Arg2:T43|CHEMICAL|GENE-N|SUBSTRATE|2466
23317159|JAK2 ATP-competitive inhibitors that indirectly inhibit the JAK-STAT pathway are new candidates for the treatment of MPN.|ATP|JAK2|2|1.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2467
23537890|It can be concluded that the quercetin's induction of HO-1 and its byproducts, without concomitant NOS-2 activity reduction, is among mechanisms contributing to the hepatoprotective effect in d-GalN/LPS hepatotoxicity.|quercetin|HO-1|7|11.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2468
23478800|Subsequent analysis revealed that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers.|cucurbitacin I|RhoA|5|9.0|Arg1:T12|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|2469
23204517|We show here that the acidic sequence of PEP-19 has intrinsic Ca(2+) binding activity, which may modulate Ca(2+) binding to CaM by stabilizing an initial Ca(2+)-CaM complex or by electrostatically steering Ca(2+) to and from CaM.|Ca(2+)|PEP-19|12|9.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2470
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|ICRF-187|DNA topoisomerase II|3|18.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2471
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|IL-6|5|52.0|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2472
23557993|Effects of DPHD were eliminated by the estrogen receptor antagonist ICI182780.|DPHD|estrogen receptor|3|8.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|2473
3002801|Enprofylline antagonized the 5'-N-ethylcarboxamidoadenosine (NECA)-induced stimulation of platelet adenylate cyclase activity with a KB of 130 microM.|NECA|adenylate cyclase|6|12.0|Arg1:T7|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR|2474
11980628|RESULTS: SOM230 binds with high affinity to SRIF receptor subtypes sst1, sst2, sst3 and sst5 and displays a 30- to 40-fold higher affinity for sst1 and sst5 than Sandostatin (octreotide; SMS 201-995) or Somatuline (BIM 23014).|SOM230|sst3|3|16.0|Arg1:T28|Arg2:T67|CHEMICAL|GENE-N|DIRECT-REGULATOR|2475
15126366|PKC-delta in particular showed a different pattern of translocation in response to I3A and PMA.|I3A|PKC-delta|13|1.0|Arg1:T20|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2476
14642426|Ginsenosides Rb2, Rd and Rg1 significantly decreased norepinephrine and/or epinephrine-induced increase of IL-6 level in macrophage cell line (RAW 264.7).|norepinephrine|IL-6|9|14.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2477
23261865|Selective antagonism of A(2A) adenosine receptors by ZM241385 significantly prevents or delays the appearance of AD and protects from the irreversible block of neurotransmission induced by 9-min OGD in the DG.|ZM241385|A(2A) adenosine receptors|11|4.0|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST|2478
23237733|Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.|4-methylumbelliferone|UGT|13|10.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|SUBSTRATE|2479
15673388|"  INTRODUCTION: The principal aim of this study was to assess the efficacy of quinidine in suppressing IKr in vitro and in modulating the rate dependence of the QT interval in the ""SQT1"" form of the short QT syndrome."|quinidine|IKr|15|18.0|Arg1:T5|Arg2:T8|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2480
12657913|  The effects of histamine H1-receptor antagonists, promethazine and homochlorcyclizine, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.|homochlorcyclizine|CYP2D6|10|18.0|Arg1:T19|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2481
11553608|ABA3 is a two-domain protein with a N-terminal NifS-like sulfurase domain and a C-terminal domain that might be involved in recognizing the target enzymes.|N|ABA3|8|1.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|PART-OF|2482
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|etravirine|hPXR|3|19.0|Arg1:T11|Arg2:T47|CHEMICAL|GENE-Y|AGONIST|2483
10082498|This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting Ang II receptor blockade than that of valsartan and losartan in normotensive subjects.|losartan|Ang II receptor|31|22.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2484
23601990|  A series of phosphorylated flavonoids were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase (CEase) and acetylcholinesterase (AChE).|phosphorylated flavonoids|acetylcholinesterase|4|22.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|2485
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|ALA|Delta 6 desaturase|48|4.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|2486
22708686|The mianserin analogue mirtazapine also displayed kappa-opioid agonist activity.|mirtazapine|kappa-opioid|4|7.0|Arg1:T23|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|2487
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|vardenafil|F820A|6|57.0|Arg1:T34|Arg2:T59|CHEMICAL|GENE-N|DIRECT-REGULATOR|2488
15771438|Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II.|4,5-cyclic sulfate|human CA-II|12|26.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2489
23526814|Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-α-tubulin levels in human acute myeloid leukemia U937 cells.|hydroxamates|acetyl-α-tubulin|18|23.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2490
11350861|In conclusion, AS-8112 is a potent dopamine D2, D3 and 5-HT3 receptors antagonist, and a novel anti-emetic agent with a broad-spectrum of anti-emetic activity.|AS-8112|5-HT3 receptors|4|13.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST|2491
10864881|Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM.|[(3)H]-BTX-B|neurotoxin site 2|13|23.0|Arg1:T24|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|2492
9732824|Both the 5 alpha-reductase inhibitor finasteride and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.|prazosin|alpha 1-adrenoceptor|18|8.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-N|ANTAGONIST|2493
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK-A|27|38.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2494
7853212|In human hepatic microsomes, mepyramine inhibited the debrisoquine 4-hydroxylation activity catalyzed by P450 2D6.|debrisoquine|P450 2D6|9|14.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|2495
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hENT2|11|20.0|Arg1:T12|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2496
15943176|  The aim of this study was to compare the in vivo effects on free radical metabolism of 2 non-steroidal anti-inflammatory drugs (NSAIDs): tenoxicam, an oxicam preferentially cyclooxygenase-1 (COX-1) inhibitor, and celecoxib, a sulfonamide selective COX-2 inhibitor.|tenoxicam|cyclooxygenase-1|26|31.0|Arg1:T2|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|2497
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|selegiline|MAO-A|17|34.0|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|2498
15991886|Lubiprostone activates a specific chloride channel (CLC2) on cells lining the gut, thereby naturally increasing intestinal fluid secretion.|Lubiprostone|chloride channel|1|5.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR|2499
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|p38 MAPK|11|44.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|2500
15736931|Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I.|lysine|bovine beta-1,4-galactosyltransferase I|6|12.0|Arg1:T37|Arg2:T57|CHEMICAL|GENE-Y|PART-OF|2501
23528251|Phenobarbital (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and vascular endothelial growth factor-a.|Phenobarbital|CAR|1|8.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|2502
23542513|In addition, cobalt protoporphyrin (CoPP), a specific HO-1 inducer, predominantly suppressed LPS-induced NO production.|cobalt protoporphyrin|HO-1|4|12.0|Arg1:T20|Arg2:T49|CHEMICAL|GENE-Y|ACTIVATOR|2503
11811354|Cyclooxygenase-1 (COX-1) inhibitors (flurbiprofen, ketoprofen and ketrolack) attenuated the nicotine-induced contraction in a concentration-dependent manner, and cyclooxygenase-2 (COX-2) inhibitors at high concentrations (nimesulide and NS-389) slightly attenuated the contraction.|ketoprofen|COX-1|9|3.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|2504
7905294|  Maximal L-glutamate/glycine-evoked currents were inhibited by ethanol in Xenopus laevis oocytes expressing recombinant heteromeric NMDA receptors consisting of NR1-NR2A, NR1-NR2B, and NR1-NR2C subunit combinations.|ethanol|NR1|7|24.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2505
23266270|DPEP inhibited LPS-induced phosphorylation of ERK, JNK, and p38.|DPEP|JNK|1|8.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|2506
20600573|However, both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of rasagiline does not depend on inhibition of MAO-B, but rather is associated with the N-propargyl moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating Bcl-2 family proteins.|N-propargyl|Bcl-2|41|54.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2507
11695891|Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.|nitro indazole|nitric oxide synthase|9|4.0|Arg1:T14|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|2508
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|human permeability glycoprotein|43|2.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|SUBSTRATE|2509
23248200|In conclusion, these studies indicate that several oral antidiabetic drugs affect the OATP1B1-mediated uptake of rosuvastatin in vitro.|rosuvastatin|OATP1B1|17|14.0|Arg1:T11|Arg2:T23|CHEMICAL|GENE-Y|SUBSTRATE|2510
16326016|Given that glutamine is the predominant precursor for releasable pools of glutamate, our observation that estradiol increases glutamine synthetase gene and protein expression suggests that hormonal regulation of glutamate neurotransmission involves hormonally responsive glia.|estradiol|glutamine synthetase|17|19.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2511
12601049|RU486 treatment prevented budesonide-mediated inhibition of VEGF secretion and VEGF mRNA expression.|RU486|VEGF|1|10.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2512
23550937|IC50 values for an expanded set of curcumin analogues established a rank order of potencies, and analyses of IKKβ and AKT2 enzyme kinetics for 4 revealed a mixed inhibition model, ATP competition dominating.|curcumin|AKT2|8|22.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|2513
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|cholesterol|LXR|3|18.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-N|DIRECT-REGULATOR|2514
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|sunitinib|PDGFR-beta|28|40.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|2515
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|myristoyl-CoA|CrAT|15|24.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|2516
23471964|Also, cells containing a triple-cysteine mutant of maspin showed elevated ERK1/2 activity, a downstream target of ROS, and enhanced proliferation and colony formation.|cysteine|maspin|7|9.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|PART-OF|2517
10653606|Inclusion of resveratrol reduced the melittin-dependent inhibition of PLA(2) and caused an increase in quinacrine-stimulated PLA(2) activity.|quinacrine|PLA(2)|18|19.0|Arg1:T11|Arg2:T41|CHEMICAL|GENE-N|ACTIVATOR|2518
23231492|"We aim to ""tilt"" the stability of the H1 loop structure from a noncanonical conformation to a (humanized) type 1 canonical conformation by studying the effect of selected mutations to the amino acid sequence of the H1, H2, and proximal residues."|amino acid|H1|36|41.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|PART-OF|2519
17553661|  4-Hydroxynonenal (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (GST) isoforms.|4-HNE|glutathione S-transferase|3|21.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE|2520
23524313|The high fat diet dramatically increased the transcript levels of CYP7A1, which was subsequently reversed by the fisetin.|fisetin|CYP7A1|19|11.0|Arg1:T14|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2521
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|DPP-4|1|17.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2522
19620795|Since they do not have inhibitory activity against mTORC2 complex, the ability of mTOR inhibition by Temsirolimus is supposed to be 40 to 50% of full inhibition in mTOR kinase.|Temsirolimus|mTOR|18|15.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|2523
23179349|The decrease in insulin and nitric oxide in rats fed the diet high in iron, fat, fructose, and salt was associated with disorders of zinc, copper, and calcium status, as well as with an increase in the relative mass of the gonads.|fructose|insulin|19|4.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2524
8161345|In contrast, xanthine oxidase oxidized 5-ethynyl-2(1H)-pyrimidinone to 5-ethynyluracil with a substrate efficiency that was only 0.02% that of xanthine.|xanthine|xanthine oxidase|25|4.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|2525
23354536|The data suggest that the decrease in tissue levels of 5-HT produced by MDMA is accompanied by a decrease in tryptophan hydroxylase activity but cannot be explained by supersensitivity of the 5-HT1a autoreceptor.|5-HT|tryptophan hydroxylase|11|21.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2526
8740147|Amezinium is much less potent as a MAO inhibitor in cells with the uptake2 transporter, such as the myocardial cells of the heart.|Amezinium|MAO|1|8.0|Arg1:T17|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR|2527
14629008|  Trimethoprim (TMP), an inhibitor of dihydrofolate reductase, decreases the level of tetrahydrofolate supplying one-carbon units for biosynthesis of nucleotides, proteins, and panthotenate.|Trimethoprim|dihydrofolate reductase|1|9.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2528
11723241|Dofetilide blocked the triply mutated bEAG T432S/A443S/A453S with an IC(50) value of 1.1 microM.|Dofetilide|T432S|1|7.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2529
7678677|We conclude that alprenolol and BAAM are competitive slowly reversible beta 1-adrenoceptor antagonists on rat left atria.|BAAM|beta 1-adrenoceptor|6|11.0|Arg1:T11|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST|2530
18773878|RTX treatment also induced foci of RAD51, gamma-H2AX, phospho-Chk1, and phospho-NBS1, although the extent of co-localization with RPA2 foci varied.|RTX|RAD51|1|7.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2531
19427182|First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased alpha-tocopherol secretion in a dose-dependent manner.|alpha-tocopherol|ABCA1|27|21.0|Arg1:T19|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF|2532
23639626|"By ""working upwards"" from mTOR, we observed that TCDD inhibited endogenous and IGF-I-induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1."|TCDD|AKT|12|17.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2533
15169831|We evaluated the effects of systemic ethanol (0.05-2.0 g/kg i.p.), the N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine (MK-801; 0.05-0.2 mg/kg i.v.), the connexin-36 gap junction blocker quinidine (5-20 mg/kg i.v.), the fast-acting barbiturate methohexital (Brevital; 5-10 mg/kg i.v.), and the benzodiazepine chlordiazepoxide (Librium; 5-10 mg/kg i.v.), as well as in situ VTA administration of NMDA and the GABA(A) receptor agonist muscimol, on VTA GABA neuron spontaneous activity and internal capsule stimulus-induced poststimulus spike discharges (ICPSDs).|MK-801|N-methyl-D-aspartate (NMDA) receptor|24|16.0|Arg1:T22|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST|2534
11916794|IMPLICATIONS: Tramadol competitively inhibits norepinephrine transporter function at desipramine-binding sites in the adrenal medullary cells and probably the noradrenergic neurons of the descending inhibitory system.|desipramine|norepinephrine transporter|10|6.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2535
23288144|Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.|Sunitinib|tyrosine kinase|1|4.0|Arg1:T16|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|2536
19057128|These findings indicate that captopril attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of MMP-2 and MMP-9 in rats.|monocrotaline|MMP-9|10|21.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|2537
17653133|  Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethylarginine to generate L-citrulline and is present in large quantities in the kidney.|L-citrulline|Dimethylarginine dimethylaminohydrolase|11|1.0|Arg1:T14|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF|2538
23404443|Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of insulin (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).|glucose|insulin|90|73.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2539
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|epidermal growth-factor receptors|1|49.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2540
23453071|  Previously, we have found that BRN-103, a nicotinamide derivative, inhibits vascular endothelial growth factor (VEGF)-mediated angiogenesis signaling in human endothelial cells.|BRN-103|vascular endothelial growth factor|7|14.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2541
19337422|Prolonged use of tolvaptan leads to increased endogenous levels of AVP and perhaps over-stimulation of V(1A) receptors.|tolvaptan|V(1A) receptors|4|16.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|2542
16997906|  Arginine decarboxylase (ADC) and ornithine decarboxylase (ODC) are involved in the biosynthesis of putrescine, which is the precursor of other polyamines in animals, plants, and bacteria.|putrescine|ornithine decarboxylase|18|7.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|PRODUCT-OF|2543
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|serine|ASCT1|14|7.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|2544
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|aminobenzolamide|CA V|34|4.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2545
20372850|TAS-102 is a novel drug containing trifluorothymidine, which is phosphorylated by TK-1 to its active monophosphated form, that in turn can inhibit TS.|TAS-102|TK-1|1|13.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|2546
23742252|  The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described.|LDK378|anaplastic lymphoma kinase|26|20.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR|2547
2858236|Bevantolol caused hypertension in pithed rats, an effect attenuated by phentolamine, implying that bevantolol may be an alpha-adrenoceptor agonist.|phentolamine|alpha-adrenoceptor|12|20.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2548
10076535|Analogous to the antiandrogens, bicalutamide and hydroxyflutamide, binding of estramustine phosphate metabolites to the androgen receptor was observed.|estramustine phosphate|androgen receptor|12|17.0|Arg1:T4|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2549
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Notch-4|32|17.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2550
22552008|Overexpression of CRBN wild-type protein, but not CRBN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated reductions in c-myc and IRF4 expression and increases in p21(WAF-1) expression.|pomalidomide|c-myc|22|25.0|Arg1:T20|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2551
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|DPP-4|1|8.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2552
23146871|Results confirm that in these cell lines significant Mn(3+) is transported by the Tf mechanism similarly to Fe(3+)Tf transport; although Mn(3+)Tf transport is markedly slower than other Mn transport mechanisms.|Mn(3+)|Tf|9|17.0|Arg1:T6|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|2553
11799102|There was a dose-dependent decrease in plasma renin activity, Ang I, and Ang II following single doses of Aliskiren starting with 40 mg.|Aliskiren|Ang II|21|15.0|Arg1:T26|Arg2:T46|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2554
23201331|It increased the activity of ALP, and osteocalcin was also elevated in response to sweroside (P<0.05).|sweroside|ALP|16|6.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|2555
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-threonine|L-serine dehydratase|26|1.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE|2556
10901669|In contrast, in male rats only exposure to HxCB, which induces mainly CYP2B1 and 2B2, decreased both coagulation factors dramatically up to 88%.|HxCB|coagulation factors|10|21.0|Arg1:T4|Arg2:T44|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2557
1712335|The vasopressor response to the calcium channel activator, BAY-K-8644, which is mediated through the opening of voltage dependent calcium channels and the subsequent translocation of extracellular calcium, was significantly inhibited by carvedilol (1 mg/kg, iv), suggesting that carvedilol is also a calcium channel antagonist, consistent with our previous in vitro studies.|carvedilol|voltage dependent calcium channels|35|19.0|Arg1:T11|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR|2558
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|allopregnanolone|3alpha-HSDs|13|22.0|Arg1:T23|Arg2:T46|CHEMICAL|GENE-N|PRODUCT-OF|2559
16997906|  Arginine decarboxylase (ADC) and ornithine decarboxylase (ODC) are involved in the biosynthesis of putrescine, which is the precursor of other polyamines in animals, plants, and bacteria.|putrescine|ADC|18|4.0|Arg1:T8|Arg2:T13|CHEMICAL|GENE-N|PRODUCT-OF|2560
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|TMA|flavin mono-oxygenase|17|5.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|2561
9581512|  The protein tyrosine kinase (PTK) inhibitor piceatannol is also an inhibitor of the rat liver cyclic AMP-dependent protein kinase (PKA) catalytic subunit (cAK), rat brain Ca(2+)- and phospholipid-dependent protein kinase C (PKC), avian gizzard Ca(2+)-calmodulin-dependent myosin light chain kinae (MLCK), and of wheat embryo Ca(2+)-dependent protein kinase (CDPK) (IC50 values 3, 8, 12, and 19 microM, respectively).|piceatannol|CDPK|9|74.0|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|2562
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|flurbiprofen|PGH synthase-2|20|36.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2563
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|17 alpha-ethinylestradiol|estrogen receptor|6|42.0|Arg1:T5|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2564
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|sorafenib|tyrosine kinase|19|13.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2565
15794712|Imatinib is a small-molecule tyrosine kinase inhibitor of the ABL fusion gene, platelet derived growth factor receptors (PDGFR) and KIT.|Imatinib|ABL|1|10.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2566
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|VEGFR|3|22.0|Arg1:T12|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|2567
23473805|Rp1 and actinomycin D reduced Src activity, and overexpression of active Src decreased the synergistic effect of Rp1 with actinomycin D.|actinomycin D|Src|3|6.0|Arg1:T8|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2568
23615073|We observed a significant reduction in CSE induced luciferase expression, NF-κB DNA binding, I-κBε degradation and c-Rel nuclear translocation in cells pretreated with vitamin C.|vitamin C|NF-κB|26|12.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|2569
18045203|  Oxybutynin (1) is a non-selective muscarinic receptor antagonist that is used clinically for the treatment of urinary incontinence.|Oxybutynin|muscarinic receptor|1|8.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|ANTAGONIST|2570
12652111|PDE4 activity in failing human heart was lower than in rabbit heart and there was no significant difference in the inhibition of human cytosolic cAMP-PDE by cilostazol and milrinone.|milrinone|human cytosolic cAMP-PDE|29|23.0|Arg1:T8|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR|2571
9626023|Some NSAIDs (eg, flurbiprofen, ketoprofen) were COX-1 selective, some (eg, ibuprofen, naproxen) were essentially nonselective, while others (eg, diclofenac, mefenamic acid) were COX-2 selective.|naproxen|COX-1|20|11.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2572
23466342|The suppression of MDR1 promoter activity and protein expression was mediated through mollugin-induced activation of AMP-activated protein kinase (AMPK).|mollugin|MDR1 promoter|13|4.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2573
2083404|However, salicylate moiety appears to interfere with aspirin inhibitory action on platelets and vascular COX.|aspirin|COX|9|16.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2574
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|7.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE|2575
19203467|Only PLZ inhibited MAO and ALA-T and elevated ALA levels.|PLZ|MAO|2|4.0|Arg1:T50|Arg2:T78|CHEMICAL|GENE-N|INHIBITOR|2576
18559268|Taxanes with affinities for microtubules well above their affinities for P-glycoprotein are shown not to be affected by multidrug resistance.|Taxanes|microtubules|1|5.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR|2577
10765977|Further, nitric oxide synthase inhibitor, L-NMMA, prevented this beneficial action of L-arginine-nitric oxide system on essential fatty acid metabolism.|L-NMMA|nitric oxide synthase|8|3.0|Arg1:T18|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR|2578
23376608|In the c-Myc siRNA-transfected and apigenin-treated cells, compared with the apigenin-treated control cells, apoptosis and phosphorylation of p38 and p53 were ameliorated.|apigenin|p38|6|20.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR|2579
23566269|  d-Amino acid oxidase (DAAO) catalyzes the oxidation of d-amino acids including d-serine, a coagonist of the N-methyl-d-aspartate receptor.|d-serine|N-methyl-d-aspartate receptor|14|20.0|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|AGONIST|2580
17094966|D-serine transport was inhibited by alanine, serine, cysteine, glutamine, and asparagine, but not anionic amino acids or cationic amino acids, suggesting that D-serine transport in Muller cells occurs via ASCT2 rather than ASCT1 or ATB0,+.|D-serine|ASCT2|29|36.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE|2581
16876889|These findings suggest that folate metabolism is compartmentalised in Leishmania and that SHMT RNA levels are responsive to environmental conditions.|folate|SHMT|5|13.0|Arg1:T10|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE|2582
7500004|Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.|cocaine|norepinephrine-transporter|10|5.0|Arg1:T25|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|2583
23401473|OATP1B1-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 µM, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 µM, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 µM, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 µM, respectively).|silybin B|OATP1B3|44|3.0|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2584
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|cocaine|NET|27|16.0|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|2585
10882160|  When peripheral decarboxylation is blocked by carbidopa or benserazide, the main metabolic pathway of levodopa is O-methylation by catechol-O-methyltransferase (COMT).|O|catechol-O-methyltransferase|18|20.0|Arg1:T3|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|2586
23050902|It was reported previously that FVII gene (F7) expression was up-regulated by ribavirin treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.|ribavirin|FVII|15|6.0|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2587
23541125|The fine particulate (PM < 2.5 μm) of wood smoke were the most potent TRPA1 agonists and several chemical constituents of wood smoke particulate, 3,5-ditert-butylphenol, coniferaldehyde, formaldehyde, perinaphthenone, agathic acid, and isocupressic acid, were TRPA1 agonists.|perinaphthenone|TRPA1|34|44.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|AGONIST|2588
23422569|Endothelial dysfunction induced by SIRT1 inhibition was prevented by treatment of the vessels with the NADPH oxidase inhibitor apocynin or superoxide dismutase.|apocynin|NADPH oxidase|19|16.0|Arg1:T21|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR|2589
7518029|In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).|haloperidol|pro-opiomelanocortin|5|14.0|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2590
17385063|Responses were blocked by the guanylate cyclase inhibitor methylene blue and were increased by the nitric oxide synthase inhibitor L-NAME, a pattern shared by nitroprusside.|methylene blue|guanylate cyclase|9|6.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2591
9633680|Levodopa is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and catechol-O-methyltransferase (COMT).|Levodopa|catechol-O-methyltransferase|1|19.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|2592
23220614|Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the Bax/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.|ISO|Bax|12|14.0|Arg1:T22|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2593
1881457|Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the transaminase enzymes for gamma-aminobutyric acid and alanine.|gamma-aminobutyric acid|transaminase|18|15.0|Arg1:T20|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2594
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|Catecholamines|phenylalanine hydroxylase|1|16.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2595
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|INNO-406|Src|25|16.0|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2596
23591777|Furthermore, cytochrome P450 2E1 (CYP2E1) content was suppressed while proinflammatory cytokines tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels increased in liver tissue after CCl4 administration.|CCl4|CYP2E1|32|7.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2597
11553608|ABA3 contains highly conserved binding motifs for pyridoxal phosphate and for a persulfide.|pyridoxal phosphate|ABA3|8|1.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2598
11369259|Heparin-binding exosite of factor Xa.   Recent studies have indicated that the basic residues Arg(93), Lys(96), Arg(125), Arg(165), Lys(169), Lys(236), and Arg(240) (chymotrypsin numbering) constitute an exosite in the catalytic domain of factor Xa that can effectively bind heparin only if the acidic N-terminal Gla domain of the proteinase was neutralized by physiological levels of calcium.|Arg|chymotrypsin|29|50.0|Arg1:T11|Arg2:T13|CHEMICAL|GENE-N|PART-OF|2599
17604186|Previous studies have explored the protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) against chemical kindling in mice.|rofecoxib|COX-2|15|18.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2600
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|threonine|neutral amino acid transporter|19|3.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|2601
23204517|We show here that the acidic sequence of PEP-19 has intrinsic Ca(2+) binding activity, which may modulate Ca(2+) binding to CaM by stabilizing an initial Ca(2+)-CaM complex or by electrostatically steering Ca(2+) to and from CaM.|Ca(2+)|CaM|22|28.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2602
23500659|Furthermore, SIL significantly protected against testosterone-provoked decline in mRNA expression of P21(WAF1/Cip1) and Bax/Bcl-xl ratio as well as caspase-3 activity.|testosterone|Bcl-xl|7|19.0|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2603
23473803|Finally, we demonstrated that the PDE4 inhibitory effect of moexipril is functionally able to induce phosphorylation of the small heat shock protein, Hsp20, by cAMP dependent protein kinase A.|moexipril|PDE4|11|7.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|2604
11566608|The considerable potential of the epidermal growth factor receptor-selective tyrosine kinase inhibitor, ZD 1839 (Iressa; AstraZeneca) to efficiently treat, and perhaps even prevent, endocrine-resistant breast cancer is highlighted.|Iressa|epidermal growth factor receptor|17|6.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2605
16207494|  In the present study, age-related changes of pyridoxal 5'-phosphate (PLP) synthesizing enzymes, pyridoxal kinase (PLK) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.|pyridoxal 5'-phosphate|pyridoxal kinase|9|17.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|PRODUCT-OF|2606
23423713|Furthermore, V(5+) significantly inhibited the TCDD-induced AhR-dependent luciferase activity.|TCDD|AhR|10|11.0|Arg1:T22|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2607
18996527|  Nicotinamide N-methyltransferase (NNMT) catalyses the conversion of nicotinamide to 1-methylnicotinamide and plays an important role in hepatic detoxification reactions.|1-methylnicotinamide|Nicotinamide N-methyltransferase|12|1.0|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF|2608
2394753|  In a recent study it has been shown that mitochondrial creatine kinase from chicken brain (Mia-CK) and heart (Mib-CK) are two distinct isoenzymes differing in ten out of the thirty N-terminal amino acids (Hossle, J.P., Schlegel, J., Wegmann, G., Wyss, M., Bohlen, P., Eppenberger, H.M., Wallimann, T., and Perriard J.C. (1988) Biochem.|N-terminal amino acids|mitochondrial creatine kinase|35|10.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|PART-OF|2609
17155857|The most advanced compound is the orally active, selective PDE4 inhibitor cilomilast (Ariflo, SB-207499, cis-4-cyano-4-[3-cyclopentyloxy-4-methoxyphenyl]-cyclohexanecarboxylic acid; GlaxoSmithKline).|Ariflo|PDE4|15|11.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|2610
1361547|Labetalol (> or = 3 x 10(-8) M) and dilevalol (> or = 10(-8) M) caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 8.60 and 8.98 at the beta 1-adrenoceptors of the rat left atria and 7.90 and 8.31, respectively, on the guinea-pig left atria which has functional beta 1- and beta 2-adrenoceptors.|isoprenaline|beta 1-adrenoceptors|31|46.0|Arg1:T17|Arg2:T26|CHEMICAL|GENE-N|AGONIST|2611
17141733|Whereas the affinity of Ce6 for LDL and liposomes increases at lower pH, it decreases for albumin.|Ce6|LDL|5|7.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR|2612
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|atosiban|OT|59|62.0|Arg1:T16|Arg2:T54|CHEMICAL|GENE-Y|ANTAGONIST|2613
10405348|Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.|2-methoxyestradiol|aromatase|15|7.0|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2614
17929114|Because of their strong affinities for the ATP-binding site compared to IM, most ATP-competitive inhibitors may be effective in IM-resistant patients.|IM|ATP-binding site|12|8.0|Arg1:T10|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|2615
21262851|All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only BDZs and pentobarbital induced a negative shift in Ca(v)1.2 channel inactivation.|pentobarbital|Ca(v)1.2|29|35.0|Arg1:T6|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2616
9643444|When given intratracheally with insulin, inhibitors including N-ethylmaleimide, p-chloromercuribenzoic acid, and 1,10-phenanthroline significantly enhanced the absolute bioavailability of insulin and the compound's hypoglycaemic effects.|p-chloromercuribenzoic acid|insulin|11|22.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2617
15381832|Using [14C]choline-labeled gastric mucosal cells in culture, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on phospholipid release was subject to a dose-dependent suppression by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|PD153035|kinase|37|34.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|2618
1327384|The selective alpha 2-adrenoceptor antagonists, idazoxan, yohimbine, rauwolscine and WY 26703 displaced [3H]-RS-15385-197 binding to rat cerebral cortex in a simple manner with Hill slopes close to unity.|[3H]-RS-15385-197|alpha 2-adrenoceptor|16|3.0|Arg1:T37|Arg2:T46|CHEMICAL|GENE-N|DIRECT-REGULATOR|2619
15748157|Atorvastatin significantly protected from glutamate-induced excitotoxicity as evidenced by propidium iodide staining, nuclear morphology, release of lactate dehydrogenase, and mitochondrial tetrazolium metabolism, but not from oxygen-glucose deprivation or apoptotic cell death.|Atorvastatin|lactate dehydrogenase|1|19.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2620
17258485|There was significant inhibition of the I(SC) responses to 30 microM ASC by the flavanoid quercetin (50 microM) and by 100 microM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) and 5-ethylisopropylamiloride (EIPA), blockers of anion exchangers and sodium-proton exchangers, respectively.|DIDS|anion exchangers|31|41.0|Arg1:T26|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|2621
23148920|The NaHS-induced eNOS phosphorylation and NO production were not affected by a PI3K/Akt inhibitor (wortmannin).|NaHS|eNOS|2|3.0|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|2622
11270983|In rings with endothelium of the previously deendothelialized left anterior descending coronary artery, indometacin (inhibitor of cyclooxygenase) and ridogrel (thromboxane A2 receptor antagonist and inhibitor of thromboxane synthase) inhibited contractions to endothelin-1.|ridogrel|thromboxane synthase|22|31.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2623
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|HO-1|10|22.0|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2624
10405348|Both paclitaxel and 2-meOE2 also inhibited stimulation of aromatase activity by IL-6 plus its soluble receptor and PGE(2).|PGE(2)|aromatase|18|9.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR|2625
23296101|Furthermore, sensitization to FITC is also enhanced by menthol, which activates TRPA1 and TRPM8.|FITC|TRPA1|5|14.0|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR|2626
15899831|The novel indole-ether quinazoline AZD2171 is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro.|AZD2171|tyrosine kinase|5|21.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|2627
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|malonyl-CoA|Fatty acid synthase|13|1.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|2628
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|Ca2+|cardiac troponin C|17|18.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2629
23349208|Both fatty acids, but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)γ-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.|EPA|cytokine|13|22.0|Arg1:T14|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2630
10871202|We tested the hypothesis that troglitazone, which improves insulin sensitivity and lowers plasma insulin levels in insulin-resistant obese subjects and patients with type 2 diabetes, would also lower circulating PAI-1 antigen concentrations and activity.|troglitazone|PAI-1|6|32.0|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2631
23017395|Results show the hypolipidemic property of FVW-FO and reduced HMG-CoA reductase activity which is proportional to the incorporation of EPA+DHA.|DHA|HMG-CoA reductase|21|10.0|Arg1:T16|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2632
23423713|Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h.|V(5+)|Cyp1b1|11|27.0|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2633
17554001|We found that glycine is released from vesicles when VIAAT is coexpressed with either the neuronal transporter GlyT2 or the glial transporter GlyT1.|glycine|VIAAT|4|10.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|SUBSTRATE|2634
17567713|We also found that TRPV1 receptors are activated by CuSO(4), ZnSO(4), and FeSO(4), three salts known to produce a metallic taste sensation.|CuSO(4)|TRPV1|10|5.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR|2635
9614060|However, the apparent affinity for lysine transport was 2.4 times lower in Cat1(-/-) cells when compared with wild type cells, a property characteristic of Cat3-mediated transport.|lysine|Cat3|7|30.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|2636
12504917|Reserpine-induced ptosis was reversed by rasagiline at doses above 2 mg x kg(-1) i.p., which inhibit MAO-A as well as MAO-B, but not at MAO-B-selective doses.|Reserpine|MAO-A|1|21.0|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|2637
23183374|AID initiates somatic hypermutation and class switch recombination (CSR) by deaminating cytosine to uracil in specific immunoglobulin (Ig) gene regions.|uracil|AID|16|1.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF|2638
9486667|Thus, the serine in position HERG 620 may participate directly in dofetilide binding; however, an intact C-type inactivation process seems to be crucial for high-affinity drug binding.|serine|HERG|4|7.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|PART-OF|2639
15110853|Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.|adamantyl|Carbonic anhydrase|10|1.0|Arg1:T13|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2640
22815312|At 100 nM total estradiol, a concentration achievable during the third trimester of pregnancy, CYP2B6 activity was predicted to increase by 1.5-3-fold, based on increased CYP2B6 activity and mRNA.|estradiol|CYP2B6|5|29.0|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2641
9013583|The concentration of indomethacin required to activate PPARgamma is in good agreement with that required to induce the differentiation of C3H10T1/2 cells to adipocytes.|indomethacin|PPARgamma|4|8.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR|2642
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|mitoxantrone|TOP2|38|23.0|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2643
23270990|  Valine residues in the pore region of SK2 (V366) and SK3 (V520) were replaced by either an alanine or a phenylalanine to evaluate the impact on the interactions with the allosteric blocker apamin.|phenylalanine|SK2|25|8.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|PART-OF|2644
11319222|A non-TZD PPARgamma ligand, GW1929, which is 7-fold more potent than rosiglitazone, inhibited ACS1 and ACS4 poorly with an IC(50) of greater than 50 microm, more than 100-fold higher than was required for rosiglitazone, thereby demonstrating the specificity of TZD inhibition.|GW1929|PPARgamma|6|3.0|Arg1:T8|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2645
10047461|The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.|Tomudex|cdk2|15|9.0|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|2646
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|IL-8|6|22.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2647
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|succinyl-CoA|5-Aminolevulinic acid synthase|25|1.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE|2648
23252711|We have used DSF to demonstrate that the binding of these compounds is independent of the presence or absence of the C-terminal tail region of CDK9, unlike the binding of the CDK9-selective inhibitor 5,6-dichlorobenzimidazone-1-β-d-ribofuranoside (DRB).|5,6-dichlorobenzimidazone-1-β-d-ribofuranoside|CDK9|35|33.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2649
23603059|Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes, AT1AR and AT1BR following sodium arsenite (SA) treatment.|sodium arsenite|AT1R|21|14.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2650
12472888|Pre-treatment with arsenite increased protein kinase B (Akt) and extracellular signal regulated kinase 1/2 (ERK1/2) phosphorylation after H2O2.|H2O2|protein kinase B|22|5.0|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR|2651
23188391|  The incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic peptide are secreted by enteroendocrine cells and augment glucose-induced insulin secretion in response to food ingestion in a glucose-dependent manner.|glucose|insulin|17|18.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2652
10200320|In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels.|15d-PGJ2|iNOS promoter|5|7.0|Arg1:T15|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR|2653
12416991|These results characterize the role of 3alpha-HSD type III in allopregnanolone formation and suggest that activation of this enzyme by fluoxetine is likely not the mechanism by which fluoxetine increases allopregnanolone concentrations.|allopregnanolone|3alpha-HSD type III|11|7.0|Arg1:T24|Arg2:T44|CHEMICAL|GENE-Y|PRODUCT-OF|2654
11544332|  We have previously isolated from human hemofiltrate an N-terminally truncated form of the hemofiltrate CC chemokine 1 (HCC-1), and characterized HCC-1[9-74] as a strong agonist of CCR1, CCR5, and to a lower extent CCR3.|N|HCC-1|9|19.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|PART-OF|2655
17251447|Ablation of RPE65 in Nrl(-/-) and Rho(-/-) mice led to the absence of 11-cis retinal, but increased the total retinoid content, with retinyl esters representing the most abundant retinoid species.|11-cis retinal|RPE65|20|3.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF|2656
9873034|Imidazole and 1-phenylimidazole promoted iNOSox dimerization, whereas clotrimazole (30 microM) and miconazole (15 microM) did not, and instead inhibited dimerization normally promoted by L-Arg and H4B.|clotrimazole|iNOSox|9|5.0|Arg1:T34|Arg2:T57|CHEMICAL|GENE-Y|INHIBITOR|2657
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|cyclo-oxygenase|37|22.0|Arg1:T8|Arg2:T16|CHEMICAL|GENE-N|PRODUCT-OF|2658
17321471|In LPS-stimulated mouse macrophages, adenosine potently inhibited TNF-alpha production and also potentiated PGE(2) release, though less potently (IC(50)=250 nM vs EC(50) approximately 8 microM, respectively).|adenosine|TNF-alpha|6|9.0|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|2659
23313623|Moreover, OAT1 and OAT3 are the targets of DDI between entecavir and JBP485.|entecavir|OAT1|12|3.0|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|2660
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|nitrendipine|Ca(v)1.2|54|59.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2661
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|c-Kit|24|9.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2662
17325510|The inhibition is presumably through its effects on the Kir6.0 subunit, but not on the SUR subunit, with the binding site different from adenosine triphosphate at the amino acid level.|amino acid|Kir6.0|30|10.0|Arg1:T15|Arg2:T39|CHEMICAL|GENE-N|PART-OF|2663
11006278|  By using the technique of site-directed spin labeling combined with EPR spectroscopy, we have observed that binding of arachidonic acid and nonsteroidal anti-inflammatory drugs induces conformational changes in the human prostaglandin endoperoxide H(2) synthase enzyme (PGHS-2).|arachidonic acid|human prostaglandin endoperoxide H(2) synthase enzyme|20|31.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR|2664
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|ester|rat dopamine transporter|9|40.0|Arg1:T18|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|2665
7853212|Histamine H1 receptor antagonists (mepyramine, diphenhydramine, chlorpheniramine and triprolidine) inhibited the lidocaine 3-hydroxylation activity catalyzed by P450 2D1 but did not inhibit the testosterone hydroxylation activities catalyzed by P450s other than P450 2D forms.|triprolidine|Histamine H1 receptor|12|1.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST|2666
12046682|  Thalidomide--removed from widespread clinical use by 1962 because of severe teratogenicity--has anti-angiogenic and immunomodulatory effects, including the inhibition of TNF alpha.|Thalidomide|TNF alpha|1|25.0|Arg1:T1|Arg2:T4|CHEMICAL|GENE-Y|INHIBITOR|2667
9059856|In order to perform a pharmacological characterization of these receptors, competition binding experiments were carried out using the muscarinic receptor antagonists pirenzepine, (11(2-diethyl-amino)methyl)-1-piperidinylacetyl-5-11-dihydro-6H-py rido(14) benzodiazepine (AF-DX 116), himbacine, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), dicyclomine and hexahydro-sila-difenidol (HHSD).|hexahydro-sila-difenidol|muscarinic receptor|53|20.0|Arg1:T26|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST|2668
23404739|The two analogues with the highest antimigratory activities, sipholenol A 4β-4-chlorobenzoate and 19,20-anhydrosipholenol A 4β-4-chlorobenzoate esters, also exhibited the most potent inhibition of PTK6 phosphorylation inhibition.|19,20-anhydrosipholenol A 4β-4-chlorobenzoate|PTK6|14|26.0|Arg1:T7|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|2669
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|EACA|gp330|17|24.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2670
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|statins|HMG-CoA reductase|6|26.0|Arg1:T17|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2671
12185406|This raises the question as to whether a DAT occupancy of less than 22% is therapeutic or whether there is another mechanism involved during treatment with bupropion.|bupropion|DAT|28|9.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2672
23547652|3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition.|Zinc|Histone Deacetylase|4|9.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2673
23580446|Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by rofecoxib(a selective COX-2 inhibitor) and rescued by exogenous PGE2.|PGE2|COX-2|3|2.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|2674
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|bcr|4|15.0|Arg1:T3|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2675
23296142|Insertion of ERα was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).|bisindolylmaleimide|protein kinase C|23|15.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|2676
23281812|Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks.|Tetrahydropyrroloquinolinone|aldosterone synthase|1|7.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2677
23231967|Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold.|methoxyaryl|adenosine A3 receptor|9|4.0|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|ANTAGONIST|2678
23313794|The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) PhIP (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.|PhIP|glutathioneperoxidase|23|37.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2679
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|uncoupling protein-2|1|19.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2680
7828655|  To study the influence of dopaminergic activity on the expression of dopamine D2 receptors and glutamic acid decarboxylase in substantia nigra, mice were treated daily for several days with an irreversibly acting dopamine D1 and dopamine D2 receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) or with a selective irreversible D2 dopamine receptor antagonist fluphenazine-N-mustard.|EEDQ|dopamine D1|43|34.0|Arg1:T12|Arg2:T39|CHEMICAL|GENE-Y|ANTAGONIST|2681
23293300|BOC, a known substrate for cytochrome P450 (P450) CYP3A and aldo-ketoreductases, was a reversible time-dependent inhibitor (k(inact) = 0.12 minute(-1), K(I) = 6.1 µM) of CYP3A4/5 but not an inhibitor of other major P450s, nor of UDP-glucuronosyltransferases 1A1 and 2B7.|BOC|CYP3A|1|12.0|Arg1:T8|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE|2682
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|estrogen|multidrug resistance-associated protein 2|32|35.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2683
10485486|Similar concentrations of caffeine also inhibit gamma- and UV radiation-induced phosphorylation of p53 on Ser15, a modification that may be directly mediated by the ATM and ATR kinases.|caffeine|ATR|4|28.0|Arg1:T10|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|2684
10388743|  The crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with calcium ions was used to model the solution structure of the light chain of factor VIIa (residues 1-142) in the absence of tissue factor.|calcium|tissue factor|13|9.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2685
9873034|Imidazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.|Imidazole|iNOSox|1|13.0|Arg1:T28|Arg2:T56|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2686
1336906|  Dihydrotachysterol3, a reduced (or hydrogenated) analog of vitamin D3 in which the A ring has been rotate through 180 degrees , is, after hepatic 25-hydroxylation, converted in vivo to a dihydroxylated metabolite, termed peak H, which is at present unidentified but with good affinity for the vitamin D receptor.|Dihydrotachysterol3|vitamin D receptor|1|54.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2687
23043184|The results show that CYP2E1 inhibits CYP2B4-mediated metabolism of benzphetamine (BNZ) with a K(i) of 0.04 µM.|BNZ|CYP2B4|12|7.0|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|2688
17603759|Purified mMDH catalysed the reduction of alpha-ketoglutarate to L-2-hydroxyglutarate with a catalytic efficiency that was about 10(7)-fold lower than that observed with oxaloacetate.|oxaloacetate|mMDH|27|2.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|2689
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|spermine|spermidine/spermine N(1)-acetyltransferase|5|12.0|Arg1:T15|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|2690
15887238|Western blot analysis of cells incubated with imatinib demonstrated activation of EGFR and downstream signaling that was reduced by inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase 1 (MEK1) and EGFR, but not Her2/ErbB2.|imatinib|EGFR|8|12.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2691
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|2-oxobutyrate|SDH|31|4.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF|2692
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|(AR)s|6|18.0|Arg1:T56|Arg2:T79|CHEMICAL|GENE-N|AGONIST|2693
23574807|  Twelve alkyl analogues (1-12) of the high-affinity serotonin transporter (SERT) inhibitor 6-nitroquipazine (6-NQ) were synthesized and studied using in vitro radioligand competition binding assays to determine their binding affinity (Ki ).|6-nitroquipazine|SERT|16|13.0|Arg1:T9|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2694
15102890|The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs. Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).|glyburide|ABCA1|17|4.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|2695
8301142|13-cis-retinoic acid, retinol, retinaldehyde, all-trans etretin, Ro 13-6298, and 9-cis retinoic acid also inhibited IL-1-induced IL-6 production.|retinaldehyde|IL-6|6|21.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2696
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|serine|neutral amino acid transporter|14|3.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|2697
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|(R)-Roscovitine|cyclin-dependent kinases|1|16.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2698
15650315|  BACKGROUND: Pranlukast, a cysteinyl leukotriene receptor 1 (CysLTR1) antagonist, inhibits not only airway smooth muscle contraction, but also allergic inflammation.|Pranlukast|cysteinyl leukotriene receptor 1|3|6.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|2699
19837759|(18)F-AV-45 displayed excellent binding affinity to Abeta plaques in the AD brain by ex vivo autoradiography in transgenic AD model mice.|(18)F-AV-45|Abeta|1|10.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2700
23301856|  Abstract Bombesin and its derivatives exhibit a high affinity for gastrin-releasing peptide receptor (GRPr), which is over-expressed in a variety of human cancers (prostate, pancreatic, lung, etc.).|Bombesin|gastrin-releasing peptide receptor|2|11.0|Arg1:T11|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2701
23274087|Our results suggest that kinases SAP/JNK and p38 up-regulation may play a role in the early stages of 6-OHDA toxicity to trigger intrinsic pathways for apoptosis and enhanced NF-κB activation.|6-OHDA|NF-κB|19|29.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|ACTIVATOR|2702
11092898|The triple mutation F316C/V356S/G400L produced a 40-fold shift in desipramine affinity.|desipramine|V356S|10|5.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR|2703
16627864|In addition, the HO pathway was blocked after dobutamine pretreatment with 10 micromol/kg tin-mesoporphyrin-IX (Dob/SnMP/Shock) or animals received 100 mg/kg of the carbon monoxide donor dichloromethane (DCM/Shock).|mesoporphyrin-IX|HO|16|5.0|Arg1:T28|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|2704
12085361|In complementary RNA (cRNA)-injected Xenopus laevis oocytes, rifamycin SV (10 micromol/L) cis-inhibited human organic anion transporting polypeptide C (SLC21A6) (OATP-C), human organic anion transporting polypeptide 8 (SLC21A8) (OATP8), human organic anion transporting polypeptide B (SLC21A9) (OATP-B), and human organic anion transporting polypeptide A (SLC21A3) (OATP-A) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes.|rifamycin SV|SLC21A9|12|52.0|Arg1:T18|Arg2:T55|CHEMICAL|GENE-Y|INHIBITOR|2705
23161664|Cadmium (Cd), an inducer of reactive oxygen species, inhibited HIF-1α mRNA expression and HIF-1α binding to the LO gene in Co-treated cells as revealed by RT-PCR and ChIP assays, respectively.|Cd|LO|3|22.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2706
12742526|Even though the activities of MAT and GNMT were elevated, the concentration of liver S-adenosylmethionine was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice.|S-adenosylmethionine|GNMT|16|8.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|2707
23325562|Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3β at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.|ursolic acid|GSK3β|3|19.0|Arg1:T13|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|2708
18847313|Plerixafor (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4.|Plerixafor|CXCR4|1|29.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|2709
12904467|Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy.|Topiramate|AMPA-receptor|1|6.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2710
10698696|  Ornithine decarboxylase (ODC) catalyses the first step in the synthesis of the polyamines putrescine, spermidine and spermine.|spermidine|Ornithine decarboxylase|18|1.0|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|PRODUCT-OF|2711
2986673|Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins.|chlorpromazine|calmodulin|6|10.0|Arg1:T16|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2712
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|vardenafil|H613A|7|16.0|Arg1:T15|Arg2:T45|CHEMICAL|GENE-N|DIRECT-REGULATOR|2713
23337530|In THP-1 cells, anagliptin reduced lipopolysaccharide-induced TNF-α production with inhibiting ERK phosphorylation and nuclear translocation of nuclear factor-κB.|anagliptin|ERK|5|12.0|Arg1:T10|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|2714
18336310|  Inhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms present in the eyes (CA I, II, IV and XII), with sulfonamides such as acetazolamide, methazolamide, ethoxzolamide and dichlorophenamide, is still widely used for the systemic treatment of glaucoma.|acetazolamide|EC 4.2.1.1|31|8.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|2715
23528251|Cobalt chloride, a typical HIF activator, induced the gene expression of CAR-target genes, including cyp2b9 and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver.|Cobalt chloride|cyp2b9|1|18.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2716
23197773|Dose-response re-determinations during chronic treatment revealed the following: 1) >250-fold (AM411, methanandamide) and >45-fold (AM4054, WIN55,212.2, Δ(9)-THC) rightward shifts in the ED(50) values for CB(1) agonists; 2) >100-fold and >20-fold leftward shifts in the ED(50) values for SR141716A and AM4113, respectively; and 3) approximately 4.8-fold and 10-fold rightward shifts in the ED(50) values for methamphetamine and the DA D(2) agonist R-(-)-NPA, respectively.|R-(-)-NPA|DA D(2)|98|92.0|Arg1:T19|Arg2:T40|CHEMICAL|GENE-Y|AGONIST|2717
7957034|  Using PET, reduced glucose metabolism (rCMRglu) and increased binding of the mu opiate receptor ligand 11C-carfentanil have been demonstrated in lateral temporal cortex overlying mesial temporal epileptic foci.|11C-carfentanil|mu opiate receptor|19|15.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2718
23562928|Anti-inflammatory activity of hexane extracts from bones and internal organs of Anguilla japonica suppresses cyclooxygenase-2-dependent prostaglandin D2 generation in mast cells and anaphylaxis in mice.|prostaglandin D2|cyclooxygenase-2|16|15.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF|2719
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|indomethacin|ATPase|5|24.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2720
12488248|GA stimulation of ES transport by oocytes coexpressing rabbit Na(+)-dicarboxylate cotransporter 1 and rat Oat3 was significantly inhibited when the preloading medium contained Li(+) or methylsuccinate (MS) or when Na(+) was absent.|ES|rabbit Na(+)-dicarboxylate cotransporter 1|4|9.0|Arg1:T31|Arg2:T51|CHEMICAL|GENE-Y|SUBSTRATE|2721
10471277|Labeling with [(125)I]IAS was blocked by 10 microM (-)-alprenolol and inhibited by addition of GTP gamma S, and [125I]IAS migrated at the same position on an SDS-PAGE gel as the beta 2AR labeled by the antagonist photoaffinity label [125I]iodoazidobenzylpindolol ([125I]IABP).|[125I]iodoazidobenzylpindolol|beta 2AR|52|44.0|Arg1:T6|Arg2:T34|CHEMICAL|GENE-N|DIRECT-REGULATOR|2722
21262851|BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.|ethanol|L-type voltage-gated calcium channels|15|23.0|Arg1:T19|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR|2723
10567921|  The N-terminus of the type 1 interferon receptor subunit, IFNAR1, has high amino acid sequence similarity to the receptor binding B subunit of the Escherichia coli-derived verotoxin 1, VT1.|N|IFNAR1|2|11.0|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|PART-OF|2724
19897080|The homologous location in the alpha3beta4 AChR is between the serine and valine/phenylalanine rings.|phenylalanine|alpha3beta4 AChR|14|6.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|PART-OF|2725
12023686|The effects of losartan and valsartan on cGMP were completely inhibited by AT2-receptor blockade.|losartan|AT2|4|13.0|Arg1:T10|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|2726
23284002|In addition, TSA induced Nrf2 nuclear translocation and up-regulated the expression of Nrf2-ARE downstream antioxidant genes, whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation.|TSA|ARE|4|15.0|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2727
14766200|  Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an enzyme that metabolizes methylated arginine to citrulline and methylamine, thus working to produce nitric oxide (NO).|methylamine|DDAH1|17|5.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|PRODUCT-OF|2728
23446230|However, whether increasing EETs production by CYP2J2 overexpression in vivo could prevent abdominal aortic aneurysm (AAA) remains unknown.|EETs|CYP2J2|5|8.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF|2729
16322797|Its special profile of actions, especially the rise in HDL-cholesterol levels induced by nicotinic acid, is unique among the currently available pharmacological tools to treat lipid disorders.|nicotinic acid|HDL|15|11.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2730
17429625|  PURPOSE: Dasatinib (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.|BMS-354825|BCR|5|17.0|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2731
17228881|The kinetic parameters for the CO2 hydration reaction proved hCA VI to possess a kcat of 3.4 x 10(5) s-1 and kcat/KM of 4.9 x 10(7) M-1 s-1 (at pH 7.5 and 20 degrees C).|CO2|hCA VI|6|10.0|Arg1:T13|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|2732
2865685|Dose-response curves for stimulation of both rate and force by the beta 2-selective agonists procaterol and zinterol were shifted to a much greater extent by selective blockade of beta 1-adrenoceptors with metoprolol than by selective blockade of beta 2-adrenoceptors with ICI 118,551, suggesting that these compounds caused their effects by activating beta 1-adrenoceptors.(ABSTRACT TRUNCATED AT 400 WORDS)|ICI 118,551|beta 2-adrenoceptors|41|38.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2733
15465654|  Troglitazone, bosentan and glibenclamide inhibit the bile salt export pump (Bsep) which transports taurocholate into bile.|taurocholate|Bsep|17|13.0|Arg1:T17|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE|2734
11319222|alpha-Tocopherol, whose ring structure forms the non-TZD portion of troglitazone, did not inhibit ACS4, indicating that the thiazolidine-2,4-dione moiety is the critical component for inhibition.|thiazolidine-2,4-dione|ACS4|21|16.0|Arg1:T6|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2735
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|nitric oxide|iNOS|14|6.0|Arg1:T36|Arg2:T52|CHEMICAL|GENE-Y|PRODUCT-OF|2736
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|(R)-Roscovitine|CDKs|1|19.0|Arg1:T11|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|2737
23201180|Fenamiphos is recalcitrant to the hydrolysis by alloforms PON1 Q192R of human serum.|Fenamiphos|Q192R|1|10.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|2738
15060759|  To verify the hypothesis that the non-conventional partial agonist (-)-CGP12177 binds at two beta(1)-adrenoceptor sites, human beta(1)-adrenoceptors, expressed in CHO cells, were labelled with (-)-[(3)H]-CGP12177.|(-)-CGP12177|beta(1)-adrenoceptor|10|17.0|Arg1:T25|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2739
16627864|In addition, the HO pathway was blocked after dobutamine pretreatment with 10 micromol/kg tin-mesoporphyrin-IX (Dob/SnMP/Shock) or animals received 100 mg/kg of the carbon monoxide donor dichloromethane (DCM/Shock).|dichloromethane|HO|29|5.0|Arg1:T32|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR|2740
1665782|Our conclusion is that chronic DPDPE treatment preferentially reduces delta-opioid receptor binding activity.|DPDPE|delta-opioid receptor|6|10.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|2741
3139361|For the binding to the progesterone receptor, both Org 2058 and Org 3236 (or 3-keto-desogestrel) were used as labelled ligands.|Org 2058|progesterone receptor|10|6.0|Arg1:T23|Arg2:T49|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2742
23050902|We observed that ribavirin enhanced ELL3 recruitment to F7, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.|ribavirin|FVII|16|17.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2743
23385959|Notably, the antioxidant Trolox™ reversed the Mn (20 mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the Mn (20 mg/kg)-induced caspase activity and F(2)-isoprostane production.|Trolox|p38|5|16.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2744
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|glutathione|MRP2|5|28.0|Arg1:T18|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|2745
18061638|Norethisterone activated PR, AR, and ERalpha.|Norethisterone|PR|1|3.0|Arg1:T22|Arg2:T56|CHEMICAL|GENE-Y|ACTIVATOR|2746
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|tolbutamide|insulin|8|4.0|Arg1:T8|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2747
23458730|Concentration-dependent inhibitory effects of baicalin on the metabolism of dextromethorphan, a dual probe of CYP2D and CYP3A, in rats.|baicalin|CYP3A|5|18.0|Arg1:T17|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|2748
18715952|PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).|PGE(2)|prostanoid receptors EP(1)|1|32.0|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2749
23327532|Styrene oxide and 4-vinylphenol possessed similar affinity for CYP2E1.|Styrene oxide|CYP2E1|1|9.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2750
22982773|Rate constants for reactivation of OP-inhibited AChE by even the best oximes, such as HI-6 and obidoxime, can vary >100-fold between OP-AChE conjugates that are easily reactivated and those that are difficult to reactivate.|HI-6|AChE|16|7.0|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR|2751
15730717|Both Bcl-X(L) and COX-2 proteins could be inhibited by IN in a dose-dependent manner.|IN|COX-2|13|7.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2752
17463062|The results showed that antalarmin increased whereas astressin2B decreased mRNA and protein expression as well as the activity of PGDH in chorion cells.|antalarmin|PGDH|5|20.0|Arg1:T8|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2753
8161345|  5-Ethynyluracil is a potent mechanism-based inactivator of dihydropyrimidine dehydrogenase (DPD, EC 1.3.1.2) in vitro (Porter et al., J Biol Chem 267: 5236-5242, 1992) and in vivo (Spector et al., Biochem Pharmacol, 46: 2243-2248, 1993.|5-Ethynyluracil|EC 1.3.1.2|1|13.0|Arg1:T1|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2754
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HCB|GST-P|35|14.0|Arg1:T19|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2755
16765071|We identified M2 pyruvate kinase, elongation factor 2, mitochondrial aconitase, pyruvate carboxylase, and heat shock protein HSP90alpha as candidates for 6-nitrotryptophan residues containing proteins, with peptide coverage over 10%, in crude extracts of peroxynitrite-treated PC12 cells.|6-nitrotryptophan|pyruvate carboxylase|25|14.0|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|PART-OF|2756
11134654|Almotriptan showed low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors in several species, including the human, while affinity for 5-HT receptors other than 5-HT(1B/1D) was clearly less.|Almotriptan|5-HT(1D)|1|13.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR|2757
23643744|These results show that repeated administration of ADX47273 or SSR180711 reverses certain behavioural and functional deficits induced by PCP, likely through down-regulation or desensitisation of mGluR5s and α7 nAChRs, respectively.|ADX47273|mGluR5s|8|27.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|2758
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|Tractocile|OT|61|62.0|Arg1:T17|Arg2:T54|CHEMICAL|GENE-Y|ANTAGONIST|2759
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|acetyl-CoA|Carnitine acetyltransferases|11|1.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|2760
23385959|Notably, the antioxidant Trolox™ reversed the Mn (20 mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the Mn (20 mg/kg)-induced caspase activity and F(2)-isoprostane production.|Mn|p38|8|16.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR|2761
22537794|Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.|[2-(trimethylammonium)ethyl]-methanethiosulfonate|DAT|26|37.0|Arg1:T5|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2762
23131177|Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor.|phenylpropylamides|melatonin MT2 receptor|4|11.0|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|AGONIST|2763
23146871|Manganese transport via the transferrin mechanism.|Manganese|transferrin|1|5.0|Arg1:T27|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE|2764
22982773|QSAR analysis of oxime reactivation of AChE inhibited by these OP compounds and others suggested that the presence of both a large substituent (i.e., ⩾the size of dimethylamine) and an alkoxy substituent in the structure of OP compounds is the common feature that results in resistance to oxime reactivation of OP-AChE conjugates whether the OP is a phosphate, phosphonate or phosphoramidate.|phosphonate|AChE|63|55.0|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR|2765
23292752|The reversible binding of dabigatran may provide safer and more predictable anticoagulant treatment than seen with irreversible, non-covalent thrombin inhibitors, e.g. hirudin.|dabigatran|thrombin|5|20.0|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2766
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|salbutamol|human beta-adrenergic receptors|26|73.0|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|AGONIST|2767
23478802|Our results suggest that modification of multiple cysteine residues by electrophilic compounds can generate both activation and desensitization of the TRPA1 channel.|cysteine|TRPA1|8|21.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|PART-OF|2768
23541086|These data suggest that T-cells can be activated by abacavir through a direct interaction with surface and intracellular major histocompatibility complex (MHC) molecules.|abacavir|MHC|10|23.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|DIRECT-REGULATOR|2769
23469927|The polyclonal antiserum recognized soman-labeled human albumin, soman-mouse albumin, and soman human transferrin but not nonphosphonylated control proteins.|soman|mouse albumin|9|10.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2770
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|noradrenaline|alpha(1D)|16|30.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|AGONIST|2771
23161873|The reduction was more pronounced in the fructose-fed group and attributed to decreased hepatic expression of ACC2, FAS, SCD1, and MTTP and a decrease in the rate of hepatic triglyceride secretion.|fructose|MTTP|8|24.0|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2772
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|abl|4|16.0|Arg1:T3|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|2773
9138687|RS-17053 (N-[2-(2-cyclopropyl methoxy phenoxy) ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole- 3-ethanamine hydrochloride; 10-100 nM), a selective alpha 1 A-adrenoceptor antagonist, produced non-parallel, biphasic, dextral shifts of E/[A] curves to NA, suggesting the involvement of more than one alpha 1-adrenoceptor subtype.|RS-17053|alpha 1 A-adrenoceptor|1|25.0|Arg1:T28|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST|2774
14585280|The synergistic effect of histone deacetylase inhibitors, including phenylbutyrate (PB), in reactivating silenced genes encouraged clinical studies on the combination of PB and demethylating agents in hematological diseases, characterized by p15 silencing.|phenylbutyrate|histone deacetylase|10|5.0|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|2775
7853212|These results indicate that histamine H1 receptor antagonists such as mepyramine are potent inhibitors of P450 2D forms because of their high affinity for these enzymes.|mepyramine|P450 2D|11|16.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|2776
17124432|A silent G1287A nucleotide substitution in exon 9 of the NET gene was studied in human conditions involving hypertension.|nucleotide|G1287A|4|3.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|PART-OF|2777
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|SU11248|VEGFR2|31|20.0|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|2778
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FAD|FADS|36|46.0|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|2779
17034761|Our results first demonstrate that auranofin suppresses the multiple steps in TLR4 signaling, especially the homodimerization of TLR4.|auranofin|TLR4|6|19.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|2780
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|noroxymorphone|CYP3A|35|17.0|Arg1:T14|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|2781
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|secretory leuko-proteinase inhibitor|4|30.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2782
16973691|beta(1)-Adrenoceptor antagonism (10 mg kg(-1) bisoprolol) prevented 92% (P < 0.05) of apoptosis induced by all three agonists, but clenbuterol-induced apoptosis could also be prevented by 96% (P < 0.05) by beta(2)-AR antagonism (10 mg kg(-1) ICI 118 551).|bisoprolol|beta(1)-Adrenoceptor|14|1.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|2783
16781459|Both H(2)S solution prepared by bubbling pure H(2)S gas and NaSH, a H(2)S donor, dose dependently induced HO-1 expression through the activation of the extracellular signal-regulated kinase (ERK).|H(2)S|HO-1|2|32.0|Arg1:T25|Arg2:T62|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2784
23470629|The present study demonstrated that human multidrug resistance-associated protein 3 vesicles accepted conjugated 3β-hydroxy-Δ(5)-bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3-sulfate.|taurolithocholic acid 3-sulfate|human multidrug resistance-associated protein 3|30|6.0|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|2785
23147415|We demonstrate that HZ mice are significantly more sensitive to local AChE inhibition (BW284c51), but remain insensitive to butyrylcholinesterase (BuChE) inhibition (bambuterol).|bambuterol|butyrylcholinesterase|28|22.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|2786
15106733|Salicylate treatment inhibited COX-2 expression induced by TNF-alpha/IFN-gamma and regulated the activation of ERK, IKK and IkappaB degradation and subsequent NF-kappaB activation in MC3T3E1 osteoblasts.|Salicylate|IkappaB|1|18.0|Arg1:T5|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|2787
17567713|We also found that TRPV1 receptors are activated by CuSO(4), ZnSO(4), and FeSO(4), three salts known to produce a metallic taste sensation.|ZnSO(4)|TRPV1|15|5.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR|2788
8643547|Reserpine and ketanserin are slightly more potent inhibitors of VMAT2-mediated transport than of VMAT1-mediated transport, whereas tetrabenazine binds to and inhibits only VMAT2.|tetrabenazine|VMAT2|18|24.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2789
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|27-hydroxycholesterol|ERβ|15|45.0|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2790
10365684|Reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in TPO mRNA by PTU or MMI.|MMI|TPO|17|12.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2791
23063590|Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by artemisinic acid.|artemisinic acid|MIF|31|25.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2792
16625817|These include: (i) centrally-acting drugs, such as the noradrenergic and dopaminergic reuptake inhibitor radafaxine, the endocannabinoid antagonist rimonabant, the selective serotonin 5-HT2c agonist APD-356, and oleoyl-estrone; (ii) drugs that target peripheral episodic satiety signals, such as glucagon-like peptide-1 (exenatide, exenatide-LAR and liraglutide), peptide YY (intranasal PYY3-36 and AC-162325) and amylin (pramlintide); (iii) drugs that block fat absorption, such as the novel lipase inhibitors cetilistat and GT-389255; and (iv) a human growth hormone fragment (AOD-9604) that increases adipose tissue breakdown.|GT-389255|lipase|89|85.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR|2793
11340119|  Pyridoxal 5'-phosphate (PLP) stimulation of erythrocyte alanine and aspartate aminotransferase (EALT, EAST) activities is a frequently used functional measure of vitamin B-6 status.|PLP|EALT|4|14.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR|2794
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hCNT1|11|16.0|Arg1:T12|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2795
17659402|We have previously found that 3-phenyl-CPP blocks hClC-Ka and rClC-K1 from the extracellular side in the pore entrance.|3-phenyl-CPP|hClC-Ka|6|8.0|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2796
23532932|TCPOBOP, a CAR ligand, modestly induced mdr1a.fLUC in pxr(+/+) and pxr(-/-) strains, consistent with CAR's minor role in mdr1a regulation.|TCPOBOP|CAR|1|4.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2797
16864903|Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils.|olopatadine|S100A12|3|10.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2798
23527317|  A series of N-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [(3)H]dopamine uptake.|[(3)H]dihydrotetrabenazine|vesicular monoamine transporter|13|24.0|Arg1:T7|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|2799
17929114|Imatinib mesylate (IM, Gleevec, Novartis Pharmaceuticals, Basel, Switzerland), which specifically inhibits the autophosphorylation of the Abl TK, has improved the treatment of CML.|Imatinib mesylate|Abl|1|23.0|Arg1:T20|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR|2800
16230360|Procainamide has been shown to inhibit DNA methyltransferase activity and reactivate silenced gene expression in cancer cells by reversing CpG island hypermethylation.|Procainamide|DNA methyltransferase|1|7.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR|2801
12213059|  6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives were synthesized and characterized as activators of adenosine 5'-triphosphate (ATP) sensitive potassium (K(ATP)) channels in the beta-cells by measuring effects on membrane potential and insulin release in vitro.|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|adenosine 5'-triphosphate (ATP) sensitive potassium (K(ATP)) channels|1|15.0|Arg1:T1|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR|2802
23261528|Moreover, icariin treatment inhibited the phosphorylations of STAT1 and STAT3 in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively.|icariin|STAT1|3|9.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR|2803
23604717|SAL-2 also downregulated COX-2 and iNOS expression induced by HNE, but salicylate did not.|SAL-2|COX-2|1|4.0|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2804
1407010|Autoradiographic studies were performed on rabbit brain slices using [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and mesulergine (in order to mask 5-HT1A and 5-HT1C binding sites) and [125I]CYP (iodocyanopindolol) in the presence of 3 mumol/l isoprenaline and 100 nmol/l 8-OH-DPAT (in order to mask beta adrenoceptor and 5-HT1A binding sites).|isoprenaline|beta adrenoceptor|49|59.0|Arg1:T14|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|2805
23470629|The present study demonstrated that human multidrug resistance-associated protein 3 vesicles accepted conjugated 3β-hydroxy-Δ(5)-bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3-sulfate.|glycocholic acid|human multidrug resistance-associated protein 3|27|6.0|Arg1:T8|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE|2806
16014042|We also measured the uptake of l-cystine in Xenopus oocytes expressing human xCT and/or 4F2hc or xCT and/or rBAT (a heavy chain homologous to 4F2hc).|l-cystine|rBAT|7|19.0|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|2807
23493374|Co-IP and coimmunolocalization confirmed that Creb1 associated with Mecp2 and cotransfection with glut3-(m)CpG in HT22 cells enhanced glut3 transcription.|(m)CpG|glut3|14|13.0|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2808
12842269|Taken together, these findings support the view that (1) OFQ is the only ppOFQ peptide that binds to and activates the ORL1 receptor and (2) OFQ II(1-28) does not bind or stimulate [35S]-GTPgammaS binding in cells expressing the mu opioid receptor.|[35S]-GTPgammaS|mu opioid receptor|41|50.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2809
11669456|S2 hOAT1 and S2 hOAT3 exhibited a time- and dose-dependent, and a saturable increase in uptake of [3H]-OTA, with apparent Km values of 0.42 microM (hOAT1) and 0.75 microM (hOAT3).|[3H]-OTA|hOAT3|19|5.0|Arg1:T3|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|2810
14871885|  Metformin, a drug widely used in the treatment of type 2 diabetes, has recently been shown to act on skeletal muscle and liver in part through the activation of AMP-activated protein kinase (AMPK).|Metformin|AMP-activated protein kinase|1|32.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|2811
1600046|While the substituted benzamide prokinetics (for example, metoclopramide, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.|cisapride|5-HT4|12|39.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|AGONIST|2812
17884974|Acetaminophen plasma concentrations remained above the in vitro IC(50) for COX-2 for at least 5 h postadministration.|Acetaminophen|COX-2|1|14.0|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|2813
11406192|These data indicate [(3)H]LY395153 is a useful probe for labeling a unique modulatory site on both native and recombinant AMPA receptors.|[(3)H]LY395153|AMPA receptors|4|26.0|Arg1:T14|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR|2814
23495205|Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.|4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate|Aromatase|13|11.0|Arg1:T16|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2815
23305993|In transactivation reporter gene assays LYSO-07 showed a pan partial agonist effect on the three PPAR subtypes (PPARγ, PPARα and PPARβ/δ).|LYSO-07|PPAR|6|16.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|AGONIST|2816
23485614|Both interventions restored the liver function markers (alanine transaminase: ALT, aspartate transaminase: AST, alkaline phosphatase: ALP, total bilirubin and total protein) and hepatic antioxidants (superoxide dismutase: SOD, catalase: CAT, reduced glutathione: GSH and glutathione peroxidase: GPx) to the normal levels than elevated levels noticed on paracetamol control at P<0.001.|paracetamol|alanine transaminase|62|9.0|Arg1:T17|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2817
23581551|  Due to its production of potent antimicrobial oxidants including hypochlorous acid, human myeloperoxidase (MPO) plays a critical role in innate immunity and inflammatory diseases.|hypochlorous acid|human myeloperoxidase|10|13.0|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PRODUCT-OF|2818
23643725|In addition, during acute exposure tests performed at the end of the chronic exposure, biofilms chronically exposed to 75 and 150μgL(-1) oxyfluorfen showed a higher CAT activity than controls.|oxyfluorfen|CAT|27|31.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ACTIVATOR|2819
10370904|2) Radioligand and functional studies at the N-methyl-D-aspartate (NMDA) type glutamate receptor characterize budipine as a low-affinity, uncompetitive antagonist with fast kinetics and moderate voltage-dependency at the phencyclidine (PCP) binding site, comparable to that observed with amantadine, thereby counteracting an increased excitatory glutamatergic activity.|amantadine|N-methyl-D-aspartate (NMDA) type glutamate receptor|44|9.0|Arg1:T28|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR|2820
10215901|Further results indicated that post-training intra-amygdala infusion of buspirone or the 5-HT1A agonist 8-hydroxy-di-n-propylaminotetralin (8-OH-DPAT) caused a time-dependent and dose-dependent retention deficit.|8-hydroxy-di-n-propylaminotetralin|5-HT1A|14|12.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|AGONIST|2821
23415902|Org 214444-0 is shown to be a stereoselective, nanomolar potent FSHR agonist and selective over the structurally related LHR and TSHR.|Org 214444-0|FSHR|1|12.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|AGONIST|2822
11256847|Rosuvastatin has been shown to be a comparatively potent inhibitor of HMG-CoA reductase activity in a purified preparation of the catalytic domain of the human enzyme, as well as in rat and human hepatic microsomes.|Rosuvastatin|HMG-CoA reductase|1|12.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2823
23266270|Furthermore, DPEP inhibited the LPS-induced phosphorylation of inhibitor κB (IκB)-α and NF-κB p50.|DPEP|NF-κB|3|16.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR|2824
16546990|Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and beta-catenin.|YC-1|JNK|5|23.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|2825
23410161|The design strategy for yet another agent, ladostigil, employed the amalgamation of active chemical moieties of the AChE inhibitor rivastigmine, and the monoamine oxidase-B (MAO-B) inhibitor rasagiline, leading to a single compound that targets both enzymes simultaneously.|rasagiline|MAO-B|32|29.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2826
17046555|Inhibition of PKC by treatment of the cells with calphostin C, GF10923X, and LY379196 totally suppressed AGE-mediated p47phox translocation and ROS generation.|calphostin C|p47phox|10|20.0|Arg1:T18|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2827
23159329|Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.|methamphetamine|ERK|4|19.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR|2828
23142325|In a previous study using isolated rat liver mitochondria, we observed that ABA inhibited the activity of adenine nucleotide translocator and FoF1-ATPase.|ABA|adenine nucleotide translocator|14|19.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|2829
9406449|In LPLs of chickens and rats, values of Ki were 66.7 and 36.4 with triolein emulsion as the substrate, and 832.4 and 66.0 with respective VLDL as the substrate.|triolein|LPLs|16|2.0|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE|2830
12942109|  Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma.|tazarotenic acid|retinoid receptors|10|18.0|Arg1:T10|Arg2:T12|CHEMICAL|GENE-N|DIRECT-REGULATOR|2831
23619284|  Tandutinib is a novel inhibitor of tyrosine kinases FLT3, PDGFR and KIT.|Tandutinib|KIT|1|13.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2832
23261524|We used nutlin-3, a well-known disruptor of p53-Mdm2 interaction, to validate the specificity of the assay.|nutlin-3|Mdm2|3|10.0|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2833
17417877|Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.|hyperoside|beta2-adrenergic receptor|10|4.0|Arg1:T22|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2834
8842678|MAO-A was inhibited by the following drugs (in ascending order of potency) : nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine.|nomifensine|MAO-A|26|1.0|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|2835
10418979|Like 17beta-estradiol, raloxifene binds with high affinity to both estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta).|17beta-estradiol|estrogen receptor-alpha|2|11.0|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2836
23494944|AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase (AChE) in all regions.|AlCl3|COX|1|13.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2837
23123646|An increase in the ADP/ATP ratio opens K(ATP) channels, leading to membrane hyperpolarization.|ADP|K(ATP) channels|5|8.0|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|2838
15562257|Mibefradil blocked currents of all Na+ channel isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for Nav1.5).|Mibefradil|Na+ channel|1|6.0|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2839
10047461|These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 kinase activities.|Tomudex|p27(kip1)|20|31.0|Arg1:T7|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2840
23271742|Together, these data suggest that arsenic degrades ΔNp63 protein at least in part via Pirh2-dependent proteolysis and that inhibition of ΔNp63 expression facilitates tumor cells to arsenic-induced death.|arsenic|ΔNp63|7|9.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2841
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|linoleic acid|Delta6-fatty acid desaturase|17|1.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|2842
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|interleukin-1beta|47|15.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2843
20223979|Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity.|Thalidomide|ubiquitin ligase|1|14.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2844
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|alpha-methyl-dopahydrazine|AAAD|18|14.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|2845
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|thiazolidinedione|PPARgamma|11|26.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2846
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|octreotide|SSTR2|14|20.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2847
16230360|Because many reports have strongly linked DNMT1 with epigenetic alterations in carcinogenesis, procainamide may be a useful drug in the prevention of cancer.|procainamide|DNMT1|14|7.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|2848
17139155|The sensors are composed of AChE and choline oxidase (ChOx) for converting the AChE-generated choline into betaine and hydrogen peroxide (H(2)O(2)), which is electrochemically oxidized at the electrode surface to produce the output signal of the sensor.|choline|choline oxidase|17|8.0|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE|2849
12668769|On the other hand, the accumulation of Ser through the C1-THF synthase/SHMT pathway in glyD plants was 2.5-fold greater than that in WT plants.|Ser|SHMT|9|14.0|Arg1:T27|Arg2:T69|CHEMICAL|GENE-N|PRODUCT-OF|2850
2506486|  Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).|clorgyline|monoamine oxidase type A|37|29.0|Arg1:T9|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|2851
16230360|As further evidence of the specificity of procainamide for DNMT1, procainamide failed to lower genomic 5-methyl-2'-deoxycytidine levels in HCT116 colorectal cancer cells when DNMT1 was genetically deleted but significantly reduced genomic 5-methyl-2'-deoxycytidine content in parental HCT116 cells and in HCT116 cells where DNMT3b was genetically deleted.|procainamide|DNMT1|8|10.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|2852
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|sunitinib|tyrosine kinase|21|13.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|2853
23059626|Met-RANTES treatment also reduced the levels of cathepsin K and metalloproteinase 13 (MMP13).|Met|MMP13|1|14.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2854
23416003|Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors.|bicyclic pyrazinone and pyrimidinone amides|TF|5|12.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2855
16735460|Using site-directed mutagenesis, histidine (H), lysine (K), and arginine (R) residues of fNaDC-3 were replaced by alanine (A), isoleucine (I), or leucine (L).|leucine|fNaDC-3|37|22.0|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|PART-OF|2856
20557886|ICI 182780, an estrogen receptor antagonist and R,R-THC, an estrogen receptor beta antagonist, counteracted the effect of 3beta-Adiol while bicalutamide, an androgen receptor antagonist, had minor effects.|ICI 182780|estrogen receptor|1|5.0|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|ANTAGONIST|2857
7858879|Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.|bosentan|ETB|20|25.0|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|ANTAGONIST|2858
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|4'-(9-acridinylamino)methanesulfon-m-anisidide|TOP2|41|29.0|Arg1:T18|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR|2859
17012403|Six amino acids commonly present in soils (Glu, Gly, alanine, serine, asparagine, and cysteine) as well as the tripeptide glutathione (gamma-glutamyl-cysteinyl-Gly) were found to be strong agonists of the GLR3.3-mediated responses.|cysteine|GLR3.3|20|39.0|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR|2860
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|NSD-1015|AAAD|29|14.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|2861
24365491|In addition, pseudoephedrine significantly suppressed the production of p-IkappaB-alpha, reducing the degradation of sequestered nuclear factor kappa B (NF-kappaB) in the cytoplasm, and inhibited the translocation of NF-kappaB/p65 to the nucleus, the transcription of TNF-alpha mRNA and the production of TNF-alpha in primary KCs. These results suggest that pseudoephedrine and ephedrine have a potent anti-inflammatory activity against D-GalN/LPS-induced acute liver failure in rats, and this comprehensive anti-inflammatory effect may result from the inhibition of TNF-alpha production.|pseudoephedrine|TNF-alpha|56|83.0|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2862
2362440|Pregnenolone and dehydroepiandrosterone protect the dehydrogenase activity, while 5-pregnene-3,20-dione, progesterone, and androstenedione protect isomerase activity from inactivation.|Pregnenolone|dehydrogenase|1|6.0|Arg1:T24|Arg2:T41|CHEMICAL|GENE-N|ACTIVATOR|2863
1600046|Some 5-HT3 antagonists have 5-HT4 agonist activity (for example, renzapride, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.|zacopride|5-HT3|14|2.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|2864
11369259|Heparin-binding exosite of factor Xa.   Recent studies have indicated that the basic residues Arg(93), Lys(96), Arg(125), Arg(165), Lys(169), Lys(236), and Arg(240) (chymotrypsin numbering) constitute an exosite in the catalytic domain of factor Xa that can effectively bind heparin only if the acidic N-terminal Gla domain of the proteinase was neutralized by physiological levels of calcium.|Arg|factor Xa|15|62.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|PART-OF|2865
23607523|A gene cassette encoding C7-cyclitol biosynthetic enzymes was identified upstream of the benzopyranopyrrole-specific ORFs. Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7-cyclitol moiety.|C7|sugar phosphate cyclase|53|44.0|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF|2866
23440928|Scanning force microscopy, circular dichroism and thioflavin T fluorescence experiments showed that carnosine does not modify the conformational features of Aβ42 but nonetheless inhibits amyloid growth.|carnosine|Aβ42|14|22.0|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2867
17513447|In myeloid cells, arginine is mainly metabolized either by inducible nitric oxide (NO) synthases (iNOS) or by arginase 1, enzymes that are stimulated by T helper 1 or 2 cytokines, respectively.|arginine|inducible nitric oxide (NO) synthases|5|11.0|Arg1:T13|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|2868
10365684|  Methimazole (MMI) and propylthiouracil (PTU) are common antithyroid drugs for treating hyperthyroidism because the 2 drugs inhibit thyroid peroxidase (TPO)-catalyzed thyroid hormone formation.|MMI|thyroid peroxidase|3|22.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|2869
10462128|The beta-adrenergic/5-HT1A receptor antagonist (+/-)pindolol and the selective 5-HT1B/D antagonist GR127935 produced no significant augmentation of venlafaxine-induced changes in either 5-HT or NA.|(+/-)pindolol|5-HT1A|5|3.0|Arg1:T3|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST|2870
18803986|CONCLUSIONS: Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases.|Lapatinib|HER2|3|12.0|Arg1:T24|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2871
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|L-cysteine|CBS|32|29.0|Arg1:T10|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE|2872
16297435|Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.|rivastigmine|cholinesterase|12|10.0|Arg1:T28|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|2873
17184764|It has been previously shown that retinoids act mainly on cell proliferation and survival in the ventral forebrain by regulating SHH and FGF8 signaling.|retinoids|SHH|7|21.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2874
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|Delta 6 desaturase|46|4.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF|2875
23042730|α-TOCO plus a pancaspase inhibitor completely abolished AMD/TNF-induced cytotoxicity.|α-TOCO|pancaspase|1|4.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2876
23373701|Moreover, the D2R inhibitor raclopride blocked the increase of both GDNF and Zif268 expression following potassium-evoked dopamine release in SH-SY5Y cells.|raclopride|GDNF|6|12.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2877
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|vascular endothelial growth factor|1|22.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|2878
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|flavokinase|28|9.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF|2879
23382458|The P-gp- and BCRP-facilitated transport of apixaban was concentration- and time-dependent and did not show saturation over a wide range of concentrations (1-100 μM).|apixaban|P-gp|7|2.0|Arg1:T11|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE|2880
23542513|Pyrrolidine dithiocarbamate (PDTC), a specific NF-κB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-κB activity.|PDTC|NF-κB|4|9.0|Arg1:T16|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|2881
23562496|Xanthohumol and 2-hydroxychalcone induced apoptosis by Bcl-2 downregulation.|2-hydroxychalcone|Bcl-2|3|7.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2882
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|AST|30|15.0|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR|2883
23583603|Agonistic activity of ICI 182 780 on activation of GSK 3β/AKT pathway in the rat uterus during the estrous cycle.|ICI 182 780|GSK 3β|4|10.0|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|AGONIST|2884
23583259|Results from mechanistic studies indicated that rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, bound to the ligand-binding domain of hPXR, as assessed by a transactivation assay and by a competitive ligand-binding assay using time-resolved fluorescence resonance energy transfer; triggered nuclear translocation of a green fluorescence protein-tagged hPXR, as visualized by confocal imaging; and recruited steroid receptor coactivator-1 (SRC-1), SRC-2, and SRC-3 to hPXR, as demonstrated by mammalian two-hybrid assays.|efavirenz|hPXR|12|55.0|Arg1:T30|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2885
23354536|The response to the 5-HT1a agonist, 8-OHDPAT (0.003-0.5 mg/kg, SC), was assessed using lower lip retraction (LLR), hypoactivity, and 5-hydroxytryptophan (5-HTP) accumulation following decarboxylase inhibition.|5-HTP|decarboxylase|31|35.0|Arg1:T10|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|2886
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|Modafinil|NET|1|28.0|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR|2887
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|Rilpivirine|CYP3A4|1|19.0|Arg1:T3|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2888
23350733|Compound 1 exhibited activity comparable to the clinically approved elastase inhibitor sivelestat in short-term assays and demonstrated superior sustained activity in longer-term assays.|sivelestat|elastase|12|10.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-N|INHIBITOR|2889
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|sevoflurane|NADH:ubiquinone oxidoreductase|9|20.0|Arg1:T28|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR|2890
11102491|However, haloperidol effectively blocked glutamate toxicity in the same cultures, suggesting that the neurotoxic actions of this amino acid were mostly due to the activation of somatic NMDA receptors.|haloperidol|NMDA receptors|3|30.0|Arg1:T14|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2891
23384967|Both BPA and DES (10-50μM) caused a significant activation of the CYP3A4 promoter via the PXR in the DPX2 human hepatoma cell line.|BPA|CYP3A4 promoter|2|14.0|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|ACTIVATOR|2892
23435541|In cultured human coronary arterial endothelial cells, confocal microscopy detected the formation of an MRs clustering when they were exposed to OxLDL, and such MR platform formation was inhibited markedly by statins, including pravastatin and simvastatin.|statins|OxLDL|34|23.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2893
23605050|Additionally, treatment with glucose/iron showed a higher HO activity.|iron|HO|6|9.0|Arg1:T14|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR|2894
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|BRL-49653|PPARgamma|14|7.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2895
14871885|Increases in glucose concentration from 0 to 3 and from 3 to 17 mM inhibited AMPK activity in primary islets from mouse, rat, and human, confirming previous findings in insulinoma cells.|glucose|AMPK|3|16.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2896
11736858|CONCLUSIONS: Ebastine (10 mg orally) causes brain histamine H1-receptor occupation of approximately 10%, consistent with its lower incidence of sedative effect, whereas (+)-chlorpheniramine occupied about 50% of brain H1-receptors even at a low but sedative dose of 2 mg; occupancy of (+)-chlorpheniramine was correlated with plasma (+)-chlorpheniramine concentration.|Ebastine|histamine H1-receptor|3|11.0|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2897
23454149|Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells.|DMBT|Akt|7|17.0|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|2898
23000451|Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase (BChE), which is capable of breaking down naturally occurring (-)-cocaine before the drug can influence the reward centers of the brain or affect other areas of the body.|(-)-cocaine|butyrylcholinesterase|33|20.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE|2899
15686475|Hence, it is proposed that a conformational change is induced when ApoCaM interacts with GAD65 or tGAD67, resulting in an increase of GAD affinity for PLP and the activation of GAD.|PLP|GAD|28|25.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2900
16790533|Although NQO1 protected against dopamine-induced proteasomal inhibition, the metabolism of aminochrome by NQO1 led to oxygen uptake because of the generation of a redox-labile cyclized hydroquinone, further demonstrating the lack of involvement of oxygen radicals in proteasomal inhibition.|hydroquinone|NQO1|27|14.0|Arg1:T33|Arg2:T55|CHEMICAL|GENE-N|PRODUCT-OF|2901
11451212|In vivo, intravenous olmesartan produces a rapid and long-lasting inhibition of All-induced pressor responses in conscious rats.|olmesartan|All|5|13.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2902
7906055|Agmatine, locally synthesized, is an endogenous agonist at imidazoline receptors, a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter.|Agmatine|imidazoline receptors|1|11.0|Arg1:T11|Arg2:T21|CHEMICAL|GENE-N|AGONIST|2903
11971019|Therefore, we describe arginase- and ODC-dependent macrophage apoptosis, which implicates polyamines in the pathophysiology of H.|polyamines|arginase|13|5.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|PRODUCT-OF|2904
23305921|  We previously reported that caffeoyl-amino acidyl-hydroxamic acid (CA-Xaa-NHOH) acted as both a good antioxidant and tyrosinase inhibitor, in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine.|caffeoyl-amino acidyl-hydroxamic acid|tyrosinase|5|18.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|2905
18803986|CONCLUSIONS: Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases.|Lapatinib|tyrosine kinases|3|13.0|Arg1:T24|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR|2906
7739347|Dihydroetorphine and etorphine have almost the same binding affinities to all types (mu, delta, and kappa) of opioid receptors and antagonist binding sites, and have similar inhibition activities to forskolin stimulated adenylyl cyclase.|Dihydroetorphine|adenylyl cyclase|1|37.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR|2907
12063084|  Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT(1A) receptors (h5-HT(1A)) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT(1A) receptors in a guanosine-5'-O-(3-[(35)S]thio)-triphosphate ([(35)S]GTP gamma S)-binding assay that was blocked completely by a selective 5-HT(1A) receptor antagonist.|Aripiprazole|dopamine D2 receptors|1|30.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|AGONIST|2908
23603382|The mRNA levels of SOD1, CAT, GPx and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+NaAsO2 treatment group.|NaAsO2|CAT|24|7.0|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2909
16014042|Interestingly, in oocytes injected with rBAT with or without xCT, uptake of l-cystine was significantly greater than that in water-injected oocytes.|l-cystine|rBAT|15|7.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|2910
2907566|Relaxant and beta 2-adrenoceptor blocking activities of labetalol, dilevalol, amosulalol and KF-4317 on the rat isolated aorta.|labetalol|beta 2-adrenoceptor|8|3.0|Arg1:T12|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|2911
17251447|Ablation of RPE65 in Nrl(-/-) and Rho(-/-) mice led to the absence of 11-cis retinal, but increased the total retinoid content, with retinyl esters representing the most abundant retinoid species.|retinoid|RPE65|37|3.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|2912
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|probenecid|hOAT3|19|35.0|Arg1:T7|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR|2913
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|PGE2|EP3|29|2.0|Arg1:T31|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2914
9563368|FP is more potent than beclomethasone dipropionate, budesonide, triamcinolone acetonide, and mometasone furoate in inhibiting human T-cell migration and proliferation, inhibiting CD4+ T-cell cytokine and basophil histamine release, attenuating adhesion molecule expression, stimulating inflammatory cell apoptosis, and inducing cellular antiprotease release.|budesonide|cytokine|9|28.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR|2915
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|ERK2|3|13.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2916
9563368|FP has an absolute affinity (KD) for the glucocorticoid receptor of 0.5 nmol/L and a relative receptor affinity 1.5-fold higher than beclomethasone-17-monopropionate (17-BMP) and mometasone furoate, 3-fold higher than budesonide, and 20-fold higher than flunisolide and triamcinolone acetonide.|flunisolide|glucocorticoid receptor|41|11.0|Arg1:T24|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2917
23085120|Furthermore, B12H restored the suppressed activation of the Akt pathway caused by glutamate as evidenced by the decreased expressions of pSer473-Akt and pSer9-GSK3β.|glutamate|Akt|14|10.0|Arg1:T19|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|2918
23578608|Meanwhile, both plant stanyl hemisuccinate and plant stanyl sorbitol succinate could remarkably promote liver X receptor alpha (LXRα) expression, and increased cholesterol 7α-hydroxylase (CYP7A1) expression and faecal total bile acid output to varying degrees.|stanyl hemisuccinate|CYP7A1|5|29.0|Arg1:T15|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2919
23418859|The results showed that intracoronary injection of salidroside at the onset of reperfusion markedly reduced the apoptosis of cardiomyocytes, significantly increasing Bcl-2 and p-Akt proteins expressions and decreasing Bax and caspase-3 expressions in the hearts subjected to ischemia followed by 120-min reperfusion.|salidroside|Bax|8|30.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2920
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Cys|ALDH|48|64.0|Arg1:T11|Arg2:T34|CHEMICAL|GENE-N|PART-OF|2921
23501055|Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.|Gambogic acid|PHD2|1|7.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|2922
23219593|4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.|4-tert-Octylphenol|cathepsins|1|6.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2923
2833901|Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.|dihydropyridine|calcium channel|6|7.0|Arg1:T41|Arg2:T77|CHEMICAL|GENE-N|INHIBITOR|2924
23327877|Compound 6 stimulated OATP1B3-mediated estradiol 17β-glucuronide uptake by increasing the apparent affinity of OATP1B3 for its substrate.|estradiol 17β-glucuronide|OATP1B3|5|4.0|Arg1:T15|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE|2925
17632548|10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref.|eicosanoid|microsomal prostaglandin E synthase 1|20|37.0|Arg1:T21|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|2926
15456329|Nabumetone itself is non-acidic and, following absorption, it undergoes extensive first-pass metabolism to form the main circulating active metabolite (6-MNA) which is a much more potent inhibitor of preferentially cyclo-oxygenase (COX)-2.|6-MNA|cyclo-oxygenase (COX)-2|23|34.0|Arg1:T19|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|2927
15627430|This study compared in vitro binding affinities and functional activities of olanzapine, clozapine, thioridazine, ziprasidone, risperidone, chlorpromazine and scopolamine at muscarinic M2 receptors with their in vivo potencies to increase acetylcholine release in the rat hippocampus.|ziprasidone|muscarinic M2 receptors|18|26.0|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2928
17664139|  Two sodium-dependent vitamin C transporter isoforms (SVCT1 and SVCT2) were identified as ascorbic acid transporters, but their roles in skin have, as yet, not been elucidated.|ascorbic acid|SVCT2|15|10.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|2929
16437532|  BACKGROUND: Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase.|galantamine|acetylcholinesterase|31|77.0|Arg1:T12|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|2930
23471964|Tumor-suppressive Maspin Functions as a Reactive Oxygen Species Scavenger: IMPORTANCE OF CYSTEINE RESIDUES.|CYSTEINE|Maspin|13|2.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|PART-OF|2931
23570789|  A series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) was identified from a high-throughput screen against the isolated enzyme.|imidazopyridazines|PfCDPK1|4|17.0|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR|2932
15814851|  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P450 enzyme complex called aromatase.|Estradiol|cytochrome P450|1|15.0|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|PRODUCT-OF|2933
23639249|I3S increased expression of RORγt, the master transcription factor for Th17 differentiation, and stimulated Th17 differentiation, in a comparative manner as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR ligand.|2,3,7,8-tetrachlorodibenzo-p-dioxin|RORγt|25|5.0|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2934
17088426|Such organization results in the local activation of PKA subsets through the generation of confined intracellular gradients of cAMP, but the mechanisms responsible for limiting the diffusion of cAMP largely remain to be clarified.|cAMP|PKA|19|9.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR|2935
23085979|Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by TCDD, siRNA-mediated Cx43 knock-down was not sufficient to stimulate proliferation in contact-inhibited cells.|TCDD|Cx43|18|6.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|2936
23411172|The expression levels of HLA-DR (MHC class II) and CD86 (costimulatory molecule) were measured as an indicator of antigen presentation in TDDCs. A significant decrease in HLA-DR expression was observed in the AP and fractionated procyanidin-treated cells in the presence of ovalbumin (OVA), but no effect on CD86 expression was observed.|procyanidin|HLA-DR|41|32.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|2937
21194017|Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA(A)-R.|R(+)etomidate|bovine brain GABA(A)-R|11|29.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR|2938
12063084|  Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT(1A) receptors (h5-HT(1A)) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT(1A) receptors in a guanosine-5'-O-(3-[(35)S]thio)-triphosphate ([(35)S]GTP gamma S)-binding assay that was blocked completely by a selective 5-HT(1A) receptor antagonist.|7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e|5-HT(1A)|3|65.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|AGONIST|2939
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|furosemide|ATPase|7|24.0|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|2940
23313376|PTE, used in combination with a known JAK2/STAT3 inhibitor, AG490, further decreased the viability of osteosarcoma cells.|AG490|STAT3|12|10.0|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|2941
1475066|  Male Sprague-Dawley rats when administered sc a sublethal dose of organophosphorus cholinesterase inhibitors such as the nerve agents, soman (100 micrograms/kg, sc), sarin (110 micrograms/kg, sc), tabun (200 micrograms/kg, sc), or VX (12 micrograms/kg, sc), developed seizures and severe muscle fasciculations within 15-20 min, lasting for 4-6 hr.|tabun|cholinesterase|36|12.0|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|2942
12063084|Combined with previous studies demonstrating the potent partial agonism of aripiprazole at dopamine D2 receptors, this study suggests aripiprazole is the first dopamine-serotonin system stabilizer.|aripiprazole|dopamine D2 receptors|11|13.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|AGONIST|2943
23194750|Isolated rat femoral arteries segments were mounted in a wire myograph and challenged with 100mM KCl or phenylephrine (PE), in the absence or presence of troglitazone, rosiglitazone, pioglitazone, LY294002 (PI3K inhibitor) and 10-DEBC (Akt inhibitor).|LY294002|PI3K|35|37.0|Arg1:T20|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR|2944
23264615|In study 1, cyclic ewes received vehicle, cortisol, PF 915275 (PF; a selective inhibitor of HSD11B1), cortisol and PF, meloxicam (a selective inhibitor of PTGS2), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus.|meloxicam|PTGS2|28|34.0|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|2945
17139155|The sensors are composed of AChE and choline oxidase (ChOx) for converting the AChE-generated choline into betaine and hydrogen peroxide (H(2)O(2)), which is electrochemically oxidized at the electrode surface to produce the output signal of the sensor.|betaine|ChOx|19|11.0|Arg1:T13|Arg2:T31|CHEMICAL|GENE-N|PRODUCT-OF|2946
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|atropine|AChE|12|14.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR|2947
23295386|Interestingly, the common phospholipid 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-PC), previously proposed to reflect nutritional status and shown to be a specific endogenous ligand of PPARα, induced CYP3A4 (up to 4-fold) and other biotransformation genes in hepatocytes with similar selectivity and potency as WY14,643.|WY14,643|CYP3A4|47|29.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2948
17545671|Our data identify cAspAT as a new member of glyceroneogenesis, transcriptionally regulated by TZD via the control of RORalpha expression by PPARgamma in adipocytes.|TZD|cAspAT|15|4.0|Arg1:T7|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2949
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|monoamine|NET|4|16.0|Arg1:T10|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2950
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|macrophage inflammatory protein 2|6|25.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2951
23500659|Testosterone significantly decreased ER-β and increased ER-α and AR expressions as compared to the control group and these effects were significantly ameliorated by SIL.|Testosterone|AR|1|9.0|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2952
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hENT2|9|21.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|2953
17182172|LPS-induced IL-6 production in ATDC5 cells was reduced by Dex or AL-438, showing that AL-438 has similar anti-inflammatory efficacy to Dex in these cells.|AL-438|IL-6|12|2.0|Arg1:T17|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2954
23578952|Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on basal and stress-induced corticosterone levels in male CD1 mice, and found that this compound dramatically increased basal levels without affecting stress responses.|JZL184|monoacylglycerol lipase|13|10.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|2955
10823899|Conversely, DAT inhibitors, such as cocaine, mazindol, and nomifensine, when administered with AMPH, blocked the reduction in [(3)H]DA uptake and the redistribution of DAT immunofluorescence to the cytosol.|[(3)H]DA|DAT|24|3.0|Arg1:T21|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE|2956
23297412|Here, we show that oral administration of resveratrol, which leads to activation of an NAD(+)-dependent protein deacetylase SIRT1, suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophin-deficient mdx mice.|resveratrol|NAD(+)-dependent protein deacetylase SIRT1|9|17.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|ACTIVATOR|2957
23631440|  New series of pyrrolidine mercaptosulfide, 2-mercaptocyclopentane arylsulfonamide, and 3-mercapto-4-arylsulfonamido pyrrolidine matrix metalloproteinase inhibitors (MMPIs) were designed, synthesized, and evaluated.|2-mercaptocyclopentane arylsulfonamide|matrix metalloproteinase|7|13.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR|2958
22410778|Exogenous stimulation of PKA activity, achieved by forskolin treatment, protected K-ras-transformed cells from apoptosis induced by glucose deprivation, enhanced complex I activity, intracellular adenosine triphosphate (ATP) levels, mitochondrial fusion and decreased intracellular reactive oxygen species (ROS) levels.|glucose|K-ras|19|13.0|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2959
23468082|METHODS: Ponatinib is an oral multitargeted kinase inhibitor that potently inhibits all 4 members of the FGFR family.|Ponatinib|kinase|3|8.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|2960
17664139|  Two sodium-dependent vitamin C transporter isoforms (SVCT1 and SVCT2) were identified as ascorbic acid transporters, but their roles in skin have, as yet, not been elucidated.|ascorbic acid|SVCT1|15|8.0|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|2961
23453838|Analogs with Z=Br, I, or OTs were weak inhibitors of the AChEs, and methyl phosphonates (R=Me) were more potent than the corresponding ethyl phosphonates (R=Et).|methyl phosphonates|AChEs|17|14.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|2962
16864903|Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils.|olopatadine|S100|3|17.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|DIRECT-REGULATOR|2963
23403272|Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway.|Paeoniflorin|NF-E2-related factor 2|1|15.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR|2964
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT1|31|28.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|2965
7816863|Moreover, clenbuterol HCl (0.1-0.5 mg/kg, IP), a lipophilic beta 2-adrenoceptor agonist, significantly increased the duration of basal aggressive behavior.|clenbuterol HCl|beta 2-adrenoceptor|3|14.0|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|AGONIST|2966
22790794|We hypothesized that blockade of human K(2P) channels contributes to the electrophysiological efficacy of dronedarone in AF.|dronedarone|human K(2P) channels|18|6.0|Arg1:T9|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|2967
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|cytokines|47|9.0|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|2968
23613149|PbAc increased the activities of lactate dehydrogenase and NADP-malic enzyme, whereas it decreased malate and glucose-6-phosphate dehydrogenase, glucose-6-phosphatase, fructose-1, 6-bisphosphatase, and BBM enzyme activities.|PbAc|lactate dehydrogenase|1|6.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR|2969
23373444|Specific activities of GO/Zr(IV)/α-ZrP and Hb/Zr(IV)/α-ZrP ternary complexes were 2.0 × 10(-3) and 6.5 × 10(-4) M(-1) s(-1), respectively.|α-ZrP|Hb|15|10.0|Arg1:T6|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR|2970
8836655|Epinastine (WAL 801CL) is an antihistaminic drug with binding affinity at certain other receptors, including alpha-adrenergic receptors and various serotonin (5-HT) receptor subtypes.|Epinastine|alpha-adrenergic receptors|1|19.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR|2971
17664139|UVB-induced oxidative stress in mice resulted in depletion of SVCT1 mRNA levels and led to significantly decreased ascorbic acid uptake in keratinocytes, providing evidence on why ascorbic acid levels are decreased on UVB irradiation in vivo.|ascorbic acid|SVCT1|18|10.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|2972
23373444|Zr(IV) increased Hb binding constant to α-ZrP by 43-fold, and affinity enhancements followed the trend Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III).|Ca(II)|Hb|40|6.0|Arg1:T48|Arg2:T66|CHEMICAL|GENE-N|DIRECT-REGULATOR|2973
16232421|On the other hand, the FUM1 (fumarase) gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all.|fumarate|fumarase|19|9.0|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|PRODUCT-OF|2974
23478800|Lastly, we found that RhoA activation by cucurbitacin I is mediated by reactive oxygen species (ROS).|cucurbitacin I|RhoA|9|6.0|Arg1:T2|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR|2975
23590882|These results support the hypothesis that apoplastic amino acids acting through heteromeric GLR3.2/GLR3.4 channels affect lateral root development via Ca(2+) signaling in the phloem.|amino acids|GLR3.4|8|14.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-N|PART-OF|2976
17016711|Dexamethasone probes glucocorticoid receptor (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.|prednisolone|GR|11|14.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2977
17092971|  Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine D(2) receptor partial agonists based largely on their activity in second messenger-based assays of dopamine D(2) receptor signalling.|Aripiprazole|dopamine D(2) receptor|1|18.0|Arg1:T1|Arg2:T50|CHEMICAL|GENE-Y|AGONIST|2978
23535287|CSA activated Nrf2 as evaluated by Western blotting.|CSA|Nrf2|1|3.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2979
15546741|In contrast to the pan-RAR/RXR agonistic profile of the lower homologue of 8a, compound 7 (LG100567), retinoids 8 showed selective binding and transactivation of RXR, devoid of significant RAR activation.|LG100567|RAR|18|6.0|Arg1:T4|Arg2:T8|CHEMICAL|GENE-N|AGONIST|2980
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|receptor for AGE|1|33.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2981
10373224|  The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.|EXP 3174|angiotensin II type 1 receptor|26|7.0|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|2982
23469927|The limit of detection on Western blots was 0.01 μg (15 picomoles) of soman-labeled albumin.|soman|albumin|16|17.0|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2983
15726024|CONCLUSION: Psychiatrists should be aware that even second-generation antipsychotics, including ziprasidone, have a propensity to cause side-effects associated with the dopamine D2 receptor blockade, such as galactorrhea.|ziprasidone|dopamine D2 receptor|13|24.0|Arg1:T11|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|2984
15892618|Other promising new drugs currently under preclinical and clinical evaluation, are VEGFR2 inhibitor PTK787/ZK 222584, thalidomide, farnesyl transferase inhibitor R115777 (tipifarnib, Zarnestra(TM)), matrix metalloproteinase inhibitors, proteasome inhibitor bortezomib (Velcade(TM)), mammalian target of rapamycin (mTOR) inhibitors, cyclooxygenase-2 (COX-2) inhibitors, platelet derived growth factor receptor (PDGF-R) inhibitors, protein kinase C (PKC) inhibitors, mitogen-activated protein kinase kinase (MEK) 1/2 inhibitors, Rous sarcoma virus transforming oncogene (SRC) kinase inhibitors, histondeacetylase (HDAC) inhibitors, small hypoxia-inducible factor (HIF) inhibitors, aurora kinase inhibitors, hedgehog inhibitors, and TGF-beta signalling inhibitors.|tipifarnib|farnesyl transferase|25|20.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|2985
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Phe|ALDH|15|21.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|PART-OF|2986
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|FOXO3a|3|27.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|2987
16757355|Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.|sorafenib|vascular endothelial growth factor receptor|4|16.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|2988
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|prostanoid IP-receptor|10|13.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|AGONIST|2989
23093496|This study showed that, in addition to ADP and ATP, other ATP derivatives are not only ligands of P2Y(12) but also agonists.|ADP|P2Y(12)|9|21.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|AGONIST|2990
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|hexestrol|estrogen receptor|11|42.0|Arg1:T7|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2991
15972446|In addition, PKC412 treatment resulted in a significant decline in the percentage of peripheral blood mast cells and serum histamine level and was associated with a decrease in KIT phosphorylation and D816V KIT mutation frequency.|PKC412|KIT|4|30.0|Arg1:T7|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|2992
23473803|  PDE4 is one of eleven known cyclic nucleotide phosphodiesterase families and plays a pivotal role in mediating hydrolytic degradation of the important cyclic nucleotide second messenger, cyclic 3'5' adenosine monophosphate (cAMP).|cAMP|PDE4|36|1.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE|2993
23416002|Amino acid derived quinazolines as Rock/PKA inhibitors.|Amino acid|PKA|1|7.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|2994
15037867|No significant effects of either polymorphism were associated with altered 5-HT-induced calcium response or fenfluramine-stimulated prolactin release.|fenfluramine|prolactin|15|16.0|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|2995
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|EP2|10|7.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|AGONIST|2996
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|edrophonium|acetylcholinesterase|18|32.0|Arg1:T11|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|2997
15554912|Eplerenone competed strongly for [(3)H]-dexamethasone binding to a MR/GR chimera containing amino acids 804-874 of the MR and weakly to a chimera containing amino acids 672-803 of the MR.|[(3)H]-dexamethasone|GR|5|16.0|Arg1:T16|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR|2998
7929150|These latter two forms of CA V had identical steady-state constants for the hydration of CO2, with maximal values of kcat/Km at 3 x 10(7) M-1 s-1 and kcat at 3 x 10(5) s-1 with an apparent pKa for catalysis of 7.4 determined from kcat/Km. In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, ethoxzolamide, and cyanate, CA V is very similar to CA II.|acetazolamide|CA V|72|79.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR|2999
16885432|In thalamus, modafinil occupied NET sites (5 mg/kg: 16 +/- 7.8%, n = 6; 8 mg/kg: 44 +/- 12%; n = 2).|modafinil|NET|4|6.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3000
11406192|The prototypic AMPA receptor potentiator cyclothiazide competitively inhibited [(3)H]LY395153 binding with a potency (K(i) approximately 7 microM) comparable to EC(50) values reported in electrophysiological studies.|[(3)H]LY395153|AMPA receptor|9|3.0|Arg1:T4|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|3001
12668769|One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (Gly) as one-carbon (1-C) source.|glycine|glycine decarboxylase complex|33|14.0|Arg1:T36|Arg2:T59|CHEMICAL|GENE-N|SUBSTRATE|3002
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|cyanopindolol|beta-adrenoceptor|39|2.0|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST|3003
23264615|  During early pregnancy in sheep, the elongating conceptus secretes interferon-τ (IFNT) and the conceptus as well as endometrial epithelia produce prostaglandins (PG) via PG synthase 2 (PTGS2) and cortisol via hydroxysteroid (11-β) dehydrogenase 1 (HSD11B1).|cortisol|hydroxysteroid (11-β) dehydrogenase 1|36|38.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF|3004
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|AChE|60|4.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|3005
23142559|Furthermore, TNF-α-induced CXCL8 secretion was (i) inhibited by the MR antagonist tiotropium and the M3R antagonist 4-DAMP and (ii) enhanced by the M1/M3R agonist pilocarpine and the cholinesterase inhibitor physostigmine.|physostigmine|cholinesterase|35|33.0|Arg1:T10|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|3006
23589302|In the present report, we show that Fer associates with the activated PDGFbeta receptor (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and Tyr1021.|Tyr|PDGFbeta receptor|28|14.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|PART-OF|3007
16702329|Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPARgamma/RXR pathway in chickens and HD11 cell lines.|eicosapentaenoic acid|PPARgamma|3|13.0|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3008
23486447|These drugs and their metabolites, along with desipramine and nortriptyline, undergo hydroxylation by CYP2D6 to less active metabolites.|nortriptyline|CYP2D6|11|16.0|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE|3009
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|oxoglutaramic acid|kynurenine aminotransferase I|27|12.0|Arg1:T9|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF|3010
12498985|Inhibition of p38(MAPK) by SB203580 (10 microM) enhanced DEM-induced increases in L-cystine transport and GSH, whereas inhibition of p42/p44(MAPK) (PD98059, 10 microM) had no effect.|SB203580|p38|8|3.0|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR|3011
23567243|Western blot assay demonstrated that DICO decreased Bcl-2 level and induced Bax translocation to cause cytochrome c release.|DICO|cytochrome c|6|16.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3012
23473053|  A series of benzo[de][1,7]naphthyridin-7(8H)-ones possessing a functionalized long-chain appendage have been designed and evaluated as novel PARP1 inhibitors.|benzo[de][1,7]naphthyridin-7(8H)-ones|PARP1|4|28.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR|3013
23056222|Results showed that DMF increased nuclear levels of Nrf2, and both DMF and adenovirus-mediated overexpression of Nrf2 (Ad-Nrf2) decreased PAI-1, alpha-smooth muscle actin (alpha-SMA), fibronectin and type 1 collagen expression in TGF-beta-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F).|DMF|type 1 collagen|13|34.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3014
11141093|Since this compound retains good AChE inhibitory activity and its hexahydrochromeno[4,3-b]pyrrole moiety is reminiscent of the hexahydropyrrolo[2,3-b]indole of physostigmine (3), we have designed and synthesized carbamates 4-6, and their biological evaluation has been assessed in vitro against human AChE and BChE.|hexahydrochromeno[4,3-b]pyrrole|AChE|11|6.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|3015
23589329|Arsenic inhibits autophagic flux activating the Nrf2-Keap1 pathway in a p62-dependent manner.|Arsenic|Keap1|1|8.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR|3016
15509185|The O-demethylation of tramadol to M1, the main analgesic effective metabolite, is catalysed by cytochrome P450 (CYP) 2D6, whereas N-demethylation to M2 is catalysed by CYP2B6 and CYP3A4.|N|CYP2B6|25|31.0|Arg1:T11|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|3017
23266270|Additionally, DPEP suppressed the production of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6.|DPEP|cytokines|3|9.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3018
22634112|The presumed cellular mechanism of action involves the generation of intracellular cAMP, which in turn can activate the effector molecules cAMP-dependent protein kinase (PKA) and Epac.|cAMP|cAMP-dependent protein kinase|12|22.0|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR|3019
23211364|  Candesartan is an angiotensin II type 1 receptor blocker (ARB) that has been to shown to limit ischemic stroke and improve stroke outcome.|Candesartan|angiotensin II type 1 receptor|1|4.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|3020
22708686|When combined, mianserin antagonized the effects of the full kappa-opioid receptor agonists in [(35)S]GTPgammaS assays and reduced the stimulation of p38 MAPK and ERK1/2 phosphorylation by dynorphin A.|[(35)S]GTPgammaS|kappa-opioid receptor|15|11.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3021
2832297|After loperamide administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an ACTH increase; the pattern of ACTH response to CRH was slightly delayed.|loperamide|ACTH|2|25.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3022
16495723|The nonselective monoamine oxidase inhibitors tranylcypromine (0.01-5 mg/kg) and phenelzine (1-25 mg/kg), the monoamine oxidase-A selective compound clorgyline (1-25 mg/kg), and the monoamine oxidase-B selective compounds pargyline (0.005-50 mg/kg) and selegiline (1-25 mg/kg) were tested for substitution 15 min or 24 h following administration, and in combination with 10 mg/kg of cocaine 24 and 48 h after administration.|pargyline|monoamine oxidase-B|35|31.0|Arg1:T23|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|3023
23000445|Wogonoside also suppressed the activation of mammalian target of rapamycin (mTOR) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.|Wogonoside|mammalian target of rapamycin|1|7.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|3024
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefprozil|flanking conserved motifs|46|6.0|Arg1:T15|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR|3025
22790794|All functional human K(2P) channels were screened for dronedarone sensitivity, revealing significant and concentration-dependent inhibition of cardiac K(2P)2.1 (TREK1; IC(50) = 26.7 muM) and K(2P)3.1 channels (TASK1; IC(50) = 18.7 muM) with maximum current reduction of 60.3 and 65.5 % in oocytes.|dronedarone|K(2P)2.1|12|22.0|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|3026
23314308|Addition of LTCC opener BAY K 8644 (10(-7)M) failed to enhance the relaxations.|BAY K 8644|LTCC|5|3.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR|3027
12697717|Collectively, these results suggest a role for 17 beta HSDXI in androgen metabolism during steroidogenesis and a possible role in nonsteroidogenic tissues including paracrine modulation of 5 alpha-androstane-3 alpha, 17 beta-diol levels.|5 alpha-androstane-3 alpha, 17 beta-diol|17 beta HSDXI|28|9.0|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|3028
11056242|RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on MCP-1 expression.|testosterone|MCP-1|40|71.0|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|3029
23578688|  A series of carbamoylmethylene linked prodrugs of 1 (BMS-582949), a clinical p38α inhibitor, were synthesized and evaluated.|BMS-582949|p38α|10|15.0|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|3030
15175324|When coexpressed with the m(2) acetylcholine (ACh) receptor in Xenopus oocytes, agonist-activated GIRK1(F137S)- and GIRK2-mediated currents are inhibited by halothane, whereas in the absence of ACh, high concentrations of halothane induce GIRK1(F137S)-mediated currents.|halothane|GIRK1|30|19.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|3031
9730867|The selective beta1AR antagonist atenolol (0.3 x 10(-6) M) did not have any effect.|atenolol|beta1AR|5|3.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST|3032
23318726|Furthermore, butein treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements (AREs).|butein|AREs|3|26.0|Arg1:T18|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|3033
23261705|Pharmacological inhibition of MTORC1 with rapamycin abrogated the insulin-induced phosphorylation of EIF4EBP1, RPS6KB1 and its downstream effector, RPS6.|rapamycin|MTORC1|6|4.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|3034
18056711|In the presence of drug, the linker is rigid and this alpha-helix extends to include Gly and the preceding Leu.|Leu|alpha-helix|21|13.0|Arg1:T27|Arg2:T39|CHEMICAL|GENE-N|PART-OF|3035
23313376|PTE also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.|PTE|Caspase3|1|39.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3036
23466488|l-glutamine decreased plasma glucose, increased plasma and pancreatic insulin, increased plasma and colonic active GLP-1 (7-36) amide secretion as well as decreased oxidative stress in streptozotocin-nicotinamide induced diabetic rats.|l-glutamine|GLP-1|1|17.0|Arg1:T16|Arg2:T53|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3037
17182172|Dex and Pred caused a reduction in cell proliferation and proteoglycan synthesis, whereas exposure to AL-438 had no effect.|Pred|proteoglycan|3|11.0|Arg1:T14|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3038
10365684|In conclusion, MMI and PTU at therapeutic concentrations can increase TPO mRNA and cellular TPO activity, although the 2 drugs inhibit the TPO-H2O2-mediated catalytic reaction.|MMI|TPO|4|25.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|3039
16781459|Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide.|Hydrogen sulfide|nuclear factor-kappaB|1|8.0|Arg1:T36|Arg2:T68|CHEMICAL|GENE-N|INHIBITOR|3040
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|amino acid|PBP|3|19.0|Arg1:T23|Arg2:T60|CHEMICAL|GENE-N|PART-OF|3041
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|CITCO|CARs|12|20.0|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR|3042
23177789|Protein tyrosine phosphatase 1B inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins.|triterpenes|Protein tyrosine phosphatase 1B|9|1.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR|3043
16316409|As CRABPI was elevated far more than any other genes, we observed that the retinoids, all-trans retinoic acid and 9-cis retinoic acid, that bind CRABPI, promoted nitroblue tetrazolium-associated functional cell differentiation in p75NTR PC-3 cells, but not in neo control PC-3 cells.|retinoids|CRABPI|16|28.0|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3044
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|kinase|4|28.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|3045
17352516|Improvements from baseline in mean glycosylated haemoglobin (HbA(1c)) were significantly greater with sitagliptin monotherapy than with placebo in patients with type 2 diabetes.|sitagliptin|glycosylated haemoglobin|18|6.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3046
17076770|In addition, they compromised the ability of dexamethasone to suppress the evoked release of ACTH from the excised tissue in vitro, a process which requires the translocation of ANXA1 from the cytoplasm to the cell surface of FS cells.|dexamethasone|ACTH|9|16.0|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3047
23430109|  Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the FLT3 inhibitors AC220 (quizartinib) and sorafenib.|quizartinib|FLT3|32|28.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|3048
17526944|Dexamethasone increased DAX-1 expression and concordantly decreased StAR protein and mRNA in testicular cells.|Dexamethasone|DAX-1|1|3.0|Arg1:T23|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3049
9836297|The alpha 2a-adrenoceptor contains three hydroxyl bearing amino acids at a position corresponding to this site (Thr393-Tyr394-Thr395).|hydroxyl|alpha 2a-adrenoceptor|6|2.0|Arg1:T16|Arg2:T39|CHEMICAL|GENE-Y|PART-OF|3050
23174265|Sprague-Dawley rats treated with a non-selective cannabinoid agonist (CP55940, 50μg/kg, 7 days, i.p.) showed enhanced co-immunoprecipitation of β-Arrestin 2 and ERK1/2, enhanced pERK protein levels, and enhanced expression of β-Arrestin 2 mRNA and protein levels in PFCx. In a neuronal cell line, we found that selective CB(2) receptor agonists upregulate β-Arrestin 2, an effect that was prevented by selective CB(2) receptor antagonist JTE-907 and CB(2) shRNA lentiviral particles.|JTE-907|β-Arrestin 2|80|64.0|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3051
3143355|During the course of glycine oxidation catalysed by the matrix extract a steady-state equilibrium in the production and utilization of 5,10-methylene-H4 folate was reached, suggesting that glycine cleavage and SHMT are linked together via a soluble pool of H4 folate.|H4 folate|SHMT|40|31.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|PRODUCT-OF|3052
9669506|Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (Ki = 74 nM) and a very low affinity for the norepinephrine transporter (Ki = 1.26 microM).|venlafaxine|5-HT transporter|3|20.0|Arg1:T26|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3053
9231746|Felodipine and nicardipine have similar affinities for 60-kDa CaMPDE isozymes but bring about different levels of enzyme inhibition, suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by dihydropyridine Ca2+-channel blockers.|dihydropyridine|CaMPDE|35|9.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|3054
12818701|alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.|BMY-7378|alpha(1D)-adrenoceptor|101|75.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|ANTAGONIST|3055
17251447|RESULTS: In comparison to wild-type mice, the retina of Nrl(-/-) mice contained elevated levels of RPE65 and cellular retinaldehyde-binding protein (CRALBP), suggesting a particular role of these two proteins for the retinoid metabolism of cones.|retinoid|CRALBP|40|27.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3056
23265880|A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.|(2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol|serotonin transporters|24|13.0|Arg1:T8|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3057
23270282|These two families of guanidine alkaloids clearly showed a structure-activity relationship with the crambescins acting on voltage-gated potassium channels, while Cramb816 blocks the voltage-gated calcium channel Cav1 with higher potency than nifedipine.|Cramb816|voltage-gated calcium channel|22|25.0|Arg1:T18|Arg2:T62|CHEMICAL|GENE-N|INHIBITOR|3058
23583259|  Rilpivirine and etravirine are second generation non-nucleoside reverse transcriptase inhibitors approved recently by the United States Food and Drug Administration for the treatment of human immunodeficiency virus-1 infection.|etravirine|reverse transcriptase|3|8.0|Arg1:T9|Arg2:T54|CHEMICAL|GENE-Y|INHIBITOR|3059
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|PDGFR-beta|1|29.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|3060
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|acetazolamide|CA V|12|29.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|3061
16368818|  Cyclooxygenase-1 (COX-1) inhibition by a selective inhibitor valeryl salicylate, or nonselective inhibitors at 10 mg/kg, including aspirin, ibuprofen, indomethacin, and picroxicam, attenuated by 29%-46% the duration of loss of righting reflex induced by diazepam (20 mg/kg) in mice.|picroxicam|Cyclooxygenase-1|28|1.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|3062
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|TPM|CA I|10|17.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR|3063
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|nucleotide|insulin|29|50.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3064
12582227|  OBJECTIVE: Preclinical evaluation of DRF 2655, a peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent.|DRF 2655|PPARalpha|6|15.0|Arg1:T11|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|3065
23178182|UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801.|MK-801|NMDA receptor|25|22.0|Arg1:T18|Arg2:T40|CHEMICAL|GENE-N|ANTAGONIST|3066
18055877|Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.|Thionamides|Rac1|1|11.0|Arg1:T14|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|3067
17673606|Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.|Desvenlafaxine succinate|human norepinephrine transporter|1|10.0|Arg1:T23|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST|3068
23220742|P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.|PRT062607|SYK|6|20.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|3069
23465612|Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.|dihydroisoquinoline|BACE-1|5|6.0|Arg1:T5|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|3070
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|ketoprofen|COX|17|6.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR|3071
17016711|Dexamethasone probes glucocorticoid receptor (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.|prednisolone|mineralocorticoid receptor|11|16.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3072
17434872|Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.|2,6-dichloro|human COX-2|17|14.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|3073
16982784|We also showed that (i) k3 was the rate-limiting step for the hydrolysis of cefotaxime by Asp104Lys, (ii) the Km for cefotaxime of the doubly substituted Asp104Lys Gly238Ser variant approached that of the Gly238Ser beta-lactamase as pH increased, and (iii) Lys at position 104 functions in an energetically additive manner with the Gly238Ser substitution to enhance catalysis of cephalothin.|cefotaxime|Asp104Lys|17|19.0|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE|3074
23532918|Ifenprodil, known as the GluNR2B antagonist of reference, was chosen as the template for the elaboration of probes.|Ifenprodil|GluNR2B|1|6.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST|3075
23605695|Pasireotide has a receptor binding profile that is distinct from that of other somatostatin analogues, binding with high affinity to somatostatin receptor subtype 5, which is strongly over expressed in corticotroph adenoma cells.|Pasireotide|somatostatin receptor subtype 5|1|22.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3076
23220614|Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the Bax/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.|U0126|Bax|3|14.0|Arg1:T21|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3077
23449981|Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen.|ceramide|SM synthase|11|17.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|3078
16757355|Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.|sorafenib|platelet-derived growth factor receptor|4|28.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|3079
10611634|In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT(1A) sites versus marked antagonist actions at halpha(2)-ARs. While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.|yohimbine|h5-HT(1A)|4|14.0|Arg1:T49|Arg2:T58|CHEMICAL|GENE-Y|AGONIST|3080
17207582|EGTA and 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetra acetic acid tetrakis (BAPTA), two Ca2+ chelators, but not nifedipine, an L-type Ca2+ channel blocker, prevented GRIP1 degradation.|nifedipine|L-type Ca2+ channel|28|31.0|Arg1:T21|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR|3081
10207608|Pretreatment of the splenocytes with both BPB and AACOCF3 suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced IL-2 secretion in a concentration-dependent manner.|AACOCF3|IL-2|9|16.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3082
19029287|  The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.|1,4-dihydropyridine|Ca(v)1.2|22|9.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3083
23552101|PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase β type I (pip5k1β), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].|phosphatidylinositol 4-phosphate|pip5k1β|23|10.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE|3084
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|phospho-FoxO3a|3|32.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3085
23376440|Arsenite-induced ROS generation and COX-2 expression were significantly attenuated by treatment with melatonin (a ROS scavenger), but enhanced by DL-buthionine-(S, R)-sulfoximine (BSO, an inhibitor of gamma-glutamylcysteine synthetase (γ-GCS) resulting in lower GSH and increased ROS levels).|DL-buthionine-(S, R)-sulfoximine|γ-GCS|23|39.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|3086
12646997|RESULTS: Icariin and papaverine showed dose-dependent inhibitory effects on PDE5 and PDE4 activities.|Icariin|PDE4|3|13.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|3087
23500772|Compared with DM8W group, SOD and ALDH2 in EtOH+DM8W group was increased, MDA was decreased.|EtOH|SOD|10|6.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|3088
16292755|Hepatic mRNA expressions of apo B-100 and apo C-III were significantly lower in probucol group than in other groups.|probucol|apo B-100|14|5.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3089
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|FKHR|1|8.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR|3090
23527529|IPI-926 is both a substrate and inhibitor (IC50 = 1.9 µM) of P-glycoprotein.|IPI-926|P-glycoprotein|1|15.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|3091
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|SU11248|tyrosine kinase|31|21.0|Arg1:T17|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|3092
23396419|(-)-Epigallocatechin gallate, cyclosporin A, rifampicin, and telmisartan inhibited transport of dioscin in OATP1B3-HEK293 cells.|dioscin|OATP1B3|17|19.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE|3093
22975155|Computational molecular modeling of RS41A and RS194B interactions with VX inhibited hAChE, bound reversibly in Michaelis type complex and covalently in the pentacoordinate reaction intermediate suggests that the faster reactivation reaction is a consequence of a tighter RS194B interactions with hAChE peripheral site (PAS) residues, in particular with D74, resulting in lower interaction energies for formation of both the binding and reactivation states.|RS41A|hAChE|5|12.0|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|3094
22659408|Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).|NAAG|metabotropic glutamate receptors|18|6.0|Arg1:T32|Arg2:T43|CHEMICAL|GENE-N|ACTIVATOR|3095
2833901|These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulin-dependent enzymes which are functionally involved in the regulation of smooth muscle contraction.|felodipine|calmodulin-dependent enzymes|11|19.0|Arg1:T22|Arg2:T66|CHEMICAL|GENE-N|INHIBITOR|3096
12818701|alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.|WB-4101|alpha(1A)-Adrenoceptor|18|1.0|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|3097
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|ABL|1|10.0|Arg1:T1|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR|3098
23142425|Subjects carrying the UGT2B7 268 His/Tyr or Tyr/Tyr genotype had significantly lower total NNAL than those carrying His/His genotype.|His|UGT2B7|18|4.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|PART-OF|3099
16686685|However, pretreatment with agents that block late I(Na), like lidocaine, mexiletine, and RSD1235, a novel mixed ion channel blocker for the rapid pharmacologic conversion of atrial fibrillation, significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II, a specific toxin that delays Na channel inactivation and amplifies late I(Na) greatly, mimicking LQT3.|RSD1235|ion channel|20|25.0|Arg1:T21|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|3100
17353509|Fenofibrate also increased myocardial hypertrophy, cardiac fibrosis, and the ratio of matrix metalloproteinase-2/tissue inhibitor of matrix metalloproteinase-2 in PO PPARalpha-deficient mice.|Fenofibrate|matrix metalloproteinase-2|1|14.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3101
15899831|Collectively, the data obtained with AZD2171 are consistent with potent inhibition of VEGF signaling, angiogenesis, neovascular survival, and tumor growth.|AZD2171|VEGF|7|14.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR|3102
12183670|Thus, bupropion acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits DAT and NET function.|bupropion|DAT|3|28.0|Arg1:T17|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR|3103
10334992|When bound to bile acids, FXR repressed transcription of the gene encoding cholesterol 7alpha-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding intestinal bile acid-binding protein, which is a candidate bile acid transporter.|bile acid|cholesterol 7alpha-hydroxylase|23|14.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|PRODUCT-OF|3104
23266503|The decrease in expression of matrix metalloproteinases (MMP)-2 and MMP-9 may contribute to the effects of baicalein.|baicalein|MMP-9|20|13.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3105
23146695|These findings demonstrate that puerarin successfully reverses hepatotoxicity in CCl(4)-induced HF rats via the underlying mechanisms of regulating serum enzymes and attenuating TNF-α/NF-κB pathway for anti-inflammation response, as well as improving metabolic function in liver tissue.|puerarin|NF-κB|5|28.0|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|3106
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|pyrano[2,3-b]quinolines|butyrylcholinesterase|17|7.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR|3107
23165153|Pretreatment of the resistant cells with a potent proteasome inhibitor Z-Leu-Leu-Leu-al augmented the CDDP sensitization elicited by the AKR inhibitors.|Z-Leu-Leu-Leu-al|proteasome|11|9.0|Arg1:T6|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|3108
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|menthol|TRPA1|3|19.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR|3109
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|valproate|S467C|12|16.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR|3110
10874136|In myocardial preparations isolated from guinea pigs treated with beta-naphthoflavone (80 mg/kg i.p.for 2 days), DT-diaphorase activity was enhanced (+36% with respect to control animals, P < 0.|beta-naphthoflavone|DT-diaphorase|10|19.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR|3111
23295229|  Aldehyde dehydrogenase 1 (ALDH1A1) catalyzes the oxidation of toxic aldehydes to carboxylic acids.|aldehydes|ALDH1A1|12|5.0|Arg1:T26|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE|3112
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|lapatinib|tyrosine kinase|39|31.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR|3113
23303191|Comparison of different human cell types revealed ∼50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.|UDP|Has1|16|25.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE|3114
23295224|Three of the AKRs used (AKR1B1, AKR1B10 and AKR3C1) could produce 2,3-butanediol from acetoin.|acetoin|AKR3C1|17|11.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE|3115
10460702|We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating eNOS activation.|[3H]L-Arg|eNOS|14|26.0|Arg1:T15|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|3116
23566884|The immunoblotting assays indicate that tomatidine is very effective in suppressing the phosphorylation of Akt and extracellular signal regulating kinase (ERK).|tomatidine|ERK|6|22.0|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|3117
1744096|We observed that the removal of the labeled upper axial ligands from CN-Cbl and Me-Cbl both paralleled the activation of human apomethionine synthase.|Me-Cbl|human apomethionine synthase|15|21.0|Arg1:T35|Arg2:T54|CHEMICAL|GENE-Y|ACTIVATOR|3118
12531805|We show that SU11248 also has potent activity against wild-type FLT3 (FLT3-WT), FLT3-ITD, and FLT3 activation loop (FLT3-Asp835) mutants in phosphorylation assays.|SU11248|FLT3|4|13.0|Arg1:T9|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR|3119
24365491|In addition, pseudoephedrine significantly suppressed the production of p-IkappaB-alpha, reducing the degradation of sequestered nuclear factor kappa B (NF-kappaB) in the cytoplasm, and inhibited the translocation of NF-kappaB/p65 to the nucleus, the transcription of TNF-alpha mRNA and the production of TNF-alpha in primary KCs. These results suggest that pseudoephedrine and ephedrine have a potent anti-inflammatory activity against D-GalN/LPS-induced acute liver failure in rats, and this comprehensive anti-inflammatory effect may result from the inhibition of TNF-alpha production.|pseudoephedrine|p65|4|34.0|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR|3120
10405348|Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.|paclitaxel|tumor necrosis factor alpha|13|3.0|Arg1:T20|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|3121
12477282|Experimental manipulation of the intracellular GSSG concentration during inhibition of cellular prooxidant production demonstrated that increased intracellular GSSG is a primary signal that is directly or indirectly required for CpG-induced NF-kappaB activation but is not in itself sufficient to trigger this in the absence of CpG ODN.|GSSG|NF-kappaB|18|31.0|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|3122
18055877|Using primary human T-lymphocytes, we show that the heterocyclic thionamides carbimazole and propylthiouracil inhibit synthesis of the proinflammatory cytokines tumor necrosis factor (TNF)alpha and interferon (IFN)gamma.|propylthiouracil|tumor necrosis factor (TNF)alpha|14|21.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3123
23561118|Results showed that EEAP and quercetin but not ferulic acid protected β-cells from glucotoxicity through several mechanisms, including: (1) maintaining β-cell viability; (2) suppressing reactive oxygen species production; (3) reducing characteristic features of apoptosis; (4) inhibiting the activation of caspase-9 and caspase-3 and the cleavage of poly (ADP-ribose) polymerase; (5) upregulating pancreatic and duodenal homeobox 1 gene expression and the insulin secretagogue action of pancreatic β-cells.|quercetin|caspase-3|6|55.0|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|3124
10076535|Down-regulation of prostate-specific antigen (PSA) expression, an AR-target gene, by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor.|bicalutamide|AR|17|11.0|Arg1:T19|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3125
11785774|The clenbuterol-induced ACTH and corticosterone responses were considerably impaired by pretreatment with piroxicam, and slightly less potently by NS-398.|piroxicam|ACTH|13|3.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3126
23589329|Collectively, these findings provide evidence that arsenic causes prolonged activation of Nrf2 through autophagy dysfunction, possibly providing a similar scenario to constitutive activation of Nrf2 found in certain human cancers.|arsenic|Nrf2|8|27.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|3127
15972446|Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.|PKC412|tyrosine kinase|7|4.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|3128
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|nitric oxide|inducible nitric oxide synthase|14|2.0|Arg1:T36|Arg2:T58|CHEMICAL|GENE-Y|PRODUCT-OF|3129
16940412|Of the two tubulin structures available, we selected for modeling the complex of a stathmin fragment with two tubulin heterodimers with two bound colchicinoid molecules and a single bound vinblastine between the two heterodimers (Nature (Lond) 435:519-522, 2005).|vinblastine|stathmin|31|16.0|Arg1:T20|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3130
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|[3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane|DAT|20|44.0|Arg1:T21|Arg2:T45|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3131
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|R 24571|calmodulin|27|3.0|Arg1:T5|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR|3132
23238103|To control for possible interactions between the expression of the estrogen receptor genes and other learning-related steroid receptors, androgen receptors (AR), corticosterone-binding glucocorticoid receptors (GR) and mineralocorticoid receptors (MR) were also measured.|corticosterone|MR|26|36.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3133
23117572|In NTERA cells treated with the histone deacetylase inhibitors SAHA and valproic acid, a significant increase in NIS mRNA (about 60- and 30-fold vs control, P<0.001 and P<0.01 respectively) and protein levels, resulting in enhanced ability to uptake radioiodine, was observed.|valproic acid|NIS|12|19.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3134
17008880|Taken together, vitamin C uptake is increased in UVB-irradiated keratinocytes through the translocation of SVCT-1 and regulates inflammatory response in the skin via the downregulation of IL-8 and MCP-1 production.|vitamin C|IL-8|4|28.0|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3135
19281809|  The low-affinity sodium glucose cotransporter (SGLT2) is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes.|glucose|sodium glucose cotransporter|15|3.0|Arg1:T25|Arg2:T32|CHEMICAL|GENE-N|SUBSTRATE|3136
10340919|METHODS: COX-1 inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).|diclofenac|COX-1|34|3.0|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|3137
15694390|Nordihydroguaiaretic acid inhibits IFN-gamma-induced STAT tyrosine phosphorylation in rat brain astrocytes.|Nordihydroguaiaretic acid|IFN-gamma|1|4.0|Arg1:T17|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR|3138
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|BPs|MEK|7|33.0|Arg1:T13|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR|3139
17409318|The accumulation of the post-D6D products of 22:5n-3, 24:6n-3 and DHA, in cell phospholipids was saturated at concentrations of >18 microM ALA.|DHA|D6D|12|6.0|Arg1:T20|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF|3140
12504917|Reserpine-induced ptosis was reversed by rasagiline at doses above 2 mg x kg(-1) i.p., which inhibit MAO-A as well as MAO-B, but not at MAO-B-selective doses.|rasagiline|MAO-B|6|25.0|Arg1:T21|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR|3141
23542513|In addition, 5HHMF blocked LPS-induced phosphorylation of IκB, resulting in suppression of the nuclear translocation of nuclear factor-κB (NF-κB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression.|5HHMF|nuclear factor-κB|4|19.0|Arg1:T13|Arg2:T35|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3142
12504917|However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and MAO-B by tranylcypromine together with the monoamine precursors.|rasagiline|MAO-B|34|76.0|Arg1:T25|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR|3143
8522988|The recombinant human 5-HT6 receptor is positively coupled to adenylyl cyclase and has pharmacological properties similar to the rat receptor with high affinity for several typical and atypical antipsychotics, including clozapine.|clozapine|human 5-HT6 receptor|32|3.0|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3144
17653850|  Agmatine is an endogenous amine that is synthesized following the decarboxylation of L-arginine by arginine decarboxylase.|L-arginine|arginine decarboxylase|13|15.0|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|3145
23415904|The 7KC/7βOHC ratio was similarly increased when NADPH generation was restricted by disruption of hexose-6-phosphate dehydrogenase.|7KC|hexose-6-phosphate dehydrogenase|2|15.0|Arg1:T26|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|3146
23220590|At therapeutic drug levels (0.015 mM) and physiologically relevant concentrations of ethanol (10 mM) and acetaldehyde (10 μM) in target tissues, cimetidine could weakly inhibit (<5%) the activities of ADH1B2 and ADH1B3 in liver, ADH2 in liver and small intestine, ADH4 in stomach, and ALDH1A1 in the three tissues, but not significantly affect ADH1A, ADH1B1, ADH1C1/2, or ALDH2.|ethanol|ALDH2|14|76.0|Arg1:T1|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|3147
15695169|Ramelteon showed very high affinity for human MT1 (Mel1a) and MT2 (Mel1b) receptors (expressed in Chinese hamster ovary [CHO] cells), and chick forebrain melatonin receptors (consisting of Mel1a and Mel1c receptors) with Ki values of 14.0, 112, and 23.1 pM, respectively, making the affinities of ramelteon for these receptors 3-16 times higher than those of melatonin.|Ramelteon|MT2|1|13.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3148
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|p-aminohippurate|hOAT3|22|4.0|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR|3149
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefprozil|PBPs|46|52.0|Arg1:T15|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR|3150
16298345|However, as with the human receptor, maraviroc was shown to be a high affinity, potent functional antagonist of macaque CCR5 thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology, safety and potential mechanism-related toxicology of novel CCR5 antagonists.|maraviroc|CCR5|9|48.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|ANTAGONIST|3151
23334403|  PURPOSE: To characterise further the previously observed cytochrome P450 3A4 (CYP3A4) interaction of the dual orexin receptor antagonist almorexant.|almorexant|orexin receptor|22|19.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST|3152
23567045|The Lac-GLN formulation contained N-lactobionyl-dioleoyl phosphatidylethanolamine (Lac-DOPE), a ligand for the asialoglycoprotein receptor (ASGR), and an antibiotic peptide gramicidin A.|N-lactobionyl-dioleoyl phosphatidylethanolamine|asialoglycoprotein receptor|5|15.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR|3153
10351938|Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils.|fluticasone propionate|cPLA2|10|3.0|Arg1:T25|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3154
2386945|Although numerous mechanisms of action of pimozide and thioridazine have been identified, both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro.|thioridazine|calmodulin|9|17.0|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST|3155
23208609|Expression of particular steroidogenic genes, including the one encoding for aromatase (CYP19A1), was significantly upregulated after incubation of H295R cells with 2-ITX, 4-ITX, and 2,4-diethyl-TX.|2,4-diethyl-TX|aromatase|31|12.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3156
8384226|RESULTS: Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF/IL-8 of GM-CSF primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of IL-3 primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L).|Nedocromil sodium|IL-3|3|40.0|Arg1:T8|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR|3157
23449888|p14ARF perturbs the androgen-induced interaction between the N terminus and C terminus of AR.|C|AR|11|14.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|PART-OF|3158
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|PI3K|1|13.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|ACTIVATOR|3159
15240345|Incubations with purified lactate dehydrogenase suggested that this enzyme was responsible for the metabolism of glycolate to oxalate in HepG2 cells.|oxalate|lactate dehydrogenase|18|4.0|Arg1:T33|Arg2:T39|CHEMICAL|GENE-N|PRODUCT-OF|3160
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|EACA|plasminogen|17|31.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|3161
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|GSH|Slc25a10|40|18.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE|3162
23159986|HDN induced by D-limonene was reversible, but with a variable renal biomarker pattern over time: Day 8 there was increased αGST, μGST and albumin; on Day 15 increased clusterin, albumin and Kim-1.|D-limonene|Kim-1|4|37.0|Arg1:T6|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3163
22614004|Using pharmacologic and molecular approaches that suppress the prolyl-hydroxylase (PHD)-mediated inhibition of HIF1α, we show that DCA inhibits HIF1α by both a PHD-dependent mechanism (that involves a DCA-induced increase in the production of mitochondria-derived α-ketoglutarate) and a PHD-independent mechanism, involving activation of p53 via mitochondrial-derived H(2)O(2), as well as activation of GSK3β.|DCA|GSK3β|21|67.0|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|3164
20426763|As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose).|AL-34662|5HT(2C)|9|46.0|Arg1:T20|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3165
16757355|A novel class of biaryl urea that inhibits C-RAF kinase was discovered using a combination of medicinal and combinatorial chemistry approaches.|biaryl urea|kinase|5|10.0|Arg1:T5|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|3166
8643547|Catecholamines exhibit a 3-fold higher affinity, and histamine exhibits a 30-fold higher affinity, for VMAT2.|Catecholamines|VMAT2|1|17.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3167
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|COT|32|20.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|3168
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT1|21|33.0|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR|3169
8667211|  Previous studies by this research team proved that vasodilating prostaglandins (PGs) E1, E2 and I2 inhibit carbonic anhydrase (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs. Relying on these findings, as well as on our clinical observations, we studied in vitro and in vivo the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on CA I and CA II.|PGs|CA|12|23.0|Arg1:T9|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR|3170
12213059|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|ATP sensitive potassium channels|1|12.0|Arg1:T17|Arg2:T31|CHEMICAL|GENE-N|ACTIVATOR|3171
10328230|  We have examined the effects of the synthetic matrix metalloproteinase inhibitor, batimastat (BB-94) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice.|batimastat|matrix metalloproteinase|13|9.0|Arg1:T13|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|3172
23231492|"We aim to ""tilt"" the stability of the H1 loop structure from a noncanonical conformation to a (humanized) type 1 canonical conformation by studying the effect of selected mutations to the amino acid sequence of the H1, H2, and proximal residues."|amino acid|H2|36|43.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-N|PART-OF|3173
12177684|In vitro and in microiontophoresis, flibanserin behaves as a 5-HT(1A) agonist, a very weak partial agonist on dopamine D(4) receptors, and a 5-HT(2A) antagonist.|flibanserin|dopamine D(4) receptors|7|23.0|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|3174
23205634|Both wild-type ABCG2 and its R482G mutant variant require cholesterol for full activity, although they exhibit different cholesterol sensitivities.|cholesterol|R482G|10|6.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR|3175
23473801|In conclusion, hinokitiol may inhibit platelet activation by inhibiting the PLCγ2-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and Akt.|hinokitiol|Akt|4|27.0|Arg1:T7|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR|3176
15650315|CONCLUSION: Our results indicate that pranlukast inhibits IL-5 synthesis via a mechanism distinct from CysLTR1 antagonism.|pranlukast|IL-5|7|9.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|3177
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|SB 200646A|5-HT receptor|58|1.0|Arg1:T7|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST|3178
23540839|  The fragment indole-6-carboxylic acid (1F1), previously identified as a flap site binder in a fragment-based screen against HIV protease (PR), has been cocrystallized with pepstatin-inhibited PR and with apo-PR.|indole-6-carboxylic acid|PR|3|32.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR|3179
8788445|The analgesic actions of (-)-pentazocine are readily reversed by nor-binaltorphimine, but not by the mu-selective opioid receptor antagonist beta-funaltrexamine, implying a kappa 1-opioid receptor mechanism of action.|beta-funaltrexamine|mu-selective opioid receptor|23|19.0|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST|3180
16867246|METHODS: We identified seven SNP(single nucleotide polymorphism) (-141Cins>del, TaqIB, TaqID, Ser311Cys, rs6275, rs6277 and TaqIA) in the DRD2 gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with chlorpromazine after 8 weeks.|nucleotide|Ser311Cys|9|21.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|PART-OF|3181
23296101|These results show that phthalate esters activate TRPA1 and TRPV1 with selectivity.|phthalate esters|TRPV1|5|10.0|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR|3182
23047001|Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).|BTZs|GSK-3β|10|22.0|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|3183
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hCNT2|9|33.0|Arg1:T8|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE|3184
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Cys|ALDH|51|64.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-N|PART-OF|3185
17526944|These observations strongly support the concept that dexamethasone suppresses rat testicular testosterone production, at least in part, by increasing the amount of complexed DAX-1-SF-1 in these cells, which leads directly to decreased availability of free SF-1 and, therefore, decreased activation of transcription of the rat StAR gene.|dexamethasone|DAX-1|8|26.0|Arg1:T5|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3186
19203467|RESULTS: Both PLZ and VIG inhibited GABA-T and elevated GABA levels.|VIG|GABA-T|6|8.0|Arg1:T47|Arg2:T77|CHEMICAL|GENE-Y|INHIBITOR|3187
23396090|In contrast, liposomal CDDP induced expression of genes from DNA damage pathways and several genes of the extrinsic pathway of apoptosis (TNFRSF10B-DR5, CD70-TNFSF7).|CDDP|DR5|5|25.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3188
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate|beta(1)-adrenoceptor|6|40.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST|3189
22537794|Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.|cocaine|DAT|19|5.0|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3190
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS4|4|10.0|Arg1:T32|Arg2:T62|CHEMICAL|GENE-Y|INHIBITOR|3191
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|prostaglandin E2|cyclooxygenase-2|14|26.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF|3192
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|cholesterol|liver X receptor|3|14.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR|3193
22512587|The present work aims towards examining the functional and structural features that facilitate the binding of small molecules based on Thiazolidinedione pharmacophore to PPARs. The intent of this article is to review all the reported thiazolidinediones and associated groups of PPARγ ligands.|thiazolidinediones|PPARγ|37|42.0|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3194
15606893|Characterization of an allosteric citalopram-binding site at the serotonin transporter.|citalopram|serotonin transporter|5|9.0|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3195
16722247|An increasing number of studies concerning the identification of single nucleotide polymorphisms in the hNET gene and their potential association with disease as well as the functional investigation of naturally occurring or induced amino acid variations in hNET have contributed to a better understanding of NET function, regulation and genetic contribution to disorders.|amino acid|hNET|34|38.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|PART-OF|3196
8102973|the D2 receptor by a factor of 2.8. Other compounds with dopamine D4 receptor selectivity were (+)-apomorphine (8.7), (+)-N-propyl-norapomorphine (NPA) (2.4) and melperone (1.3).|melperone|dopamine D4 receptor|37|13.0|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST|3197
14744615|This response was: (1) partly blocked in dogs pretreated intravenously with the antagonists SB224289 (5-HT(1B); 2,3,6,7-tetrahydro-1'-methyl-5-[2'-methyl-4' (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl]furo[2,3-f]indole-3-spiro-4'-p iperidine hydrochloride), rauwolscine (alpha(2)), BRL44408 (alpha(2A); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole) or MK912 (alpha(2C); (2S,12bS)-1'3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2Hbenzo[b]furo[2,3-a]q uinazoline)-2,4'-pyrimidin-2'-one); (2) markedly blocked after SB224289 plus rauwolscine; and (3) unaffected after BRL15572 (5-HT(1D); 1-(3-chlorophenyl)-4-[3,3-diphenyl (2-(S,R) hydroxypropanyl) piperazine] hydrochloride) or imiloxan (alpha(2B)).|imiloxan|alpha(2B)|140|142.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST|3198
21262851|BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.|neurosteroids|L-VGCCs|18|28.0|Arg1:T20|Arg2:T53|CHEMICAL|GENE-N|INHIBITOR|3199
23219161|The protein is formed by an N-terminal helicase-like domain, a C-terminal DNA polymerase domain, and a large central domain that spans between the two.|C|C-terminal DNA polymerase domain|12|12.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|PART-OF|3200
17603759|  L-2-hydroxyglutaric aciduria is a metabolic disorder in which L-2-hydroxyglutarate accumulates as a result of a deficiency in FAD-linked L-2-hydroxyglutarate dehydrogenase, a mitochondrial enzyme converting L-2-hydroxyglutarate to alpha-ketoglutarate.|L-2-hydroxyglutarate|L-2-hydroxyglutarate dehydrogenase|26|19.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE|3201
9007522|NS-49, an alpha 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs.|NS-49|alpha 1A-adrenoceptor|1|4.0|Arg1:T21|Arg2:T27|CHEMICAL|GENE-Y|AGONIST|3202
12652111|A combination of cilostazol (>15 microM) and the PDE4 selective inhibitor, rolipram (5 microM), inhibited levels of cytosolic cAMP-PDE activity similar to those inhibited by milrinone on its own.|rolipram|PDE4|16|12.0|Arg1:T21|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR|3203
15210974|These experimental results suggest that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A, supporting previous indications that LEV possesses a mechanism of action distinct from that of other antiepileptic drugs.|LEV|SV2A|12|6.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3204
17163232|This trial investigated the possibility of pharmacokinetic interactions between the AT1 receptor antagonist olmesartan medoxomil and the thiazide diuretic hydrochlorothiazide in healthy subjects.|olmesartan medoxomil|AT1 receptor|14|11.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|3205
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|AST|8|56.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3206
23200736|In addition, tigecycline dose-dependently decreased cytochrome c release and caspase-3 activity.|tigecycline|caspase-3|4|11.0|Arg1:T11|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|3207
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|quinacrine|PLA(2)|36|31.0|Arg1:T8|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR|3208
15627430|Since thioridazine binds with similar high affinities to muscarinic receptors as olanzapine and clozapine, muscarinic autoreceptor blockade was ruled out as a primary mechanism [Neuropsychopharmacology 26 (2002) 583].|clozapine|muscarinic receptors|14|9.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR|3209
17082235|Glinides, sulfonylureas, and other acidified sulfonamides may be promising leads in the development of new PPARgamma agonists.|Glinides|PPARgamma|1|18.0|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|AGONIST|3210
19651196|The mechanism of OP poisoning involves inhibition of acetylcholinesterase (AChE) leading to inactivation of the enzyme which has an important role in neurotransmission.|OP|AChE|4|11.0|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|3211
9873034|Imidazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.|miconazole|iNOSox|8|13.0|Arg1:T31|Arg2:T56|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3212
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|7|14.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3213
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|TIC|P450s|6|19.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF|3214
14508322|Inhibition of binding of the alpha2-receptor antagonist [3H]RX821002 to recombinant alpha2-receptors by etomidate was tested in human embryonic kidney (HEK293) cells in vitro.|etomidate|alpha2-receptors|16|14.0|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR|3215
16291873|Binding sites for hERG blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix (Tyr-652, Phe-656) and residues in the pore helix (Thr-623, Ser-624, Val-625).|Ser|hERG|38|4.0|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|PART-OF|3216
10193665|Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).|zotepine|norepinephrine transporter|40|35.0|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3217
10548268|The irreversible MAO-B inhibitors, pargyline (30 mg/kg) and l-deprenyl (3-10 mg/kg) also decreased responding maintained by ethanol reinforcement; these results are consistent with previous findings that both drugs decreased ethanol intake in mice.|l-deprenyl|MAO-B|12|3.0|Arg1:T2|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|3218
14508322|In alpha2B-receptor-expressing HEK293 cells, etomidate rapidly increased phosphorylation of the extracellular signal-related kinases ERK1/2.|etomidate|extracellular signal-related kinases|6|12.0|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR|3219
7909690|Atovaquone, a naphthoquinone, is a moderate inhibitor of dihydroorotate dehydrogenase in vitro (Ki = 27 microM) but induces major accumulations of CA-asp and DHO.|Atovaquone|dihydroorotate dehydrogenase|1|11.0|Arg1:T32|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR|3220
23603339|The androgen receptor seemed to be involved in DHEA-mediated diminishment of CYP1A2 induction, which was attenuated in the presence of bicalutamide, the androgen receptor antagonist.|bicalutamide|androgen receptor|22|25.0|Arg1:T20|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST|3221
10688973|The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist (-)-quadazocine exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.|buprenorphine|opioid receptor|7|3.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|AGONIST|3222
10864881|Comparison of all the beta-adrenoceptor antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>atenolol.|timolol|beta-adrenoceptor|24|5.0|Arg1:T30|Arg2:T44|CHEMICAL|GENE-N|ANTAGONIST|3223
14967461|Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2).|PKI166|Her2|21|38.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|3224
12907245|In contrast, doxorubicin and VP-16 induced p53, and inhibition of p53 decreased drug-induced cell death, suggesting a pro-apoptotic role for p53.|VP-16|p53|6|8.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR|3225
8666140|Single-strand conformational analysis and nucleotide sequencing of the entire coding region of the PC3 gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 (Arg/Gln53) and 14 (Gln/Glu638), neither of which was associated with NIDDM in this population.|nucleotide|Gln/Glu638|5|34.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-N|PART-OF|3226
10947967|  C-terminal amidation, a required post-translational modification for the bioactivation of many neuropeptides, entails sequential enzymic action by peptidylglycine alpha-mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5).|C|EC 4.3.2.5|1|34.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|PART-OF|3227
23395003|  Polycomb repressive complex 1 (PRC1) catalyzes lysine 119 monoubiquitylation on H2A (H2AK119ub1) and regulates pluripotency in embryonic stem cells (ESCs).|lysine|H2A|9|15.0|Arg1:T1|Arg2:T25|CHEMICAL|GENE-N|PART-OF|3228
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|naproxen|COX|37|41.0|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|3229
16918396|The data produced has highlighted that the atypical profile of APD such as olanzapine and clozapine may reflect antagonism of the 5-HT(2A) and 5-HT(2C) receptors, whilst that of, ziprasidone and quetiapine may reflect partial agonist activity at the 5-HT(1A) receptor, and that of aripiprazole may reflect partial agonist activity at the 5-HT(1A) receptor as well as is its claimed partial agonist activity at the dopamine D(2) receptor.|clozapine|5-HT(2C)|16|27.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST|3230
11979347|A common polymorphism in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C-->T substitution at nucleotide 677, is associated with homocysteine (Hcy) level elevation.|C|MTHFR|13|9.0|Arg1:T18|Arg2:T53|CHEMICAL|GENE-Y|PART-OF|3231
2248058|Moclobemide is a relatively weak MAO-A inhibitor in vitro and yet more potent in vivo than other reversible inhibitors, suggesting that the compound may be converted in vivo to an active form.|Moclobemide|MAO-A|1|6.0|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|3232
23047001|Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).|ATP|glycogen synthase kinase-3β|15|18.0|Arg1:T8|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3233
23517028|Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design.|Arylpiperazine|β1-Adrenergic Receptor|13|6.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3234
7816863|Intraperitoneal administration of (+/- )propranolol HCl (2.5-10 mg/kg), a nonselective beta-adrenoceptor antagonist, dose dependently attenuated the desipramine-induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses.|(+/- )propranolol HCl|beta-adrenoceptor|4|16.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|ANTAGONIST|3235
23589499|MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations.|2-Arylbenzofurans|MAO|5|1.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR|3236
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|NO|argininosuccinate synthase|24|10.0|Arg1:T5|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF|3237
23237828|Treatment with actinomycin D prevented cycloheximide-stimulated SOCS-3 mRNA expression, suggesting that the effect of cycloheximide requires new mRNA synthesis.|actinomycin D|SOCS-3|3|7.0|Arg1:T5|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3238
23073075|  Fingolimod (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (S1PR) subtypes.|FTY720|sphingosine-1-phosphate receptor|3|20.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR|3239
22708686|In [(35)S]GTPgammaS assays, mianserin selectively activated kappa-opioid receptors.|[(35)S]GTPgammaS|kappa-opioid receptors|2|14.0|Arg1:T18|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3240
22708686|In rat striatum and nucleus accumbens, mianserin stimulated [35S]GTPgammaS binding in a nor-BNI-sensitive manner with maximal effects lower than those of the full kappa-opioid agonists (-)-U50,488 and dynorphin A.|[35S]GTPgammaS|kappa-opioid|10|28.0|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3241
2833901|Felodipine and the p-chloro analogue inhibited Ca2+/calmodulin-dependent caldesmon kinase with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.|p-chloro|caldesmon kinase|4|8.0|Arg1:T39|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR|3242
12177684|  Flibanserin has preferential affinity for serotonin 5-HT(1A), dopamine D(4k), and serotonin 5-HT(2A) receptors.|Flibanserin|5-HT(1A)|1|7.0|Arg1:T1|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3243
8799556|RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes.|RS 17053|alpha 1B|1|18.0|Arg1:T39|Arg2:T58|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3244
23583485|The IC50 values were 1.61μg/mL, 20.06μg/mL, 34.76μg/mL (CYP3A4/midazolam), 46.73μg/mL (CYP3A4/testosterone), and 54.52μg/mL, respectively.|testosterone|CYP3A4|17|16.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|3245
15126366|I3A was unable to cause the same extent of association of the C1b domain of PKC-delta with lipids, compared with PMA or the physiological regulator diacylglycerol, and was able to partially block the association induced by these agents, measured by surface plasmon resonance.|PMA|PKC-delta|22|16.0|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3246
23376438|The ZEN metabolites induced loss of mitochondrial membrane potential (MMP), mitochondrial changes in Bcl-2 and Bax proteins, and cytoplasmic release of cytochrome c and apoptosis-inducing factor (AIF).|ZEN|apoptosis-inducing factor|2|29.0|Arg1:T23|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3247
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|PI3K|10|45.0|Arg1:T12|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR|3248
17653133|  Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethylarginine to generate L-citrulline and is present in large quantities in the kidney.|dimethylarginine|Dimethylarginine dimethylaminohydrolase|8|1.0|Arg1:T8|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE|3249
10768100|RESULTS: Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml troglitazone for 72 h caused a reduction of both PAI-1 secretion (by 29 +/- 5%; p < 0.01) and PAI-1 mRNA expression (by 26 +/- 3%; p < 0.05).|troglitazone|PAI-1|17|40.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3250
23583258|Oxysterol-dependent NOX1 activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.|Oxysterol|interleukin|1|8.0|Arg1:T17|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR|3251
23522182|RESULTS: HbA1c was reduced numerically from baseline by 0.3-0.8% with AZD1656 and by 0.1% with placebo over the first 2 months of treatment, after which effects of AZD1656 started to decline.|AZD1656|HbA1c|13|3.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3252
10381787|Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.|meloxicam|cyclooxygenase-1|10|5.0|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|3253
23357361|Since β-asarone induced lamin B1 expression, a model is proposed in which β-asarone inhibits colorectal cancer by inducing senescence through lamin B1.|β-asarone|lamin B1|14|22.0|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3254
10947967|In contrast, 2, 4-dioxo-5-acetamido-6-phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopamine-beta-hydroxylase.|ascorbate|dopamine-beta-hydroxylase|17|35.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|3255
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|Mn(3+)|transferrin|16|33.0|Arg1:T11|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE|3256
23604717|Collectively, SAL-2 inhibited COX-2 and iNOS gene expression through suppression of NF-κB leading to the inhibition of PGE2 synthesis.|PGE2|COX-2|19|5.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF|3257
23376440|These data indicate that arsenite promotes an induction of ROS, which results in an induction of COX-2 expression through activation of the MAPK pathway.|arsenite|COX-2|5|18.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3258
12527923|It is especially effective against MMP-2 and -9 more so than other MMP inhibitors such as Marimastat, Ro 32-3555 and D-2163.|D-2163|MMP|22|13.0|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR|3259
22846225|Chelerythrine, a redox-sensitive PKC inhibitor that inhibits PKMζ and disrupts LTP maintenance and memory storage, was also reported by Wu-Zhang et al.|Chelerythrine|PKC|1|5.0|Arg1:T14|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR|3260
23435541|In addition, colocalization of acid sphingomyelinase (ASM) and ceramide was induced by OxLDL, which was blocked by statins.|statins|acid sphingomyelinase|22|6.0|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR|3261
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|aspartate|AdSS|19|4.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|3262
23478800|Moreover, they established that the inhibitory effect of cucurbitacin I on Rac1 activity involves the alteration of the balance between Rho and Rac.|cucurbitacin I|Rac1|10|13.0|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|3263
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|CGP 20712|human beta-adrenergic receptors|56|73.0|Arg1:T20|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST|3264
11971019|Apoptosis was abolished by inhibition of ODC and was restored by the polyamines spermidine and spermine.|polyamines|ODC|13|7.0|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF|3265
23333834|Results confirmed that YR-11 peptide inhibited pro-inflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of NF-κB.|YR-11|cytokines|4|8.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR|3266
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|pomalidomide|DDB1|13|25.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3267
23228696|In this current study, paclitaxel was found to increase phosphorylation of mitogen-activated protein kinase (MAPK) kinase 3/6 (MKK3/6)-p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells.|paclitaxel|MAPK|6|25.0|Arg1:T13|Arg2:T33|CHEMICAL|GENE-N|ACTIVATOR|3268
8710929|These events are stimulated by NE and by guanethidine, an hNET substrate, and they are blocked by cocaine and the antidepressant desipramine.|NE|hNET|6|12.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|3269
23604720|From the 10 isolated compounds, methyl-3,5-di-O-caffeoylquinate showed the most potent inhibition, with IC50 values of 0.30 and 0.67 μM for rAR and rhAR, respectively.|methyl-3,5-di-O-caffeoylquinate|rhAR|7|25.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|3270
23468082|CONCLUSIONS: These encouraging preclinical findings suggest the inhibition of both FGFR2 and mTOR by the ponatinib-ridaforolimus combination may provide a new therapeutic strategy to treat advanced endometrial cancers with dual pathway dysregulation.|ridaforolimus|FGFR2|18|12.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|3271
15794712|Imatinib is a small-molecule tyrosine kinase inhibitor of the ABL fusion gene, platelet derived growth factor receptors (PDGFR) and KIT.|Imatinib|tyrosine kinase|1|5.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|3272
23598363|Our findings indicate that imatinib protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.|cisplatin|BAX|9|22.0|Arg1:T8|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR|3273
23147415|We demonstrate that HZ mice are significantly more sensitive to local AChE inhibition (BW284c51), but remain insensitive to butyrylcholinesterase (BuChE) inhibition (bambuterol).|bambuterol|BuChE|28|24.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|3274
23599431|The latter effect was mimicked by a CXCR7-selective agonist TC14012 and abolished by siRNA knockdown of CXCR7.|TC14012|CXCR7|10|8.0|Arg1:T1|Arg2:T34|CHEMICAL|GENE-Y|AGONIST|3275
16599255|Some of the new compounds proved in a slightly modified colorimetric Ellmann's assay to be potent inhibitors of acetylcholinesterase and of butyrylcholinesterase which is another catalytic enzyme hydrolysing acetylcholine.|acetylcholine|acetylcholinesterase|30|20.0|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE|3276
10381000|In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (GTPCH), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (BH4), the obligate cofactor for TPH.|tetrahydrobiopterin|GTP cyclohydrolase I|27|12.0|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|3277
11553608|The purified recombinant protein possesses a cysteine desulfurase activity, is yellow in color, and shows a NifS-like change in absorbance in the presence of L-cysteine.|L-cysteine|cysteine desulfurase|27|7.0|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE|3278
23432582|Moreover, since reduced levels of p21CIP1 and Chk2 proteins but no change in p53 levels could be detected in MCF-7 cells after BSC 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis.|BSC|p21CIP1|24|7.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3279
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|MPTP|parkin|26|33.0|Arg1:T8|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3280
15210974|  Here, we show that the synaptic vesicle protein SV2A is the brain binding site of levetiracetam (LEV), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy.|LEV|synaptic vesicle protein SV2A|19|7.0|Arg1:T12|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3281
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|Imatinib mesilate|bcr|1|15.0|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|3282
10405348|  The aromatase enzyme, which converts androstenedione to oestrone, regulates the availability of oestrogen to support the growth of hormone-dependent breast tumours.|androstenedione|aromatase|7|2.0|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE|3283
10220509|Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.|prostaglandin|cyclooxygenase 2|10|4.0|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF|3284
10471277|Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol.|[(125)I]iodoazidosalmeterol|beta 2-adrenergic receptor|17|8.0|Arg1:T31|Arg2:T40|CHEMICAL|GENE-N|DIRECT-REGULATOR|3285
9572299|As seen for spermidine stimulation, high-affinity haloperidol inhibition is governed by the region around amino acid 198, based on results from chimeric murine NR2A/NR2B (epislon1/epsilon2) receptors.|amino acid|NR2B|16|27.0|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|PART-OF|3286
1744096|Methylcobalamin (Me-Cbl) is tightly bound to methionine synthase and is required for enzymatic activity.|Me-Cbl|methionine synthase|3|9.0|Arg1:T12|Arg2:T50|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3287
12660248|Restoration of l-methionine rapidly down-regulates MAT2A mRNA levels; for this effect, l-methionine needs to be converted into AdoMet.|AdoMet|MAT2A|20|6.0|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF|3288
23071106|Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca(2+) channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells.|nicardipine|L-type Ca(2+) channel|40|33.0|Arg1:T24|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR|3289
11078056|Selective COX-2 inhibitors, such as meloxicam, celecoxib (SC-58635), and rofecoxib (MK-0966), are NSAIDs that have been modified chemically to preferentially inhibit COX-2 but not COX-1.|rofecoxib|COX-2|15|30.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR|3290
23238783|The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.|bupropion|CYP2B6|12|9.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|3291
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|LRP|30|29.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR|3292
8605869|TWIK-1 channels are probably involved in the control of background K+ membrane conductances.|K+|TWIK-1|11|1.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE|3293
23518299|In addition, SFN protected 6-OHDA-induced apoptosis via blocking DNA fragmentation and caspase-3 activation.|SFN|caspase-3|4|13.0|Arg1:T17|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR|3294
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|m-CPP|5-HT2A|19|12.0|Arg1:T9|Arg2:T61|CHEMICAL|GENE-Y|AGONIST|3295
23486479|Structural Explanation for Allolactose (lac Operon Inducer) Synthesis by lacZ β-Galactosidase and the Evolutionary Relationship between Allolactose Synthesis and the lac Repressor.|Allolactose|β-Galactosidase|4|13.0|Arg1:T29|Arg2:T39|CHEMICAL|GENE-N|PRODUCT-OF|3296
12126787|The AGE-induced increases in VEGF expression and PKC activation were inhibited by the pan-specific PKC inhibitor, calphostin C, and by the antioxidant drug and compounds, gliclazide, N-acetylcysteine, and vitamin E.|calphostin C|VEGF|18|5.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3297
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|nilotinib|Abl|20|17.0|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|3298
23146690|In combination with clofarabine, the ability of resveratrol to reduce the contents of Sp1 and its target gene products was also evident in a time- and dose-dependent experiment.|clofarabine|Sp1|4|15.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3299
23374869|Inhibition of monoamine oxidase by phthalide analogues.|phthalide|monoamine oxidase|6|3.0|Arg1:T24|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|3300
15277241|GSTZ1-1 is identical with maleylacetoacetate isomerase, which catalyzes the penultimate step in the catabolic pathways for phenylalanine and tyrosine.|phenylalanine|maleylacetoacetate isomerase|18|5.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|3301
23220590|Human alcohol dehydrogenases and aldehyde dehydrogenases (ALDHs), the principal enzymes responsible for metabolism of ethanol, are complex enzyme families that exhibit functional polymorphisms among ethnic groups and distinct tissue distributions.|ethanol|ALDHs|18|8.0|Arg1:T10|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE|3302
2833901|The cAMP phosphodiesterase was inhibited completely by felodipine and the p-chloro analogue with IC50 values of 3.7 and 1.5 microM respectively.|p-chloro|cAMP phosphodiesterase|11|2.0|Arg1:T26|Arg2:T67|CHEMICAL|GENE-N|INHIBITOR|3303
15379894|The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice.|nordihydroguaiaretic acid|arachidonic acid 5-lipoxygenase|6|2.0|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|3304
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|cefditoren|PBP|28|19.0|Arg1:T26|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR|3305
16926278|Truncated proteins with a complete GAF-B were dimers, but those lacking the N-terminal 46 amino acids of GAF-B were monomers, indicating that these residues are vital for GAF-B-mediated PDE5 dimerization.|N|GAF-B|14|19.0|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|PART-OF|3306
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|α-smooth muscle actin|17|48.0|Arg1:T16|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3307
23319419|Mutations introduced into EAG to replicate the ICA binding site in ERG did not alter the functional response to ICA.|ICA|ERG|8|12.0|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3308
23117790|Small interfering RNA directed BDNF, orexin-A, and SB334867 [N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea; a specific orexin-1 receptor antagonist] were administered directly into the hypothalamus.|SB334867|orexin-1 receptor|10|21.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST|3309
17510490|Therefore, either Phgdh or ASCT1 is provided to each segment of renal tubules, suggesting that metabolic interplay mediated by L-serine biosynthesis and supply may exist in the kidney too.|L-serine|Phgdh|22|4.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF|3310
11736858|CONCLUSIONS: Ebastine (10 mg orally) causes brain histamine H1-receptor occupation of approximately 10%, consistent with its lower incidence of sedative effect, whereas (+)-chlorpheniramine occupied about 50% of brain H1-receptors even at a low but sedative dose of 2 mg; occupancy of (+)-chlorpheniramine was correlated with plasma (+)-chlorpheniramine concentration.|(+)-chlorpheniramine|H1-receptors|53|39.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3311
17498959|Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.|Sulfated glucosamine|MMP-2|1|4.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR|3312
15814851|Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.|estrogen|aromatase|15|3.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|3313
23645249|Genistein inhibition of adipose differentiation was accompanied by increased estrogen receptor (ER)-β gene expression and was modestly recapitulated by ERβ selective agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN).|2,3-bis (4-hydroxyphenyl)-propionitrile|ERβ|26|23.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|AGONIST|3314
23558297|AA effects of vinclozolin are mediated by two metabolites, which have an antagonistic effect on the androgen receptor.|vinclozolin|androgen receptor|4|18.0|Arg1:T8|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST|3315
12535612|A larger conformation change constant for GAD67 than GAD65 supported a significant conformational change induced by the initial PLP binding to GAD67, which affects the other binding site affinity of GAD67.|PLP|GAD67|19|32.0|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3316
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol|CB1|44|2.0|Arg1:T21|Arg2:T29|CHEMICAL|GENE-Y|AGONIST|3317
15694390|In addition, two other 5-LO inhibitors (Rev5901 and AA861) did not mimic the effect of NDGA, and the 5-LO metabolites, 5-hydroxyeicosatetraenoic acid and LTB(4), were unable to reverse NDGA-driven suppression of STAT activation or affect basal STAT phosphorylation.|Rev5901|5-LO|9|6.0|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|3318
23424204|Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, BPA significantly decreased the IR, Akt and GLUT4 protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.|BPA|Akt|31|37.0|Arg1:T14|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3319
14642426|Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of IL-6 level in macrophage rather than in the brain.|norepinephrine|IL-6|36|41.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3320
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|lactate dehydrogenase|6|19.0|Arg1:T21|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR|3321
23288144|In addition, blocking of AhR activation by resveratrol, a well-known AhR antagonist, prevented the SUN-induced CYP1A1 gene expression, further confirms the involvement of AhR.|SUN|CYP1A1|18|19.0|Arg1:T3|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3322
9313928|In addition, three IP ligands, iloprost, carbacyclin and isocarbacyclin, and one TP ligand, STA2, bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.|isocarbacyclin|IP|12|5.0|Arg1:T36|Arg2:T89|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3323
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|Troglitazone|PPARgamma|1|38.0|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3324
9007522|  The effects of NS-49 ((R)-(-)-3'-(2-amino-1-hydroxyethyl)-4'-fluoromethane sulfonanilide hydrochloride), an alpha 1A-adrenoceptor-selective agonist, on intraurethral pressure and blood pressure were investigated in anesthetized dogs.|NS-49|alpha 1A-adrenoceptor|4|23.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|AGONIST|3325
10598120|Thus vasopeptidase inhibition with omapatrilat was more effective than ACE inhibition with captopril in preventing changes in LV geometry and premature mortality in hamsters with dilated heart failure.|captopril|ACE|13|10.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|3326
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|5alpha-dihydroprogesterone|3alpha-hydroxysteroid dehydrogenases|4|19.0|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|SUBSTRATE|3327
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|ICI 182,780|estrogen receptor|1|21.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR|3328
8667211|  Previous studies by this research team proved that vasodilating prostaglandins (PGs) E1, E2 and I2 inhibit carbonic anhydrase (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs. Relying on these findings, as well as on our clinical observations, we studied in vitro and in vivo the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on CA I and CA II.|PGs|carbonic anhydrase|12|20.0|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR|3329
12213059|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (54) was found to bind and activate the SUR1/Kir6.2 K(ATP) channels in the low nanomolar range and to be at least 1000 times more potent than the reference compound diazoxide with respect to inhibition of insulin release from rat islets.|diazoxide|K(ATP) channels|45|22.0|Arg1:T14|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR|3330
10373224|  The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.|irbesartan|angiotensin II type 1 receptor|18|7.0|Arg1:T1|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|3331
23319591|Methylation of histone H3 on lysine 4 by the lysine methyltransferase SET1 protein is needed for normal clock gene expression.|lysine|histone H3|6|3.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|PART-OF|3332
11920914|  The rates of inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) by paraoxon, haloxon, DDVP and enantiomers of neutral alkyl methylphosphonyl thioates and cationic alkyl methylphosphonyl thiocholines were measured in the presence and absence of AChE peripheral site inhibitors: gallamine, d-tubocurarine, propidium, atropine and derivatives of coumarin.|DDVP|AChE|19|9.0|Arg1:T15|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|3333
17620346|All the above COX-2 inhibitors except for rofecoxib had no reactivity with the aldehyde group of benzaldehyde used as a model compound of allysine aldehyde under a physiological pH condition.|rofecoxib|COX-2|8|4.0|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|3334
23296142|Insertion of ERα was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).|BIS|protein kinase C|25|15.0|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR|3335
23220589|The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.|BT-03|AChE|27|5.0|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR|3336
23397054|The brain-to-plasma partition coefficient of elacridar in the wild-type mice was 0.82, as compared with 3.5 in Mdr1a/b(-/-) mice, 6.6 in Bcrp1(-/-) mice, and 15 in Mdr1a/b(-/-)Bcrp1(-/-) mice, indicating that both P-gp and Bcrp limit the brain distribution of elacridar.|elacridar|P-gp|57|49.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE|3337
17340133|Limited availability of L-arginine increases DNA-binding activity of NF-kappaB and contributes to regulation of iNOS expression.|L-arginine|NF-kappaB|4|9.0|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR|3338
16326016|Our microarray analysis of the rodent hypothalamus has revealed that estradiol increases the expression of a number of glial-specific genes, including glutamine synthetase, an enzyme that inactivates glutamate through its conversion to glutamine.|glutamate|glutamine synthetase|30|23.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE|3339
23256819|Second, in order to study the response of RHE to chemical sensitizers, the ((13)C)methyldodecanesulfonate was chosen as an NMR probe, and we compared adducts formed on human serum albumin (HSA) in solution and adducts formed in RHE.|((13)C)methyldodecanesulfonate|human serum albumin|16|36.0|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3340
23581848|Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.|hydroxamate|histone deacetylase|7|16.0|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR|3341
17049513|  Recent studies have reported that imatinib mesylate, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.|imatinib mesylate|BCR|6|18.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|3342
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|cibenzoline|ion channel|17|2.0|Arg1:T10|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|3343
12063084|The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.|aripiprazole|human 5-HT1A receptor|3|12.0|Arg1:T11|Arg2:T19|CHEMICAL|GENE-Y|AGONIST|3344
17899080|  Recently, it was shown that glycoproteins with N-glycans close to the NH(2) terminus can directly enter the calnexin/calreticulin cycle and bypass BiP binding.|NH(2)|glycoproteins|13|7.0|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|PART-OF|3345
23047001|  Glycogen synthase kinase-3β (GSK-3β) plays a key role in type II diabetes and Alzheimer's diseases, to which non-ATP competitive inhibitors represent an effectively therapeutical approach due to their good specificity.|ATP|GSK-3β|23|5.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3346
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine|AChE|47|4.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR|3347
18627212|  Irbesartan (Aprovel, Avapro, Irbetan, Karvea), an angiotensin II receptor type 1 antagonist, is approved in many countries worldwide for the treatment of hypertension.|Avapro|angiotensin II receptor type 1|5|13.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST|3348
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|Rilpivirine|CYP3A4|1|30.0|Arg1:T10|Arg2:T48|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3349
22614004|We hypothesized that DCA will also reverse the 'pseudohypoxic' mitochondrial signals that lead to HIF1α activation in cancer, even in the absence of hypoxia and inhibit cancer angiogenesis.|DCA|HIF1α|4|16.0|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR|3350
23536519|Resveratrol (100 μM) significantly decreased the glycolytic enzymes (pyruvate kinase and lactate dehydrogenase) in Caco2 cells, while an increase in citrate synthase activity and a decrease in glucose consumption were observed in both cell lines.|Resveratrol|citrate synthase|1|26.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|ACTIVATOR|3351
16842172|Low doses of dopamine D2 receptor agonists such as bromocriptine and pergolide may be able to enhance working memory and executive functions, but these effects may be dependent on the nature of the tasks used and the baseline performance levels of the subjects.|pergolide|dopamine D2 receptor|12|4.0|Arg1:T7|Arg2:T10|CHEMICAL|GENE-Y|AGONIST|3352
16855072|In nondiabetic obese subjects, treatment with sitagliptin 200 mg bid was generally well tolerated without associated hypoglycemia and led to maximal inhibition of plasma DPP-4 activity, increased active GLP-1, and reduced glycemic excursion.|sitagliptin|GLP-1|8|31.0|Arg1:T9|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3353
23449981|Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen.|phosphatidylcholine|SM synthase|9|17.0|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|3354
15947036|Moreover, 4-methylhistamine potently activated the hH(4)R (pEC(50) = 7.4 +/- 0.1; alpha = 1), and this response was competitively antagonized by the selective H(4)R antagonist JNJ 7777120 [1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine] (pA(2) = 7.8).|4-methylhistamine|hH(4)R|3|7.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR|3355
15618715|By comparing the inhibition potential between rat and human CMVs, the inhibition of BSEP- and MRP2-mediated transport by midecamycin and cyclosporin A was relatively similar whereas the inhibitory effect on BSEP-mediated transport by cloxacillin and glibenclamide was more marked in humans than in rats.|cloxacillin|BSEP|35|32.0|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|3356
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|dichlorophenamide|hCA VI|14|35.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|3357
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl|5-HT2C|61|57.0|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST|3358
23200255|N-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition.|N|PDE4|1|10.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR|3359
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|adrenomedullin|1|17.0|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3360
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|INNO-406|Abl|25|17.0|Arg1:T3|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR|3361
15229223|Here we present the characterization of its mechanism of action showing that melatonin is a specific inhibitor of E(2)-induced ERalpha-mediated transcription in both estrogen response element- and AP1-containing promoters, whereas ERbeta-mediated transactivation is not inhibited or even activated at certain promoters.|melatonin|ERalpha|13|24.0|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR|3362
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|Ca2+|cTnC|17|22.0|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3363
23381882|Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p-Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs.|Midazolam|CYP3A4|14|16.0|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE|3364
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|BMY7378|rat cloned alpha(1d)-adrenoceptor|5|49.0|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST|3365
1600046|A number of selective 5-HT3 antagonists have been developed including ondansetron, granisetron, tropisetron renzapride and zacopride.|zacopride|5-HT3|18|5.0|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST|3366
22537794|RESULTS: (+/-)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approximately threefold higher affinity than its S-enantiomer.|DA|DAT|18|15.0|Arg1:T25|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|3367
23303191|Glucose-free medium, leading to depletion of the UDP-sugars, markedly reduced hyaluronan synthesis by all HAS isoenzymes while raising its concentration from 5 to 25 mm had a moderate stimulatory effect.|UDP|HAS|9|17.0|Arg1:T22|Arg2:T40|CHEMICAL|GENE-N|SUBSTRATE|3368
16781459|While either blockage of HO activity by the HO inhibitor, tin protoporphyrin IX, or down-regulation of HO-1 expression by HO-1 small interfering RNA (siRNA) reversed the inhibitory effects of H(2)S on iNOS expression and NO production, HO-1 overexpression produced the same inhibitory effects of H(2)S.|NO|iNOS|43|40.0|Arg1:T6|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF|3369
15664409|As thiamine metabolism deficiencies have been seen in placental infarcts previously, these indicate that PP20/hTPK may have a role in placental diseases.|thiamine|PP20|2|16.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE|3370
17498959|  In the present study, sulfated glucosamine (SGlc) that has been reported to relieve joint pain and inflammation in many arthritis patients was studied for its inhibitory effects on MMP-2 and MMP-9 in human fibrosarcoma cells.|SGlc|MMP-2|9|32.0|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR|3371
16864903|Amlexanox, which also binds to S100A12, inhibited the THP-1 migration induced by S100A12.|Amlexanox|S100A12|1|7.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3372
22972179|Phosphorylation of AMPK at Thr172 increased by 1.4-fold within 5 min, and remained elevated throughout a 30-min time course, in response to 2-deoxyglucose.|Thr|AMPK|5|3.0|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PART-OF|3373
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|alkyl|dopamine transporter|41|56.0|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR|3374
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|monoamine|SERT|4|18.0|Arg1:T10|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE|3375
12213829|Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the ATP inhibition of K(IR)6.2/SUR1, but had no effect on homomeric K(IR)6.2 channels.|ATP|SUR1|25|33.0|Arg1:T15|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR|3376
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|Catecholamines|EC 1.14.16.1|1|19.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|3377
1472079|Cadmium did not increase the breakdown of UDPGA by microsomal UDPGA pyrophosphatase but strongly decreased (30-66%) the synthesis of the cofactor in the cytosol by inhibiting UDP-glucose dehydrogenase (UDPGDH).|Cadmium|UDPGDH|1|33.0|Arg1:T35|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|3378
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|AG 013736|VEGFR|23|12.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR|3379
23213199|Pretreatment with E(2) prevented MPTP opening induced by H(2)O(2), which preceded loss of mitochondrial membrane potential.|H(2)O(2)|MPTP|12|8.0|Arg1:T8|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR|3380
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|glipizide|PPARgamma|8|24.0|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|AGONIST|3381
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|platelet-derived growth factor|1|30.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR|3382
22708686|When combined, mianserin antagonized the effects of the full kappa-opioid receptor agonists in [(35)S]GTPgammaS assays and reduced the stimulation of p38 MAPK and ERK1/2 phosphorylation by dynorphin A.|mianserin|p38|4|28.0|Arg1:T9|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR|3383
3004501|Kinetic analysis revealed that the inhibition of the leukotriene C synthetase reaction by diethylcarbamazine was competitive with respect to LTA4.|diethylcarbamazine|leukotriene C synthetase|14|9.0|Arg1:T24|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR|3384
23388095|Inducible heme-oxygenase 1 mRNA expressions were significantly higher in the DMOG group.|DMOG|heme-oxygenase 1|11|2.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3385
10076535|Down-regulation of prostate-specific antigen (PSA) expression, an AR-target gene, by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor.|estramustine|AR|15|11.0|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3386
10351938|We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 (PLA2).|LTC4|PLA2|13|21.0|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF|3387
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-serine|SDH|24|4.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE|3388
15206110|Apart from the consequences of iron deprivation, gallium exerts cytotoxic effects by direct interaction with the iron-dependent enzyme ribonucleotide reductase, resulting in reduced dNTP pools and inhibition of DNA synthesis.|gallium|ribonucleotide reductase|9|20.0|Arg1:T30|Arg2:T40|CHEMICAL|GENE-N|DIRECT-REGULATOR|3389
23394205|Optimization from a high quality screening hit within tight SAR space led to compound 6 (AZ20) which inhibits ATR immunoprecipitated from HeLa nuclear extracts with an IC50 of 5 nM and ATR mediated phosphorylation of Chk1 in HT29 colorectal adenocarcinoma tumor cells with an IC50 of 50 nM.|AZ20|Chk1|17|38.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|3390
18794803|The CRAF inhibitor sorafenib was found to induce a time-dependent reduction in both BAD phosphorylation and Bcl-2 expression in the D594G/G469E lines only.|sorafenib|BAD|4|14.0|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR|3391
15204055|The patients were divided into two groups according to the 5HT-2A affinity of the individual medications (high 5HT-2A affinity--clozapine, olanzapine, risperidone vs.|clozapine|5HT-2A|22|19.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3392
23517912|The results suggested that fisetin treatment inhibits mTORC1 activity in an Akt-dependent manner.|fisetin|Akt|5|12.0|Arg1:T18|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR|3393
18381445|  Statins are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors broadly used for the control of hypercholesterolemia.|Statins|3-hydroxy-3-methylglutaryl-CoA reductase|1|3.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR|3394
15577244|Especially, the compound 1 showed strong inhibition (IC50=1.33 microM) against the enzyme tyrosinase, as compared to the standard tyrosinase inhibitors kojic acid (IC50=16.67 microM) and L-mimosine (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes.|kojic acid|tyrosinase|25|16.0|Arg1:T3|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR|3395
15526107|In conclusion, the fact that, on the one hand, the cardiovascular effects of carteolol were not attenuated by the beta(1)-adrenoceptor blocker bisoprolol and, on the other, carteolol significantly decreased lymphocyte beta(2)-adrenoceptor density and function is in favour of the idea that the ISA of carteolol is mediated by beta(2)-adrenoceptors.|carteolol|beta(1)-adrenoceptor|17|23.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR|3396
12085361|Direct transport of rifampicin could be shown for OATP-C (apparent K(m) value 13 micromol/L) and OATP8 (2.3 micromol/L).|rifampicin|OATP8|4|21.0|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE|3397
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|nicardipine|PDE 1A2|24|14.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR|3398
15985434|To understand this interaction, we determined the crystal structure of PDXK in complex with (R)-roscovitine, N6-methyl-(R)-roscovitine, and O6-(R)-roscovitine, the two latter derivatives being designed to bind to PDXK but not to CDKs. Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal-binding site of PDXK rather than in the anticipated ATP-binding site.|N6-methyl-(R)-roscovitine|PDXK|21|43.0|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3399
9353417|Tiapride, a D2 antagonist that lacks antipsychotic activity, was also included.|Tiapride|D2|1|4.0|Arg1:T22|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST|3400
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|MK-499|IKr|31|2.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR|3401
23394218|Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.|4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide|kinases|3|35.0|Arg1:T3|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR|3402
16874462|  Proline oxidase (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to pyrroline- 5-carboxylate (P5C).|pyrroline- 5-carboxylate|Proline oxidase|19|1.0|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF|3403
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|CGP79787|tyrosine kinase|29|21.0|Arg1:T16|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR|3404
23064031|NFD suppressed EGF-mediated protein levels of c-Jun and c-Fos, and reduced MMP-9 expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity.|NFD|c-Jun|1|7.0|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR|3405
23103426|Hepatic mitochondrial complex II activity was practically unchanged by (PhSe)(2), whereas it significantly inhibited renal complex II activity.|(PhSe)(2)|renal complex II|10|21.0|Arg1:T23|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR|3406
6701456|The binding of FHA-HIS was inhibited on 35-79% of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine.|clemastine|histamine H1 receptor|21|15.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST|3407
10432475|In conclusion, (-)-pindolol modulates, both alone and together with 5-HT reuptake inhibitors, dopaminergic, adrenergic, and serotonergic transmission in the FCX via a complex pattern of actions at beta 1/2-ARs, 5-HT1A, and 5-HT1B receptors.|(-)-pindolol|5-HT1B|4|42.0|Arg1:T19|Arg2:T51|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3408
23287539|The differential neuroprotective effect could be due to the stereo-specific augmentation of Cu/Zn-SOD activity by trans-hinokiresinol, when compared with cis-hinokiresinol.|trans-hinokiresinol|SOD|16|14.0|Arg1:T18|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR|3409
10432475|The selective 5-HT1A receptor antagonist, WAY100,635, slightly attenuated the (-)-pindolol-induced increase in DA and NAD levels, while the selective 5-HT1B antagonist, SB224,289, was ineffective.|WAY100,635|5-HT1A|7|3.0|Arg1:T35|Arg2:T55|CHEMICAL|GENE-Y|ANTAGONIST|3410
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|flavone|P450 2A13|37|6.0|Arg1:T4|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR|3411
23581551|The fluoroindole compound with three carbons in the side chain and one amide group exhibited a selectivity index of 35 (Ki/IC50) with high inhibition of MPO activity (IC50 = 18 nM), whereas its effect on SERT was in the micromolar range.|amide|MPO|13|28.0|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR|3412
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-isopropylamino|insulin|11|63.0|Arg1:T16|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3413
23356880|Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase (LOX)-pathway (one having as precursors the polyunsaturated fatty acids containing a cis-cis-1,4-pentadiene system).|cis-cis-1,4-pentadiene|LOX|34|20.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE|3414
23142425|  Gene polymorphisms of the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes-cytochrome P450 (CYP) monooxygenase 2A13 (CYP2A13) and UDP-glucuronosyltransferases (UGT)-2B7 could contribute to the levels of NNK-related metabolites in urine, thereby increasing the susceptibility to urothelial carcinoma (UC).|NNK|UDP-glucuronosyltransferases (UGT)-2B7|40|29.0|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE|3415
9525919|Identification of binding sites for bepridil and trifluoperazine on cardiac troponin C.|trifluoperazine|cardiac troponin C|8|10.0|Arg1:T17|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3416
12504917|  Rasagiline [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible monoamine oxidase (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.|Rasagiline|monoamine oxidase|1|15.0|Arg1:T1|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR|3417
15277241|GSTZ1-1 is identical with maleylacetoacetate isomerase, which catalyzes the penultimate step in the catabolic pathways for phenylalanine and tyrosine.|tyrosine|maleylacetoacetate isomerase|20|5.0|Arg1:T10|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE|3418
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|noroxymorphone|CYP2D6|35|24.0|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE|3419
12646997|RESULTS: Icariin and papaverine showed dose-dependent inhibitory effects on PDE5 and PDE4 activities.|Icariin|PDE5|3|11.0|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|3420
1712335|In anesthetized spontaneously hypertensive rats, the antihypertensive activity of carvedilol was nearly abolished by combined pretreatment of the rats with high doses of the alpha 1 adrenoceptor antagonist, prazosin (1 mg/kg, iv), and the nonselective beta adrenoceptor antagonist, propranolol (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by carvedilol may be accounted for by blockade of beta and alpha 1 adrenoceptors.|propranolol|beta adrenoceptor|46|42.0|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST|3421
2262902|  To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v. adenosine agonists, N6-(R-phenylisopropyl)adenosine (R-PIA), N6-(S-phenylisopropyl)adenosine, 5'-(N-cyclopropyl)-carboxamidoadenosine, antagonists, theophylline and 8-p-(sulfophenyl)theophylline as well as enprofylline on ethanol-(i.p.)-induced motor incoordination was evaluated by rotorod.|8-p-(sulfophenyl)theophylline|adenosine|56|28.0|Arg1:T18|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST|3422
23624148|Sciadopitysin caused a significant elevation of alkaline phosphatase activity, collagen synthesis, osteocalcin production, mineralization, and glutathione content in the cells (P<0.05).|Sciadopitysin|osteocalcin|1|14.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3423
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|CYC202|CDKs|6|19.0|Arg1:T12|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|3424
23339625|We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively.|MDZ|CYP3A|44|53.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE|3425
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|TEA|OCTN2|8|17.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE|3426
23200901|Bidirectional transport assays of the Aconitum alkaloids were performed with or without P-gp (cyclosporine A and verapamil), BCRP (Ko143) and MRP2 (MK571) inhibitors.|cyclosporine A|P-gp|15|13.0|Arg1:T20|Arg2:T45|CHEMICAL|GENE-N|INHIBITOR|3427
10611634|Yohimbine displays marked affinity at human (h)alpha(2A)-, halpha(2B)- and halpha(2C)-ARs, significant affinity for h5-HT(1A), h5-HT(1B), h5-HT(1D), and hD(2) receptors and weak affinity for hD(3) receptors.|Yohimbine|h5-HT(1D)|1|41.0|Arg1:T37|Arg2:T67|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3428
15240882|  Thyroid hormones are involved in the regulation of many physiological processes and regulate gene transcription by binding to their nuclear receptors TRalpha and TRbeta.|Thyroid hormones|TRbeta|1|24.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3429
16921342|  Phospholipase D (PLD) catalyzes the hydrolysis of the phosphodiester bond of glycerophospholipid phosphatidylcholine to generate phosphatidic acid (PA) and choline.|phosphatidic acid|Phospholipase D|18|1.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|PRODUCT-OF|3430
23292752|FXa inhibitors, e.g. rivaroxaban and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa. Both agents have a rapid onset of action, a wide therapeutic window, little or no interaction with food and other drugs, minimal inter-patient variability, and display similar pharmacokinetics in different patient populations.|apixaban|FXa|8|1.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR|3431
17664022|  The inhibitory effect of clonidine (non-selective alpha2-adrenoceptor agonist) and oxymetazoline (alpha2A-adrenoceptor selective agonist) was compared on basal and stimulated gastric motor activity (gastric tone and contractions) using the balloon method in the rat.|clonidine|alpha2-adrenoceptor|5|8.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-N|AGONIST|3432
23643631|In conclusion, our findings suggest melamine increased inflammation and oxidative stress via activation of NF-κB/COX-2 and NOX/ROS pathway, and first revealed the critical role of NOX in melamine-induced ROS production, suggesting the potential of NOX inhibitor against melamine toxicity.|melamine|NF-κB|7|16.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|ACTIVATOR|3433
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|Hydrogen sulfide|CBS|1|29.0|Arg1:T1|Arg2:T50|CHEMICAL|GENE-Y|PRODUCT-OF|3434
23295227|Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.|fidarestat|AR|41|30.0|Arg1:T22|Arg2:T52|CHEMICAL|GENE-Y|INHIBITOR|3435
23146871|This approach was used to compare the uptake of Mn(3+)Tf into neuronal cell lines with published descriptions of Fe(3+) uptake via the Tf mechanism, and to obtain quantitative information on Mn uptake via the Tf mechanism.|Fe(3+)|Tf|23|30.0|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE|3436
17075268|  BACKGROUND: Histamine synthesized by histidine decarboxylase (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.|Histamine|histidine decarboxylase|3|6.0|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF|3437
22080037|Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase.|Mercury|cyclooxygenase-2|1|6.0|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3438
23042953|These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process.|cholesterol|ABCA1|39|35.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE|3439
23256625|This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the HMG-coA reductase inhibitors simvastatin and rosuvastatin.|rosuvastatin|HMG-coA reductase|23|18.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR|3440
23291264|In addition, urinary CCL2 rather than KIM-1 increased in chronic renal failure rats after administration of low-dose cisplatin (2mg/kg), suggesting that urinary CCL2 was selective for cisplatin-induced nephrotoxicity in renal impairment.|cisplatin|KIM-1|19|8.0|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR|3441
12498985|Inhibition of p38(MAPK) by SB203580 (10 microM) enhanced DEM-induced increases in L-cystine transport and GSH, whereas inhibition of p42/p44(MAPK) (PD98059, 10 microM) had no effect.|PD98059|MAPK|30|27.0|Arg1:T2|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR|3442
23578608|Results showed that oral administration of plant stanyl hemisuccinate (2×, 5×) and plant stanyl sorbitol succinate (2×, 5×) effectively attenuated the serum total cholesterol and low density lipoprotein cholesterol levels, while had no effect on the serum triacylglycerol and high density lipoprotein cholesterol.|stanyl hemisuccinate|low density lipoprotein|8|32.0|Arg1:T5|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR|3443
6222739|The effective binding of medroxyprogesterone acetate to the glucocorticoid receptor was confirmed by direct binding studies utilizing a tritiated derivative of this steroid.|medroxyprogesterone acetate|glucocorticoid receptor|5|9.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR|3444
23361846|  Methadone N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.|Methadone|CYP3A4|1|15.0|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE|3445
11488610|I- was less able and Cs+ was more able to quench the fluorescence of Trp residues in the holoenzyme of GAD (holoGAD) than the apoenzyme (apoGAD).|Trp|holoGAD|15|23.0|Arg1:T16|Arg2:T44|CHEMICAL|GENE-Y|PART-OF|3446
18574460|Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for 4-iodopropofol, 4-bromopropofol and 4-chloropropofol in Na(V)1.4, and 450 nM for 4-chloropropofol in Na(V)1.2. Recovery from fast inactivation was prolonged in the presence of drug leading to an accumulation of block during repetitive stimulation at high frequencies (100 Hz).|4-iodopropofol|Na(V)1.4|18|24.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR|3447
14500570|AMPK activation in turn increases fatty acid oxidation (by effects on enzymes that govern malonyl CoA synthesis and possibly its degradation) and inhibits triglyceride synthesis.|triglyceride|AMPK|26|1.0|Arg1:T17|Arg2:T29|CHEMICAL|GENE-N|no_relation|3448
14500570|Recent studies suggest that the ability of leptin, adiponectin, 5'-aminoimidazole 4-carboxamide riboside (AICAR), adrenergic agonists, and metformin to diminish adiposity may be mediated, at least in part, by AMPK activation in peripheral tissues.|5'-aminoimidazole 4-carboxamide riboside|AMPK|12|37.0|Arg1:T2|Arg2:T23|CHEMICAL|GENE-N|no_relation|3449
14500570|Recent studies suggest that the ability of leptin, adiponectin, 5'-aminoimidazole 4-carboxamide riboside (AICAR), adrenergic agonists, and metformin to diminish adiposity may be mediated, at least in part, by AMPK activation in peripheral tissues.|AICAR|AMPK|16|37.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-N|no_relation|3450
14500570|Recent studies suggest that the ability of leptin, adiponectin, 5'-aminoimidazole 4-carboxamide riboside (AICAR), adrenergic agonists, and metformin to diminish adiposity may be mediated, at least in part, by AMPK activation in peripheral tissues.|metformin|AMPK|23|37.0|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|no_relation|3451
14500570|In addition, preliminary studies suggest that malonyl CoA and AMPK take part in fuel-sensing and signaling mechanisms in the hypothalamus that could regulate food intake and energy expenditure.|malonyl CoA|AMPK|8|11.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|no_relation|3452
23215461|Relative to plasma-derived fibrinogen (pdFI), rFI predominately contained a simplified, neutral carbohydrate structure and >4-fold higher levels of the γ'-chain transcriptional variant that has been reported to bind thrombin and Factor XIII.|carbohydrate|Factor XIII|16|36.0|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|no_relation|3453
23382458|Naproxen was the first nonsteroidal antiinflammatory drug that was demonstrated as a weak P-gp inhibitor.|Naproxen|P-gp|1|14.0|Arg1:T8|Arg2:T25|CHEMICAL|GENE-N|no_relation|3454
3440035|It antagonizes the satiety effect of CCK-8 in the rat and is protective against ceruletide-, taurocholate- and diet-induced pancreatitis.|ceruletide|CCK-8|15|7.0|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|no_relation|3455
3440035|It antagonizes the satiety effect of CCK-8 in the rat and is protective against ceruletide-, taurocholate- and diet-induced pancreatitis.|taurocholate|CCK-8|17|7.0|Arg1:T9|Arg2:T20|CHEMICAL|GENE-Y|no_relation|3456
3440035|Lorglumide is therefore a useful pharmacological tool to study the functions of CCK.|Lorglumide|CCK|1|13.0|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|no_relation|3457
3440035|For its pharmacological properties, its relatively low toxicity and because it is active also after oral administration, lorglumide is a candidate for diagnostic or therapeutic use in man when an involvement of CCK is suspected.|lorglumide|CCK|20|35.0|Arg1:T11|Arg2:T14|CHEMICAL|GENE-Y|no_relation|3458
23401473|Interaction of silymarin flavonolignans with organic anion-transporting polypeptides.|flavonolignans|organic anion-transporting polypeptides|4|6.0|Arg1:T14|Arg2:T30|CHEMICAL|GENE-N|no_relation|3459
23401473|The present study examined the effect of silymarin flavonolignans on OATP1B1-, OATP1B3-, and OATP2B1-mediated transport in cell lines stably expressing these transporters and in human hepatocytes.|flavonolignans|OATP2B1|9|16.0|Arg1:T9|Arg2:T23|CHEMICAL|GENE-Y|no_relation|3460
23401473|The extent of silymarin-drug interactions depends on OATP isoform specificity and concentrations of flavonolignans at the site of drug transport.|flavonolignans|OATP|14|8.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-N|no_relation|3461
23401473|Higher than customary doses of silymarin, or formulations with improved bioavailability, may increase the risk of flavonolignan interactions with OATP substrates in patients.|flavonolignan|OATP|19|22.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-N|no_relation|3462
17436082|Since the main factors for the development of POI are the surgical manipulation and the gastrointestinal effects of opioid-receptor agonists used for pain management, the effect of TZP-101 was investigated in rats subjected to surgery, to morphine treatment (3 mg/kg s.c.), or to a combination of both.|TZP-101|opioid-receptor|29|19.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-N|no_relation|3463
17436082|Since the main factors for the development of POI are the surgical manipulation and the gastrointestinal effects of opioid-receptor agonists used for pain management, the effect of TZP-101 was investigated in rats subjected to surgery, to morphine treatment (3 mg/kg s.c.), or to a combination of both.|morphine|opioid-receptor|39|19.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|no_relation|3464
23340651|We also demonstrated that 3% O(2) affected BMSC differentiation in p53 and reactive oxygen species (ROS) independent pathways.|O(2)|p53|7|15.0|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3465
23340651|We also demonstrated that 3% O(2) affected BMSC differentiation in p53 and reactive oxygen species (ROS) independent pathways.|oxygen|p53|18|15.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3466
23201622|High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix.|polyethyleneimine|ephrinB2|23|24.0|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|no_relation|3467
23201622|The use of PEI to transfect human MSCs (hMSCs) with ephrinB2 is assessed here.|PEI|ephrinB2|4|13.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|no_relation|3468
23201622|This select interaction, coupled with the transient gene expression profile of PEI, makes the PEI-ephrinB2 GAM an ideal candidate matrix for a bone targeted GAM.|PEI|ephrinB2|13|18.0|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3469
23201622|This select interaction, coupled with the transient gene expression profile of PEI, makes the PEI-ephrinB2 GAM an ideal candidate matrix for a bone targeted GAM.|PEI|ephrinB2|17|18.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3470
17259370|Because it is unknown if ACSL4 is expressed in vascular cells involved in atherosclerosis, we investigated the ability of rosiglitazone to inhibit ACSL activity and fatty acid partitioning in human and murine arterial smooth muscle cells (SMCs) and macrophages.|rosiglitazone|ACSL|21|24.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-N|no_relation|3471
17259370|Because it is unknown if ACSL4 is expressed in vascular cells involved in atherosclerosis, we investigated the ability of rosiglitazone to inhibit ACSL activity and fatty acid partitioning in human and murine arterial smooth muscle cells (SMCs) and macrophages.|fatty acid|ACSL|27|24.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|no_relation|3472
17259370|Furthermore, rosiglitazone acutely inhibited partitioning of fatty acids into phospholipids in human SMCs and inhibited fatty acid partitioning into diacylglycerol and triacylglycerol in human SMCs and macrophages through a PPAR-gamma-independent mechanism.|rosiglitazone|PPAR-gamma|3|31.0|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3473
17259370|Furthermore, rosiglitazone acutely inhibited partitioning of fatty acids into phospholipids in human SMCs and inhibited fatty acid partitioning into diacylglycerol and triacylglycerol in human SMCs and macrophages through a PPAR-gamma-independent mechanism.|fatty acids|PPAR-gamma|8|31.0|Arg1:T13|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3474
17259370|Furthermore, rosiglitazone acutely inhibited partitioning of fatty acids into phospholipids in human SMCs and inhibited fatty acid partitioning into diacylglycerol and triacylglycerol in human SMCs and macrophages through a PPAR-gamma-independent mechanism.|fatty acid|PPAR-gamma|17|31.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3475
17259370|Furthermore, rosiglitazone acutely inhibited partitioning of fatty acids into phospholipids in human SMCs and inhibited fatty acid partitioning into diacylglycerol and triacylglycerol in human SMCs and macrophages through a PPAR-gamma-independent mechanism.|diacylglycerol|PPAR-gamma|21|31.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3476
17259370|Furthermore, rosiglitazone acutely inhibited partitioning of fatty acids into phospholipids in human SMCs and inhibited fatty acid partitioning into diacylglycerol and triacylglycerol in human SMCs and macrophages through a PPAR-gamma-independent mechanism.|triacylglycerol|PPAR-gamma|23|31.0|Arg1:T16|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3477
23333908|Total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides were lowered in the majority of normolipidemic, hyperlipidemic, and diabetic animal models, whereas high-density lipoprotein cholesterol (HDL-C) was generally not affected by the consumption of HS extract.|cholesterol|HDL|2|33.0|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|no_relation|3478
23333908|Total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides were lowered in the majority of normolipidemic, hyperlipidemic, and diabetic animal models, whereas high-density lipoprotein cholesterol (HDL-C) was generally not affected by the consumption of HS extract.|cholesterol|HDL|6|33.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|no_relation|3479
23333908|Total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides were lowered in the majority of normolipidemic, hyperlipidemic, and diabetic animal models, whereas high-density lipoprotein cholesterol (HDL-C) was generally not affected by the consumption of HS extract.|triglycerides|HDL|12|33.0|Arg1:T5|Arg2:T16|CHEMICAL|GENE-N|no_relation|3480
23333908|Total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides were lowered in the majority of normolipidemic, hyperlipidemic, and diabetic animal models, whereas high-density lipoprotein cholesterol (HDL-C) was generally not affected by the consumption of HS extract.|cholesterol|HDL|31|33.0|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|no_relation|3481
23333908|Over half of the RCTs showed that daily consumption of HS tea or extracts had favorable influence on lipid profiles including reduced total cholesterol, LDL-C, triglycerides, as well as increased HDL-C.|cholesterol|HDL|24|34.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|no_relation|3482
23333908|Over half of the RCTs showed that daily consumption of HS tea or extracts had favorable influence on lipid profiles including reduced total cholesterol, LDL-C, triglycerides, as well as increased HDL-C.|triglycerides|HDL|28|34.0|Arg1:T8|Arg2:T18|CHEMICAL|GENE-N|no_relation|3483
23592595|We synthesized a serotonin derivative to enable selective tagging of serotonylation and to investigate its effect on Ras; the latter displayed undisrupted interaction with Raf-1 at the Ras binding domain.|serotonin|Ras binding domain|4|29.0|Arg1:T1|Arg2:T4|CHEMICAL|GENE-N|no_relation|3484
8626538|  A fourth member of the diacylglycerol kinase (DGK) gene family termed DGK delta was cloned from the human testis cDNA library.|diacylglycerol|DGK delta|6|14.0|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|no_relation|3485
8626538|The cDNA sequence contains an open reading frame of 3,507 nucleotides encoding a putative DGK protein of 130,006 Da. Interestingly, the new DGK isozyme contains a pleckstrin homology domain found in a number of proteins involved in signal transduction.|nucleotides|pleckstrin homology domain|11|29.0|Arg1:T3|Arg2:T27|CHEMICAL|GENE-N|no_relation|3486
8626538|Furthermore, the C-terminal tail of this isozyme is very similar to those of the EPH family of receptor tyrosine kinases.|C|receptor tyrosine kinases|4|19.0|Arg1:T5|Arg2:T30|CHEMICAL|GENE-N|no_relation|3487
8626538|Furthermore, the C-terminal tail of this isozyme is very similar to those of the EPH family of receptor tyrosine kinases.|tyrosine|receptor tyrosine kinases|20|19.0|Arg1:T6|Arg2:T30|CHEMICAL|GENE-N|no_relation|3488
8626538|The primary structure of the delta-isozyme also has two cysteine-rich zinc finger-like structures (C3 region) and the C-terminal C4 region, both of which have been commonly found in the three isozymes previously cloned (DGKs alpha, beta and gamma).|cysteine|DGKs alpha, beta and gamma|10|38.0|Arg1:T7|Arg2:T32|CHEMICAL|GENE-N|no_relation|3489
8626538|The primary structure of the delta-isozyme also has two cysteine-rich zinc finger-like structures (C3 region) and the C-terminal C4 region, both of which have been commonly found in the three isozymes previously cloned (DGKs alpha, beta and gamma).|zinc|DGKs alpha, beta and gamma|11|38.0|Arg1:T8|Arg2:T32|CHEMICAL|GENE-N|no_relation|3490
8626538|The primary structure of the delta-isozyme also has two cysteine-rich zinc finger-like structures (C3 region) and the C-terminal C4 region, both of which have been commonly found in the three isozymes previously cloned (DGKs alpha, beta and gamma).|C|DGKs alpha, beta and gamma|20|38.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|no_relation|3491
8626538|Increased DGK activity without marked preference to arachidonoyl type of diacylglycerol was detected in the particulate fraction of COS-7 cells expressing the transfected DGKdelta cDNA.|diacylglycerol|DGKdelta|11|24.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|no_relation|3492
23386390|  The effect of add-on therapy with sitagliptin on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus (T2DM) receiving insulin alone or insulin combined with oral antidiabetic drugs.|sitagliptin|insulin|7|28.0|Arg1:T5|Arg2:T15|CHEMICAL|GENE-N|no_relation|3493
23386390|Concomitant oral drugs included sulfonylureas, α-glucosidase inhibitors and metformin.|sulfonylureas|α-glucosidase|5|7.0|Arg1:T6|Arg2:T20|CHEMICAL|GENE-N|no_relation|3494
23386390|Concomitant oral drugs included sulfonylureas, α-glucosidase inhibitors and metformin.|metformin|α-glucosidase|10|7.0|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|no_relation|3495
23386390|The baseline HbA1c and glycated albumin levels were identified as factors that predicted the response to add-on therapy with sitagliptin.|sitagliptin|HbA1c|20|3.0|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3496
23386390|Stratified analysis based on the insulin regimen revealed a stronger antidiabetic effect and a high efficacy of sitagliptin when it was added to basal insulin therapy.|sitagliptin|insulin|18|25.0|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|no_relation|3497
23386390|The results of this investigation confirmed that add-on therapy with sitagliptin to various insulin regimens could improve glycemic control without severe hypoglycemia and/or weight gain.|sitagliptin|insulin|11|14.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3498
17645691|In contrast, in placenta only biliverdin-IX alpha reductase and SVCT2 were upregulated.|biliverdin|SVCT2|7|11.0|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|no_relation|3499
23385219|Integrated analysis of the results from general toxicity studies, transcriptomics and metabonomics profiles suggested that p53 signaling pathway induced by oxidative damage was the crucial step in AFB1-induced acute hepatotoxicity, whereas gluconeogenesis and lipid metabolism disorder were found to be the major metabolic effects after acute AFB1 exposure.|AFB1|p53|29|17.0|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|no_relation|3500
23385219|Integrated analysis of the results from general toxicity studies, transcriptomics and metabonomics profiles suggested that p53 signaling pathway induced by oxidative damage was the crucial step in AFB1-induced acute hepatotoxicity, whereas gluconeogenesis and lipid metabolism disorder were found to be the major metabolic effects after acute AFB1 exposure.|AFB1|p53|49|17.0|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|no_relation|3501
17352828|The effectiveness of IL-1 inhibition was first evaluated in a mouse model of monosodium urate crystal-induced inflammation.|monosodium urate|IL-1|14|4.0|Arg1:T2|Arg2:T6|CHEMICAL|GENE-N|no_relation|3502
7601910|This analysis revealed significant differences in the expression level of the nicotinic acetylcholine receptor subunit alpha (NAChR), transforming growth factor beta 2 (TGF beta 2), type 1 cellular retinoid binding protein (CRBP-1), retinoic acid receptor gamma (RAR gamma), and cAMP response element binding protein (CREB).|acetylcholine|nicotinic acetylcholine receptor subunit alpha|13|12.0|Arg1:T2|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3503
7601910|This analysis revealed significant differences in the expression level of the nicotinic acetylcholine receptor subunit alpha (NAChR), transforming growth factor beta 2 (TGF beta 2), type 1 cellular retinoid binding protein (CRBP-1), retinoic acid receptor gamma (RAR gamma), and cAMP response element binding protein (CREB).|retinoid|nicotinic acetylcholine receptor subunit alpha|35|12.0|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3504
7601910|This analysis revealed significant differences in the expression level of the nicotinic acetylcholine receptor subunit alpha (NAChR), transforming growth factor beta 2 (TGF beta 2), type 1 cellular retinoid binding protein (CRBP-1), retinoic acid receptor gamma (RAR gamma), and cAMP response element binding protein (CREB).|retinoic acid|nicotinic acetylcholine receptor subunit alpha|42|12.0|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3505
7601910|This analysis revealed significant differences in the expression level of the nicotinic acetylcholine receptor subunit alpha (NAChR), transforming growth factor beta 2 (TGF beta 2), type 1 cellular retinoid binding protein (CRBP-1), retinoic acid receptor gamma (RAR gamma), and cAMP response element binding protein (CREB).|cAMP|nicotinic acetylcholine receptor subunit alpha|52|12.0|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3506
6150080|Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane.|Amine|Amine oxidase|1|1.0|Arg1:T11|Arg2:T27|CHEMICAL|GENE-N|no_relation|3507
6150080|Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane.|clorgyline|Amine oxidase|16|1.0|Arg1:T12|Arg2:T27|CHEMICAL|GENE-N|no_relation|3508
6150080|Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane.|semicarbazide|Amine oxidase|14|1.0|Arg1:T13|Arg2:T27|CHEMICAL|GENE-N|no_relation|3509
6150080|  Amine oxidase activity, previously described in homogenates of brown adipose tissue of the rat, has now been investigated in preparations of isolated fat cells.|Amine|Amine oxidase|1|1.0|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|no_relation|3510
6150080|It was found that the specific activities of both monoamine oxidase A (MAO) and of the semicarbazide-sensitive clorgyline-resistant amine oxidase (SSAO) were higher in isolated fat cells than in the original whole tissue.|monoamine|SSAO|10|24.0|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|no_relation|3511
6150080|It was found that the specific activities of both monoamine oxidase A (MAO) and of the semicarbazide-sensitive clorgyline-resistant amine oxidase (SSAO) were higher in isolated fat cells than in the original whole tissue.|semicarbazide|SSAO|19|24.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|no_relation|3512
6150080|It was found that the specific activities of both monoamine oxidase A (MAO) and of the semicarbazide-sensitive clorgyline-resistant amine oxidase (SSAO) were higher in isolated fat cells than in the original whole tissue.|clorgyline|SSAO|20|24.0|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|no_relation|3513
23416065|Human serum albumin-based design of a diflunisal prodrug.|diflunisal|Human serum albumin|7|1.0|Arg1:T17|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3514
23416065|The acetylated albumin had twofold weaker binding affinity for diflunisal as demonstrated by fluorescence quenching.|diflunisal|acetylated albumin|10|2.0|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|no_relation|3515
23416065|Reduced binding affinity means that diflunisal is more easily released from acetylated albumin into the circulation.|diflunisal|acetylated albumin|6|12.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3516
23416065|Taken together, our results not only provide a template for design of HSA-based prodrugs, but also pave the way toward more effective use of diflunisal in the clinic.|diflunisal|HSA|27|14.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|no_relation|3517
23298292|The method consists of antisolvent co-precipitation from an aqueous solution containing both an amino acid core material (e.g. D,L-valine), and either bovine serum albumin (BSA) or lysozyme (Lys) as model proteins.|amino acid|Lys|14|37.0|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|no_relation|3518
23298292|The method consists of antisolvent co-precipitation from an aqueous solution containing both an amino acid core material (e.g. D,L-valine), and either bovine serum albumin (BSA) or lysozyme (Lys) as model proteins.|D,L-valine|Lys|21|37.0|Arg1:T2|Arg2:T8|CHEMICAL|GENE-Y|no_relation|3519
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|phenylepherine|peroxisome proliferator-activated receptor α|14|5.0|Arg1:T2|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3520
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|acetylcholine|peroxisome proliferator-activated receptor α|31|5.0|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3521
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|Ach|peroxisome proliferator-activated receptor α|33|5.0|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3522
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|sodium nitroprusside|peroxisome proliferator-activated receptor α|36|5.0|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3523
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|SNP|peroxisome proliferator-activated receptor α|39|5.0|Arg1:T15|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3524
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|isoproterenol|peroxisome proliferator-activated receptor α|42|5.0|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3525
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|ISO|peroxisome proliferator-activated receptor α|44|5.0|Arg1:T17|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3526
22859660|  The modulating effect of peroxisome proliferator-activated receptor α ligand on haemodynamic effects of phenylepherine (PE), angiotensin II (AII), endothelin 1 (ET1), acetylcholine (Ach), sodium nitroprusside (SNP) and isoproterenol (ISO) were evaluated in glycerol-induced acute kidney injury in rats.|glycerol|peroxisome proliferator-activated receptor α|49|5.0|Arg1:T18|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3527
22859660|On the medullary blood flow (MBF), while the lower doses of PE and AII increased the perfusion unit on the fenofibrate-treated group, the higher doses decreased the perfusion unit.|fenofibrate|AII|24|17.0|Arg1:T21|Arg2:T37|CHEMICAL|GENE-Y|no_relation|3528
22859660|The effects of PE and AII on the cortical blood flow (CBF) of fenofibrate-treated group is similar to that of MBF for the same group but not for ET1.|fenofibrate|ET1|16|31.0|Arg1:T22|Arg2:T40|CHEMICAL|GENE-Y|no_relation|3529
22859660|The study showed that fenofibrate did not attenuate increased blood pressure induced by PE, AII and ET1 but caused enhanced vasodilation by Ach, SNP and ISO.|fenofibrate|ET1|5|18.0|Arg1:T8|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3530
22859660|The study showed that fenofibrate did not attenuate increased blood pressure induced by PE, AII and ET1 but caused enhanced vasodilation by Ach, SNP and ISO.|Ach|ET1|24|18.0|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3531
22859660|The study showed that fenofibrate did not attenuate increased blood pressure induced by PE, AII and ET1 but caused enhanced vasodilation by Ach, SNP and ISO.|SNP|ET1|26|18.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3532
22859660|The study showed that fenofibrate did not attenuate increased blood pressure induced by PE, AII and ET1 but caused enhanced vasodilation by Ach, SNP and ISO.|ISO|ET1|28|18.0|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3533
9669506|Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.|venlafaxine|serotonin and norepinephrine transporters|3|10.0|Arg1:T33|Arg2:T42|CHEMICAL|GENE-N|no_relation|3534
9669506|Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.|serotonin|serotonin and norepinephrine transporters|10|10.0|Arg1:T34|Arg2:T42|CHEMICAL|GENE-N|no_relation|3535
9669506|Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.|norepinephrine|serotonin and norepinephrine transporters|12|10.0|Arg1:T35|Arg2:T42|CHEMICAL|GENE-N|no_relation|3536
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|serotonin|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|23|23.0|Arg1:T7|Arg2:T36|CHEMICAL|GENE-N|no_relation|3537
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|5-hydroxytryptamine|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|25|23.0|Arg1:T8|Arg2:T36|CHEMICAL|GENE-N|no_relation|3538
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|5-HT|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|27|23.0|Arg1:T9|Arg2:T36|CHEMICAL|GENE-N|no_relation|3539
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|norepinephrine|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|31|23.0|Arg1:T10|Arg2:T36|CHEMICAL|GENE-N|no_relation|3540
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|[3H]cyanoimipramine|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|37|23.0|Arg1:T11|Arg2:T36|CHEMICAL|GENE-N|no_relation|3541
9669506|  In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively.|[3H]nisoxetine|serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters|42|23.0|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|no_relation|3542
9669506|Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters.|Duloxetine|5-HT and the norepinephrine transporters|1|18.0|Arg1:T21|Arg2:T39|CHEMICAL|GENE-N|no_relation|3543
9669506|Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters.|5-HT|5-HT and the norepinephrine transporters|5|18.0|Arg1:T22|Arg2:T39|CHEMICAL|GENE-N|no_relation|3544
9669506|Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters.|norepinephrine|5-HT and the norepinephrine transporters|7|18.0|Arg1:T23|Arg2:T39|CHEMICAL|GENE-N|no_relation|3545
9669506|Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters.|5-HT|5-HT and the norepinephrine transporters|18|18.0|Arg1:T24|Arg2:T39|CHEMICAL|GENE-N|no_relation|3546
9669506|Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters.|norepinephrine|5-HT and the norepinephrine transporters|21|18.0|Arg1:T25|Arg2:T39|CHEMICAL|GENE-N|no_relation|3547
16303771|  Tissue-type plasminogen activator (tPA), a serine protease well known for generating plasmin, has been demonstrated to induce matrix metalloproteinase-9 (MMP-9) gene expression and protein secretion in renal interstitial fibroblasts.|serine|plasmin|9|15.0|Arg1:T2|Arg2:T35|CHEMICAL|GENE-Y|no_relation|3548
23334403|Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.|Almorexant|CYP3A4|1|4.0|Arg1:T19|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3549
23334403|Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.|simvastatin|CYP3A4|14|4.0|Arg1:T20|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3550
23334403|Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.|atorvastatin|CYP3A4|16|4.0|Arg1:T21|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3551
23334403|This suggests that the observed interaction of almorexant with simvastatin is mainly caused by intestinal CYP3A4 inhibition, whereas the interaction with atorvastatin is more due to hepatic CYP3A4 inhibition.|almorexant|CYP3A4|8|29.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3552
23334403|This suggests that the observed interaction of almorexant with simvastatin is mainly caused by intestinal CYP3A4 inhibition, whereas the interaction with atorvastatin is more due to hepatic CYP3A4 inhibition.|simvastatin|CYP3A4|10|29.0|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3553
23334403|This suggests that the observed interaction of almorexant with simvastatin is mainly caused by intestinal CYP3A4 inhibition, whereas the interaction with atorvastatin is more due to hepatic CYP3A4 inhibition.|atorvastatin|CYP3A4|23|29.0|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3554
23603058|Saline and DON alone did not induce an acute phase reaction as indicated by unaltered plasma levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) while LPS caused a significant rise of both cytokines.|DON|IL-6|3|28.0|Arg1:T11|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3555
1665782|Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.|[D-Pen2,D-Pen5]enkephalin|rat brain opioid receptors|4|11.0|Arg1:T17|Arg2:T27|CHEMICAL|GENE-N|no_relation|3556
1665782|  In previous studies, we have demonstrated that chronic etorphine or [D-Ala2,D-Leu5]enkephalin (DADLE) treatment of rats results in the reduction of mu- and delta-opioid receptor binding activities as tolerance develops.|etorphine|mu- and delta-opioid receptor|10|29.0|Arg1:T10|Arg2:T20|CHEMICAL|GENE-N|no_relation|3557
1665782|  In previous studies, we have demonstrated that chronic etorphine or [D-Ala2,D-Leu5]enkephalin (DADLE) treatment of rats results in the reduction of mu- and delta-opioid receptor binding activities as tolerance develops.|[D-Ala2,D-Leu5]enkephalin|mu- and delta-opioid receptor|12|29.0|Arg1:T13|Arg2:T20|CHEMICAL|GENE-N|no_relation|3558
1665782|  In previous studies, we have demonstrated that chronic etorphine or [D-Ala2,D-Leu5]enkephalin (DADLE) treatment of rats results in the reduction of mu- and delta-opioid receptor binding activities as tolerance develops.|DADLE|mu- and delta-opioid receptor|19|29.0|Arg1:T16|Arg2:T20|CHEMICAL|GENE-N|no_relation|3559
1665782|As both etorphine and DADLE are relatively non-specific opioid ligands, interacting with both mu- and delta-receptors, these studies could not determine whether down-regulation of a specific receptor type occurs.|etorphine|mu- and delta-receptors|3|15.0|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|no_relation|3560
1665782|As both etorphine and DADLE are relatively non-specific opioid ligands, interacting with both mu- and delta-receptors, these studies could not determine whether down-regulation of a specific receptor type occurs.|DADLE|mu- and delta-receptors|5|15.0|Arg1:T8|Arg2:T24|CHEMICAL|GENE-N|no_relation|3561
23260346|The selectivity that darapladib and other Lp-PLA(2) inhibitors display across the larger serine hydrolase family has not, however, been reported.|darapladib|serine hydrolase|4|16.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|no_relation|3562
23260346|The selectivity that darapladib and other Lp-PLA(2) inhibitors display across the larger serine hydrolase family has not, however, been reported.|serine|serine hydrolase|16|16.0|Arg1:T3|Arg2:T13|CHEMICAL|GENE-N|no_relation|3563
23261715|Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein (AKR1B19) by oxidized glutathione and SH-reagents.|oxidized glutathione|AKR1B19|16|13.0|Arg1:T22|Arg2:T41|CHEMICAL|GENE-Y|no_relation|3564
23261715|Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein (AKR1B19) by oxidized glutathione and SH-reagents.|SH|AKR1B19|19|13.0|Arg1:T23|Arg2:T41|CHEMICAL|GENE-Y|no_relation|3565
23261715|Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein (AKR1B19) by oxidized glutathione and SH-reagents.|aldose|AKR1B19|9|13.0|Arg1:T24|Arg2:T41|CHEMICAL|GENE-Y|no_relation|3566
23261715|AKR1B19 exhibits the highest catalytic efficiency for 4-oxo-2-nonenal, a major product of lipid peroxidation, compared to known reductases of this aldehyde.|4-oxo-2-nonenal|reductases|8|20.0|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|no_relation|3567
23261715|AKR1B19 exhibits the highest catalytic efficiency for 4-oxo-2-nonenal, a major product of lipid peroxidation, compared to known reductases of this aldehyde.|aldehyde|reductases|23|20.0|Arg1:T10|Arg2:T32|CHEMICAL|GENE-N|no_relation|3568
9399970|The present findings indicate that dezocine shares similar stimulus effects with both mu and delta agonists, its stimulus effects are reversed by mu-selective antagonists, and its rate-decreasing effects are not mediated by activity at mu, kappa or delta opioid receptors.|dezocine|mu, kappa or delta opioid receptors|6|37.0|Arg1:T25|Arg2:T46|CHEMICAL|GENE-N|no_relation|3569
23254196|Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling.|genistein|RhoA|2|16.0|Arg1:T17|Arg2:T42|CHEMICAL|GENE-Y|no_relation|3570
23254196|Genistein had no effect on resting intracellular [Ca(2+)] or thrombin-induced increase in Ca(2+) mobilization.|Genistein|thrombin|1|15.0|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|no_relation|3571
23254196|Genistein had no effect on resting intracellular [Ca(2+)] or thrombin-induced increase in Ca(2+) mobilization.|Ca(2+)|thrombin|9|15.0|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|no_relation|3572
23254196|Genistein had no effect on resting intracellular [Ca(2+)] or thrombin-induced increase in Ca(2+) mobilization.|Ca(2+)|thrombin|18|15.0|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|no_relation|3573
23254196|Addition of the inhibitors of endothelial nitric oxide synthase or estrogen receptor did not alter the protective effect of genistein.|nitric oxide|estrogen receptor|7|11.0|Arg1:T13|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3574
23254196|Addition of the inhibitors of endothelial nitric oxide synthase or estrogen receptor did not alter the protective effect of genistein.|estrogen|estrogen receptor|11|11.0|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3575
23254196|Addition of the inhibitors of endothelial nitric oxide synthase or estrogen receptor did not alter the protective effect of genistein.|genistein|estrogen receptor|20|11.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3576
23254196|These findings demonstrated that genistein improves thrombin-induced endothelial barrier dysfunction in ECs through PKA-mediated suppression of RhoA signaling.|genistein|RhoA|5|17.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|no_relation|3577
17325243|Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction.|L-arginine|SLC7A1|11|14.0|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3578
17325243|METHODS AND RESULTS: We have identified a novel C/T polymorphism in the 3'UTR of the principal arginine transporter, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 gene (SLC7A1).|arginine|SLC7A1|18|39.0|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3579
17325243|METHODS AND RESULTS: We have identified a novel C/T polymorphism in the 3'UTR of the principal arginine transporter, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 gene (SLC7A1).|cationic amino acid|SLC7A1|26|39.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3580
17325243|To complement these studies, we generated an endothelial-specific transgenic mouse overexpressing L-arginine transporter SLC7A1.|L-arginine|SLC7A1|13|15.0|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|no_relation|3581
17325243|The Slc7A1 transgenic mice exhibited significantly enhanced responses to the endothelium-dependent vasodilator acetylcholine (-log EC50 for wild-type versus Slc7A1 transgenic: 6.87+/-0.10 versus 7.56+/-0.13; P<0.001).|acetylcholine|Slc7A1|13|20.0|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|no_relation|3582
17184764|Deficiency in RA due to inactivation of the mouse Raldh2 gene or to complete absence of retinoids in vitamin-A-deficient (VAD) quails, leads to abnormal morphogenesis of various forebrain derivatives.|RA|mouse Raldh2|3|9.0|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3583
17184764|Deficiency in RA due to inactivation of the mouse Raldh2 gene or to complete absence of retinoids in vitamin-A-deficient (VAD) quails, leads to abnormal morphogenesis of various forebrain derivatives.|retinoids|mouse Raldh2|17|9.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3584
17184764|Deficiency in RA due to inactivation of the mouse Raldh2 gene or to complete absence of retinoids in vitamin-A-deficient (VAD) quails, leads to abnormal morphogenesis of various forebrain derivatives.|vitamin-A|mouse Raldh2|19|9.0|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3585
17184764|Using the VAD quail model, which survives longer than the Raldh-deficient mouse embryos, we found that retinoids act in maintaining the correct position of anterior and dorsal boundaries in the forebrain by modulating FGF8 anteriorly and WNT signaling dorsally.|retinoids|WNT|19|39.0|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|no_relation|3586
23204325|Surprisingly, the proliferation rate of Mig6(+/-) pancreatic islets was lower than wild-type islets despite having comparable β-cell mass and glucose tolerance.|glucose|Mig6|24|7.0|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|no_relation|3587
6701456|Demonstration of histamine receptors on human platelets by flow cytometry.|histamine|histamine receptors|3|3.0|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|no_relation|3588
6701456|  Fluoresceinated human albumin conjugated with histamine (FHA-HIS) has been used for the demonstration of histamine receptors on human platelets.|histamine|FHA|17|8.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|no_relation|3589
6701456|  Fluoresceinated human albumin conjugated with histamine (FHA-HIS) has been used for the demonstration of histamine receptors on human platelets.|histamine|FHA|6|8.0|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|no_relation|3590
6701456|It is concluded that histamine H1 as well as H2 receptors occur on human platelets but the receptors are not equally distributed in the platelet population.|histamine|H2 receptors|5|10.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3591
15892618|  Receptor and non-receptor tyrosine kinases (TKs) have emerged as clinically useful drug target molecules for treating gastrointestinal cancer.|tyrosine|TKs|4|7.0|Arg1:T13|Arg2:T55|CHEMICAL|GENE-N|no_relation|3592
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|serotonin|alpha2A adrenoreceptor|39|27.0|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3593
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|norepinephrine|alpha2A adrenoreceptor|9|27.0|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3594
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|5-hydroxytryptamine|alpha2A adrenoreceptor|11|27.0|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3595
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|phenylethanolamine|alpha2A adrenoreceptor|16|27.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3596
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|N|alpha2A adrenoreceptor|17|27.0|Arg1:T15|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3597
17544870|The influence of candidate gene polymorphisms involved in norepinephrine and 5-hydroxytryptamine or receptor function (phenylethanolamine N-methyltransferase, guanine nucleotide binding protein beta polypeptide 3, alpha2A adrenoreceptor, and solute carrier family 6 [neurotransmitter transporter, serotonin] member 4 [homo sapiens] [SLC6A4]) on weight loss and gastric functions was evaluated.|guanine nucleotide|alpha2A adrenoreceptor|19|27.0|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3598
17544870|The LS/SS genotype of the promoter for SLC6A4 was associated with enhanced weight loss with sibutramine.|sibutramine|SLC6A4|16|8.0|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3599
17544870|The role of genetic variation in SLC6A4 on weight loss in response to sibutramine deserves further study.|sibutramine|SLC6A4|14|7.0|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|no_relation|3600
22815248|PSM pre-treatment decreased serum transaminases and LDH activities and MDA levels and increased the levels of cell protector GSH.|MDA|LDH|10|7.0|Arg1:T23|Arg2:T36|CHEMICAL|GENE-N|no_relation|3601
22815248|PSM pre-treatment decreased serum transaminases and LDH activities and MDA levels and increased the levels of cell protector GSH.|GSH|LDH|19|7.0|Arg1:T24|Arg2:T36|CHEMICAL|GENE-N|no_relation|3602
16249494|The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.|prostaglandin|FP-receptor|4|10.0|Arg1:T28|Arg2:T40|CHEMICAL|GENE-Y|no_relation|3603
16249494|The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.|prostanoid|FP-receptor|9|10.0|Arg1:T29|Arg2:T40|CHEMICAL|GENE-Y|no_relation|3604
16249494|  PURPOSE: This study was designed to clarify the involvement of the prostanoid FP receptor in the intraocular pressure (IOP)-lowering effects of latanoprost, travoprost, bimatoprost, and unoprostone with the use of FP-receptor-deficient (FPKO) mice.|latanoprost|prostanoid FP receptor|26|13.0|Arg1:T6|Arg2:T38|CHEMICAL|GENE-Y|no_relation|3605
16249494|  PURPOSE: This study was designed to clarify the involvement of the prostanoid FP receptor in the intraocular pressure (IOP)-lowering effects of latanoprost, travoprost, bimatoprost, and unoprostone with the use of FP-receptor-deficient (FPKO) mice.|travoprost|prostanoid FP receptor|28|13.0|Arg1:T8|Arg2:T38|CHEMICAL|GENE-Y|no_relation|3606
16249494|  PURPOSE: This study was designed to clarify the involvement of the prostanoid FP receptor in the intraocular pressure (IOP)-lowering effects of latanoprost, travoprost, bimatoprost, and unoprostone with the use of FP-receptor-deficient (FPKO) mice.|bimatoprost|prostanoid FP receptor|30|13.0|Arg1:T9|Arg2:T38|CHEMICAL|GENE-Y|no_relation|3607
16249494|  PURPOSE: This study was designed to clarify the involvement of the prostanoid FP receptor in the intraocular pressure (IOP)-lowering effects of latanoprost, travoprost, bimatoprost, and unoprostone with the use of FP-receptor-deficient (FPKO) mice.|unoprostone|prostanoid FP receptor|33|13.0|Arg1:T11|Arg2:T38|CHEMICAL|GENE-Y|no_relation|3608
16249494|  PURPOSE: This study was designed to clarify the involvement of the prostanoid FP receptor in the intraocular pressure (IOP)-lowering effects of latanoprost, travoprost, bimatoprost, and unoprostone with the use of FP-receptor-deficient (FPKO) mice.|prostanoid|prostanoid FP receptor|13|13.0|Arg1:T26|Arg2:T38|CHEMICAL|GENE-Y|no_relation|3609
16249494|In addition, bunazosin (0.1%) was also applied to demonstrate functional uveoscleral outflow in FPKO mice.|bunazosin|FP|4|18.0|Arg1:T5|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3610
16249494|In FPKO mice, latanoprost, travoprost, bimatoprost, and unoprostone showed no significant IOP-lowering effect.|latanoprost|FP|5|2.0|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3611
16249494|In FPKO mice, latanoprost, travoprost, bimatoprost, and unoprostone showed no significant IOP-lowering effect.|travoprost|FP|7|2.0|Arg1:T16|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3612
16249494|In FPKO mice, latanoprost, travoprost, bimatoprost, and unoprostone showed no significant IOP-lowering effect.|bimatoprost|FP|9|2.0|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3613
16249494|In FPKO mice, latanoprost, travoprost, bimatoprost, and unoprostone showed no significant IOP-lowering effect.|unoprostone|FP|12|2.0|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|no_relation|3614
16249494|Bunazosin significantly lowered IOP in both WT (22.1 +/- 1.6%) and FPKO mice (22.2 +/- 2.1%).|Bunazosin|FP|1|15.0|Arg1:T19|Arg2:T34|CHEMICAL|GENE-Y|no_relation|3615
16249494|CONCLUSIONS: A single application of latanoprost, travoprost, bimatoprost, or unoprostone had no effect on IOP in FPKO mice with presumed functional uveoscleral outflow pathways.|latanoprost|FP|7|21.0|Arg1:T20|Arg2:T36|CHEMICAL|GENE-Y|no_relation|3616
16249494|CONCLUSIONS: A single application of latanoprost, travoprost, bimatoprost, or unoprostone had no effect on IOP in FPKO mice with presumed functional uveoscleral outflow pathways.|travoprost|FP|9|21.0|Arg1:T21|Arg2:T36|CHEMICAL|GENE-Y|no_relation|3617
16249494|CONCLUSIONS: A single application of latanoprost, travoprost, bimatoprost, or unoprostone had no effect on IOP in FPKO mice with presumed functional uveoscleral outflow pathways.|bimatoprost|FP|11|21.0|Arg1:T22|Arg2:T36|CHEMICAL|GENE-Y|no_relation|3618
16249494|CONCLUSIONS: A single application of latanoprost, travoprost, bimatoprost, or unoprostone had no effect on IOP in FPKO mice with presumed functional uveoscleral outflow pathways.|unoprostone|FP|14|21.0|Arg1:T23|Arg2:T36|CHEMICAL|GENE-Y|no_relation|3619
10334992|Identification of a nuclear receptor for bile acids.|bile acids|nuclear receptor|7|4.0|Arg1:T9|Arg2:T17|CHEMICAL|GENE-N|no_relation|3620
1400062|The objective of the present study was to determine whether the extended pressor response induced by PAF was caused by prolonged activation of the 5-lipoxygenase pathway or slow clearance of LTs from the lung parenchyma.|LTs|5-lipoxygenase|31|25.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|no_relation|3621
1400062|Rat lungs were perfused with a nonrecirculating physiological salt solution that contained indomethacin and albumin.|indomethacin|albumin|13|15.0|Arg1:T20|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3622
23257178|Proteins Aus1 and Dan1 were not found to be involved in steroid import.|steroid|Dan1|12|4.0|Arg1:T3|Arg2:T23|CHEMICAL|GENE-N|no_relation|3623
23552265|The formation of lipid hydroperoxides was partially inhibited by superoxide dismutase (SOD).|hydroperoxides|SOD|5|13.0|Arg1:T7|Arg2:T40|CHEMICAL|GENE-N|no_relation|3624
23552265|The formation of lipid hydroperoxides was partially inhibited by superoxide dismutase (SOD).|superoxide|SOD|10|13.0|Arg1:T8|Arg2:T40|CHEMICAL|GENE-N|no_relation|3625
20497523|Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta.|estrogen|estrogen receptor alpha|17|12.0|Arg1:T20|Arg2:T47|CHEMICAL|GENE-Y|no_relation|3626
20497523|Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta.|estrogen|estrogen receptor alpha|12|12.0|Arg1:T21|Arg2:T47|CHEMICAL|GENE-Y|no_relation|3627
20497523|Estrogens bind both estrogen receptor (ER)alpha and beta.|Estrogens|estrogen receptor (ER)alpha and beta|1|4.0|Arg1:T6|Arg2:T30|CHEMICAL|GENE-N|no_relation|3628
20497523|Estrogens bind both estrogen receptor (ER)alpha and beta.|estrogen|estrogen receptor (ER)alpha and beta|4|4.0|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|no_relation|3629
20497523|Finally, EE and ERA-63 were tested for their immune modulating potential in established collagen induced arthritis in DBA/1J mice.|EE|collagen|3|15.0|Arg1:T18|Arg2:T45|CHEMICAL|GENE-N|no_relation|3630
20497523|Finally, EE and ERA-63 were tested for their immune modulating potential in established collagen induced arthritis in DBA/1J mice.|ERA-63|collagen|5|15.0|Arg1:T19|Arg2:T45|CHEMICAL|GENE-N|no_relation|3631
20497523|Treatment with EE or ERA-63 suppressed clinical signs in collagen induced arthritis (CIA) in WT mice.|EE|collagen|3|10.0|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|no_relation|3632
20497523|Treatment with EE or ERA-63 suppressed clinical signs in collagen induced arthritis (CIA) in WT mice.|ERA-63|collagen|5|10.0|Arg1:T9|Arg2:T29|CHEMICAL|GENE-N|no_relation|3633
19428322|AMP-activated protein kinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C.|AMP|AMP-activated protein kinase|1|1.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|no_relation|3634
19428322|  We investigated the effect of compound C, a well-known inhibitor of the intracellular energy sensor AMP-activated protein kinase (AMPK), on proliferation and viability of human U251 and rat C6 glioma cell lines.|AMP|AMPK|17|21.0|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|no_relation|3635
19428322|Compound C caused G(2)/M cell cycle block, accompanied by apoptotic glioma cell death characterized by caspase activation, phosphatidylserine exposure and DNA fragmentation.|phosphatidylserine|caspase|24|21.0|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|no_relation|3636
19428322|Compound C diminished AMPK phosphorylation and enzymatic activity, resulting in reduced phosphorylation of its target acetyl CoA carboxylase.|acetyl CoA|acetyl CoA carboxylase|17|17.0|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|no_relation|3637
23391631|The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model.|aryl hydrocarbon|aryl hydrocarbon receptor|4|4.0|Arg1:T17|Arg2:T43|CHEMICAL|GENE-Y|no_relation|3638
23391631|The current study was designed to investigate the potential effect of Pb(2+) to induce cardiotoxicity in vivo and in vitro rat model and to explore the molecular mechanisms and the role of aryl hydrocarbon receptor (AhR) and regulated gene, cytochrome P4501A1 (CYP1A1), in Pb(2+)-mediated cardiotoxicity.|Pb(2+)|CYP1A1|12|49.0|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|no_relation|3639
23391631|The current study was designed to investigate the potential effect of Pb(2+) to induce cardiotoxicity in vivo and in vitro rat model and to explore the molecular mechanisms and the role of aryl hydrocarbon receptor (AhR) and regulated gene, cytochrome P4501A1 (CYP1A1), in Pb(2+)-mediated cardiotoxicity.|aryl hydrocarbon|CYP1A1|36|49.0|Arg1:T12|Arg2:T42|CHEMICAL|GENE-Y|no_relation|3640
23391631|The current study was designed to investigate the potential effect of Pb(2+) to induce cardiotoxicity in vivo and in vitro rat model and to explore the molecular mechanisms and the role of aryl hydrocarbon receptor (AhR) and regulated gene, cytochrome P4501A1 (CYP1A1), in Pb(2+)-mediated cardiotoxicity.|Pb(2+)|CYP1A1|53|49.0|Arg1:T13|Arg2:T42|CHEMICAL|GENE-Y|no_relation|3641
23391631|At the in vitro level, rat cardiomyocyte H9c2 cell lines were incubated with increasing concentration of Pb(2+) (25, 50, and 100μM) and the expression of hypertrophic genes, α- and β-myosin heavy chain (α-MHC and β-MHC), brain Natriuretic Peptide (BNP), and CYP1A1 were determined at the mRNA and protein levels using real-time PCR and Western blot analysis, respectively.|Pb(2+)|CYP1A1|18|56.0|Arg1:T16|Arg2:T23|CHEMICAL|GENE-Y|no_relation|3642
23142547|Rev1 is a dCMP transferase, but additionally plays non-catalytic functions in translesion synthesis.|dCMP|dCMP transferase|4|4.0|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|no_relation|3643
23142547|Supporting functional significance of this interaction, both the Rev1 pathway and Rad5 are required for translesion synthesis and mutagenesis of 1,N(6)-ethenoadenine.|1,N(6)-ethenoadenine|Rad5|22|13.0|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|no_relation|3644
23142547|Furthermore, disrupting the Rev1-Rad5 interaction by mutating Rev1 did not affect its dCMP transferase, but led to inactivation of the Rev1 non-catalytic function in translesion synthesis of UV-induced DNA damage.|dCMP|Rev1|14|23.0|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|no_relation|3645
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|histidine|FCGR2A|18|54.0|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3646
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|phenylalanine|FCGR2A|25|54.0|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3647
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|arginine|FCGR2A|55|54.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3648
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|arginine|FCGR2A|56|54.0|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3649
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|valine|FCGR2A|57|54.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3650
17704420|Combined analysis of these two polymorphisms showed that patients with the favorable genotypes (FCGR2A, any histidine allele, and FCGR3A, any phenylalanine allele) showed a median PFS of 3.7 months (95% CI, 2.4 to 4.4 months), whereas patients with any two unfavorable genotypes (FCGR2A arginine/arginine or valine/valine) had a PFS of 1.1 months (95% CI, 1.0 to 1.4 months; P = .004; log-rank test).|valine|FCGR2A|58|54.0|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3651
2922761|The retinoids had no effect on prothrombin times of animals fed the supplemented diet.|retinoids|prothrombin|2|7.0|Arg1:T32|Arg2:T46|CHEMICAL|GENE-Y|no_relation|3652
2922761|13cisRA-dosed animals showed no change in prothrombin times.|13cisRA|prothrombin|1|7.0|Arg1:T35|Arg2:T48|CHEMICAL|GENE-Y|no_relation|3653
2922761|For all retinoid-dosed groups maintained on the purified diet, changes in prothrombin times occured as early as 1 week.|retinoid|prothrombin|3|13.0|Arg1:T4|Arg2:T40|CHEMICAL|GENE-Y|no_relation|3654
2922761|Hence, plasma osteocalcin is a better predictor of retinoid-induced bone effects than serum alkaline phosphatase.|retinoid|alkaline phosphatase|10|15.0|Arg1:T19|Arg2:T45|CHEMICAL|GENE-N|no_relation|3655
23087261|Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis.|Lysine|protein kinase C|1|12.0|Arg1:T4|Arg2:T25|CHEMICAL|GENE-N|no_relation|3656
23087261|Mass spectroscopy has revealed that ubiquitination of OAT1 consists of polyubiquitin chains, primarily through lysine 48 linkage.|lysine|OAT1|16|8.0|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|no_relation|3657
23087261|Transfection of cells with the dominant negative mutant of ubiquitin Ub-K48R, which prevents the formation of Lys48-linked polyubiquitin chains, abolishes PKC-stimulated OAT1 ubiquitination and internalization.|Lys|OAT1|18|24.0|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|no_relation|3658
23087261|Together, our findings demonstrate for the first time that Lys48-linked polyubiquitination is essential for PKC-regulated OAT1 trafficking.|Lys|OAT1|11|17.0|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|no_relation|3659
22585533|β-Eudesmol induces JNK-dependent apoptosis through the mitochondrial pathway in HL60 cells.|β-Eudesmol|JNK|1|3.0|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|no_relation|3660
22585533|These data suggest that β-eudesmol induces apoptosis in HL60 cells via the mitochondrial apoptotic pathway, which is controlled through JNK signaling.|β-eudesmol|JNK|5|21.0|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|no_relation|3661
11067741|Stable expression of varied levels of inducible nitric oxide synthase in primary cultures of endothelial cells.|nitric oxide|inducible nitric oxide synthase|8|7.0|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|no_relation|3662
23228182|With the optimal film thickness, the adsorptions from bovine serum albumin, human serum, and human plasma onto the pSerMA-grafted surfaces, as evaluated by a surface plasmon resonance (SPR) biosensor, were 1.8, 9.2, and 12.9 ng/cm(2), respectively, comparable to the traditional antifouling material such as poly(ethylene glycol).|pSerMA|bovine serum albumin|22|10.0|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3663
23228182|With the optimal film thickness, the adsorptions from bovine serum albumin, human serum, and human plasma onto the pSerMA-grafted surfaces, as evaluated by a surface plasmon resonance (SPR) biosensor, were 1.8, 9.2, and 12.9 ng/cm(2), respectively, comparable to the traditional antifouling material such as poly(ethylene glycol).|poly(ethylene glycol)|bovine serum albumin|59|10.0|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|no_relation|3664
23183374|A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching.|cytidine|AID|10|13.0|Arg1:T6|Arg2:T30|CHEMICAL|GENE-Y|no_relation|3665
23183374|  Activation-induced cytidine deaminase (AID) is a DNA mutator enzyme essential for adaptive immunity.|cytidine|AID|2|5.0|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3666
11340119|Stability of vitamin B-6-dependent aminotransferase activity in frozen packed erythrocytes is dependent on storage temperature.|vitamin B-6|vitamin B-6-dependent aminotransferase|3|3.0|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|no_relation|3667
11340119|Activities of EALT and EAST, with and without added PLP, were determined in fresh erythrocytes (d 0) and frozen samples on d 1, 7, 14, 28, 58 and 84.|PLP|EAST|11|5.0|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|no_relation|3668
15199474|P2Y12, a new platelet ADP receptor, target of clopidogrel.|ADP|ADP receptor|6|6.0|Arg1:T20|Arg2:T33|CHEMICAL|GENE-N|no_relation|3669
15199474|P2Y12, a new platelet ADP receptor, target of clopidogrel.|clopidogrel|ADP receptor|11|6.0|Arg1:T21|Arg2:T33|CHEMICAL|GENE-N|no_relation|3670
15199474|Several purinergic receptors have been described on platelets; P2X (1), a calcium channel, and P2Y1 a Gq-coupled seven-transmembrane domain receptor, have been found not to be antagonized by clopidogrel.|calcium|Gq-coupled seven-transmembrane domain receptor|16|22.0|Arg1:T18|Arg2:T29|CHEMICAL|GENE-N|no_relation|3671
15199474|Several purinergic receptors have been described on platelets; P2X (1), a calcium channel, and P2Y1 a Gq-coupled seven-transmembrane domain receptor, have been found not to be antagonized by clopidogrel.|clopidogrel|Gq-coupled seven-transmembrane domain receptor|35|22.0|Arg1:T19|Arg2:T29|CHEMICAL|GENE-N|no_relation|3672
16395286|Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.|tetracyclines|vascular endothelial growth factor|4|10.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|no_relation|3673
16395286|In the present study, we determined the dose-response effects of doxycycline and minocycline on cerebral MMP-9 using our mouse model with VEGF focal hyperstimulation delivered with adenoviral vector (AdVEGF) in the brain.|doxycycline|VEGF|12|32.0|Arg1:T7|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3674
16395286|In the present study, we determined the dose-response effects of doxycycline and minocycline on cerebral MMP-9 using our mouse model with VEGF focal hyperstimulation delivered with adenoviral vector (AdVEGF) in the brain.|minocycline|VEGF|14|32.0|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|no_relation|3675
12517247|Angiotensin II (AII) receptor antagonists are a relatively new class of antihypertensive agent that block AII Type 1 (AT(1)) receptors, and reduce the pressor effects of AII in the vasculature.|Angiotensin II|AII|1|35.0|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3676
12517247|Angiotensin II (AII) receptor antagonists are a relatively new class of antihypertensive agent that block AII Type 1 (AT(1)) receptors, and reduce the pressor effects of AII in the vasculature.|AII|AII|4|35.0|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3677
12517247|Angiotensin II (AII) receptor antagonists are a relatively new class of antihypertensive agent that block AII Type 1 (AT(1)) receptors, and reduce the pressor effects of AII in the vasculature.|AII|AII|18|35.0|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3678
12517247|Angiotensin II (AII) receptor antagonists are a relatively new class of antihypertensive agent that block AII Type 1 (AT(1)) receptors, and reduce the pressor effects of AII in the vasculature.|AII|AII|35|35.0|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|no_relation|3679
12517247|By this mechanism, they induce similar pharmacological effects compared with angiotensin-converting enzyme (ACE) inhibitors, resulting in a lowering of blood pressure.|angiotensin|ACE|12|15.0|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|no_relation|3680
12517247|However, AII receptor blockers differ from ACE inhibitors with respect to side effects, and induce less cough, a side effect which may be related to bradykinin or other mediators such as substance P.|AII|ubstance P|3|36.0|Arg1:T12|Arg2:T32|CHEMICAL|GENE-Y|no_relation|3681
12517247|However, AII receptor blockers differ from ACE inhibitors with respect to side effects, and induce less cough, a side effect which may be related to bradykinin or other mediators such as substance P.|bradykinin|ubstance P|29|36.0|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|no_relation|3682
12517247|However, AII receptor blockers differ from ACE inhibitors with respect to side effects, and induce less cough, a side effect which may be related to bradykinin or other mediators such as substance P.|substance P|ubstance P|35|36.0|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|no_relation|3683
12517247|Eprosartan acts at vascular AT(1) receptors (postsynaptically) and at presynaptic AT(1) receptors, where it inhibits sympathetically stimulated noradrenaline release.|Eprosartan|AT(1) receptors|1|16.0|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3684
12517247|Eprosartan acts at vascular AT(1) receptors (postsynaptically) and at presynaptic AT(1) receptors, where it inhibits sympathetically stimulated noradrenaline release.|noradrenaline|AT(1) receptors|27|16.0|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3685
18773878|To our knowledge, this is the first demonstration in mammalian cells that depletion of RAD51 causes sensitivity to thymidylate deprivation.|thymidylate|RAD51|20|16.0|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|no_relation|3686
18773878|Phosphorylation of replication protein A (RPA2 subunit) and formation of damage-induced foci were strikingly evident following IC(50) doses of RTX.|RTX|RPA2|25|7.0|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3687
23572520|We used transient kinetic methods to determine a minimal mechanism for spontaneous GSNO-mediated transnitrosation of human glutathione transferase (GST) P1-1, a major detoxification enzyme and key regulator of cell proliferation.|glutathione|human glutathione transferase (GST) P1-1|17|16.0|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3688
15606893|  The serotonin transporter (SERT), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety.|serotonin|sodium/chloride-dependent transporters|2|14.0|Arg1:T3|Arg2:T26|CHEMICAL|GENE-N|no_relation|3689
15606893|  The serotonin transporter (SERT), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety.|sodium|sodium/chloride-dependent transporters|14|14.0|Arg1:T11|Arg2:T26|CHEMICAL|GENE-N|no_relation|3690
15606893|  The serotonin transporter (SERT), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety.|chloride|sodium/chloride-dependent transporters|15|14.0|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|no_relation|3691
15680473|Cocaine- and amphetamine-regulated transcript peptide potentiates spinal glutamatergic sympathoexcitation in anesthetized rats.|Cocaine|Cocaine- and amphetamine-regulated transcript peptide|1|1.0|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3692
15680473|Cocaine- and amphetamine-regulated transcript peptide potentiates spinal glutamatergic sympathoexcitation in anesthetized rats.|amphetamine|Cocaine- and amphetamine-regulated transcript peptide|3|1.0|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|no_relation|3693
15680473|  Cocaine- and amphetamine-regulated transcript (CART) is widely expressed in the rat central nervous system, notably in areas involved in control of autonomic and neuroendocrine functions.|Cocaine|CART|1|6.0|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3694
15680473|  Cocaine- and amphetamine-regulated transcript (CART) is widely expressed in the rat central nervous system, notably in areas involved in control of autonomic and neuroendocrine functions.|amphetamine|CART|3|6.0|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|no_relation|3695
15680473|The aim of this study was to evaluate the effects of CART peptide fragment 55-102, referred to herein as CARTp, by intrathecal injection on blood pressure (BP) and heart rate (HR) before and after intrathecal glutamate in urethane-anesthetized male Sprague-Dawley rats.|glutamate|CARTp|42|21.0|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|no_relation|3696
